MoneyControl-First-1-10-Pages.csv

,time,Label,author,title,summary,description,article_text,url
0,"April 13, 2020 12:04 PM IST",1,Sunil Matkar,Max Financial gains 5% on Max Life extending insurance partnership with Yes Bank,"Max Financial Services share price rallied 4.7 percent intraday on April 13 after its insurance subsidiary extended five-year bancassurance partnership with private sector lender Yes Bank.
It was trading at Rs 363.75, up Rs 11.70, or 3.32 percent, on the BSE at 1138 hours.
""Max Life Insurance and Yes Bank announced a five-year extension to their strategic bancassurance relationship.
The companies began their partnership in February 2005, with a core commitment towards securing the financial future of their customers.
The partnership has settled death claims of more than Rs 70 crore, and offered protection worth around Rs 34,500 crore to policyholders and their families.",Max Life-Yes Bank relationship has over the years sold approximately 2.8 lakh policies.,"Max Financial Services share price rallied 4.7 percent intraday on April 13 after its insurance subsidiary extended five-year bancassurance partnership with private sector lender Yes Bank.

The stock has rallied nearly 28 percent since March 23 but before that it corrected 52 percent since March 5. It was trading at Rs 363.75, up Rs 11.70, or 3.32 percent, on the BSE at 1138 hours.

""Max Life Insurance and Yes Bank announced a five-year extension to their strategic bancassurance relationship. Through this renewal of their bancassurance partnership both the companies have reaffirmed their commitment to invest in building a digitally enabled ecosystem that will provide a seamless experience for customers in their financial planning and protection journey,"" the company said in its BSE filing.

To commemorate the extension of the partnership for another five years, the companies will dedicate the current financial year as the ‘Year of the Customer’ with sharper focus on customer obsession, it added.

""In the coming five years, we plan to further enhance our business and make investments in the area of technology, new product development, and customer service to ensure we journey together to help our customers realise their real value and financially protect their future,"" Prashant Tripathy, Managing Director & CEO, Max Life said.

The companies began their partnership in February 2005, with a core commitment towards securing the financial future of their customers.

Max Life-Yes Bank relationship has over the years sold approximately 2.8 lakh policies. The partnership has settled death claims of more than Rs 70 crore, and offered protection worth around Rs 34,500 crore to policyholders and their families.",https://www.moneycontrol.com/news/business/markets/max-financial-gains-5-on-max-life-extending-insurance-partnership-with-yes-bank-5138311.html
1,"April 13, 2020 08:55 PM IST",0,Kshitij Anand,Looking to invest in US market? Subscription for Motilal Oswal S&P 500 Index Fund opens tomorrow,"On April 13, the company announced the launch of the Motilal Oswal S&P 500® Index Fund, an open-ended scheme replicating/tracking the S&P 500® Index.
Motilal Oswal S&P 500® Index Fund will open for subscription on April 15 and will close on April 23.
Motilal Oswal S&P 500 Index Fund will provide Indian investors the opportunity to partake in the performance of leading 500 companies listed in the US, the company said.
The S&P 500 Index is widely regarded as the best single gauge of largecap US equities and covers approximately 80 percent of the available market.
Close The S&P 500 Index is the world's largest index with a track record of 63 years, making it one of the oldest indices in the world.",Motilal Oswal S&P 500® Index Fund will open for subscription on April 15 and will close on April 23,"If you wish to invest in companies based out of the US are looking to diversify your portfolio, then do check out the latest launch by Motilal Oswal Asset Management Company. On April 13, the company announced the launch of the Motilal Oswal S&P 500® Index Fund, an open-ended scheme replicating/tracking the S&P 500® Index.

Motilal Oswal S&P 500® Index Fund will open for subscription on April 15 and will close on April 23.

The minimum application amount is Rs 500 and in multiples of Re 1 thereafter. The fund managers for this scheme are Herin Visaria for foreign securities and Abhiroop Mukherjee for the debt component.

Motilal Oswal S&P 500 Index Fund will provide Indian investors the opportunity to partake in the performance of leading 500 companies listed in the US, the company said. The S&P 500 Index is widely regarded as the best single gauge of largecap US equities and covers approximately 80 percent of the available market. Some of the big-ticket companies which are part of the index include names like Microsoft, Apple, Amazon, Facebook, J&J, Visa, Alphabet (Google), among others. Close The S&P 500 Index is the world’s largest index with a track record of 63 years, making it one of the oldest indices in the world. related news Wall Street tumbles as investors brace for dour earnings

Rupee settles on flat note at 76.27 against US dollar

“If you entered the Indian equity markets and you had no clue where to start you would start with the A group in BSE. Similarly, if you entered the global equity markets from another planet and you had no clue where to start you would start with S&P 500. It’s the world’s A group or the world’s largecap index composed of some of the biggest global companies,” Aashish Somaiyaa, Managing Director & CEO, Motilal Oswal Asset Management Company, explained.",https://www.moneycontrol.com/news/business/markets/looking-invest-in-the-us-market-motilal-oswal-launches-s-nfo-open-till-april-15-5139871.html
2,"April 13, 2020 01:14 PM IST",0,Kshitij Anand,"Timing the market is not possible, but investors could look at buying index funds","The choice of stocks vs mutual funds is always an individual choice.
I will advise buying the Index fund right now, Satish Kumar, Head of Equities, Equirus Securities, said in an interview with Moneycontrol’s Kshitij Anand.
Edited excerpt:Q) What would you advise – lump sum or staggered approach in direct equities or mutual funds?
A) Timing the market is not possible.
The choice of stocks versus mutual funds is always an individual choice.","Timing the market is not possible. However, at this juncture, it is better to have a staggered approach. The choice of stocks vs mutual funds is always an individual choice. I will advise buying the Index fund right now.","Timing the market is not possible. However, at this juncture, it is better to have a staggered approach. The choice of stocks vs mutual funds is always an individual choice. I will advise buying the Index fund right now, Satish Kumar, Head of Equities, Equirus Securities, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt:

Q) What would you advise – lump sum or staggered approach in direct equities or mutual funds?

A) Timing the market is not possible. However, at this juncture, it is better to have a staggered approach. The choice of stocks versus mutual funds is always an individual choice. I will advise buying the index fund right now.

Q) We have already seen a big casualty in the form of IndiaNivesh Securities broking arm shutting down the operations. Do you think this could just be the starting?

A) The broking industry will see more casualties in the near future.

Q) Where are the hotspots in terms of investment in the current scenario?

A) Right now the stock prices have no meaning as investors are trying to price their worst nightmares. So pinpointing what will go down because of the fundamental reason is futile.

Hotspot test is simple from now on (i.e. if markets fall further) higher the FII holding higher the correction.

Q) What is you take on the ESG sector? Could they turn out to be big winners once COVID-19 crisis is over?

A) It’s a fad and like all fad, it will also be over pretty soon. No company can survive which doesn’t care from its customers or employees. Social impact well that’s debatable.

I can argue that even carmakers are not ESG compliant (because they make a car which causes pollution) why to single out only tobacco or fossil fuel companies.

Q) With the starting of April we also start a new financial year – what are your expectations from the FY21? What are your views on earnings, markets, flows, as well as demand?

A) Excel extrapolation is a simple job and as an analyst, I am also forced to do it. However, as of now, no one knows what will be the earnings growth or decline.

One can pick any number as per one’s convenience. Market flows will remain muted until market recovers by 20 percent then we can start seeing some flows back to the market

Q) Once the lockdown is over and we (the whole world) come out of COVID-19 - what will be the new normal which the world will be looking at in investments, insurance, food habits, consumption etc.?

A) Human beings are extremely resilient and have the habit of forgetting the painful past. While for some months one may wear masks and maintain social distance; however, the fatigue of changing ingrained habits will be too much.

Moreover, please remember at worst, it will take 12-18 months for vaccine and then we will be back to basics in no time.

Q) We have seen massive wealth erosion in most of the top-quality stocks in FY20, and as we step into FY21 some of those names could give multibagger returns if someone is investing in them now. Could you highlight 3-5 such stocks that hold that potential?

A) Multi bagger we don’t know - getting 2X, 3x returns requires patience and a hell lot of it. For the next 12 months scenario we like large caps. Our picks are HDFC Bank, ICICI Bank, Britannia, PI Industries, Ultratech, and Siemens.

Q) Any particular sector(s) which investors should go underweight on at least for the next year or in the current FY?

A) May be where the mass gathering is required like malls cinema halls. What I mean here that one can be underweight sectors like Retail, airlines, etc.

As I said earlier for some months people will remain cautious and during that period P&L of many companies will take deep hit. Having said that, during the P&L hit these companies will give excellent buying opportunities.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/timing-the-market-is-not-possible-but-investors-could-look-at-buying-index-funds-5135111.html
3,"April 13, 2020 02:34 PM IST",-2,Nishant Kumar,"Zee Entertainment share price plunges 14%, looks on course to snap 4-day winning run","Zee Entertainment share price plunged over 14 percent in intraday trade on BSE on April 13 and looked on course to break its winning streak of the last four consecutive sessions.
Zee had acquired an 80 percent equity stake in Margo Networks Private Limited (“SugarBox”) in 2017.
Now, Zee will invest Rs 522 crore in its arm, Margo Networks Pvt Ltd, which offers content distribution services under 'SugarBox' brand that empowers users without an active internet connection to use mobile apps.
ZEEL will provide operational support, including through providing performance and corporate guarantees as appropriate and necessary, and has authorised SugarBox to finalise the terms of 10 years contract with RailTel Corporation of India Ltd, it added.
Shares of Zee Entertainment were trading 10.50 percent down at Rs 134.20 on BSE at 1415 hours.",The company will extend financial and operational support to SugarBox in which Zee acquired an 80 percent stake in 2017.,"Zee Entertainment share price plunged over 14 percent in intraday trade on BSE on April 13 and looked on course to break its winning streak of the last four consecutive sessions.

In a BSE filing on April 9, the company said that the board at a meeting held a day earlier agreed to extend financial and operational support to SugarBox, a company in which Zee acquired 80 percent stake in 2017.

Zee had acquired an 80 percent equity stake in Margo Networks Private Limited (“SugarBox”) in 2017. As per the regulatory filing, this investment was made to exploit synergies of the technology developed by SugarBox with the company's business and to significantly augment the digital content consumption.

Now, Zee will invest Rs 522 crore in its arm, Margo Networks Pvt Ltd, which offers content distribution services under 'SugarBox' brand that empowers users without an active internet connection to use mobile apps.

ZEEL will provide operational support, including through providing performance and corporate guarantees as appropriate and necessary, and has authorised SugarBox to finalise the terms of 10 years contract with RailTel Corporation of India Ltd, it added.

Shares of Zee Entertainment were trading 10.50 percent down at Rs 134.20 on BSE at 1415 hours.",https://www.moneycontrol.com/news/business/markets/zee-entertainment-share-price-plunges-14-looks-on-course-to-snap-4-day-winning-run-5137941.html
4,"April 13, 2020 11:45 AM IST",-1,Sunil Matkar,"Bandhan Bank share price slips 10% despite strong growth in Q4 advances, deposits","Bandhan Bank share price fell nearly 10 percent intraday on April 13 despite the private lender posting strong growth in Q4 advances and deposits.
""Retail deposits increased 34 percent to Rs 44,760 crore year-on-year and CASA deposits jumped 19 percent to Rs 21,028 crore compared to the same period last year,"" Bandhan Bank said.
""Total overdue (0+ dpd) as on March 31, 2020 was lower than December 31, 2019.
Further, deposits from microbanking customers continues to be strong and stable despite three weeks of lockdown,"" it said.
Bandhan Bank has liquidity coverage ratio (LCR) of around 161 percent as of March 31, 2020.",The capital adequacy ratio of the bank at the end of March 2020 stood at around 26.7 percent and Tier 1 Common Capital Ratio ratio at around 25.5 percent.,"Bandhan Bank share price fell nearly 10 percent intraday on April 13 despite the private lender posting strong growth in Q4 advances and deposits.

The stock has tanked 59 percent in e last two months amid global selloff driven by the coronavirus crisis. It was trading at Rs 179.45, down Rs 12.85, or 6.68 percent, on the BSE at 1057 hours.

Loans and advances grew by 60 percent year-on-year (up 10 percent QoQ) to approximately Rs 71,825 crore, while deposits increased by 32 percent on yearly basis (up 4 percent QoQ) to approximately Rs 57,073 crore in the quarter ended March 2020.

""Retail deposits increased 34 percent to Rs 44,760 crore year-on-year and CASA deposits jumped 19 percent to Rs 21,028 crore compared to the same period last year,"" Bandhan Bank said. The numbers included merged entity.

On its microbanking business, the bank said its collection efficiency for the country from January 1, 2020 to March 21, 2020 stood at around 98.7 percent.

For the remaining days of the quarter, the government announced a 21-day nationwide lockdown from March 25. and some states activated lockdown in the weekend of March 22-23.

""Total overdue (0+ dpd) as on March 31, 2020 was lower than December 31, 2019. Further, deposits from microbanking customers continues to be strong and stable despite three weeks of lockdown,"" it said.

Bandhan Bank has liquidity coverage ratio (LCR) of around 161 percent as of March 31, 2020. ""As on March 31, the bank was having excess liquidity amounting to around Rs 8,402 crore. In addition to above, the bank is in a position to draw up to around Rs 1,815 crore under MSF (marginal standing facility) of RBI,"" it said.

Capital adequacy ratio of the bank at the end of March 2020 stood at around 26.7 percent and Tier 1 Common Capital Ratio (CET 1) ratio at around 25.5 percent.

""The numbers mentioned above as on March 31, 2020 are provisional unaudited numbers and is subject to review by the audit committee and board of directors and are also subject to audit by the statutory auditors of the bank,"" Bandhan Bank said in its BSE filing.",https://www.moneycontrol.com/news/business/markets/bandhan-bank-share-price-slips-10-despite-strong-growth-in-q4-advances-deposits-5138201.html
5,"April 13, 2020 12:07 PM IST",1,Sandip Das,Cadila Healthcare shares rise 2% on USFDA nod to market diabetes drug,"Share price of Cadila Healthcare was up over 2 percent intraday on April 13 after the company received a tentative nod from the USFDA to market generic Empagliflozin tablets, used for the improvement of blood sugar control in adults with type 2 diabetes in the US market.
Catch All Market Live Updates HereZydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD: Jardiance Tablets), the company said in a filing to the exchanges.
The medication is used together with diet and exercise to improve blood sugar control in adults with Type 2 diabetes mellitus.
It is also used to reduce the risk of cardiovascular death in adult patients with Type 2 diabetes mellitus and established cardiovascular disease.
It has touched an intraday high of Rs 365.95 and an intraday low of Rs 352.","Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD: Jardiance Tablets), the company said in a filing to the exchanges","Share price of Cadila Healthcare was up over 2 percent intraday on April 13 after the company received a tentative nod from the USFDA to market generic Empagliflozin tablets, used for the improvement of blood sugar control in adults with type 2 diabetes in the US market.

Catch All Market Live Updates Here

Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD: Jardiance Tablets), the company said in a filing to the exchanges.

The medication is used together with diet and exercise to improve blood sugar control in adults with Type 2 diabetes mellitus. It is also used to reduce the risk of cardiovascular death in adult patients with Type 2 diabetes mellitus and established cardiovascular disease. The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad, the company said.

The share price surged over 40 percent in the last 1 month and was quoting at Rs 359.40, up Rs 8.70, or 2.48 percent. It has touched an intraday high of Rs 365.95 and an intraday low of Rs 352.

The stock witnessed a spurt in volume by more than 1.23 times and was trading with volumes of 545,439 shares, compared to its five day average of 664,231 shares, a decrease of -17.88 percent.",https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-shares-rise-2-on-usfda-nod-to-market-diabetes-drug-5138351.html
6,"April 14, 2020 10:05 AM IST",0,Kshitij Anand,This Radhakishan Damani-owned stock might be down but not out; experts suggest buy on dips,"""Nearly 50 percent of our stores remain closed for operations based on a directive by the local authorities,"" it said in a statement.
The announcement of the closure of about 50 percent of the D-Mart stores is a near-term shock.
The ones who have bought the stock should hold on, while new investors could wait for a dip before accumulating, suggest experts.
“We expect more than 20 percent growth in D-Mart in the next 2-3 years horizon on strong growth store expansion.
Strong growth momentum will drive performance,” Amarjeet Maurya, AVP Research at Angel Broking Ltd told Moneycontrol.","For investors who are holding the stock should hold on to the stock, and keep accumulating the stock on every dip, because D-mart has a unique business model.","Veteran stock market investor Radhakishan Damani-led Avenue Supermarts was locked in a lower circuit on Monday after the company, which operates retail chain DMart, said operations of half of its stores are closed following the directions issued by authorities amid the lockdown.

The company is retailing only essential items from the operating stores and average footfall is ""significantly lower than usual"".

""Nearly 50 percent of our stores remain closed for operations based on a directive by the local authorities,"" it said in a statement.

D-Mart also commenced e-commerce home delivery and bulk deliveries to large housing complexes across the majority of its stores during the first week of April.

The stock has rallied about 24 percent so far in 2020 despite steep fall seen in the benchmark indices. Both Sensex and Nifty50 are in a bear market and are trading near crucial support levels.

The announcement of the closure of about 50 percent of the D-Mart stores is a near-term shock. Experts feel that it doesn’t alter the long-term outlook of the company. The ones who have bought the stock should hold on, while new investors could wait for a dip before accumulating, suggest experts.

“We expect more than 20 percent growth in D-Mart in the next 2-3 years horizon on strong growth store expansion. The average growth expansion is 24-25 stores per year. But, in the future, management is likely to change the strategy which could lead to additions of 30 stores per year. Strong growth momentum will drive performance,” Amarjeet Maurya, AVP Research at Angel Broking Ltd told Moneycontrol.

“Also, since inception, they have not closed any single story. They also sell the product which is cheaper than e-retail websites. Hence, growth is likely to continue.",https://www.moneycontrol.com/news/business/markets/avenue-supermarts-this-radhakishan-damani-owned-stock-might-be-down-but-not-out-experts-suggest-buy-on-dips-5139551.html
7,"April 13, 2020 12:39 PM IST",0,Kshitij Anand,‘Allocate 30%-40% of investable corpus now at the current levels and rest on declines',"For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction.
A) Given the current situation, few essential consumer products and healthcare products are in high demand as it helps consumers to sail through difficult times.
In the current situation, investors can accumulate stocks from these sectors in a staggered manner for the long term.
Amid all, we believe there are quite a few top names that are trading either close to or below their historical average P/E and provide a margin of safety at current levels.
Q) Any particular sector(s) which investors should go underweight on at least for the next year or in the current FY?","In our opinion, it is an excellent time to build a long term portfolio as many fundamentally sound counters are available at a good bargain, says Gurpreet Sidana.","For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction, Gurpreet Sidana, Chief Operating Officer, Religare Broking Ltd, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) It is a tough situation, not only for the Indian economy but for the markets across the globe. It’s different from earlier downturns as it is triggered by a pandemic and the exact impact or peak can’t be quantified yet.

However, this is also true that the market emerges much stronger and garners exceptional returns for those who utilise these corrections to accumulate quality companies with a long-term investment horizon.

Maybe a first-timer is still contemplating over his investment plan but a smart investor knows this well and will thus try to exploit this opportunity.

Now, coming to the choice of instrument or mode of investment, it is completely personal, depending on the risk profile of the individual.

In our opinion, it is an excellent time to build a long term portfolio as many fundamentally sound counters are available at a good bargain.

At the same time, you may let your mutual fund SIP running, to take advantage of averaging at lower levels. For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction.

Q) We have already seen a big casualty in the form of IndiaNivesh Securities broking arm shutting down the operations. Do you think this could just be the starting?

Pharma, FMCG and private bank stocks are preferred bets while SIP in largecap funds and sectoral funds (beaten-down sectors such as Auto, Banks, and Oil & Gas) are advisable.

A) Undoubtedly, the current times are challenging and businesses across levels are feeling the heat. Profitability will get hit in these tough times and I am sure most businesses are searching for a way to stay afloat.

In line with the others, some of the brokerage firms, which were already in financial stress, are worst hit due to liquidity crunch after COVID -19 lockdown.

Q) A lot has been said about COVID-19 hotspots – but where are the hotspots in terms of investment in the current scenario?

But, I do not see the situation being so grim. We see most of the leading players are on course the journey of transformation and the lockdown period is only helping to cover the distance fast. However, consolidation in the industry is inevitable as there isn’t enough space for too many players.

A) Given the current situation, few essential consumer products and healthcare products are in high demand as it helps consumers to sail through difficult times. Both FMCG and healthcare sectors are hotspots wherein consistent buying is seen amid coronavirus scare.

We believe these two defensive sectors are safe bets in such volatile markets. Although these sectors are also facing challenges due to lockdown wherein factories are either closed or working with less manpower and supply chains have been hit.

Q) What is your take on the ESG sector? Do you think companies in the ESG space could get attention?

However, once things begin to recover, there is a likelihood that these sectors would witness a stronger demand for essential items. In the current situation, investors can accumulate stocks from these sectors in a staggered manner for the long term.

A) The ESG space companies take into account the non-financial performance indicators that include environmental, social and corporate governance factors.

These parameters are usually used by socially conscious investors to screen securities to invest. It may offer a potential long-term performance advantage when integrated into investment analysis and portfolio construction.

Q) What is your expectations from the FY21? What are your views on earnings, markets, flows, as well as demand?

In India, the ESG based investing is not as big as compared to some of the developed countries. And, companies following the ESG matrix would also face the brunt of a slowdown and that would impact their earnings trajectory. However, their recovery could be comparatively stronger once we see the revival of the economy.

A) We do not expect a very promising start for FY21 as we are still grappling with the pandemic which has hit economic activity across the globe. We believe Q1 of FY21E will be majorly impacted by the nationwide lockdown, which will lead to earnings downgrade for most of the companies.

Also, FIIs may continue to be net sellers if the situation does not improve in the coming days. Adding to the worries, if the virus spread intensifies further or continues for longer than excepted, it could also induce redemption pressure and that in turn would trigger selling from the DIIs as well.

Nevertheless, Nifty P/E now hovers around its historical average, which provides a good investment opportunity and the past trend suggests that every major fall is followed by a strong rebound in the markets.

Q) In the post-COVID-19 world, what will be the new normal which the world will be looking at in investments, insurance, food habits, consumption, etc.?

Hence, as and when the coronavirus cases start receding, we could see a gradual recovery in demand and pick up in the economy, which would lead to an increase in fund flows to the markets.

A) We may see investors taking the concept of valuation more seriously and plan their future investments accordingly. Also, they might have realised by now the importance of having defensive stocks in their portfolio as a hedge, to sail through the tough time.

Further, the unexpected rise in cases of coronavirus only reinstates the fact that insurance is a necessity and not a discretionary spend and therefore we could see an increase in insurance penetration in India.

Additionally, the consumption would pick up. However, it would be gradual especially for discretionary goods and services.

Q) We have seen massive wealth erosion in most of the top-quality stocks in FY20, and as we step into FY21 some of those names could give multibagger returns if someone is investing in them now. Could you highlight 3-5 such stocks that hold that potential?

A) The Indian markets have corrected sharply from their peaks and we have seen massive wealth erosion in most of the top-quality stocks as growth and earnings for FY21E are expected to get adversely impacted.

Also, with a change in the market dynamics, we could see a change in the sectoral allocation by the fund managers to stay relevant.

Amid all, we believe there are quite a few top names that are trading either close to or below their historical average P/E and provide a margin of safety at current levels.

We recommend accumulating stocks like ICICI Bank, Hindustan Unilever (HUL), Cipla, Reliance Industries and HDFC Life Insurance gradually for healthy long term gains.

Q) Any particular sector(s) which investors should go underweight on at least for the next year or in the current FY?

A) Among the sectors, PSU Banking, metal, realty and auto are affected more by the virus-led economic disruption and thus recovery in these sectors will be gradual.

We would advise investors to stay away from these sectors (at least for the next 2 quarters) or take selective bets until there are meaningful signs of revival.

On the flip side, we are overweight on FMCG, pharma and selective names in private banking as they are already witnessing buying interest or showing resilience at the higher levels and would rebound faster once the economy recovers.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/allocate-30-40-of-investable-corpus-now-at-the-current-levels-and-rest-on-declines-5135561.html
8,"April 13, 2020 01:33 PM IST",2,Sunil Matkar,Indoco Remedies surges 16% as it ships Paracetamol tablets to UK,"Shares of Indoco Remedies rallied nearly 16 percent intraday on April 13 after the company delivered the first shipment of Paracetamol tablets to the UK.
The company informed exchanges that it has been part of the great initiative by the Indian government to export Paracetamol tablets to the UK in its fight against COVID-19.
""The first shipment of 11.70 lakh Paracetamol tablets to the UK was airlifted on April 12 from Goa airport,"" the company said in its BSE filing.
Paracetamol tablets are used for the treatment of pain and fever.
Catch All Market Live Updates HereThe permission granted by the Indian Government is for a total air shipment of 4.48 crore tablets.",The permission granted by the Indian Government is for a total air shipment of 4.48 crore tablets.,"Shares of Indoco Remedies rallied nearly 16 percent intraday on April 13 after the company delivered the first shipment of Paracetamol tablets to the UK.

The entire pharma sector has been gaining more traction than other sectors since the government allowed exports of anti-malarial and other drugs that are used in the treatment of COVID-19 patients.

Indoco itself surged more than 83 percent in nearly three weeks. It was quoting at Rs 260.25, up Rs 14.10 or 5.73 percent on the BSE, at 1307 hours IST.

The company informed exchanges that it has been part of the great initiative by the Indian government to export Paracetamol tablets to the UK in its fight against COVID-19.

""The first shipment of 11.70 lakh Paracetamol tablets to the UK was airlifted on April 12 from Goa airport,"" the company said in its BSE filing.

Paracetamol tablets are used for the treatment of pain and fever.

Catch All Market Live Updates Here

The permission granted by the Indian Government is for a total air shipment of 4.48 crore tablets. ""The remaining quantity is ready for shipment and will be airlifted depending on availability of flights,"" it said.",https://www.moneycontrol.com/news/business/markets/indoco-remedies-surges-16-as-it-ships-paracetamol-tablets-to-uk-5138901.html
9,"April 13, 2020 12:21 PM IST",2,Sunil Matkar,GPT Infraprojects jumps 20% on road-widening order in Manipur,"GPT Infraprojects share price rallied 20 percent intraday on April 13 after the company received a Rs 114.68-crore road-widening order in Manipur.
The stock has consistently been in an uptrend from last week, rising 55 percent so far since.
It was quoting at Rs 21.45, up Rs 3.46 or 19.23 percent, on the BSE at 1154 hours.
The order, valued at Rs 114.68 crore, was received from the National Highways & Infrastructure Development Corporation, Ministry of Road Transport & Highways, Government of India, New Delhi, it added.
Catch All Market Live Updates HereThe company has Rs 1,650-crore orders, including a cumulative order inflow of Rs 114.68 crore, in the current financial year.","The company has orders worth Rs 1,650-crore, including a cumulative order inflow of Rs 1,14.68 crore, in the current financial year.","GPT Infraprojects share price rallied 20 percent intraday on April 13 after the company received a Rs 114.68-crore road-widening order in Manipur.

The stock has consistently been in an uptrend from last week, rising 55 percent so far since. It was quoting at Rs 21.45, up Rs 3.46 or 19.23 percent, on the BSE at 1154 hours.

""We bagged a contract of widening to two lanes with hard shoulder of Churachandpur to Tuivai section of NH 102B (package 4A) in Manipur on EPC mode,"" the flagship company of GPT Group said in its BSE filing.

The order, valued at Rs 114.68 crore, was received from the National Highways & Infrastructure Development Corporation, Ministry of Road Transport & Highways, Government of India, New Delhi, it added.

Catch All Market Live Updates Here

The company has Rs 1,650-crore orders, including a cumulative order inflow of Rs 114.68 crore, in the current financial year.",https://www.moneycontrol.com/news/business/markets/gpt-infraprojects-jumps-20-on-road-widening-order-in-manipur-5138361.html
10,"April 13, 2020 01:05 PM IST",-1,Sandip Das,Polyplex Corp share price falls 5%,"The share price of Polyplex Corporation was down almost 5 percent intraday on April 13 after the board approved a Rs 5,481.50-lakh buyback offer at a maximum price of Rs 475 per share.
The Board of Directors approved the buyback in a meeting on April 9.
Catch All Market Live Updates HereThe stock, which has jumped over 24 percent in the last five days, and was quoting at Rs 398.00, down Rs 20.50, or 4.90 percent.
It touched an intraday high of Rs 432 and an intraday low of Rs 387.15.
It was trading with volumes of 1,390 shares, compared to its five day average of 6,054 shares, a drop of 77.04 percent.","The stock was trading with volumes of 1,390 shares compared to its five-day average of 6,054 shares.","The share price of Polyplex Corporation was down almost 5 percent intraday on April 13 after the board approved a Rs 5,481.50-lakh buyback offer at a maximum price of Rs 475 per share.

The Board of Directors approved the buyback in a meeting on April 9.

Catch All Market Live Updates Here

The stock, which has jumped over 24 percent in the last five days, and was quoting at Rs 398.00, down Rs 20.50, or 4.90 percent. It touched an intraday high of Rs 432 and an intraday low of Rs 387.15.

It was trading with volumes of 1,390 shares, compared to its five day average of 6,054 shares, a drop of 77.04 percent.",https://www.moneycontrol.com/news/business/stocks/polyplex-corp-share-price-falls-5-5138501.html
11,"April 13, 2020 02:09 PM IST",0,Sandip Das,"D-Street Buzz: 300 stocks hit lower circuit on BSE; M&M, Motherson Sumi jump 4%","All sectoral indices barring metal and pharma are trading in the red with the auto index down over 3 percent.
The top losers included Mahindra & Mahindra, Motherson Sumi Systems and TVS Motor Company down over 4 percent followed by Maruti Suzuki, Eicher Motors and Bajaj Auto.
Among the banking names, Bandhan Bank, RBL Bank, HDFC Bank, Kotak Mahindra Bank and Bank of Baroda, down 3-4 percent each.
150 stocks hit 52-week low on BSE including Phoenix Mills, Chalet Hotels, Oberoi Realty and Godrej Industries among others.
307 stocks hit lower circuit on BSE including Avenue Supermarts, Balrampur Chini Mills, Edelweiss Financial Services and IIFL Holdings.",All sectoral indices barring metal and pharma are trading in the red with the auto index down over 3 percent.,"The Indian stock market is trading in the red after the nationwide lockdown was extended till April 30.

Sensex is down 522.42 points or 1.68% at 30637.20, and the Nifty down 138.15 points or 1.52% at 8973.75.

All sectoral indices barring metal and pharma are trading in the red with the auto index down over 3 percent.

The top losers included Mahindra & Mahindra, Motherson Sumi Systems and TVS Motor Company down over 4 percent followed by Maruti Suzuki, Eicher Motors and Bajaj Auto.

Among the banking names, Bandhan Bank, RBL Bank, HDFC Bank, Kotak Mahindra Bank and Bank of Baroda, down 3-4 percent each.

India VIX is up 3.74 percent and is trading at 51.61 level.

Nifty Pharma outperformed jumping almost 3 percent led by Aurobindo Pharma which jumped 6 percent followed by Dr Reddy's Labs, Cipla, Lupin and Biocon.

150 stocks hit 52-week low on BSE including Phoenix Mills, Chalet Hotels, Oberoi Realty and Godrej Industries among others.

307 stocks hit lower circuit on BSE including Avenue Supermarts, Balrampur Chini Mills, Edelweiss Financial Services and IIFL Holdings.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-300-stocks-hit-lower-circuit-on-bse-mm-motherson-sumi-jump-4-5139051.html
12,"April 13, 2020 04:29 PM IST",0,Sandip Das,Slideshow | Winners & Losers: 10 stocks that moved the most on April 13,"Zee Entertainment | Share price fell over 8 percent on April 13.
In a BSE filing on April 9, the company said that the board at a meeting held a day earlier agreed to extend financial and operational support to SugarBox, a company in which Zee acquired 80 percent stake in 2017.",Pharma stocks rallied with Nifty Pharma jumping over 2 percent. Avenue Supermarts hit lower circuit on April 13.,"Zee Entertainment | Share price fell over 8 percent on April 13. In a BSE filing on April 9, the company said that the board at a meeting held a day earlier agreed to extend financial and operational support to SugarBox, a company in which Zee acquired 80 percent stake in 2017.",https://www.moneycontrol.com/news/business/stocks/slideshow-winners-losers-10-stocks-that-moved-the-most-on-april-13-5139781.html
13,"April 14, 2020 08:15 PM IST",1,Kshitij Anand,D-Street Talk podcast | These 7 ‘phoenix' stocks could give returns over 20% each,"“We believe there are several such Phoenixes (stocks that have corrected > 70% from their life-time highs) available at huge bargains relative to their business fundamentals,” says Shah.
Stocks that can be categorized as Phoenix include names like Sun Pharma, M&M, HPCL, Tata Motors, Cummins India, Federal Bank, and Tata Communications.
The stock(s) should have a credible business history over business cycles, a reasonable business models with decent management pedigree, robust balance sheet and inexpensive valuations on a historical basis.
(Tune in to the podcast for more): The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Stocks that can be categorized as Phoenix include names like Sun Pharma, M&M, HPCL, Tata Motors, Cummins India, Federal Bank, and Tata Communications.","As per ancient Greek mythology, a Phoenix is a long-lived bird that cyclically regenerates or is otherwise born again -- there are several instances and several stocks in reality that have corrected very sharply during times of panics but have, thereafter, rebounded very strongly when things improve or mend, Dharmesh Shah, Head – Technical, ICICI direct said in a podcast ‘D-Street Talk’ with Moneycontrol.

“We believe there are several such Phoenixes (stocks that have corrected > 70% from their life-time highs) available at huge bargains relative to their business fundamentals,” says Shah.

Stocks that can be categorized as Phoenix include names like Sun Pharma, M&M, HPCL, Tata Motors, Cummins India, Federal Bank, and Tata Communications.

From a technical analysis set-up, chart patterns of such companies indicate a value area emerging suggesting buying such stocks to reap handsome gains over a one-year period

“Our study of three major bear markets (classic empirical evidence) of 1992, 2000, 2008 has produced interesting revelations. Buying good companies post 70% correction from their all-time highs and holding them for a period of one year generates super normal returns of at least 60% for such stocks,” he said.

The stock(s) should have a credible business history over business cycles, a reasonable business models with decent management pedigree, robust balance sheet and inexpensive valuations on a historical basis.

Shah further added that the near-term outlook may be hazy for such companies, but the risk-reward turns extremely favourable for investors as market has already priced in extreme pessimistic scenarios.

Also, as the anxiety around the event settles down and a new bull phase eventually commences, these companies return abnormally high alpha for investors, he explains.

(Tune in to the podcast for more)

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/podcast/d-street-talk-podcast-these-7-phoenix-stocks-could-give-returns-over-20-each-5140871.html
14,"April 13, 2020 12:50 PM IST",1,Sunil Matkar,Lupin share price gains 8% after Nagpur unit receives EIR from USFDA,"The share price of Lupin gained 7.7 percent intraday on April 13 after the pharma major’s Nagpur facility received Establishment Inspection Report (EIR) from the US health regulator.
The stock has been on buyers' radar for fifth successive sessions and has risen more than 46 percent since April 1.
The stock was trading at Rs 832, up Rs 44.25, or 5.62 percent, on the BSE at 1227 hours.
""...announced the receipt of the Establishment Inspection Report (EIR) after closure of the US FDA inspection of its Nagpur, India facility,"" the company told BSE.
Catch All Market Live Updates Here""Nagpur facility is our largest and most advanced oral solid dosage facility,"" Managing Director Nilesh Gupta said.","The US Food and Drug Administration inspected the facility between January 6 and 10, 2020.","The share price of Lupin gained 7.7 percent intraday on April 13 after the pharma major’s Nagpur facility received Establishment Inspection Report (EIR) from the US health regulator.

The stock has been on buyers' radar for fifth successive sessions and has risen more than 46 percent since April 1.

In fact, the entire pharma sector has been buzzing amid value buying and short-covering after the government allowed exports of anti-malarial drugs, which some, including US President Donald Trump, think are useful in treating COVID-19 patients. COVID-19 is the respiratory illness caused by the coronavirus.

The stock was trading at Rs 832, up Rs 44.25, or 5.62 percent, on the BSE at 1227 hours.

""...announced the receipt of the Establishment Inspection Report (EIR) after closure of the US FDA inspection of its Nagpur, India facility,"" the company told BSE.

The US Food and Drug Administration had inspected the facility between January 6 and 10, 2020.

Catch All Market Live Updates Here

""Nagpur facility is our largest and most advanced oral solid dosage facility,"" Managing Director Nilesh Gupta said.

Lupin leads in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women's health areas.

It has 15 manufacturing sites, seven research centres and a global workforce of at least 20,000.",https://www.moneycontrol.com/news/business/markets/lupin-share-price-gains-8-after-nagpur-unit-receives-eir-from-usfda-5138531.html
15,"April 13, 2020 04:08 PM IST",1,Sunil Matkar,IG Petrochemicals share locked in upper circuit after liquidation of subsidiary,"Share of IG Petrochemicals was locked in 5 percent upper circuit on April 13 after the liquidation of its subsidiary.
It closed at Rs 134.20, up Rs 6.35 or 4.97 percent on the BSE.
The company informed exchanges that subsidiary IGPL (FZE) has been liquidated with effect from April 12 due to the absence of any operations.
Meanwhile, the chemical manufacturing company on March 30 temporarily suspended operations at its plant situated at Taloja due to the lockdown.
IG Petrochemicals is a market leader in phthalic anhydride (PAN) and also produces maleic anhydride which is used in agro and food businesses.",The company informed exchanges that subsidiary IGPL (FZE) has been liquidated with effect from April 12 due to the absence of any operations.,"Share of IG Petrochemicals was locked in 5 percent upper circuit on April 13 after the liquidation of its subsidiary.

It closed at Rs 134.20, up Rs 6.35 or 4.97 percent on the BSE.

The company informed exchanges that subsidiary IGPL (FZE) has been liquidated with effect from April 12 due to the absence of any operations.

Meanwhile, the chemical manufacturing company on March 30 temporarily suspended operations at its plant situated at Taloja due to the lockdown.

IG Petrochemicals is a market leader in phthalic anhydride (PAN) and also produces maleic anhydride which is used in agro and food businesses. IGPL also manufactures Benzoic Acid (BA) as a by-product.",https://www.moneycontrol.com/news/business/markets/ig-petrochemicals-share-locked-in-upper-circuit-after-liquidation-of-subsidiary-5139851.html
16,"April 13, 2020 11:48 AM IST",1,Sandip Das,L&T share price jumps 5% on order wins for water & effluent treatment,"Share price of Larsen & Toubro jumped over 5 percent intraday on April 13 after the company bagged orders for its water & effluent treatment business.
The Water a Effluent Treatment Business of L&T Construction has secured three Engineering Procurement Construction (EPC) Water Management orders from the Karnataka Urban Infrastructure Development and Finance Corporation, the company said in a filing to the exchanges.
Catch All Market Live Updates HereThe projects aim to deliver continuous pressurized water supply (24X7) to consumers and achieve target NRW (Non-Revenue Water) by reducing losses through the development of suitable water infrastructure and utility improvements.
The stock jumped over 10 percent in the last 5 days and was quoting at Rs 855.95, up Rs 43.60, or 5.37 percent.
It has touched an intraday high of Rs 855.95 and an intraday low of Rs 809.","The stock jumped over 10 percent in the last 5 days and was quoting at Rs 855.95, up Rs 43.60, or 5.37 percent.","Share price of Larsen & Toubro jumped over 5 percent intraday on April 13 after the company bagged orders for its water & effluent treatment business.

The Water a Effluent Treatment Business of L&T Construction has secured three Engineering Procurement Construction (EPC) Water Management orders from the Karnataka Urban Infrastructure Development and Finance Corporation, the company said in a filing to the exchanges.

Catch All Market Live Updates Here

The projects aim to deliver continuous pressurized water supply (24X7) to consumers and achieve target NRW (Non-Revenue Water) by reducing losses through the development of suitable water infrastructure and utility improvements. The projects are designed to deliver water to about 29 lakh people, it said.

The company approved fund raising and the company received global contracts on April 9. In its BSE filing, L&T said the board of directors on April 9 approved long-term borrowing up to Rs 9,000 crore, either through external commercial borrowings, term loans, non-convertible debentures or any other instrument as may be appropriate.

The stock jumped over 10 percent in the last 5 days and was quoting at Rs 855.95, up Rs 43.60, or 5.37 percent. It has touched an intraday high of Rs 855.95 and an intraday low of Rs 809.",https://www.moneycontrol.com/news/business/stocks/lt-share-price-jumps-5-on-order-wins-for-water-effluent-treatment-5138181.html
17,"April 14, 2020 03:57 PM IST",1,Jocelyn Fernandes,Gaja Capital infuses Rs 204 crore in Sachin Bansal's Navi Technologies,"Flipkart co-founder and its former CEO Sachin Bansal's newest venture Navi Technologies has bagged a Rs 204 crore infusion from private equity company Gaja Capital, The Economic Times reported.
Gaja Capital has joined International Finance Corporation (which infused Rs 3 crore for 4.5 percent stake in January 2o2o) as an institutional investor in Navi.
Promoted by Gopal Jain, Gaja also has stake in other ventures such as Avendus Capital, Carnation and Chumbak.
Bansal is still the biggest stakeholder in the company, having infused as much as Rs 3,007 crore.
He is busy re-purposing the Flipkart capital to build a robust portfolio, mainly in the financial sector and the mobility space and to also back other entrepreneurs in the country.","Navi Tech, previously known as BAC Acquisitions, was co-founded by Bansal and his IIT-Delhi batchmate Ankit Agarwal.","Flipkart co-founder and its former CEO Sachin Bansal's newest venture Navi Technologies has bagged a Rs 204 crore infusion from private equity company Gaja Capital, The Economic Times reported.

The infusion is through sale of 14 million shares, as per filings with the Registrar of Companies, accessed by Tofler.

Gaja Capital has joined International Finance Corporation (which infused Rs 3 crore for 4.5 percent stake in January 2o2o) as an institutional investor in Navi.

Promoted by Gopal Jain, Gaja also has stake in other ventures such as Avendus Capital, Carnation and Chumbak.

Bansal is still the biggest stakeholder in the company, having infused as much as Rs 3,007 crore. He has also been named as the Managing Director for a period of five years, the filing said.

Other investors are co-founder Ankit Aggarwal (Rs 40 crore), and angel investors Sharad Sundarmony, Sunil Edward, Ramesh Sundare and Nitin Jagpratap, as per a Business Standard report.

Navi Tech, previously known as BAC Acquisitions, was co-founded by Bansal and his IIT-Delhi batchmate Agarwal.

Bansal has turned into a serial investor after his exit from Flipkart. He is busy re-purposing the Flipkart capital to build a robust portfolio, mainly in the financial sector and the mobility space and to also back other entrepreneurs in the country.",https://www.moneycontrol.com/news/business/startup/gaja-capital-infuses-rs-204-crore-in-sachin-bansals-navi-technologies-5143651.html
18,"April 13, 2020 12:23 PM IST",-1,Kshitij Anand,"Lockdown fallout: ICICIdirect lowers Sensex target for FY22 to 33,500","COVID-19 is a black swan event with far-reaching implications for businesses worldwide as well as for stock markets.
In a recent research note, ICICIdirect revised its target for both Sensex and Nifty50 downwards for the year 2020 as earnings are likely to take a hit.
“The Indian economy is no exception with a stringent 21-day lockdown period underway.
With almost nil manufacturing activity in this 21-day period and slow ramp-up thereafter amid subdued consumer sentiment, we downgrade our Nifty earnings estimates to the tune of 4% for FY20E, 18% for FY21E and 13% for FY22E,” said the report.
“Incorporating the downward revision, we now expect Nifty earnings to grow at a CAGR of 13.2% in FY19-22E versus the expectation of 18.6% CAGR in the past,” it said.","With almost nil manufacturing activity in this 21-day period and slow ramp-up thereafter ICICIdirect downgrades Nifty earnings estimates to the tune of 4% for FY20E, 18% for FY21E and 13% for FY22E.","COVID-19 is a black swan event with far-reaching implications for businesses worldwide as well as for stock markets. In a recent research note, ICICIdirect revised its target for both Sensex and Nifty50 downwards for the year 2020 as earnings are likely to take a hit.

“The Indian economy is no exception with a stringent 21-day lockdown period underway. With almost nil manufacturing activity in this 21-day period and slow ramp-up thereafter amid subdued consumer sentiment, we downgrade our Nifty earnings estimates to the tune of 4% for FY20E, 18% for FY21E and 13% for FY22E,” said the report.

“Incorporating the downward revision, we now expect Nifty earnings to grow at a CAGR of 13.2% in FY19-22E versus the expectation of 18.6% CAGR in the past,” it said.",https://www.moneycontrol.com/news/business/markets/lockdown-fallout-icicidirect-lowers-sensex-target-for-fy22-to-33500-5138011.html
19,"April 13, 2020 03:36 PM IST",2,Sunil Matkar,"AIA Engineering share price jumps 17% as work resumes at Ahmedabad, Trichy plants","AIA Engineering share price shot up 17.45 percent intraday on April 13 after the company said it resumed operations at its Ahmedabad and Trichy plants.
""The manufacturing operations at company's plants located around Ahmedabad as well as the Trichy plant have been restarted on staggered basis after obtaining necessary permission from the concerned government authorities,"" company said in its BSE filing.
In view of the lockdown, the company had put on hold operations of plants and offices at various locations from March 23.
In this evolving situation due to COVID-19, the overall adverse impact on the operations was not immediately known, the company had said on March 24.
The stock was trading at Rs 1,425.45, up Rs 160.75 or 12.71 percent, on the BSE at 1507 hours.",The company has restarted operations in a staggered manner at these two plants.,"AIA Engineering share price shot up 17.45 percent intraday on April 13 after the company said it resumed operations at its Ahmedabad and Trichy plants.

""The manufacturing operations at company's plants located around Ahmedabad as well as the Trichy plant have been restarted on staggered basis after obtaining necessary permission from the concerned government authorities,"" company said in its BSE filing.

In view of the lockdown, the company had put on hold operations of plants and offices at various locations from March 23.

In this evolving situation due to COVID-19, the overall adverse impact on the operations was not immediately known, the company had said on March 24.

AIA Engineering specialises in the design, development, manufacture, installation and servicing of high chromium wear, corrosion and abrasion resistant castings used in the cement, mining and thermal power generation industries.

The stock was trading at Rs 1,425.45, up Rs 160.75 or 12.71 percent, on the BSE at 1507 hours.",https://www.moneycontrol.com/news/business/markets/aia-engineering-share-price-jumps-17-as-work-resumes-at-ahmedabad-trichy-plants-5139761.html
20,"April 13, 2020 02:07 PM IST",2,Nishant Kumar,Analysts suggest these 15 quality mid-caps for 1-year investment horizon,"Based on the recommendations of some analysts, here are 15 mid-cap stocks that you may consider for a one-year horizon.
We maintain buy rating on the stock with a target price of Rs 1,674 based on 45 times FY21E adjusted EPS,"" said the analyst.
Escorts | Buy | LTP: Rs 690.40 | Target price: Rs 820 | Upside: 19%Escorts is the third-largest agricultural tractor manufacturer in India having strong presence in north India.
Avenue Supermarts | Buy | LTP: Rs 2,392.65 | Target price: 2,520 | Upside: 5%Avenue Supermarts owns and operates the supermarket chain D-MART.
Nippon Life India Asset Management | Buy | LTP: Rs 287 | Target price: Rs 485 | Upside: 69%Nippon Life India Asset Management is the fifth largest AMC in India.","Due to the COVID-19 pandemic, most large and mid-cap stocks have corrected significantly. They are expected to remain volatile unless the issue of coronavirus comes under control.","At this juncture, when the market looks to be in a shamble and investor sentiment is fragile, most brokerages and analysts recommend going for quality large and mid-caps.

Due to the COVID-19 pandemic, most large and mid-cap stocks have corrected significantly. They are expected to remain volatile unless the issue of coronavirus comes under control.

""We believe that in the near-term market, mid-cap stocks would remain volatile but for the long term, all mid-cap quality stocks will outperform. Hence we believe that investors should keep accumulating in every level of correction,"" said Amarjeet Maurya, AVP Research, Angel Broking.

Analysts advise that one should look at stocks that are less likely to be impacted by COVID-19.

""We have to turn cautious and invest higher mix towards staples, FMCG and domestic-oriented companies with strong leadership that are not likely to be impacted by the coronavirus problem in the long-term,"" said Vinod Nair, Head of Research at Geojit Financial Services.

Based on the recommendations of some analysts, here are 15 mid-cap stocks that you may consider for a one-year horizon. Take a look:

Analyst: Vinod Nair, Head of Research at Geojit Financial Services

Jubilant Foodworks | Buy | LTP: Rs 1,421.20 | Target price: Rs 1,674 | Upside: 18%

Jubilant Foodworks is a leading quick-service restaurant company with strong revenue growth of 27 percent CAGR for the last 9 years.

In the current scenario, with earnings impact already factored in the price, the valuation looks very attractive. Jubilant has a free cash flow of Rs 244 crore as of FY19.

""With no leverage and adequate cash balance of Rs 596 crore, Jubilant is well placed to meet its operational challenges. We maintain buy rating on the stock with a target price of Rs 1,674 based on 45 times FY21E adjusted EPS,"" said the analyst.

Escorts | Buy | LTP: Rs 690.40 | Target price: Rs 820 | Upside: 19%

Escorts is the third-largest agricultural tractor manufacturer in India having strong presence in north India.

The near-term headwinds is unlikely to impact Indian farmers flow of activities while strong Rabi season and 1.7 lakh crore interim stimulus package for farmers will signal positive for the company.

The joint venture with KUBOTA, a global leader in tractor, will lead to higher global footprint .

""Given the company’s growth outlook and strong balance sheet we value Escorts at 19 times FY21 EPS and recommend buy with a target of Rs 820,"" said the analyst.

Mahanagar Gas | Buy | LTP: Rs 901 | Target price: Rs 1,083 | Upside: 20%

Mahanagar Gas is Mumbai's sole distributor of gas, an essential commodity, the demand for which will not be impacted much by the present COVID-19 scenario.

The recent decline in natural gas prices will lower costs and expand margins going forward. The demand for gas is set to pick up drastically in the country, with the government encouraging the use of clean fuels and reduce pollution levels in the country.

Bharat Electronics | Buy | LTP: Rs 70.15 | Target price: Rs 90 | Upside: 28%

Bharat Electronics is well-positioned to benefit from rising defence expenditure, given its technological superiority (in-house R&D spend nearly 10 percent of revenues) and strong execution capabilities and GoI focus on indigenous procurement.

COVID is not going to impact defense spending, while strong execution and dividend yield of 5.4 percent makes it attractive.

Current order backlog is at Rs 54,959 crore (4.5 times FY19 sales), provides strong earning visibility for the next 3 years.

Currently the stock is trading at 1 year forward at P/E of 8 times which 38 percent discount of historical average of 13 times.

""Given strong balance sheet, RoE nearly 20 percent and strong earnings visibility, we have a buy rating with a target price of Rs 90,"" said the analyst.

Analyst: Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities

Manappuram Finance | Buy | LTP: Rs 111.30 | Target price: Rs 140 | Stop loss: Rs 90 | Upside: 26%

The stock has corrected to the levels of the year 2016-2018. It has formed multiple bottom around Rs 78 and Rs 80 during the same period before heading for the dream run to Rs 194 levels.

Technically, such type of support zones acts as reversal points in the catastrophic falls. The analyst advises buying 50 percent at the current levels and the remaining 50 percent at Rs 95.

Info Edge (India) | Buy | LTP: Rs 2,230 | Target price: Rs 2,800 | Stop loss: Rs 1,900 | Upside: 26%

It has fallen to Rs 1,580 during the recent fall, which is exactly 50 percent retracement of the rally started from the lows of the year 2008.

Technically, it’s a properly corrected stock from recent highs. The analyst advises buying 50 percent at the current levels and the remaining 50 percent at Rs 2,000.

SRF | Buy | LTP: Rs 3,250.05 | Target price: Rs 3,800 | Stop loss: Rs 2,450 | Upside: 17%

The year 2019 was one of the most successful years for SRF as it gained almost 144 percent during the year 2019. It was at Rs 1,535 in the month of January 2019 and closed at Rs 3,450 in the month of December 2019.

The level of Rs 2,500 acted as strong support in times of crisis. In the recent fall, it has fallen to the same buying support zone.

The analyst advises buying 50 percent at the current levels of Rs 3,000 and remaining 50 percent at Rs 2,600.

Torrent Pharma | Buy | LTP: Rs 2,543 | Target price: Rs 3,400 | Stop loss: Rs 2,000 | Upside: 34%

Since the beginning of the year 2020, the stock has appreciated by 36 percent, which is unusual but at the same time, it shows that the company has attracted fresh flows and should do well in the long run.

Those who have missed the boat may enter at every major support, said the analyst who advises buying 50 percent at the current levels of Rs 2,550 and remaining 50 percent at Rs 2,200.

Analyst: Amarjeet Maurya, AVP Research, Angel Broking

Bata India | Buy | LTP: Rs 1,238 | Target price: Rs 1,434 | Upside: 16%

The analyst expects Bata India to report net revenue CAGR of nearly 11 percent to about Rs 3,974 crore over FY2019-22E, mainly due to increasing brand consciousness among Indian consumers, new product launches, higher number of store additions in tier-II and tier-III cities and focus on high growth women’s segment.

""Further, on the bottom-line front, we expect CAGR of nearly 20 percent to Rs 562 crore over the same period on the back of margin improvement (increasing premium product sales),"" said the analyst.

Avenue Supermarts | Buy | LTP: Rs 2,392.65 | Target price: 2,520 | Upside: 5%

Avenue Supermarts owns and operates the supermarket chain D-MART. Focused on value retailing, it offers a wide range of fast-moving consumer (food and non-food) products, general merchandise and apparel.

The analyst expects D-MART to report consolidated revenue and PAT CAGR of 18 percent and 26 percent, respectively, over FY2019-22E.

Hawkins Cooker | Buy | LTP: Rs 4155.10 | Target price: Rs 4,536 | Upside: 9%

""We forecast Hawkins to report healthy top-line CAGR of nearly 11 percent to Rs 892 crore over FY19-22E on the back of government initiatives, new product launches, strong brand name and wide distribution network,"" said the analyst.

On the bottom-line front (reported PAT), the analyst estimates about 21 percent CAGR to Rs 96 crore due to strong revenue and operating margin improvement (on the back of correction in raw material prices).

Analyst: Narendra Solanki, Head - Equity Research ( Fundamental), Anand Rathi Shares and Stock Brokers

Aarti Industries | Buy | LTP: Rs 911.30 | Target price: Rs 1,200 | Upside: 32%

Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals manufactured by Aarti are used in the downstream manufacture of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes, etc.

On the back of the coming NCB, APIs and intermediate capacities along with revenue from many-year deals from Q4 FY20, the analyst expects revenue and PAT to clock growth in higher teens over FY20-22.

""The coming capex, commencement of many-year deals and greater share of high-margin products are expected to drive future revenue and profit. At the current price the company is trading at attractive valuations,"" said the analyst.

Tata Consumer Products | Buy | LTP: 309.05 | Target price: 473 | Upside: 53%

With a presence in more than 40 countries, Tata Consumer houses a strong portfolio of brands including Tata Tea, Tetley, Vitax, Eight O’Clock Coffee and Himalayan water. It aims to boost coffee business with its JV with Starbucks. In the last couple of years, in order to improve effectiveness, unlock synergies, optimize costs and streamline operations, the company exited some of its loss-making businesses and restructured its international operations.

Simplifying the business structure with the focus on core businesses should drive growth in the long-term.

In May 2019, Tata Chemicals Ltd. (TCL) announced transaction to merge the Consumer Businesses of TCL with the company. The move comes in line with its strategy to expand portfolio of fast growing FMCG sector in India and abroad.

The merger is expected to result in revenue and cost synergies including from supply chain opportunities and operational improvements. During the announcement, management noted that it expects the merger to result in pre-tax synergies of 2-3 percent of the company’s India branded business revenues over the next 18-24 months.

Nippon Life India Asset Management | Buy | LTP: Rs 287 | Target price: Rs 485 | Upside: 69%

Nippon Life India Asset Management is the fifth largest AMC in India. The total AUM of the company in mutual funds is nearly 2 lakh Cr which is about 8.4 percent of the entire market as of FY19.

Besides the mutual fund business, the company has a sizeable AUM under Portfolio Management services and alternate Investment funds. The company also manages funds for provident fund bodies and the government managed pension funds schemes.

The company has a very strong distribution network which includes nearly 75,000 distributors and 74 banks. This strong network has given the company access to about 47 lakh unique customers.

The strategy of the company is to focus on leadership in the retail segment which forms 40 percent of AUM. This helps the company to reduce its dependency on HNI investments which are cyclical in nature.

The company which has grown at a CAGR of 15 percent over the past 5 years, has decent growth potential. NAM India has a very strong and a growing SIP book of over Rs 10,000 crore per year which helps to provide predictable flows. Additionally, product innovation and strong distribution network should continue to drive growth.

Dr. Lal Pathlabs | Buy | LTP: Rs 1,475.45 | Target price: Rs 1,999 | Upside: 35%

The company has very strong and continuously improving financials with its Revenue, EBITDA & PAT growth at a CAGR of 16 percent, 18 percent, 20 percent respectively over the past 5 years. The company has a very healthy balance sheet and has maintained very high return ratios. Recently, Indian Council of Medical Research (ICMR), has empanelled the company’s National Reference Lab at Rohini, New Delhi for Covid 19 testing.

With rising penetration of healthcare services and medical insurance, rising disposal income, the industry is structurally well positioned for long term growth.

The industry is expected to grow at a CAGR of 13-15 percent for the next 5 years according to WHO data .

This under penetration and growth prospects puts large chain’s like DLPL in a very sweet spot to register exponential growth in future.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/analysts-suggest-these-15-quality-mid-caps-for-1-year-investment-horizon-5136291.html
21,"April 13, 2020 02:07 PM IST",1,Sunil Matkar,Caplin Point climbs 7% as subsidiary gets US FDA nod for anesthetic drug,"Shares of Caplin Point Laboratories gained 7.6 percent intraday on April 13 after its subsidiary received US health regulator's approval for an anesthetic drug.
It was trading at Rs 308.90, up Rs 18.85 or 6.50 percent on the BSE at 13:25 hours.
""Caplin Steriles, a subsidiary company, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Ropivacaine hydrochloride injection,"" the company said in its BSE filing.
Ropivacaine Hydrochloride is a long-acting local anaesthetic drug used for surgery or acute pain management.
Caplin Steriles Limited has developed and filed 16 ANDAs along with partners; 8 have been approved so far.",Ropivacaine Hydrochloride is a long acting local anesthetic drug used for surgery or acute pain management.,"Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?

Shares of Caplin Point Laboratories gained 7.6 percent intraday on April 13 after its subsidiary received US health regulator's approval for an anesthetic drug.

The stock rallied nearly 62 percent in the last three weeks on value-buying and short covering in pharma space. It was trading at Rs 308.90, up Rs 18.85 or 6.50 percent on the BSE at 13:25 hours.

""Caplin Steriles, a subsidiary company, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Ropivacaine hydrochloride injection,"" the company said in its BSE filing.

Ropivacaine Hydrochloride is a long-acting local anaesthetic drug used for surgery or acute pain management.

Ropivacaine Hydrochloride injection USP had sales of about $34 million in the US in calender year 2019, the company said.

Caplin Steriles Limited has developed and filed 16 ANDAs along with partners; 8 have been approved so far.

""We would be launching this product shortly,"" CC Paarthipan, Chairman of Caplin said.",https://www.moneycontrol.com/news/business/markets/caplin-point-climbs-7-as-subsidiary-gets-us-fda-nod-for-anesthetic-drug-5138981.html
22,"April 13, 2020 01:12 PM IST",1,Sunil Matkar,"Dr Reddy's rises 6% on cancer drug launch, EIR from USFDA for Telangana facility","Shares of Dr Reddy's Laboratories gained 6.5 percent intraday on April 13 after the company launched blood cancer drug Invista in the country and received Establishment Inspection Report from the US health regulator for Telangana facility.
The company's cancer product is a formulation of Dasatinib that is bioequivalent to the innovator brand, the company said in a statement.
In addition, Dr Reddy's received the establishment inspection report (EIR) from US Food and Drug Administration, for API manufacturing plant 5 at Miryalaguda, Telangana.
""And the inspection classification of this facility is determined as 'Voluntary Action Indicated' (VAI),"" company said in its BSE filing.
(with inputs from PTI)The stock was trading at Rs 3,810, up Rs 191.85 or 5.30 percent on the BSE at 1253 hours IST.","The company's cancer product is a formulation of Dasatinib that is bioequivalent to the innovator brand, the company said in a statement.","Shares of Dr Reddy's Laboratories gained 6.5 percent intraday on April 13 after the company launched blood cancer drug Invista in the country and received Establishment Inspection Report from the US health regulator for Telangana facility.

The company's cancer product is a formulation of Dasatinib that is bioequivalent to the innovator brand, the company said in a statement.

Patent on Dasatinib is owned by Bristol-Myers-Squibb. The Indian patent has expired on April 12, 2020.

Invista, which is available in strengths of 50, 70 and 100 mg tablets, is indicated for the treatment of primarily Chronic Myeloid Leukemia (CML). CML is a type of blood-cell cancer that begins in the bone marrow.

In addition, Dr Reddy's received the establishment inspection report (EIR) from US Food and Drug Administration, for API manufacturing plant 5 at Miryalaguda, Telangana.

It indicated that the USFDA closed the audit. ""And the inspection classification of this facility is determined as 'Voluntary Action Indicated' (VAI),"" company said in its BSE filing. (with inputs from PTI)

The stock was trading at Rs 3,810, up Rs 191.85 or 5.30 percent on the BSE at 1253 hours IST.",https://www.moneycontrol.com/news/business/markets/dr-reddys-rises-6-on-cancer-drug-launch-eir-from-usfda-for-telangana-facility-5138891.html
23,"April 13, 2020 04:48 PM IST",0,Kshitij Anand,"The Market Podcast | This fund manager managing over Rs 60,000 cr has special advice for new investors","The most difficult thing to do on D-Street for investors is to put in money but it is even tougher if you are a new investor.
But, history suggests that investment made in difficult times like these have made money, Sampath Reddy is a Chief Investment Officer at Bajaj Allianz Life Insurance Company Limited who manages about Rs 60,000 cr in term of AUM told Moneycontrol in a ‘Market Podcast’.
“Investment made during challenging times like these have reward investors based on historical data.
Reddy further added that this time is right for investors to get into the market.
(Tune in to listen to the full podcast): The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","Once we see the first signs of economic recovery, stock prices will react faster. Anyone who is investing in markets now should at least have a time frame of 3-5 years.","The most difficult thing to do on D-Street for investors is to put in money but it is even tougher if you are a new investor. But, history suggests that investment made in difficult times like these have made money, Sampath Reddy is a Chief Investment Officer at Bajaj Allianz Life Insurance Company Limited who manages about Rs 60,000 cr in term of AUM told Moneycontrol in a ‘Market Podcast’.

“Investment made during challenging times like these have reward investors based on historical data. I would suggest that new investors should make use of the opportunity because a lot of companies are trading below their intrinsic value,” he said.

Reddy further added that this time is right for investors to get into the market. Always remember, that these tough times will not last long. At best it could take another 6 –months to a year for companies to recover and bounce back towards normalcy.

But, once we see the first signs of economic recovery, stock prices will react faster. Anyone who is investing in markets now should at least have a time frame of 3-5 years.

(Tune in to listen to the full podcast)

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/podcast/the-market-podcast-this-fund-manager-managing-over-rs-60000-cr-has-special-advice-for-new-investors-5132351.html
24,"April 13, 2020 11:57 AM IST",1,Rakesh Patil,"Slideshow | Bajaj Finance, Hero Moto, Axis Bank among 10 stocks to buy","The benchmark indices are trading lower on April 13 with Nifty hovering around 9,000 level.
Except pharma all other sectors are trading in the red.
Here are the 10 stocks which could give 6-42 percent upside:",Here are the 10 stocks which could give 6-42 percent upside.,"The benchmark indices are trading lower on April 13 with Nifty hovering around 9,000 level. Except pharma all other sectors are trading in the red. Here are the 10 stocks which could give 6-42 percent upside:",https://www.moneycontrol.com/news/business/stocks/slideshow-bajaj-finance-hero-moto-axis-bank-among-10-stocks-to-buy-5132251.html
0,"April 13, 2020 11:17 AM IST",1,Kshitij Anand,"Cipla, ICICI Bank, Infosys among 7 stocks that should be on buyers' radar: Shrikant Chouhan","edited excerpts:A) Last week assured investors that by investing on every dip they can earn better returns in the short to medium-term.
The factors that have lead to a sharp rally are stimulus hopes and COVID-19 cases going down across the globe.
Q) What are the factors which investors should watch out for in the coming week, which is again be truncated one?
A) We should focus on following stocks for the coming week with a positional view of buy -- Reliance Industries, Cipla, ICICI Bank, Infosys, HDFC Bank, ITC and Escorts.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","If India does well in terms of handling the outbreak of coronavirus then the FIIs flows will increase for the top 5 companies of Nifty 50, says Shrikant Chouhan.","Defensives are likely to hog the limelight. From 2009 to 2015, we saw a V-shaped rally in pharmaceuticals, technology, and FMCG stocks, Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) Last week assured investors that by investing on every dip they can earn better returns in the short to medium-term. The factors that have lead to a sharp rally are stimulus hopes and COVID-19 cases going down across the globe.

If our government fails to fulfil expectations on the stimulus side and COVID-19 cases continue to increase then it would be a double whammy. Investors should be cautiously optimistic from here onwards.

Q) What are the factors which investors should watch out for in the coming week, which is again be truncated one?

A) Even if it is a spoiler for the economy, India should not compromise while tackling with coronavirus.

The world is watching India as to how it is going to deal with the coronavirus crisis. It is the real testing time for India and if we can save ourselves from this crisis, there will be a huge foreign direct investment flow in India in the coming days.

The most important thing is strong control over the spread of coronavirus. Stocks and sectors have stabilised, the market will soon start trading in a range.

A) Currently, largecap stocks are available at comparatively cheaper valuations. Then why does anyone need to run behind small and midcap stocks?

Q) We cannot close our eyes to is ""recession"" as well as COVID – 19 outbreak. Both the events are interlinked and will have long-lasting damage to the economies across the world including India. What are your views?

A) I believe in the theory of ""the market discounts lots of things well in advance"". Of course, we cannot close our eyes to recession as well as COVID-19 outbreak but at the same time, we cannot forget that one or the other sector takes the leadership and that helps move the market higher. Our focus should be on recession-proof sectors.

A) Defensives are likely to hog the limelight. From 2009 to 2015, we saw a V-shaped rally in pharmaceuticals, technology, and FMCG stocks.

If India does well in terms of handling the outbreak then the FIIs flows will increase for the top five companies of Nifty 50.

We should increase our exposure to telecom companies. Internet data is one of the most essential commodities in the current times it would be playing a big role.

A) We should focus on following stocks for the coming week with a positional view of buy -- Reliance Industries, Cipla, ICICI Bank, Infosys, HDFC Bank, ITC and Escorts.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/cipla-icici-bank-infosys-among-7-stocks-that-should-be-on-buyers-radar-shrikant-chouhan-5135061.html
1,"April 13, 2020 10:54 AM IST",1,Rakesh Patil,Deploy Nifty modified Put Butterfly strategy amid high volatility: Shubham Agarwal,"For the week both Nifty and Bank Nifty got a lot of traction and despite of the long weekend the indices held on to their gains.
Weekly returns on both Nifty and Bank Nifty were in double digits, 12% and 15% respectively.
There was 8% long interest addition for Nifty which basically all the addition that came in on the last session of the week.
Around 57% stocks added long interest, while the rest covered shorts.
In long interest additions, on the other hand, Capital Goods led by Voltas, L&T, BHEL, and Banking led by HDFC Bank, Bank of Baroda, Canara Bank were major recipients.",The only characteristic of the F&O market that remains reminiscent of the turmoil is the very level of implied volatility. Which reminds of the fact that any complacency derived from this up move could turn completely misleading just in a session’s time.,"Shubham Agarwal

The only good news amid the ongoing crisis led by COVID-19 was the way equities behaved this week across the globe. Our own Nifty was no different where after a big dent in past few weeks finally there was a respite that did not get sold into.

For the week both Nifty and Bank Nifty got a lot of traction and despite of the long weekend the indices held on to their gains. Weekly returns on both Nifty and Bank Nifty were in double digits, 12% and 15% respectively.

On the open interest front in futures though there was anomaly in the activity in both indices. There was 8% long interest addition for Nifty which basically all the addition that came in on the last session of the week. Bank Nifty however, added 15% interest for the week, half of it was contributed by longs and half by the shorts created in the beginning of the week.

Aggregate futures OI did not see similar augmentation in the total OI, mainly due to the force of depleting OI by short covering. None the less the highlight of the week remains the secular rise as amid this turmoil this week will go down in history for having not a single stock with weekly loss to record.

One more positive this week was the share of fresh interest. Around 57% stocks added long interest, while the rest covered shorts.

Dicing the stock futures OI sector wise two notables are very clear, one that the short-covering sectors remain limited and secondly while the Price gain is phenomenal, OI gain is fairly limited.

Among short-covering sectors metal had secular short-covering except for Vedanta and led by Jindal Steel. In long interest additions, on the other hand, Capital Goods led by Voltas, L&T, BHEL, and Banking led by HDFC Bank, Bank of Baroda, Canara Bank were major recipients.

Coming down to the options arena, the implied volatility still remains high and so does the size of daily swings. This has taken its toll on the available liquidity. Option participants remain afraid and away especially from stock options.

As far as index options are concerned, the rise has definitely positively impacted the composition and pushed out a lot of call writers and invited fresh Put writers. This, in turn, has raised the OI PCR fairly higher to an almost upper extreme.

Sentimentally, the only characteristic of the F&O market that remains reminiscent of the turmoil is the very level of implied volatility. Which reminds of the fact that any complacency derived from this up move could turn completely misleading just in a session’s time.

Being hedged at all times is quintessential accounting for a hedge cost in each and every trade hence, weekly hedge in Nifty is advised via Modified Butterfly.

Modified Put Butterfly is a 4-legged strategy where 1 lot of Put close to current underlying level is bought against that 2 lots of lower strike Puts are sold and 1 more lot of Put is bought but closer to the Put sold strike. This keeps the lower but constant profits in case of a downward breakout. This is a fairly risk-averse and a universal strategy.

(The author is CEO & Head of Research at Quantsapp Private Limited.)

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/technicals/deploy-nifty-modified-put-butterfly-strategy-amid-high-volatility-shubham-agarwal-5132241.html
2,"April 10, 2020 11:24 AM IST",1,Kshitij Anand,"'After lockdown, V-shaped recovery possible in auto, NBFCs, private banks, metals'","A V-shaped recovery is likely in most beaten-down stocks and sectors.
Auto, auto ancillaries, NBFCs, private banks, and metals will witness recovery as the pent-up demand is likely to compensate for the lost days, Umesh Mehta, Head of Research, Samco Securities, says in an interview to Moneycontrol’s Kshitij Anand.
Q) Which are the companies that are likely to see a V-shaped recovery after the lockdown?
A) A V-shaped recovery in stock prices can be witnessed in most beaten-down stocks and sectors.
Auto, auto ancillaries, NBFCs, private banks, and metals will witness recovery as the pent-up demand is likely to compensate for the lost days.","Auto, auto ancillaries, NBFCs, private banks, and metals will witness recovery, says Umesh Mehta of Samco Securities.","A V-shaped recovery is likely in most beaten-down stocks and sectors. Auto, auto ancillaries, NBFCs, private banks, and metals will witness recovery as the pent-up demand is likely to compensate for the lost days, Umesh Mehta, Head of Research, Samco Securities, says in an interview to Moneycontrol’s Kshitij Anand.

Edited excerpts:

Q) It was comparatively a better week for Indian markets but what is the way forward? What are the reasons for the rally – stimulus hopes, a drop in coronavirus cases?

A) Indian markets are aping the US and other global indices, as there is a revival in confidence with regards to fighting this pandemic. Many countries are showing a reduction in COVID-19-related cases and this is boosting sentiment.

Another factor that led to the rally this week was the fact that the lockdown period is coming to an end. Whether this period will be extended is anybody’s guess, but for now, investors’ hopes are up that most of the negatives are already factored in.

Q) What are the factors that investors should watch out for in the coming week, which again will be a truncated one? Initial reports suggest that the lockdown will be extended in the metros, will that be a spoiler?

A) Investors are hawk-eyed to the news on the extension of the lockdown. This will be the deciding factor that will guide bourses in the coming week.

Any surprises will cause the indices to move either with a gap-up or a gap-down. Global cues will also be a major force for the markets in the coming week. Traders should be extremely cautious and take bets only if they have a high-risk appetite.

Q) Small & midcaps have outperformed. Is it value buying which is leading to the outperformance or the liquidity factor, which is not enough in some of these names when compared to largecaps?

A) Buying is more event-driven at this point than value-driven. Investors are following the ‘buy-on-dips’ strategy but in the process, they are forgetting that companies that have performed in the past are not necessarily going to emerge winners post this pandemic.

It is extremely essential to analyse the impact of lockdowns and restrictions in trade on businesses before buying them.

Since there is uncertainty in how long the lockdown will last or if it will be extended, it is too early to assess the gravity of the crisis.

Q) One thing which we cannot close our eyes to is “recession” and the coronavirus outbreak. Both the events are interlinked and will have a lasting impact on the economies across the world, including India. What are your views?

A) Markets and the economy, in general, have witnessed recessions once every decade. It is indeed a tough time as this pandemic is not due to a financial crisis but is a health hazard.

Hence, the impact will be much larger, affecting varied industries. Recessions are tough times with job losses, shut down in small businesses and the steeper the fall, the longer time it will take for economies to revive just like it has in the past.

Q) Which are the companies that are likely to see a V-shaped recovery after the lockdown?

Hence, only risk-taking investors who have the patience to remain invested for a good five years should start accumulating equities. It will not be advisable for the faint-hearted to venture into the market when the VIX is at 51 while the lower range is 30.

A) A V-shaped recovery in stock prices can be witnessed in most beaten-down stocks and sectors. Auto, auto ancillaries, NBFCs, private banks, and metals will witness recovery as the pent-up demand is likely to compensate for the lost days.

There may be a postponement in demand but nonetheless demand will remain for such companies. FMCG, as a sector, will not be attractive from investing point of view because of high valuations and the fact that a bullish consensus is already built into prices.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/after-lockdown-v-shaped-recovery-possible-in-auto-nbfcs-private-banks-metals-5131111.html
3,"April 10, 2020 11:21 AM IST",1,,Titan Q4FY20 preview: A good start to the quarter marred by COVID-19,"To view the full content of this article, you have to be a Pro:Already a Moneycontrol Pro subscriber?
Or Open in AppNot a Moneycontrol Pro subscriber yet?
Subscribe to Moneycontrol Pro:What's included:",,"To view the full content of this article, you have to be a Pro:

Already a Moneycontrol Pro subscriber? Or Open in App

Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:







What's included:",https://www.moneycontrol.com/news/business/moneycontrol-research/titan-q4fy20-preview-a-good-start-to-the-quarter-marred-by-covid-19-5129941.html
4,"April 13, 2020 09:01 AM IST",-1,Kshitij Anand,Stay with equities! 3 potential signs which suggest we are near a bottom,"Nobody in January would have imagined a complete lockdown of the world for an uncertain period of time along with such massive destruction of wealth.
We would assign a 50-60 percent probability to the world slowly opening up in May/June 2020 and India can even open earlier too.
Currently, there are two risks that businesses are facing – productivity loss and liquidity crunch, with the latter one being far more detrimental!
The RBI and Government will take counter-cyclical measures to support either specific industries or general businesses to tide over the liquidity squeeze.
Consensus negative opinion makes it the least risky thing since all optimism has been driven out of its price.”","Current market cap to GDP ratio stood at 54%, last seen only in the 2008 crisis. Usually, through the cycles it oscillates between 50% to 150%.","Vikas Khemani

We are in unprecedented times. Nobody in January would have imagined a complete lockdown of the world for an uncertain period of time along with such massive destruction of wealth. That’s what life is all about.

Risk means more things can happen than will happen. Currently, the world is grappling with these questions:

Q) How long and serious the COVID-19 spread can get; will it get worse before it gets better?

Q) How the lockdown will impact the businesses and economies structurally?

While answers to many of these questions are uncertain and will evolve with each passing day, one thing we believe is that the spread happened at a time when everyone was caught off guard.

Now that it’s a full-blown crisis, Governments and organizations around the globe have come out with full might to curtail the spread and find a cure.

And, it will be a matter of limited time before which it will either get curtailed through a cure or a pause in the spread of new cases or a combination of both.

We would assign a 50-60 percent probability to the world slowly opening up in May/June 2020 and India can even open earlier too. But, never forget the balance probability, so one has to be watching & agile to the evolving situation.

How will business and economies get impacted?

Currently, there are two risks that businesses are facing – productivity loss and liquidity crunch, with the latter one being far more detrimental! We believe companies with good balance sheets and flexible cost structures will be able to navigate through.

The RBI and Government will take counter-cyclical measures to support either specific industries or general businesses to tide over the liquidity squeeze.

But one can never be sure of the effectiveness of these measures, hence businesses with leverage and high fixed costs will be at high risk and will have to tread cautiously.

Our view on the markets - is it a good time to invest?

Very often, we get this question about how much more downside is left? Truthfully, the answer to this is known by none.

Mark Howard once said:

“When everyone believes something is risky, their unwillingness to buy usually reduces its price to the point where it is not risky at all. Consensus negative opinion makes it the least risky thing since all optimism has been driven out of its price.”",https://www.moneycontrol.com/news/business/markets/stay-with-equities-3-potential-signs-which-suggest-we-are-near-a-bottom-5135281.html
5,"April 13, 2020 08:19 AM IST",0,Rakesh Patil,"'ABCD harmonic pattern suggests Nifty can touch 9,600'","Also, the index has given a breakout of inverse head and shoulders pattern on a lower time frame by giving decisive close above 9000 levels and target as this pattern is also around 9,600 levels.
We recommend buying Tata Motors around Rs 73 with a stop loss of Rs 66 and a target price of Rs 85.
HCL Technologies | Rating: Buy around Rs 458 |Target: Rs 528 | Stop Loss: Rs 428 | Upside: 12 percentIT as a sector is expected to outperform in the current scenario.
We recommend buying HCL Tech around Rs 468 keeping a stop loss of Rs 428, for the target of Rs 528.
We suggest buying Just Dial around Rs 318 with the stop loss of Rs 298 and target Rs 350.",The index has given a breakout of inverse head and shoulders pattern on a lower time frame by giving decisive close above 9000 levels and target as this pattern is also around 9600 levels.,"Shabbir Kayyumi

Nifty has bounced by more than 1,000 points and has managed to close above crucial resistance and swing high of 9,040. The weekly candlestick has formed a bullish pattern by closing above the last three weeks high (9,040) and now it can trade towards previous swing high standing around 9,600 mark.

Nifty is forming ‘ABCD’ harmonic pattern and currently, its ‘D’ leg is in progress which can either be equal to ‘A’ leg which comes to 9,600 marks or it can extend to 1.618 of ‘A’ which is near 10,000 marks suggesting index can trade higher with positive sentiments towards pattern targets.

Also, the index has given a breakout of inverse head and shoulders pattern on a lower time frame by giving decisive close above 9000 levels and target as this pattern is also around 9,600 levels.

Furthermore, the benchmark index has managed to close above important moving averages 5 DMA (8,600) and 20 DMA (8,720) suggests one should opt for buy on the dip. On a flip side, a decisive close below strong psychological levels of 8,500 can push index towards crucial support and line of parity standing around 7,800 marks.

Banking Index has managed to close around crucial psychological levels of 20,000 and 5 day’s highest high is suggesting a reversal of short term trend and relief rally towards 25,000 levels cannot be ruled out, conversely, any decisive trading below 18,500 will be a sign of active bears.

Trade Recommendation

Tata Motors | Rating: Buy around Rs 73 | Target: Rs 85 | Stop Loss: Rs 66 | Upside: 13 percent

It has formed a double bottom pattern on the daily chart, which should resolve on the upside after its brief consolidation. The momentum oscillator RSI is in positive territory and entering into a trending phase.

The MACD too indicates good momentum-trend follow through. We recommend buying Tata Motors around Rs 73 with a stop loss of Rs 66 and a target price of Rs 85.

HCL Technologies | Rating: Buy around Rs 458 |Target: Rs 528 | Stop Loss: Rs 428 | Upside: 12 percent

IT as a sector is expected to outperform in the current scenario. Weaken strength in rupee against the dollar could also help this sector to remain strong in the coming week. Recently, the stock gave double bottom breakout and still consolidating above the neckline of the breakout suggest upside move will continue in the near term also.

The momentum oscillator also exited the oversold zone on the daily chart. We recommend buying HCL Tech around Rs 468 keeping a stop loss of Rs 428, for the target of Rs 528.

Just Dial | Rating: Buy around Rs 318 | Target: Rs 350| Stop Loss: Rs 298 | Upside: 10 percent

After hitting the peak of RS 623, the stock gave a sharp fall towards till Rs 250-260 zone from where the chances of developing demand are higher. As of now, the appearance of bullish Harami on the daily chart is giving cues to accumulate this stock at lower levels. The momentum oscillator RSI which is currently overbought took a turn on the north side.

As long as it sustains above the mentioned zone, the possibility of moving on the upside is higher and it can hit our target with ease. We suggest buying Just Dial around Rs 318 with the stop loss of Rs 298 and target Rs 350.

(The author is Head of Technical Research at Narnolia Financial Advisors Ltd.)

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/abcd-harmonic-pattern-suggests-nifty-can-touch-9600-5134821.html
6,"April 09, 2020 02:32 PM IST",2,Sandip Das,"D-Street Buzz: 490 stocks hit upper circuit on BSE; volumes of Tata Motors, Cipla surge","Mahindra and Mahindra shares surged after CRISIL reaffirmed its ratings on debt programmes and bank loans.
35 stocks hit 52-week high on BSE including Cipla, Divis Labs, Alembic Pharma, Cadila Healthcare, Alkem Labs and Dr Reddy's Labs among others.
490 stocks hit upper circuit on BSE including SpiceJet, Future Retail, RAIL Vikas Nigam, IRCTC, Wockhardt, KRBL and Jubilant Lifesciences among others.
The most active shares in terms of volumes included Tata Motors which was trading with volumes of 7,187,759 shares, compared to its five day average of 2,216,482 shares, an increase of 224.29 percent.
The other active stocks included NCC, ITC, Future Consumer and Ashok Leyland among others.","490 stocks hit upper circuit on BSE including SpiceJet, Future Retail, RAIL Vikas Nigam, IRCTC, Wockhardt, KRBL and Jubilant Lifesciences among others.","Bulls have taken control of Dalal Street following its global peers with Sensex is up 912.80 points or 3.05 percent at 30806.76, and the Nifty jumped 268.90 points or 3.07 percent at 9017.65.

US President Donald Trump said on Wednesday he would like to reopen the US economy with a “big bang” but that the death toll from the coronavirus needs to be on the downslope before that can happen, said a Reuters report.

Mahindra and Mahindra shares surged after CRISIL reaffirmed its ratings on debt programmes and bank loans.

M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long term rating at AAA/Stable and short term rating at A1+ for company's bank facilities.

The other gainers included Bajaj Auto, Hero MotoCorp, Tata Motors and Eicher Motors.

Nifty Pharma gained 5 percent led by Cipla which zoomed 13 percent after the company received final approval for its Abbreviated new drug application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (USFDA), as per company release.

The other gainers included Aurobindo Pharma, Lupin, Ajanta Pharma, Divis Labs and Sun Pharmaceutical Industries.

All sectoral indices are trading in the green with the auto index outperforming, spiking by over 8 percent led by Mahindra & Mahindra and Maruti Suzuki which surged over 10 percent each.

35 stocks hit 52-week high on BSE including Cipla, Divis Labs, Alembic Pharma, Cadila Healthcare, Alkem Labs and Dr Reddy's Labs among others.

490 stocks hit upper circuit on BSE including SpiceJet, Future Retail, RAIL Vikas Nigam, IRCTC, Wockhardt, KRBL and Jubilant Lifesciences among others.

The most active shares in terms of volumes included Tata Motors which was trading with volumes of 7,187,759 shares, compared to its five day average of 2,216,482 shares, an increase of 224.29 percent.

ICICI Bank share price jumped 6 percent and was trading with volumes of 1,566,696 shares, compared to its five day average of 2,104,485 shares, a decrease of -25.55 percent.

The other active stocks included NCC, ITC, Future Consumer and Ashok Leyland among others.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/d-street-buzz-490-stocks-hit-upper-circuit-on-bse-volumes-of-tata-motors-cipla-surge-5126931.html
7,"April 13, 2020 09:57 AM IST",-1,Sandip Das,Avenue Supermarts share price hits 5% lower circuit,"The share price of Avenue Supermarts, which owns and operates retail chain Mart, slumped 5 percent lower circuit in the morning trade on April 13 after the company said half of its stores were closed and were getting fewer customers due to the lockdown.
The company was retailing only essential items from the operating stores and average footfall was ""significantly lower than usual"" due to several restrictions imposed by the authorities, Avenue Supermarts said in an update on business operation to bourses.
""We continue to sell daily-use essential items such as grocery and FMCG products from all our stores and have stopped the sale of non-essential items (general merchandise and apparel),"" Avenue Supermarts said.
It was trading with volumes of 3,937 shares, compared to its five-day average of 53,732 shares, a decrease of 92.67 percent.
AK Prabhakar, Head, Research, IDBI Capital in an interview to Moneycontrol placed Avenue Supermart in the category of multibaggers of the future.","There were pending sell orders of 8,287 shares, with no buyers available.","The share price of Avenue Supermarts, which owns and operates retail chain Mart, slumped 5 percent lower circuit in the morning trade on April 13 after the company said half of its stores were closed and were getting fewer customers due to the lockdown.

The company was retailing only essential items from the operating stores and average footfall was ""significantly lower than usual"" due to several restrictions imposed by the authorities, Avenue Supermarts said in an update on business operation to bourses.

Catch All Market Live Updates Here

The stock, which rose more than 66 percent in the last nine months, was quoting at Rs 2,287.90, down Rs 120.40, or 5 percent. It has touched an intraday high of Rs 2,345.50 and an intraday low of Rs 2,287.90.

""We continue to sell daily-use essential items such as grocery and FMCG products from all our stores and have stopped the sale of non-essential items (general merchandise and apparel),"" Avenue Supermarts said.

There were pending sell orders of 8,287 shares, with no buyers available. It was trading with volumes of 3,937 shares, compared to its five-day average of 53,732 shares, a decrease of 92.67 percent.

AK Prabhakar, Head, Research, IDBI Capital in an interview to Moneycontrol placed Avenue Supermart in the category of multibaggers of the future. The company had been growing at 25 percent in the last few years, he had said.

“We think the company is pulling consumers away from unorganised stores due to high discounting and now, delivery to home on the minimum charge would help the company grow in the next few years around those levels,” he said.

“The DMart chain offers a considerable amount of discount when compared to e-commerce platforms. The operating margin is higher compared to its peers due to the company’s low-cost structure,” Angel Broking said in a note.

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/avenue-supermarts-share-price-hits-5-lower-circuit-5137711.html
8,"April 09, 2020 04:17 PM IST",0,Sandip Das,Winners & Losers: 10 stocks that moved the most on April 9,"Mahindra and Mahindra | Share price surged 17 percent after CRISIL reaffirmed its rating.
M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long-term rating at AAA/Stable and short-term rating at A1+ for the company's bank facilities.","Auto Index surged over 10 percent followed by metal, pharma and infra. BSE Midcap and Smallcap indices rose over 3 percent each.",Mahindra and Mahindra | Share price surged 17 percent after CRISIL reaffirmed its rating. M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long-term rating at AAA/Stable and short-term rating at A1+ for the company's bank facilities.,https://www.moneycontrol.com/news/business/stocks/winners-losers-10-stocks-that-moved-the-most-on-april-9-5127651.html
9,"April 12, 2020 09:47 AM IST",2,Rakesh Patil,"Slideshow | Market breaks 7-week losing streak on stimulus hopes; auto, pharma outperform","On the BSE, Reliance Industries gained the most in terms of market value, followed by HDFC Bank, HUL, TCS and Maruti Suzuki last week.
Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.","Last week, the market rallied on hopes of stimulus package from the government and supporting global cues as some countries reported reduction in the number of daily coronavirus cases.","On the BSE, Reliance Industries gained the most in terms of market value, followed by HDFC Bank, HUL, TCS and Maruti Suzuki last week. Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/slideshow-market-breaks-7-week-losing-streak-on-stimulus-hopes-auto-pharma-outperform-5134691.html
10,"April 10, 2020 12:36 PM IST",2,Nishant Kumar,Indices rally despite lockdown gloom; 16 stocks from BSE 500 surge over 50%,"In the BSE 500 index, as many as 437 stocks logged gains.
Axis Bank, Sun Pharma and Reliance Industries logged gains of 38.51 percent, 35.86 percent and 29.28 percent, respectively.
As many as 13 stocks logged gains of more than 20 percent while 22 stocks rose more than 10 percent during that period.
""This uptrend seems to be a short-term bear market rally and may not be sustainable,"" said Vinod Nair, Head of Research at Geojit Financial Services.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","In order to keep coronavirus infections under check, Prime Minister Narendra Modi had announced a pan-India lockdown for 21 days on March 24, effective from 00:00 hours on March 25.","The benchmarks, Sensex and Nifty, have logged gains of nearly 17 percent each since March 24, data from Ace Equity showed.

In order to keep coronavirus infections under check, Prime Minister Narendra Modi had announced a pan-India lockdown for 21 days on March 24, effective 00:00 hours on March 25.

Since March 25, there were a total of 10 trading sessions. Out of 10, the benchmarks ended in the green in 5 sessions.

While Nifty is back above 9,000-mark, Sensex, too, has reclaimed 31,000 level.

This may offer some relief even though Sensex and Nifty are still 26 percent down from their all-time highs of 42,273.87 and 12,430.50, respectively, that they had hit in January 2020.

Amid all the uncertainty in the market, the recent correction in the market has been termed as an investment opportunity by most experts and brokerages.

In the BSE 500 index, as many as 437 stocks logged gains. Out of 437, 16 stocks surged over 50 percent since March 24. As many as 337 stocks jumped more than 10 percent in that period.

Among the 63 stocks from the BSE 500 index that lost during the period of lockdown, as many as 20 fell more than 10 percent.

In the 30-share Sensex pack, all stocks logged gains during the period, with Mahindra and Mahindra (up 41.58 percent) emerging as the top gainer of the pack.

Axis Bank, Sun Pharma and Reliance Industries logged gains of 38.51 percent, 35.86 percent and 29.28 percent, respectively. As many as 13 stocks logged gains of more than 20 percent while 22 stocks rose more than 10 percent during that period.

Among the sectoral indices on BSE, Healthcare emerged as the top gainer, jumping as much as 29 percent during that period.

BSE Energy, Oil & Gas, FMCG and Telecom logged gains of 26 percent, 23.59 percent, 21.64 percent and 20.36 percent, respectively, during the period of lockdown so far. BSE IT, with a gain of 6.45 percent, remained at the end of the sectoral indices.

Will the rally sustain?

The market is in uncertain territory. Unless the issue of COVID-19 comes under control, the market will continue to experience bouts of volatility.

Experts are of the view that such intermittent rally is a trading rally in a bear market which may not be sustainable.

""This uptrend seems to be a short-term bear market rally and may not be sustainable,"" said Vinod Nair, Head of Research at Geojit Financial Services.

Nair added that there is an expectation that the worst affected sectors and MSMEs may get some relief in another package to be announced shortly by the government. Markets will continue to fluctuate based on news coming out regarding the spread of infections and any lifting of lockdown in India.

Not much has changed for the market and there is very little for it to cheer.

The real picture of the economy is worrysome and it cannot be said how long it will take to get the economy on track.

Singapore's banking group DBS has revised the country's GDP estimate to 1.5 percent for the current fiscal amid the current lockdown due to COVID-19. This comes a day after American brokerage Goldman Sachs revised its forecast for the country's real GDP growth to 1.6 percent as against 3.3 percent it had estimated earlier.

India's industrial output grew at 4.5 percent as against a 0.2 percent growth rate year-on-year, as per the Index of Industrial Production (IIP) data released by the government on April 9.

But experts are of the view that this will deteriorate sharply due to the lockdown.

""There is not much to cheer from this data as IIP growth is likely to sharply fall going forward due to the impact of COVID-19 crisis. Even after the lockdown is lifted, demand for consumer discretionary items will take time to recover given the poor consumer sentiments in midst of job losses and pay cuts. Capital goods demand will also remain weak as businesses will be wary of capex in these uncertain times,” said Rajani Sinha, Chief Economist & Head Research at Knight Frank India.

The hopes are pinned on the economic stimulus that the government may bring in the coming days. The stimulus announced in the past were not enough to meet the need of the economy, experts said.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/indices-rally-despite-lockdown-gloom-16-stocks-from-bse-500-surge-over-50-5130201.html
11,"April 13, 2020 10:17 AM IST",2,Sandip Das,Gulf Oil Lubricants share price jumps 12% after board declares dividend,"The share price of Gulf Oil Lubricants jumped over 12 percent in the morning trade on April 13 after the board fixed April 23 as the Record Date for payment of interim dividend for the financial year 2019-20.
The company has declared an interim dividend of Rs 7 per share on 5,01,05,710 equity shares of Rs 2 each, the Hinduja group firm told the exchanges.
Catch All Market Live Updates HereThe stock, which has surged more than 22 percent in the last five days, was quoting at Rs 636.05, up Rs 69.75, or 12.32 percent.
It touched an intraday high of Rs 659.95 and an intraday low of Rs 615.00.
It was trading with volumes of 212 shares, compared to its five-day average of 308 shares, a decrease of 31.08 percent.",The company has declared an interim dividend of Rs 7 per equity share for the financial year 2019-20.,"The share price of Gulf Oil Lubricants jumped over 12 percent in the morning trade on April 13 after the board fixed April 23 as the Record Date for payment of interim dividend for the financial year 2019-20.

The company has declared an interim dividend of Rs 7 per share on 5,01,05,710 equity shares of Rs 2 each, the Hinduja group firm told the exchanges.

Catch All Market Live Updates Here

The stock, which has surged more than 22 percent in the last five days, was quoting at Rs 636.05, up Rs 69.75, or 12.32 percent. It touched an intraday high of Rs 659.95 and an intraday low of Rs 615.00. It was trading with volumes of 212 shares, compared to its five-day average of 308 shares, a decrease of 31.08 percent.",https://www.moneycontrol.com/news/business/stocks/gulf-oil-lubricants-share-price-jumps-12-after-board-declares-dividend-5137791.html
13,"April 13, 2020 07:08 AM IST",2,Nishant Kumar,"Hot Stocks | ACC, Eicher Motors can give 14-22% return in short term","Vikas JainNifty made a sharp comeback on the back of positive global cues to form higher double bottoms on weekly charts.
The index closed in positive after seven consecutive weeks of fall with a broad-based positive momentum across sectors and stocks.
We believe now Nifty will try to consolidate and witness some weakness from higher levels of 9,500-9,600.
On the downside, multiple supports exist in the range of Rs 930-950 levels, protecting the downside from the current levels.
Short position can be initiated in the range of Rs 495-505 for a target of Rs 445 with a stop loss of Rs 530.","As Nifty is almost 21 percent up from its 52 week low, it confirms a strong bottom is in place and any fall near 8,650 levels would be a good opportunity to create longs in the index.","Vikas Jain

Nifty made a sharp comeback on the back of positive global cues to form higher double bottoms on weekly charts. It closed the week ended April 9 near the high of the week.

The index closed in positive after seven consecutive weeks of fall with a broad-based positive momentum across sectors and stocks.

As the index is almost 21 percent up from its 52 week low, it confirms a strong bottom is in place and any fall near 8,650 levels would be a good opportunity to create longs in the index.

Among individual sectors, pharma, FMCG, private banks and auto indices have gained 41 percent, 28 percent, 26 percent and 25 percent, respectively, from their 52-week lows, outperforming the headline index Nifty50.

High beta sectors like metal, media have gained traction along with the broader markets to gain in the range of 13-15 percent from their lows.

India VIX declined 43 percent from its all-time high to close at 50 levels.

We believe now Nifty will try to consolidate and witness some weakness from higher levels of 9,500-9,600.

One should note that midcaps and smallcaps have underperformed by a large margin during the current rally and may witness a good amount of action over the next few trading sessions.

The full-year results for FY20 would start trickling from the next week and one can expect individual stock-wise momentum depending on the results and outlook of the management for the next year after the pandemic crisis of COVID-19.

Bank Nifty has resistance near 20,600 at its short-term moving average and recent high crossover of the same would witness an extended move to 21,800 levels. On the downside, support is placed at 18,800-19,100 levels.

Here are three stock recommendations for the next 3-4 weeks:

ACC | Buy | LTP: Rs 1,007.70 | Target price: Rs 1,150 | Stop loss: Rs 915 | Upside: 14%

The stock has been trading in a range, holding its support levels of Rs 900 and has made higher bottoms on the weekly charts.

Crossover of its short-term 20-day average will give a breakout and week-on-week positive close reinforces our positive stance.

On the downside, multiple supports exist in the range of Rs 930-950 levels, protecting the downside from the current levels.

Eicher Motors | Buy | LTP: 13,700 | Target price: Rs 16,700 | Stop loss: Rs 12,300 | Upside: 22%

The stock has found support near Rs 12,500, which is exactly the 61.8 percent Fibonacci retracement from its all-time high of Rs 33,480.

The sector is witnessing positive momentum and the stock has witnessed a sharp up move in the current week and we believe bottoms are in place for a strong up move.

The key technical indicators such as RSI has also reversed, turning upwards. The stock looks poised for a breakout from the current levels.

Dabur India | Sell | LTP: Rs 483.55 | Target price: Rs 445 | Stop loss: Rs 530 | Downside: 8%

The stock failed to cross its 52-week high and made a lower top witnessing a sharp correction from higher levels with strong volumes.

Overbought RSI and a decline in price are also signalling weakness in the stock.

On the higher side, the stock will face major hurdle around Rs 520-525, its recent high connecting the average rising trend line.

Short position can be initiated in the range of Rs 495-505 for a target of Rs 445 with a stop loss of Rs 530.

(The author is Senior Research Analyst at Reliance Securities)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-acc-eicher-motors-can-give-14-22-return-in-short-term-5128751.html
14,"April 13, 2020 10:43 AM IST",-1,Nishant Kumar,"National Fertilizers snaps 6-day winning streak, share price falls over 6%","National Fertilizers (NFL) share price fell over 6 percent in the morning on BSE on April 13, trading in the red after six consecutive sessions of gains.
The company is manufacturing urea at its units in Panipat, Bathinda, Nangal and Vijaipur (Vijaipur- I and Vijaipur II).
On April 9, the company told BSE that ICRA had downgraded its long term-CC limits rating to 'ICRA AA-' from 'ICRA AA'.
ICRA revised ratings on term loans to 'ICRA AA-' from 'ICRA AA'.
Shares of National Fertilizers were trading 2.70 percent down at Rs 23.45 on BSE at 1020 hours.","On April 9, the company told BSE ICRA had downgraded its long term- CC limits rating to 'ICRA AA-' from 'ICRA AA'. The outlook was revised to 'stable' from 'negative'.","National Fertilizers (NFL) share price fell over 6 percent in the morning on BSE on April 13, trading in the red after six consecutive sessions of gains.

In a regulatory filing on BSE on April 13, the company said, ""The subsidy income on urea production from Vijaipur-I from 02.04.2014, up to its re-assessed capacity, would come down by Rs 665 per MT (Rs 2,300—Rs 1,635). For the period 02.04.2014 to 31.12.2019, this would result in lower subsidy income by Rs 330.41 crore.""

The company is manufacturing urea at its units in Panipat, Bathinda, Nangal and Vijaipur (Vijaipur- I and Vijaipur II). Urea is covered under the subsidy scheme of the Government of India.

On April 9, the company told BSE that ICRA had downgraded its long term-CC limits rating to 'ICRA AA-' from 'ICRA AA'. The outlook was revised to 'stable' from 'negative'.

ICRA revised ratings on term loans to 'ICRA AA-' from 'ICRA AA'. The outlook was revised to 'stable' from 'negative'.

The rating downgrade factors in the weakening cost competitiveness of NFL in urea operations, arising from a sharp rise in energy consumption in the current fiscal, which was brought about by unscheduled plant outages, ICRA said in a note.

Besides, production of urea beyond RAC was also less remunerative in a scenario of subdued international prices, which impacted its cash accruals.

With tightening of energy norms by the government from FY2021, NFL’s cash accruals would further take a hit, even though the company was embarking on an energy-saving project that would partially mitigate the risk, ICRA said.

The downgrade in rating also factors the weakening credit metrics of the company due to elevated debt, brought about by higher subsidy receivables and increase in the scale of trading operations leading to higher working capital borrowings and large debt-funded capital expenditure, and investments in the Joint venture company, Ramagundam Fertilisers & Chemicals Limited (RFCL), ICRA added.

Shares of National Fertilizers were trading 2.70 percent down at Rs 23.45 on BSE at 1020 hours.",https://www.moneycontrol.com/news/business/markets/national-fertilizers-snaps-6-day-winning-streak-share-price-falls-over-6-5137881.html
15,"April 12, 2020 09:34 AM IST",1,Sandip Das,"Top 10 stocks that moved the most last week; Cipla, M&M, RBL Bank top charts","Shares of Lupin jumped 33 percent after the company launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market.
The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement.
Morgan Stanley has an overweight call on the stock with a target of Rs 948 per share, according to a report by CNBC-TV18.","Suven Lifesciences, Cipla, Maruti Suzuki, Mahindra & Mahindra, PVR and RBL Bank are some of the stocks that moved the most last week.","Shares of Lupin jumped 33 percent after the company launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market. The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement. Morgan Stanley has an overweight call on the stock with a target of Rs 948 per share, according to a report by CNBC-TV18.",https://www.moneycontrol.com/news/business/stocks/cipla-maruti-suzuki-mahindra-mahindra-pvr-and-rbl-bank-slideshow-top-10-stocks-that-moved-the-most-last-week-cipla-mm-rbl-bank-top-charts-5130811.html
16,"April 13, 2020 08:13 AM IST",1,Priyanka Roshan,"In pics | Stocks in the news: HDFC, Dr Reddy's Labs, Gulf Oil Lubricants, SRF, Godrej Consumer, CSB Bank","Chalet Hotels | India Ratings reaffirmed rating at BBB+ and A2+ for the term loans & fund based working capital limits and the non-fund based working capital limits respectively.
The outlook which was positive earlier has been placed on 'Rating Watch Negative'.",HDFC | JK Paper | Godrej Consumer Products | Piramal Enterprises | ITI | IndiGrid | Lakshmi Vilas Bank | Shakthi Finance | SMS Pharmaceuticals | VST Tillers are among some of the stocks which are in news today.,Chalet Hotels | India Ratings reaffirmed rating at BBB+ and A2+ for the term loans & fund based working capital limits and the non-fund based working capital limits respectively. The outlook which was positive earlier has been placed on 'Rating Watch Negative'.,https://www.moneycontrol.com/news/business/stocks/in-pics-stocks-in-the-news-hdfc-dr-reddys-labs-gulf-oil-lubricants-srf-godrej-consumer-csb-bank-onmobile-global-5129821.html
17,"April 11, 2020 08:11 AM IST",0,Kshitij Anand,COVID-19 impact: Invest for long term to know the true potential of the small and midcaps,"The complete shutdown of the business has led to high fixed costs, high working capital, and low liquidity, etc.
Q) What are the factors which investors should watch out for in the coming week, which is again be truncated one?
The complete shutdown of the business has led to high fixed costs, high working capital, and low liquidity, etc.
Investors would have to invest for the long term to know the true potential of the small and mid-caps.
: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","The complete shutdown of the business has led to high fixed costs, high working capital, and low liquidity, etc. but one has to identify the value buying which results in high-risk reward as compared to the large caps.","The complete shutdown of the business has led to high fixed costs, high working capital, and low liquidity, etc. but one has to identify the value buying which results in high-risk reward as compared to the large caps, Gaurav Garg, Head of Research at CapitalVia Global Research - Investment Advisor, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt:

A) On April 9, the Nifty50 closed with an uptick of 363.16 points or 4.15 percent and on a weekly basis, it surged up by about 12 percent.

The benchmark indices ended with a positive note with an expectation of stimulus package from the government. The number of COVID-19 cases in India is low compare to the other nations like US and European countries like Italy, Spain where the number of deaths is in thousands as compared to the hundreds in India.

Although the government has announced various relief measures to save the economy, investors are still expecting a second stimulus package from the government which might be focused on MSMEs which is the worst hit.

Q) What are the factors which investors should watch out for in the coming week, which is again be truncated one?

A) The measures taken by the government are highly appreciated, especially the decision on lockdown of the entire country for 21 days. Many states in India have already expressed their views on expanding the lockdown until April 30.

While the number of cases in India is now getting steeper and lockdown is the only solution to prevent the widespread of the virus. Going forward, any extension of the lockdown, especially in the hotspot areas, with the objective of containing the virus, might be a positive sign to the market.

On a weekly basis Rupee is making a fresh low due to uncertainty over COVID-19 cases and it difficult to identify the bottom.

Although the market remaining under pressure, the decline in India VIX suggests some consolidation is expected around 9,000 levels. Resistance for Nifty is placed at 9,200 and 9500 levels while support is now placed at 9,000 and 8,700 levels.

Q) Small & Midcaps outperform - is it value buying which is leading to outperformance or the liquidity factors which is not enough in some of these names as compared to large caps?

A) Most of the investors are in the dilemma of whether markets have already bottomed out or would bottom out in the next few months. Frankly speaking, no one would have any idea but due to the sharp fall of the market, many investors would find it attractive to invest in small and mid-cap.

Many believe that the small & mid-cap companies may not survive after this pandemic. The complete shutdown of the business has led to high fixed costs, high working capital, and low liquidity, etc. but one has to identify the value buying which results in high-risk reward as compared to the large caps.

Investors would have to invest for the long term to know the true potential of the small and mid-caps.

Q) One thing which we cannot close our eyes to is ‘recession’ is as well as COVID – 19 outbreak. Both the events are interlinked and will have long-lasting damage to the economies across the world including India. What are your views?

A) The global economy is expected to tip into recession in 2020 as the COVID-19 pandemic has affected global production, supply chains, trade, and tourism.

The reduction in international crude oil prices, if sustained, can improve India’s terms of trade, but these gains are not expected to offset the drag from the shutdown and loss of external demand.

However, domestic growth would depend on the speed with which the outbreak is contained, and the pace at which economic activity returns to normalcy.

Q) Which are the companies that are likely to see a V – shaped recovery after the lockdown?

A) It is expected to see a V-shaped recovery in stocks like Bharat Petroleum Corporation Limited, CEAT Limited, Avenue Supermarts Limited, Havells India Limited, ICICI Bank Limited, Jubilant Foodworks Limited, Mahindra & Mahindra Limited as most of these stocks are trading below their 100 DEMA and 200 DEMA.

Technically, the above-mentioned stocks are indicating reversal patterns in their daily charts. Since these stocks are fundamentally sound and are available at attractive valuations, they are likely to grab investors’ attention in the near future.

Q) Any technical trading ideas which investors can look at for the coming week?

A) Volatility is expected to remain high in the upcoming week as well. However, it can be observed that most of the stocks have recovered significantly in the past few trading sessions.

So, investors should be investing in selective stocks considering the volatility in specific sectors as well as financials of the stocks they are going to invest in.

However, ‘Buy at dip’ would be advised by keeping a close watch on the movement of currency and crude oil prices as well as the movement of international markets.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-impact-invest-for-long-term-to-know-the-true-potential-of-the-small-and-midcaps-5132111.html
18,"April 13, 2020 09:29 AM IST",-1,Rakesh Patil,HDFC slips nearly 3% after China's central bank buys stake,"The share price of housing finance lender HDFC ended 2.8 percent lower on April 13 after China's central bank bought over 1 percent stake in the company.
China's central bank, People's Bank of China (PBOC), has bought a 1,74,92,909 crore shares, or 1.01 percent stake in housing finance major HDFC Ltd on behalf of the Chinese sovereign wealth fund SAFE.
The transaction is not for the Chinese Central bank itself, said HDFC Chairman, Deepak Parekh, in an exclusive interaction with Moneycontrol.
Invesco Oppenheimer Developing Markets Fund, Government of Singapore and People's Bank of China featured among the foreign portfolio investors (FPIs) that held significant size of shares in HDFC during the January-March quarter of financial year 2019-20.
Similarly, the Saudi Arabian Monetary Authority (SAMA) has also picked up a 0.7 percent stake in HDFC on behalf of Saudi sovereign wealth fund, Parekh said.","China's central bank, People's Bank of China (PBOC), has bought a 1,74,92,909 crore shares, or 1.01 percent stake in housing finance major HDFC Ltd on behalf of the Chinese sovereign wealth fund SAFE.","The share price of housing finance lender HDFC ended 2.8 percent lower on April 13 after China's central bank bought over 1 percent stake in the company.

China's central bank, People's Bank of China (PBOC), has bought a 1,74,92,909 crore shares, or 1.01 percent stake in housing finance major HDFC Ltd on behalf of the Chinese sovereign wealth fund SAFE.

The transaction is not for the Chinese Central bank itself, said HDFC Chairman, Deepak Parekh, in an exclusive interaction with Moneycontrol.

Invesco Oppenheimer Developing Markets Fund, Government of Singapore and People's Bank of China featured among the foreign portfolio investors (FPIs) that held significant size of shares in HDFC during the January-March quarter of financial year 2019-20.

Also Read - Government of Singapore, People's Bank of China feature among HDFC shareholders in March quarter

The shareholding pattern data for the March quarter, released by HDFC on April 11, showed FPIs held 70.88 percent shares of the public shareholding segment of the company.

Similarly, the Saudi Arabian Monetary Authority (SAMA) has also picked up a 0.7 percent stake in HDFC on behalf of Saudi sovereign wealth fund, Parekh said. SAMA’s name isn’t reflected in the names of major shareholders as the holding in the company is less than one percent.

Housing Development Finance Corporation ended at Rs 1,654.45, down Rs 47.50, or 2.79 percent. on the BSE.",https://www.moneycontrol.com/news/business/stocks/hdfc-rises-3-after-chinas-central-bank-buys-stake-5137621.html
19,"April 10, 2020 12:38 PM IST",2,Nishant Kumar,Pharma sector sits pretty amid market turmoil; 5 stocks that you can buy,"Pharma stocks have been in the focus amid the turmoil caused by the coronavirus outbreak , as experts and brokerages say that the sector is better placed to navigate the economic crisis brought by the pandemic.
The highly contagious virus has taken a huge toll on most sectors, but pharma companies have withstood the carnage, with some stocks delivering healthy returns.
Pharma, as a sector, has emerged a strong contender to drive the next leg of the rally.
In anticipation, pharma stocks have seen a huge run-up in the last few days.
At its April 8 closing price of Rs 327, the stock trade at 43/32/24 times FY20/21/22E P/E and FY22E RoCE of 12 percent.","The panic created by COVID-19 has taken a heavy toll on most sectors but pharma companies seem to have withstood the carnage, with some stocks delivering healthy returns during this period.","Pharma stocks have been in the focus amid the turmoil caused by the coronavirus outbreak , as experts and brokerages say that the sector is better placed to navigate the economic crisis brought by the pandemic.

The highly contagious virus has taken a huge toll on most sectors, but pharma companies have withstood the carnage, with some stocks delivering healthy returns.

Experts say that the pharma and healthcare sectors have a crucial role in supporting the government and people and are doing a great job by managing medicine supplies as demand remains strong.

The BSE Healthcare index has closed in the green in the last four consecutive sessions. BSE Healthcare has emerged as the top gainer among sectoral indices, jumping 29 percent since March 25, the day the three-week lockdown began.

Pharma, as a sector, has emerged a strong contender to drive the next leg of the rally. In anticipation, pharma stocks have seen a huge run-up in the last few days.

Since February 1, the BSE Healthcare index is 4 percent up against a 23 percent fall in the Sensex, as of April 9 close, data from Ace Equity shows.

Shares of IOL Chemicals & Pharmaceuticals, Abbott India, Torrent Pharmaceuticals, Cadila Healthcare and Cipla have surged up to 44 percent since February 1.

However, shares of Take Solutions, Shalby, Jubilant Life Sciences, Aster DM Healthcare and Piramal Enterprises have cracked up to 50 percent during the period.

The road ahead

Brokerages say the 21-day lockdown has sprung several unprecedented challenges for the sector such as lower employee attendance, logistic problems and a shortage of accessories like packaging and labelling material. These have led to lower capacity utilisation at most plants.

The sector, however, is well-positioned to endure the coronavirus pain, brokerages say.

""In pharma, barring few supply-related disturbances, we do not envisage material earnings impact in FY21. Also, note that in this unprecedented global lockdown, pharma and healthcare services, being at the top layer of essential services, remain exempted everywhere,"" said brokerage firm ICICI Direct.

HDFC Securities has a positive view on the sector, too. The brokerage says its positive stance on Indian pharma is premised on sector’s relative resilience to coronavirus disruption, favourable currency tailwinds and stable outlook for India and the US business.

HDFC forecasts 11 percent growth for its covered companies over the next two years. However, the brokerage identifies extended lockdown as a risk, as it can impact demand and manufacturing.

Moreover, a delay in key approvals, delay in the USFDA plant resolution due to travel advisory, EM markets currency risks and subdued demand are seen as the key risks for the sector.

Stocks to consider

Brokerages say while in the short term most companies will bounce back from the last five years of underperformance, this time around, the leader will be different. Hence, one needs to choose stocks carefully.

Edelweiss Broking suggests following five stocks:

Ajanta Pharma

Edelweiss sees Ajanta Pharma as a turnaround story. The brokerage expects the company's margin to improve to 31 percent by FY22 from 27 percent in FY19.

It expects FY20/21/22 EPS of Rs 53/70/83, respectively. At its April 8 closing price of Rs 1,367.5, the stock trades at 23/19/16 times FY20/21/22E P/E and FY22E RoCE of 20 percent.

Degrowth in the Africa business is a point of worry but Edelweiss is quite comfortable with Ajanta's US and India numbers. ""We expect Africa to grow by 12 percent over the next two years,"" Edelweiss said.

Abbott India

Edelweiss sees it as a CAGR story. The brokerage highlighted that Abbott India has seen strong sales growth (organic: 15 percent CAGR; inorganic: 18 percent) in the last 10 years compared to an average 11 percent growth by other Indian pharmaceutical players.

This has been driven by strong execution and acquisition of Piramal Healthcare’s domestic formulation business in May 2010, Edelweiss said.

The brokerage expects FY20/21/22E EPS of Rs 313/360/416. At its April 8 closing price of Rs 17,481, the stock trades at 56/49/42 times FY20/FY21/FY22E P/E and FY22E RoCE of 23 percent.

""The Indian government periodically issues a price cap on certain essential drugs. About 40 percent of Abbott’s portfolio falls under Drug Price Control Orders (DPCO), so any incremental coverage would pose a risk to earnings,"" Edelweiss said.

Dr Reddy’s Laboratories

It is 'new management, new story' theme for Edelweiss as India business is a key focus for the company now.

Edelweiss highlights that despite its strong innovation capabilities since inception, Dr Reddy’s Laboratories is not even among the top 10 domestic formulation players. Its India business was never a focus area for the management, which led to market share loss over a period of time.

""But for the new management, India will be a key focus area. It recently acquired a large portfolio from a competitor,"" Edelweiss said.

The brokerage expects FY20/21/FY22 EPS of Rs 120/150/174. At its April 8 closing price of Rs 3,683, the stock trades at 31/25/22 times FY20/21/22E P/E and FY22E RoCE of 20 percent.

Any delay in gCopaxone launch can impact FY22E earnings of the company significantly, said Edelweiss. Also, any USFDA issue with its Bachupally facility is a risk.

Laurus Labs

Edelweiss sees the company as a classic investment story.

The brokerage thinks the earnings of the company will shoot up to Rs 34 per share in FY21E from Rs 9 per share in FY19.

The stock trades at 12 times FY21E P/E. RoCE is seen improving to 13 percent in FY21E from 6 percent in FY19.

Edelweiss expects FY20/21/22 EPS of Rs 24/34/37. At its April 8 closing price of Rs 391, the stock trades at 17/12/11 times FY20/21/22E P/E and FY22E RoCE of 14 percent.

The brokerage said its margin assumption for FY21/22 is 22 percent but any pricing pressure in API/formulation can impact EPS significantly.

Biocon

It is a participant of mega theme -- biosimilar and TINA, said Edelweiss.

Edelweiss points out that the total biosimilar market size was pegged at $20 billion in 2019 by various studies. The same is expected to touch $60 billion by 2025, the highest growth category for pharma companies globally.

The brokerage is of the view that Biocon has proven its mettle by launching Pegfilgrastim ($4 billion) in the US last year. In March, it received approval for Lantus ($6 billion).

The brokerage expects FY20/21/22 EPS of Rs 7.5/10.2/13.4. At its April 8 closing price of Rs 327, the stock trade at 43/32/24 times FY20/21/22E P/E and FY22E RoCE of 12 percent.

Any facility-related USFDA action is a risk for the stock.

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/pharma-sector-sits-pretty-amid-market-turmoil-5-stocks-that-you-can-buy-5130401.html
20,"April 13, 2020 10:23 AM IST",-1,Sandip Das,Maruti shares fall 4% after Kotak retains 'sell' call,"Maruti Suzuki Dzire comes in at 10th with a sales figure of 5,476 against just a minor fall as compared to February’s sales number of 7,296.
RC Bhargava, Chairman of Maruti Suzuki India has strongly recommended resumption of economic activity and voiced his opposition at any further extension of the lockdown period beyond April 14.
The four-wheelers manufacturer Maruti Suzuki India has sold 83,792 units in the month of March 2020.
Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.
Maruti Suzuki India has suspended production at its facilities in Haryana till further notice.",The research firm is of the view that valuations are expensive at this juncture suggesting the stock factors in 7 percent CAGR in volumes over FY2020-50E.,"Maruti Suzuki Dzire comes in at 10th with a sales figure of 5,476 against just a minor fall as compared to February’s sales number of 7,296.

Share price of auto major Maruti Suzuki was down over 4 percent intraday on April 13 after research and broking firm Kotak Institutional Equities maintained its sell call on the stock and has slashed target to Rs 4,900 from Rs 5,800 per share, a CNBC-TV18 report said.

The research firm is of the view that valuations are expensive at this juncture suggesting the stock factors in 7 percent CAGR in volumes over FY2020-50E.

Catch All Market Live Updates Here

Maruti Suzuki's risk-reward at current market price remains fair adding that the near term will remain weak for the passenger vehicle industry.

RC Bhargava, Chairman of Maruti Suzuki India has strongly recommended resumption of economic activity and voiced his opposition at any further extension of the lockdown period beyond April 14.

In an exhaustive interview with Moneycontrol, he outlined the measures the government should take to recover from this massive setback and said the onus of creating demand in post-COVID 19 era rests on both the government and industry.

The four-wheelers manufacturer Maruti Suzuki India has sold 83,792 units in the month of March 2020. The company had sold 1,58,076 units in March 2019. The sales during March 2020 are not comparable with sales in March 2019 due to the suspension of operations with effect from March 22nd 2020, in line with national policy, said the company in a release.

Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.

Maruti Suzuki India has suspended production at its facilities in Haryana till further notice. The company’s research and development centre at Rohtak would also remain closed, it said. “As a next step, the government policy now requires closure of production and, accordingly, the company has taken a decision on production closure,” the company said.

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/maruti-shares-fall-4-after-kotak-retains-sell-call-5137831.html
21,"April 12, 2020 11:04 AM IST",1,Rakesh Patil,Story in a chart | 'Cup and Handle' pattern in Amara Raja suggests buying opportunity,"Shabbir KayyumiThe Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community.
In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal.
A Cup & Handle reversal pattern forms after a down trend, and its completion marks a trend reversal to up trend.
In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle.
Recent formation of cup and Handle pattern breakout on a close above Rs 490 marks suggests buying in the stock for higher targets of Rs 590.","Amara Raja Batteries has recently crossed the strong resistance line standing around Rs 490 levels, indicating strong bullish breakout.","Shabbir Kayyumi

The Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community. In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal. A Cup & Handle reversal pattern forms after a down trend, and its completion marks a trend reversal to up trend.

In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle. A trend line is drawn by connecting these highest points of the two peaks, which is called as “Neckline"". This trend line is the most important component of C & H pattern.

Why to buy Amara Raja Batteries?

C&H patterns are an integral part of technical analysis, but successful traders combine these techniques with technical indicators and other forms of technical analysis to maximize their odds of success.

Amara Raja has recently crossed the strong resistance line standing around Rs 490 levels indicating strong bullish breakout. Recent formation of cup and Handle pattern breakout on a close above Rs 490 marks suggests buying in the stock for higher targets of Rs 590. Decent volume participation while giving breakout is also giving support to C&H pattern.

Cup & Handle pattern and Buy signal on Amara Raja Batteries

Buy Signal:

> A close above neckline (490) of Cup & Handle pattern is indicating trend reversal to uptrend.> Short- term moving average 20 DMA (490) defines short-term trend is providing support to buyers as prices are sustained and trading around it.> Mid- term moving average 50 DMA (455) defines mid-term trend is very well augur with bulls as prices are sustained and trading above it.

> Decent volume participation while pattern breakout will also give additional confirmation.

Profit booking:

Target as per Cup & Handle pattern is calculated by adding height of Cup to neckline which comes to Rs 590, however one can book profits near previous swing high which is around Rs 580.

Stop loss:

Entire bullish view negates on breaching of Handle on closing basis and one should exit from long position. In case of Amara Raja, it is placed around Rs 444 levels.

Conclusion:

We recommend buying Amara Raja Batteries around Rs 500 with a stop loss of Rs 444 for higher targets of Rs 590 as indicated in above chart.

(The author is Head of Technical Research at Narnolia Financial Advisors Ltd.)

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/story-in-a-chart-cup-and-handle-pattern-in-amara-raja-suggests-buying-opportunity-5134811.html
22,"April 11, 2020 08:11 AM IST",2,Rakesh Patil,Slideshow | 15 stocks for dual benefits of high dividend yield and attractive valuations,"In the current destruction, valuations have become attractive in several pockets.
But experts suggest that stocks that yield high dividends have a dual benefit.
The stock price goes up when the market phase changes and the dividend income earned also stays.
Here is a list of 15 stocks that can be considered for investment on the basis of good corporate governance, fundamentals and dividend yield.","Here is the list of 15 stocks which can be considered for investment on the basis of good corporate governance, fundamentals and dividend yield.","In the current destruction, valuations have become attractive in several pockets. But experts suggest that stocks that yield high dividends have a dual benefit. The stock price goes up when the market phase changes and the dividend income earned also stays. Here is a list of 15 stocks that can be considered for investment on the basis of good corporate governance, fundamentals and dividend yield.",https://www.moneycontrol.com/news/business/stocks/slideshow-15-stocks-for-dual-benefits-of-high-dividend-yield-and-attractive-valuations-5131061.html
23,"April 13, 2020 10:31 AM IST",0,Kshitij Anand,"Over 50 stocks with a m-cap of Rs 10,000 cr trade below 2008 P/E; should you buy?","The situation of COVID-19 is much different than the global financial crisis of 2008,” Pritam Deuskar, Fund Manager, Bonanza Portfolio Ltd told Moneycontrol.
There are as many as 54 stocks that are trading at valuations lower than the global financial crisis of 2008.
Yet it may not be correct to measure a business merely based on the P/E ratio, suggest experts.
The crisis of 2020 is the existential crisis and not the financial crisis that we saw in 2008.
Well, there are over 50 stocks that are trading at a lower valuation when compared to the global financial crisis.",A lower P/E ratio does not always imply that the company is undervalued. The reason behind the lower P/E ratio can be the poor financial performance or decrease in earning.,"Stocks that are trading at a P/E multiple which was lower than 2008 levels include ITC, HDFC Bank, Infosys. Kotak Mahindra Bank, Wipro, Axis Bank, ONGC, IOC, BOCL, Bajaj Finance, SBI, and L&T.

“Out of all these stocks, one should see businesses that are least affected in terms of starting again after COVID-19 is over. If lockdown does get extended then companies that have major supply chain issues are going to take bit longer to smoothen earlier track,” he said.

“Any decisions to invest in a particular stock cannot be solely on looking at P/E levels. As upcoming earnings growth or degrowth changes the entire scenario. The situation of COVID-19 is much different than the global financial crisis of 2008,” Pritam Deuskar, Fund Manager, Bonanza Portfolio Ltd told Moneycontrol.

The question now is – are all stocks that are trading below 2008 levels an attractive buy? Well, the answer is ‘NO’. And, investors should avoid making that mistake of picking anything because it is available cheap.

The recent wave of sell-off pushed many bluechip and midcaps stocks to their multi-year low which makes them an attractive buy at current levels, data showed. There are as many as 54 stocks that are trading at valuations lower than the global financial crisis of 2008.

Many quality large as well as mid-cap stocks have fallen in double digits in the past two months as a spike in COVID-19 related cases across the world triggered a risk-off sentiment that led to relentless selling by foreign investors of more than Rs 60,000 crore in the cash segment of the Indian equity market in March.

P/E ratio is the shortest & fastest way to get started when valuing a company. Yet it may not be correct to measure a business merely based on the P/E ratio, suggest experts.

“A lower P/E ratio does not always imply that the company is undervalued. The reason behind the lower P/E ratio can be the poor financial performance or decrease in earnings,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor told Moneycontrol.

“Similarly, a higher P/E ratio does not always indicate that the company is overvalued. The reason behind the higher P/E ratio can be an increase in earnings at a higher rate or overall improved financial performance,” he said.

This means that if the company increases its earnings then investor’s decision of investing in high P/E ratio stock is not always wrong because ultimately due to an increase in earnings, the P/E value will fall in near future.

Valuation is an important factor while picking stocks, and no doubt most of the companies are big-ticket names in their respective sector. But, basing your calculation on just one indicator might not be enough because situation in 2020 is completely different what we saw in 2008.

Why we say that is because if the lockdown does get extended we are looking at massive earnings downgrades in almost all the sectors leaving aside defensives. The crisis of 2020 is the existential crisis and not the financial crisis that we saw in 2008.

“If there is something that the global financial crises episode in the past has taught us is that picking stocks only because they are trading at cheaper valuations is an inappropriate strategy. What investors need to look for are good businesses,” Nirali Shah, Senior Research Analyst, Samco Securities told Moneycontrol.

“Quality businesses that have the ability to tide through tough times and emerge stronger by increasing their market share are the true winners. Undoubtedly, many stocks are now available at attractive levels. Investors can keep this as a starting point to pick the fundamentally strong hidden gems to invest in,” she said.

Other factors to track:

There are other factors that one should keep a tab on while making a buy or a sell decision. Price-earnings ratio is a good barometer; however, experts feel that more investors should also consider companies with low supply chain issues, have a strong balance sheet, as well as high RoCE companies.

“Rather than P/E, the PEG ratio is an important factor investors should check before buying stocks. Comparing P/E to the growth of companies is a strong measure to predict if indeed the valuations are cheap vis-à-vis the growth of a company’s business,” says Shah of Samco Securities.

She further added that return ratios such as ROE, ROCE, management and supply chain efficiencies, leverage, free cash flow are a few other factors to look out for before investing in stocks.

What to buy?

Well, there are over 50 stocks that are trading at a lower valuation when compared to the global financial crisis. But, analysts recommend only a handful of names for cherry-picking.

Garg of CapitalVia Global Research Limited- Investment Advisor recommends HDFC Bank, ITC, NTPC, as well as L&T.

Shah of Samco Securities recommends a number of names such as HDFC Bank, Infosys, Kotak Mahindra Bank, Marico, Bajaj Finance, Hero Motocorp, Tech Mahindra would be good picks for investment at this point in time. A staggered buy approach would be a sound way to play the current volatility.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/over-50-stocks-with-a-m-cap-of-rs-10000-cr-trade-below-2008-pe-should-you-buy-5135841.html
24,"April 11, 2020 10:09 AM IST",2,Kshitij Anand,Stellar rally! More than 180 stocks outperform Nifty; rose over 13-40% in 3 days,"There are nearly 300 stocks in the S&P BSE Small-cap index which rose more than 13 percent in three trading sessions.
There are as many as 186 stocks in the S&P BSE 500 index which outperformed Nifty50.
It was exciting three days as bulls helped the S&P BSE Sensex, and Nifty50 climb key resistance levels.
Investors’ wealth rose by over Rs 12 lakh crore in a truncated week.
“Hence, the near term breather towards 8,500 should not be construed as negative, instead it should be capitalised as an incremental buying opportunity in the upcoming truncated week,” he said.","The Nifty mid-cap, small-cap behaved in tandem with benchmarks as it rallied over 7 percent, each. Sectorally, all major indices ended in green led by auto, pharma, and financials","Note: Here is a list of top 100 stocks from 186 based on returns in the week gone by. The list is for reference only and not buy or sell ideas.

There are nearly 300 stocks in the S&P BSE Small-cap index which rose more than 13 percent in three trading sessions. These include Sintex Industries, VA Tech Wabag, Uniply Industries, Jyothy Labs, JK Paper, and Manali Petro among others.

There are as many as 186 stocks in the S&P BSE 500 index which outperformed Nifty50. These included names such as Care Ratings, Balkrishna Industries, Shipping Corp, Natco Pharma, Dabur India, Tata Motors, Apollo Tyres, Dr Reddy’s Laboratories, Dish TV, TCS, Ipca Laboratories, Titan Company, and JSPL among others.

Both Sensex and Nifty50 rallied by about 13 percent for the week ended April 9 while the broader markets underperformed as the S&P BSE Mid-cap index was up 11.3 percent, and the S&P BSE Smallcap index closed 9.4 percent higher.

It was exciting three days as bulls helped the S&P BSE Sensex, and Nifty50 climb key resistance levels. Investors’ wealth rose by over Rs 12 lakh crore in a truncated week.

Positive global cues helped bulls to fuel a massive short-covering rally on D-Street. Foreign institutional investors who were net sellers in March and most part of April also turned net buyers in the last three sessions pouring over Rs 4,000 crores.

Expectations of further stimulus measures from the government, fall in new cases of COVID-19 in the United States as well as Europe, and expectations of smart money moving towards India post-MSCI rejig helped the sentiment.

""The benchmark indices ended with a positive note with an expectation of stimulus package from the government. The number of COVID-19 cases in India is low compare to the other nations like US and European countries like Italy, Spain where the number of deaths is in thousands as compared to the hundreds in India,"" Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor told Moneycontrol.

""Although the government has announced various relief measures to save the economy, investors are still expecting a second stimulus package from the government which might be focused on MSMEs which is the worst hit,"" he said.

The coming week will be an interesting one as the initial lockdown period will come to an end. But, initial reports suggest that this period is likely to get extended.

On the macro front, inflation data will be eyed and a further stimulus from the govt. to boost the economy or support the MSME sector will lift sentiments.

""This uptrend seems to be a short term bear market rally and may not be sustainable. In India, there is an expectation that the worst affected sectors and MSMEs may get some relief in another package to be announced shortly,"" Vinod Nair, Head of Research at Geojit Financial told Moneycontrol.

""Markets will continue to fluctuate based on news coming out regarding the spread of infections and any lifting of lockdown in India,"" he said.

Technical Outlook:

Equity benchmarks settled the truncated week on a cheerful note underpinned by firm global cues. The Nifty50 closed the week at 9,111, up by 12.7 percent.

The Nifty Mid-cap, small-cap behaved in tandem with benchmarks as it rallied over 7 percent, each. Sectorally, all major indices ended in green led by auto, pharma, and financials.

The weekly price action formed a sizable bull candle carrying higher high-low after seven weeks decline, indicating a pause in the corrective phase.

Any cool off from hereon due to elevated global volatility would get anchored around 8,500 as it is 61.8 percent retracement of last three session sharp up move (8,055 – 9,132), at 8,466, suggest experts.

“In the process, index surpassed intermediate resistance of 9,000, on expected lines, signifying acceleration of upward momentum towards 9,500 in coming weeks, Dharmesh Shah, Head – Technical, ICICI direct told Moneycontrol.

“Hence, the near term breather towards 8,500 should not be construed as negative, instead it should be capitalised as an incremental buying opportunity in the upcoming truncated week,” he said.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/stellar-rally-more-than-180-stocks-outperform-nifty-rose-over-13-40-in-3-days-5134181.html
0,"April 08, 2020 04:30 PM IST",-1,Rakesh Patil,"Taking Stock: Investors book profits as Sensex breaks below 30,000","Profit-taking after a massive rally seen in the previous trading session pulled the S&P BSE Sensex below 30,000 while Nifty50 also gave up 8,800 levels on April 8.
Let’s look at the final tally on D-Street – the S&P BSE Sensex fell 173 points to 29,893 while the Nifty50 closed 43 points lower at 8,748.
Broader markets outperformed as the S&P BSE Midcap index was up 1.9 percent while the S&P BSE Smallcap index closed 1.86 percent higher.
Stocks & Sectors:Sectorally, the action was seen in the S&P BSE Healthcare index which was up 3.8 percent followed by the S&P BSE Auto index that was up 1.9 percent, and the S&P BSE Utilities closed 1.8 percent higher.
On the other hand, profit taking was seen in the S&P BSE Realty index that was down 1.6 percent, followed by S&P BSE Consumer Durables index that fell 1.4 percent, and IT index fell 1.4 percent.",The Nifty formed a Shooting Star kind of pattern on daily charts.,"Profit-taking after a massive rally seen in the previous trading session pulled the S&P BSE Sensex below 30,000 while Nifty50 also gave up 8,800 levels on April 8.

Let’s look at the final tally on D-Street – the S&P BSE Sensex fell 173 points to 29,893 while the Nifty50 closed 43 points lower at 8,748.

Sectorally, the selling pressure was visible in Realty, IT, Consumer Durables, and Bankex while buying was seen in Healthcare, auto, as well as Utilities.

Broader markets outperformed as the S&P BSE Midcap index was up 1.9 percent while the S&P BSE Smallcap index closed 1.86 percent higher.

Although news reports related to a next stimulus package lifted sentiment but muted global cues, as well as uncertainty around COVID-19, dampened the sentiment. Also, India could be looking at extending the lockdown which could hurt economic activity.

""Markets gave up gains, following a negative opening in the European Markets and uncertainty regarding the spread of Covid-19 infections. Markets are also uncertain as to the government response after the official 21-day lockdown expires on April 14,” Vinod Nair, Head of research at Geojit Financial Services told Moneycontrol.

“Some states are looking to extend the lockdown and some are for withdrawing it in a phased manner. The longer the lockdown stays, more the impact on the economy and companies,” he said.

Top Nifty gainers include names like NTPC, Cipla, Sun Pharma, Bharti Infratel, and Vedanta.

Top Nifty losers include names like Hindalco, Shree Cements, Titan Company, and TCS.

Stocks & Sectors:

Sectorally, the action was seen in the S&P BSE Healthcare index which was up 3.8 percent followed by the S&P BSE Auto index that was up 1.9 percent, and the S&P BSE Utilities closed 1.8 percent higher.

On the other hand, profit taking was seen in the S&P BSE Realty index that was down 1.6 percent, followed by S&P BSE Consumer Durables index that fell 1.4 percent, and IT index fell 1.4 percent.

Volume spike of over 100% was seen in stocks like Cadila Healthcare, Federal Bank, Petronet LNG, and Motherson Sumi.

Long Buildup was seen in stocks like Cadila Healthcare, Torrent Pharma, TVS Motor, Biocon, and Shriram Transport Finance

Short Buildup was seen in stocks like Ramco Cements, HDFC Bank, and Tata Chemicals etc. among others.

Beating the muted sentiment there are over 40 stocks that have hit fresh 52-week high which include names like Abbott India, Nestle India, GSK Consumer Health, DR Reddy’s Laboratories, Alkem Laboratories, and Torrent Pharma etc. among others.

Stocks in news:

West Coast Paper Mills share price got locked at 5 percent upper circuit on April 8 after the company started production, albeit partially, at its Dandeli unit.The stock finally closed with gains of over 3 percent.

Shares of Sudarshan Chemical Industries rose nearly 4 percent on April 8 after India Ratings revised its outlook on the company to ""positive"" from ""stable"".

Cadila Healthcare share price surged nearly 12 percent on BSE on April 8, a day after the company said it received approval from the US drug regulator for Perphenazine tablets.

Galaxy Surfactants share price rose over 4 percent on April 8 after the company partially resumed the operations.

Shares of Adani Green Energy jumped almost 5 percent on BSE on April 8, a day after the company said it received Rs 3,707 crore for the formation of the joint-venture (JV) with a French firm TOTAL.

Technical View:

The Nifty formed a Shooting Star kind of pattern on daily charts

The index witnessed profit taking around 9000 levels

In the next trading session if this counter slips below 8650 levels then weakness will be confirmed and in such a scenario it shall ideally resume downswing with initial targets present between 8550 – 8360 levels.

Strength in the index shall not be expected unless it closes above 9000 levels.

Considering the high volatility witnessed in today’s session traders are advised to remain neutral for the day in next session while fresh buying opportunity shall arise on a close above 9000 levels, says Mazhar Mohammad of Chartviewindia.in.",https://www.moneycontrol.com/news/business/markets/taking-stock-investors-book-profits-as-sensex-breaks-below-30000-5122071.html
1,"April 09, 2020 10:07 AM IST",0,Sandip Das,"Nifty likely to trade in 8,000-9,000 range; 5 stocks for 1-3 months investment","Overall, Nifty is likely to trade in a broader range of 8,000 and 9,000 levels before the next directional move.
Recent couple of sessions have seen high volumes.
Price has given breakout on upside from Bollinger Band with expansion of bands on daily chart indicating continuation of trend in the direction of breakout.
Dr Reddy's Laboratories: Buy | CMP: Rs 3683 | Stop loss: Rs 3500 | Target: Rs 4250 | Return: 15%Looking at broader monthly charts, the stock has formed rounding bottoming out pattern over four-year period.
Price has given breakout on upside from Bollinger Band with expansion of bands on daily chart indicating continuation of trend in the direction of breakout.","If VIX sustains above 50 levels, then pressure can be seen in the market. It needs to move below 40 levels for stability to return in the market.","Ashish Chaturmohta

Nifty witnessed a volatile session of trade. After opening in the negative, it rallied back immediately but couldn’t sustain at higher levels and closed lower. The Nifty closed at 8,749 levels down 0.49 percent for the day.

Broader market indices, BSE Midcap and Smallcap outperformed the benchmark indices with a gain of 1.9 percent and 1.86 percent, respectively, for the day. The market on NSE was negative with 2 stocks declining for every advance.

Intraday, Nifty touched high of 9,132 which is a 3-week high, but fresh selling emerged from higher levels. Thus, it formed a bearish shooting star candle on the daily chart. On a shorter time frame, the index has formed a bullish inverted head and shoulders pattern on the daily chart.

The index is facing resistance above 9,000 i.e. the neckline level, thus it must sustain above 9,000 for the market to move higher towards 9,500-9,600 levels. On the downside below 8,600 levels, the index can see a decline towards 8,360 levels.

Overall, Nifty is likely to trade in a broader range of 8,000 and 9,000 levels before the next directional move.

In Nifty April monthly expiry options, maximum open interest for Put is seen at strike price 8,000 followed by 7,500; while for Call maximum open interest is seen at 9,000 followed by 10,000. Nifty options distribution data is suggesting a wide range of 8000 and 9000.

India VIX index, a measure of volatility, after touching 11 year high of 86.6 has seen cooling off and currently at 52 levels. If VIX sustains above 50 levels, then pressure can be seen in the market. It needs to move below 40 levels for stability to return to the market.

Here are the top 5 stocks which are good bets for 1-3 months:

Alkem Laboratories: Buy | CMP: Rs 2671 | Stop loss: Rs 2535 | Target: Rs 3070 | Return: 15%

The stock witnessed major consolidation between Rs 1650 and Rs 2300 odd levels over almost 2-year period. Thus, it has formed a base for next leg of major uptrend. In January, the stock witnessed breakout from the base to touch high of Rs 2716 and then corrected Rs 2200 odd. It has taken support and bounced back to hit new all-time high of Rs 2736 in yesterday's session.

Recent couple of sessions have seen high volumes. Thus, indicating fresh buying participation in the stock in current market scenario. Price has given breakout on upside from Bollinger Band with expansion of bands on daily chart indicating continuation of trend in the direction of breakout. Relative strength index and Stochastic have given positive crossover with their respective averages on daily.

Thus, the stock can be bought at current levels and on dips to Rs 2630 with stop loss below Rs 2535 for target of Rs 3070 levels.

Dabur India: Buy | CMP: Rs 488 | Stop loss: Rs 463 | Target: Rs 560 | Return: 14%

The stock touched all-time high of Rs 525 in early March this year and then declined to Rs 386 levels. In the process, it corrected 78.6 percent Fibonacci retracement of the major rise from Rs 358 to Rs 525. Over the last 3 weeks, the stock has seen consolation between Rs 386 and Rs 455 levels.

Volumes have been above average at lower levels and breakout from consolidation has also happened on higher volumes. Thus, indicating buying participation in the stock. The price has moved above 200-day moving average after consolidating below it. Stochastic has given positive crossover with its average on daily chart. Thus, the stock can be bought at current levels and on dips to Rs 480 with stop loss below Rs 463 for target of Rs 560 levels.

Dr Reddy's Laboratories: Buy | CMP: Rs 3683 | Stop loss: Rs 3500 | Target: Rs 4250 | Return: 15%

Looking at broader monthly charts, the stock has formed rounding bottoming out pattern over four-year period. Volumes at lower levels have been high indicating accumulation in the stock. Now the stock is witnessing breakout on strong momentum and high volumes. Price has given breakout on upside from Bollinger Band with expansion of bands on daily chart indicating continuation of trend in the direction of breakout.

The Average Directional Index (ADX) line, indicator of trend strength is turning up from equilibrium level of 20 with rising Plus Directional line on daily chart. Thus, stock can be bought at current levels and on dips to Rs 3625 with stop loss below Rs 3500 for target of Rs 4250 levels.

HDFC Life Insurance: Buy | CMP: Rs 477 | Stop loss: Rs 450 | Target: Rs 560 | Return: 17%

From all-time high levels of Rs 646, the stock has seen major correction to touch low of Rs 340. Here, the stock has taken support around its previous consolidation lows i.e. its earlier base. It bounced back from lows to current levels. Price has moved above short term 21-day exponential moving average which was acting as resistance on bounce back during the decline. Volumes have been higher at lower levels indicating accumulation in the stock. Stochastic has given positive crossover with its average on daily chart.

Thus, the stock can be bought at current levels and on dips to Rs 470 with stop loss below Rs 450 for target of Rs 560 levels.

Eicher Motors: Sell | LTP: Rs 13158 | Stop loss: Rs 13800 | Target: Rs 11200 | Return: 17%

The stock is in major downtrend forming lower top and lower bottom on weekly chart. It has formed bearish head and shoulders pattern on monthly chart. The stock has broken key support of Rs 15,000. Breakdown has been on high volumes indicating selling pressure in the stock.Momentum indicators are in bearish mode on short term as well as on long term chart. Thus, the stock can be sold at current levels and on rise to Rs 13350 with stop loss above Rs 13800 for target of Rs 11200 levels.

The author is Head of Technical and Derivatives, Sanctum Wealth Management.

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/nifty-likely-to-trade-in-8000-9000-range-5-stocks-for-1-3-months-investment-5124851.html
2,"April 09, 2020 01:40 PM IST",2,Kshitij Anand,Bulls make a comeback as Sensex reclaims 31k; 4 factors leading the rally,"Sectorally, the rally was seen in auto, telecom, banks, IT, consumer discretionary, finance, healthcare, industrials and consumer durable space.
Strong global cues, and expectations of further stimulus measures from the Indian Government as well as central bankers across the world are boosting sentiment, suggest experts.
“The government is likely to unveil a second stimulus package in the coming days to focus on the help of MSME.
One of the big factors which fuelled optimism in global markets is the comment made by the US President on opening up the economy.
So far from the month of April, they have remained net sellers for about Rs 400 crore.","Sectorally, the rally was seen in auto, telecom, consumer discretionary, finance, healthcare, and consumer durable space.","Bulls fuelled a smart rally which pushed the S&P BSE Sensex beyond 31,000 in trade on April 9, the last trading day for the week, while the Nifty50 reclaimed 9,100 levels.

At close, the BSE Sensex rallied 1,265.66 points or 4.23 percent to 31,159.62 and the Nifty50 climbed 363.15 points or 4.15 percent to 9,111.90.

For the week, the benchmark indices surged nearly 13 percent each.

Sectorally, the rally was seen in auto, telecom, banks, IT, consumer discretionary, finance, healthcare, industrials and consumer durable space.

Strong global cues, and expectations of further stimulus measures from the Indian Government as well as central bankers across the world are boosting sentiment, suggest experts.

“Market closed on a firm note amid gains in global, and Asian peers on hopes that the COVID-19 pandemic is nearing a peak in major hotspots countries and that governments would roll out more stimulus measures,” Sundar Sanmukhani, Head of Fundamental Research Desk at Choice Broking said.

“The government is likely to unveil a second stimulus package in the coming days to focus on the help of MSME. Sectorally, all indices were trading in green with auto and pharma index leasing the rally,” he said.

We have collated a list of factors that could be driving optimism on D-Street:

Strong Global Cues:

Tracking strong close in the US markets, Asian shares also started on a firm footing on hopes the COVID-19 pandemic is nearing a peak and that governments would roll out more stimulus measures.

New York Governor Andrew Cuomo said the state’s efforts at social distancing were working in getting the virus under control in one of the biggest hotspots in the country, said a Reuters report.

Shares in China, where the novel coronavirus first emerged late last year, rose 0.37 percent. Australian shares were up 3.46 percent. Hong Kong's Hang Seng was up 1.38 percent and South Korea's Kospi gained 1.61 percent.

European markets too traded higher with Germany's DAX rising 0.4 percent and Britain's FTSE up 0.65 percent at the time of updating this copy.

Investors will keep a close eye on stimulus measures likely to be announced by the government and the possibility of extension of lockdown amid rising numbers of coronavirus cases, suggest experts.

A second stimulus package India is poised to announce in the coming days will be worth around 1 trillion rupees ($13 billion) and focus on help for small and medium businesses weathering the coronavirus outbreak, two senior officials said on Wednesday, said a Reuters report.

Last month, India outlined a Rs 1.7 lakh cr economic stimulus plan providing direct cash transfers and food security measures to give relief to millions of poor hit by an ongoing 21-day nationwide lockdown.

The official which Reuters spoke to said that a separate package could be announced for bigger companies after assessing the extent of the hit they have faced due to the lockdown imposed to fight the outbreak. Although, a finance ministry spokesman declined to comment on the report published by Reuters.

One of the big factors which fuelled optimism in global markets is the comment made by the US President on opening up the economy.

US President Donald Trump said on Wednesday he would like to reopen the US economy with a “big bang” but that the death toll from the coronavirus needs to be on the downslope before that can happen, said a Reuters report.

Trump did not give a timeframe on when he would like to reopen the economy, but his chief economic adviser, Larry Kudlow, said on Tuesday it was possible this could happen in four to eight weeks, added the report.

After pulling out more than Rs 60,000 crore from the cash segment of the Indian equity markets, foreign investors turned net buyers in the last two sessions pouring in more than Rs 2,600 crore, provisional data showed.

So far from the month of April, they have remained net sellers for about Rs 400 crore. FPI has been net sellers in the cash segment in January, February, as well as March, provisional data showed on Moneycontrol.com.",https://www.moneycontrol.com/news/business/markets/bulls-make-a-comeback-as-sensex-reclaims-31k-4-factors-leading-the-rally-5126261.html
3,"April 09, 2020 10:29 AM IST",1,Kshitij Anand,Don't miss out! Motilal Oswal names 15 firms that are potential buyback candidates,"Top companies with comfortable cash positions could turn out to be potential buyback candidates.
However, the applicability of recent buyback tax makes the promoters wary of going ahead with buybacks,” Umesh Mehta, Head of Research, Samco Securities told Moneycontrol.
Following the sharp correction in stock prices since Feb’20 and the multi-year low trailing valuations, Motilal Oswal analyzed and identified companies with strong cash positions and those that are potential buyback candidates.
MOFSL scanned through its coverage universe through the lens of (1) Debt/Equity, (2) Net-cash/market-cap, (3) High pay-out ratios, (4) and Trailing Valuations to come out with names which could be potential buyback candidates.
Thus, companies having net cash greater than 10 percent of their net worth for FY19 and FY20E can finance buybacks through cash and cash equivalents, said the Motilal Oswal note.",Companies having net cash greater than 10 percent of their net worth for FY19 and FY20E can finance buybacks through cash and cash equivalents.,"Indian market is down by about 30 percent from its recent high which has pushed many good bluechip stocks to trade at multi-year low trailing valuations. Top companies with comfortable cash positions could turn out to be potential buyback candidates.

Amid the market mayhem due to the COVID-19 outbreak, prominent companies such as Sun Pharma, Dalmia Bharat, NIIT Technologies, Granules India, Emami, Motilal Oswal Financial Services, Thomas Cook, Sterlite Technologies, Delta Corp, GHCL, and Ramkrishna Forging have announced buybacks recently.

The fall of Nifty from an all-time high of 12,400 to the recent swing low of 7,511 on March 24 has created a scenario where most of the stocks are trading at hefty discounts or below their intrinsic value.

“It is said that probably the best possible use of cash by businesses is when stocks can be bought below its intrinsic value – this applies to buybacks as well. However, the applicability of recent buyback tax makes the promoters wary of going ahead with buybacks,” Umesh Mehta, Head of Research, Samco Securities told Moneycontrol.

“It is best suited for the promoters to increase their holdings where possible. And if the promoters are of the view that the business is currently trading way below their intrinsic value, they may give a heads up for a buyback,” he said.

Following the sharp correction in stock prices since Feb’20 and the multi-year low trailing valuations, Motilal Oswal analyzed and identified companies with strong cash positions and those that are potential buyback candidates.

MOFSL scanned through its coverage universe through the lens of (1) Debt/Equity, (2) Net-cash/market-cap, (3) High pay-out ratios, (4) and Trailing Valuations to come out with names which could be potential buyback candidates.

Consumer, Technology and the Automobile sectors fit the bill perfectly in the aforementioned criteria. Additionally, MOSL ran two screens to highlight potential buyback candidates by considering companies that have (a) higher probability of returning cash to their shareholders, and (b) earnings/cash yield >6.5%.

Looking at companies that have higher net cash on the balance sheet and sustainable cash generation abilities throw up 15 names that include companies like ITC, Coal India, Maruti Suzuki, Bajaj Auto, Eicher Motors, NMDC, and ACC, etc. among others.

Companies where valuation have declined greater than 35 percent of their 5-year average (P/E for Consumer, Media, Logistics, Healthcare, Technology, Others, Auto, Retail and Telecom, and P/B for Capital Goods, Oil and Gas, Metals, Cement, Utilities and Infra).

A company can opt for buyback up to 10 percent of its net worth without a special resolution being passed and it can buy back up to 25 percent of net worth post a special resolution.

Thus, companies having net cash greater than 10 percent of their net worth for FY19 and FY20E can finance buybacks through cash and cash equivalents, said the Motilal Oswal note.

“The recent fall will be a big opportunity for the promoters and cash-rich companies to increase their holding in the company. Buyback from the market will be helpful to arrest the sharp declines and stabilise the price of the stock,” Jashan Arora Director, Master Capital Services told Moneycontrol.

There are 15 companies according to Motilal Oswal study which have an earnings yield and cash yield of over 6.5 percent that include names like ITC, HCL Technologies, Coal India, Bajaj Auto, NMDC, ACC, Bharat Electronics.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/dont-miss-out-motilal-oswal-names-15-firms-that-are-potential-buyback-candidates-5121271.html
4,"April 09, 2020 09:45 AM IST",2,Rakesh Patil,"IDBI Bank share price rises 10% on stake sell, fund raising report","IDBI Bank share price rose 10 percent in the early trade on April 9 after board approved stake sell in IDBI Federal Life Insurance Company.
The company in its board meeting has approved in principle the proposal to sell company's stake in IDBI Federal Life Insurance Company Limited (IFLI) to the extent of 23-27 percent.
The board has approved the exercise of Call Option on the Bank's Perpetual Tier 1 Bond Series I of Rs 245.10 crore due on June 22, 2020, subject to RBIapproval.
The board also approved the Rupee Bond Borrowing limit of Rs 7,500 crore for FY 2020-21.
At 09:26 hrs, IDBI Bank was quoting at Rs 20.95, up Rs 1.10, or 5.54 percent on the BSE.",The board  approved the Rupee Bond Borrowing limit of Rs 7500 crore for FY 2020-21.,"IDBI Bank share price rose 10 percent in the early trade on April 9 after board approved stake sell in IDBI Federal Life Insurance Company.

The company in its board meeting has approved in principle the proposal to sell company's stake in IDBI Federal Life Insurance Company Limited (IFLI) to the extent of 23-27 percent.

The board has approved the exercise of Call Option on the Bank's Perpetual Tier 1 Bond Series I of Rs 245.10 crore due on June 22, 2020, subject to RBI

approval.

The board also approved the Rupee Bond Borrowing limit of Rs 7,500 crore for FY 2020-21.

It would be borrowed in one or more tranches comprising of additional Tier I Bonds up to Rs 3,000 crore, Basel III Tier 2 bonds up to Rs 3,500 crore and Senior/Infrastructure Bonds up to Rs 1,000 crore by way of private placement during FY 2020-21.

At 09:26 hrs, IDBI Bank was quoting at Rs 20.95, up Rs 1.10, or 5.54 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/idbi-bank-share-price-rises-10-on-stake-sell-fund-raising-report-5124811.html
6,"April 09, 2020 12:17 PM IST",1,Sunil Matkar,Manali Petro locked in upper circuit as propylene oxide production begins,"Shares of Manali Petrochemicals were locked in 10 percent upper circuit after the company recommenced production of propylene oxide.
The petrochemical company informed exchanges on April 8 that the production of propylene oxide has recommenced on April 7 at its plant 1.
The propylene oxide is the feedstock for propylene glycol which is a pharmaceutical input.
""The decision on resumption of production of the other products will be decided in due course,"" Manali Petrochemicals said in its BSE filing.
On April 3, the company said it has restarted production of propylene glycol at its both the plants.",The propylene oxide is the feedstock for propylene glycol which is a pharmaceutical input.,"Shares of Manali Petrochemicals were locked in 10 percent upper circuit after the company recommenced production of propylene oxide.

The stock has been one of the biggest gainers in the last two weeks, rising 82 percent after seeing a 62 percent correction from January 17 to March 25. It was trading at Rs 16.28 on the BSE, up Rs 1.48 or 10 percent at 1144 hours IST.

The petrochemical company informed exchanges on April 8 that the production of propylene oxide has recommenced on April 7 at its plant 1.

The propylene oxide is the feedstock for propylene glycol which is a pharmaceutical input.

""The decision on resumption of production of the other products will be decided in due course,"" Manali Petrochemicals said in its BSE filing.

On April 3, the company said it has restarted production of propylene glycol at its both the plants.

On account of the COVID-19 situation and 21-day nationwide lockdown from March 25, the plant operations had been shut down from March 27.",https://www.moneycontrol.com/news/business/markets/manali-petro-locked-in-upper-circuit-as-propylene-oxide-production-begins-5125941.html
7,"April 09, 2020 07:51 AM IST",0,Priyanka Roshan,"In pics | Stocks in the news: HDFC Bank, SBI Life, IDBI Bank, NLC India, IndusInd Bank, Ajanta Pharma","Titan Company: Quarter started well, but COVID impacted sales in March.
Jewellery business saw a 5 percent decline.
Watches division grew 1 percent despite impact in March.
Eyewear saw 20 percent decline.
Other businesses saw a growth of 42 percent on a low base.","HDFC Bank, SBI Life, IDBI Bank, NLC India, IndusInd Bank and Ajanta Pharma are among some of the stocks which are in news today.","Titan Company: Quarter started well, but COVID impacted sales in March. Jewellery business saw a 5 percent decline. Watches division grew 1 percent despite impact in March. Eyewear saw 20 percent decline. Other businesses saw a growth of 42 percent on a low base.",https://www.moneycontrol.com/news/business/stocks/in-pics-stocks-in-the-news-hdfc-bank-sbi-life-idbi-bank-nlc-india-indusind-bank-ajanta-pharma-5123981.html
8,"April 09, 2020 02:18 PM IST",1,Sandip Das,Slideshow | Top 5 stock ideas by BP Equities for 44-118% returns in 12-18 months,"IG Petrochemicals: Buy | CMP: Rs 102 | Target: Rs 223 | Return: 118% - Possibility of further contraction in the margin is minimal and the brokerage sees a positive reversal in margin going forward as spreads improve.
Stock is available at 4.9x FY21E EPS of Rs 20.2.
Value the stock based on a 15-year average P/E of 11x to its FY21E earnings.","La Opala, GM Breweries, IG Petrochemicals, CDSL and BSE are the 5 stocks which BP Equities is recommending for up to 118 percent return.",IG Petrochemicals: Buy | CMP: Rs 102 | Target: Rs 223 | Return: 118% - Possibility of further contraction in the margin is minimal and the brokerage sees a positive reversal in margin going forward as spreads improve. Stock is available at 4.9x FY21E EPS of Rs 20.2. Value the stock based on a 15-year average P/E of 11x to its FY21E earnings.,https://www.moneycontrol.com/news/business/stocks/slideshow-top-5-stock-ideas-by-bp-equities-for-44-118-returns-in-12-18-months-5126171.html
9,"April 09, 2020 07:21 AM IST",2,Nishant Kumar,"Hot Stocks | Here's why HDFC Life, ITC are a buy in the short term","A breakout on either side will give a classical consolidation range pattern breakout and will define the next level for the banking index.
In the case of sharp short-covering and a pennant pattern breakout, Nifty may go to 9,650 level.
ITC | Buy | LTP: Rs 178.60 | Target price: Rs 200 | Stop loss: Rs 165 | Upside: 12%For the last couple of trading sessions, ITC has been sustaining above its horizontal trendline breakout on the daily interval.
The stock is trading above its 21-day exponential moving average and also above its four-week consolidation range on the daily scale.
Traders can short the stock in a range of Rs 995-1,008 for the target of Rs 820 with a stop loss above Rs 1,130 on a daily closing basis.","Once India VIX settles below 70 levels, there will be a decline in volatility. On April 8, India VIX, after hitting intraday low of 46.97, witnessed a sharp rally of almost 10 percent from the day’s low point.","Rohan Patil

After witnessing a positive breakout of a pennant pattern, the benchmark index Nifty went through a sharp decline and left a long trailing trail candle with closing inside the pattern on the daily chart on April 8.

It was a roller-coaster day for the Nifty. Among the sectoral indices, Nifty Pharma, Auto and Media managed to hold the gains while Bank, Financial Services, Realty, Metal and IT remained under pressure.

For the past two trading sessions, the breadth of the market has been in the favour of bulls, for every loser, there were more than three gainers.

Nifty's weekly chart does not seem to be that promising due to its straight vertical fall but momentum oscillator RSI (14) is currently below 30 level and most stocks are showing significant oversold rally, so one cannot negate a sharp oversold rally in benchmark index in coming days.

Once India VIX settles below 70 levels, there will be a decline in volatility.

On April 8, India VIX, after hitting an intraday low of 46.97, witnessed a sharp rally of almost 10 percent from the day’s low point.

Due to this sharp surge in India VIX, the market went through a roller coaster ride on April 8.

We are expecting Bank Nifty to trade in a broad range of 17,000 to 21,500 level.

A breakout on either side will give a classical consolidation range pattern breakout and will define the next level for the banking index.

Current chart formation suggests Nifty may find major support around 8,300 level which is well supported with an upward rising trend line, which is drawn by joining the lows of March 24.

However, on the higher side, the index will continue to face hurdles around 9,150 level. In the case of sharp short-covering and a pennant pattern breakout, Nifty may go to 9,650 level.

Here are three stock recommendations for the next 3-4 weeks:

HDFC Life Insurance Company | Buy | LTP: Rs 477.10 | Target price: Rs 540 | Stop loss: Rs 440 | Upside: 13.20%

The stock seems to have broken its last week’s consolidation range and is currently witnessing a pennant pattern breakout on the daily time frame.

The 200-week exponential moving average is acting as an anchor point and is one of the main reasons for the likely short-term bottom in the stock.

The counter has been forming a base near Rs 440 levels for the last few trading sessions which is supported by momentum oscillator RSI (14) which has rebounded from the oversold zone with positive crossover on a weekly interval.

Traders can accumulate the stock in a range of Rs 475-479 for the target of Rs 540 with a stop loss below Rs 440 on a daily closing basis.

ITC | Buy | LTP: Rs 178.60 | Target price: Rs 200 | Stop loss: Rs 165 | Upside: 12%

For the last couple of trading sessions, ITC has been sustaining above its horizontal trendline breakout on the daily interval.

The stock is trading above its 21-day exponential moving average and also above its four-week consolidation range on the daily scale.

This stock has been forming a base near Rs 165-170 levels for the last few trading sessions which is supported by momentum oscillator RSI (14) which has rebounded from the oversold zone with positive crossover on the weekly interval.

Traders can accumulate the stock in the range of Rs 178–179.50 for the target of Rs 200 with a stop loss below Rs 165 on a daily closing basis.

PVR | Sell | LTP: Rs 1,000.95 | Target price: Rs 820 | Stop loss: Rs 1,130 | Downside: 18.08%

PVR has breached its almost three-week-long consolidation pattern and is currently trading below its support level on a daily timeline.

Majority of indicators and oscillators are negatively poised and looking week.

The stock has drifted below its 50 and 100-day exponential moving average on the weekly timeframe, which indicates bears are in full control to push price lower.

The counter is likely to underperform the benchmark index which is visible on the Relative Strength (RS) indicator on a weekly interval.

Traders can short the stock in a range of Rs 995-1,008 for the target of Rs 820 with a stop loss above Rs 1,130 on a daily closing basis.

(The author is Technical Analyst, Bonanza Portfolio)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-heres-why-hdfc-life-itc-are-a-buy-in-the-short-term-5122861.html
10,"April 09, 2020 11:50 AM IST",1,Sunil Matkar,NLC India share price climbs 7% after mining resumes at Neyveli,"NLC India share price gained 6.7 percent intraday on April 9 after the company resumed mining operations of Neyveli Mines.
It was trading at Rs 46.25 on the BSE, up Rs 1.35, or 3.01 percent, at 1110 hours.
The lignite mining and power generation company informed exchanges on April 8 that the operations at Neyveli Mines were resumed on April 8.
To comply with the 21-day lockdown order, operations at opencast mines at Neyveli, including removal of overburden and mining of lignite, were put on hold, NLC told BSE on March 31.
But since NLC's opencast mines were linked to pit-head thermal power stations, lignite supply was continued from the pit head-stock to maintain the power generation.",The lignite mining and power generation company informed exchanges that operations at Neyveli Mines resumed on April 8.,"NLC India share price gained 6.7 percent intraday on April 9 after the company resumed mining operations of Neyveli Mines.

The stock has rallied 21 percent in the last two weeks after falling 36 percent from March 4. It was trading at Rs 46.25 on the BSE, up Rs 1.35, or 3.01 percent, at 1110 hours.

The lignite mining and power generation company informed exchanges on April 8 that the operations at Neyveli Mines were resumed on April 8.

To comply with the 21-day lockdown order, operations at opencast mines at Neyveli, including removal of overburden and mining of lignite, were put on hold, NLC told BSE on March 31.

But since NLC's opencast mines were linked to pit-head thermal power stations, lignite supply was continued from the pit head-stock to maintain the power generation.",https://www.moneycontrol.com/news/business/markets/nlc-india-share-price-climbs-7-after-mining-resumes-at-neyveli-5125831.html
11,"April 09, 2020 12:52 PM IST",1,Sunil Matkar,Aurobindo Pharma share price jumps 6% on USFDA nod for antidepressant,"Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating.
Aurobindo Pharma share price rallied more than 6 percent intraday on April 9 after the company received approval from the US health regulator for an antidepressant drug.
At 1209 hours, it was quoting at Rs 462.15, up Rs 23.90, or 5.45 percent, on the BSE.
Not only Aurobindo but the entire pharma sector has been buzzing for more than two weeks now.
Aurobindo Pharma had received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in 10 mg and 20 mg strengths, the company said in a BSE filing.",Aurobindo said this was the first ANDA to be approved out of APL Healthcare formulation facility in Hyderabad.,"Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?

Aurobindo Pharma share price rallied more than 6 percent intraday on April 9 after the company received approval from the US health regulator for an antidepressant drug.

The stock has gained 58 percent after dropping to Rs 294.7 on March 23, the lowest since May 2014. At 1209 hours, it was quoting at Rs 462.15, up Rs 23.90, or 5.45 percent, on the BSE.

Not only Aurobindo but the entire pharma sector has been buzzing for more than two weeks now.

Aurobindo Pharma had received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in 10 mg and 20 mg strengths, the company said in a BSE filing.

Fluoxetine tablets are generic version of Eli Lilly's Prozac' tablets.

The company said the product will be launched in April 2020 and has an estimated market size of $42 million for the 12 months ending February 2020, according to IQVIA.

Fluoxetine is indicated for the acute and maintenance treatment of major depressive disorders in adult patients and in children aged between 8 and 18.

This was the first ANDA to be approved out of APL Healthcare formulation facility in Hyderabad, India, for oral products, it said.",https://www.moneycontrol.com/news/business/markets/aurobindo-pharma-share-price-jumps-6-on-usfda-nod-for-antidepressant-5126111.html
12,"April 09, 2020 01:51 PM IST",1,Sunil Matkar,"L&T share price gains 3% on fund-raising nod, global orders","Larsen & Toubro share price gained more than 3 percent intraday on April 9 after the board approved fund raising and the company received global contracts.
The stock gained for the fourth consecutive session, rising 7.8 percent, while it rallied 18 percent from 2020's low touched on March 24.
The stock was trading at Rs 819.10, up Rs 11.45, or 1.42 percent on the BSE at 1321 hours.
Further, the power transmission and distribution business of L&T Construction has bagged orders in India and abroad.
Another order was for supplying and installing medium voltage capacitor banks with related accessories under different discoms in Uttar Pradesh, it added.",The power transmission and distribution business of L&T Construction has bagged orders in India and abroad.,"Larsen & Toubro share price gained more than 3 percent intraday on April 9 after the board approved fund raising and the company received global contracts.

The stock gained for the fourth consecutive session, rising 7.8 percent, while it rallied 18 percent from 2020's low touched on March 24. It had corrected 48 percent in two months.

The stock was trading at Rs 819.10, up Rs 11.45, or 1.42 percent on the BSE at 1321 hours.

In its BSE filing, L&T said the board of directors on April 9 approved long-term borrowing up to Rs 9,000 crore, either through external commercial borrowings, term loans, non-convertible debentures or any other instrument as may be appropriate.

Further, the power transmission and distribution business of L&T Construction has bagged orders in India and abroad.

""In Kuwait, we received order to upgrade substations and related power facilities in KNPC's Mina Al Ahmadi oil refinery and in Oman, the division has won a 400 kV grid station order which will be a crucial element in the Sultanate's major transmission initiative to interconnect the grids in the south and north with the PDO Area,"" the engineering and construction major said.

In Egypt, L&T has bagged order to design, supply, construct and commission a 220 kV gas insulated substation, while its renewable subsidiary has won large EPC orders on the domestic and international fronts to establish solar photovoltaic plants totalling more than 500 MW.

""An order has been won to strengthen the urban HT distribution network in Chennai with addition of ring main units and feeder remote terminal units on a total turnkey basis. Also, fully automated, unmanned 33 kV Gas Insulated Substations will be established at select locations,"" company said.

Another order was for supplying and installing medium voltage capacitor banks with related accessories under different discoms in Uttar Pradesh, it added.

In addition, L&T's hydrocarbon engineering division on April 8 received EPCC contract for setting up a new 9 MMTPA atmospheric & vacuum distillation unit (AVU) and allied facilities (EPCC-1 Package) for Barauni refinery capacity expansion project at Indian Oil Corporation's Barauni refinery in Bihar.

On April 7, too, the smart world & communication business of L&T Construction secured an order from the Indian Army for a unified network management system and to manage, support and operate the countrywide armed forces network under the network for spectrum.",https://www.moneycontrol.com/news/business/markets/lt-share-price-gains-3-on-fund-raising-nod-global-orders-5126671.html
13,"April 09, 2020 12:03 PM IST",1,Rakesh Patil,Cadila Healthcare share price hits 52-week high on USFDA nod for cancer drug,"Cadila Healthcare share price touched 52-week high of Rs 378, rising 8 percent intraday on April 9 after the company received final approval from the US drug regulator for a blood cancer drug.
Zydus Cadila has received final approval from the US Food and Drug Administration to market Imatinib Mesylate Tablets, 100 mg and 400 mg, as per a company release.
This medication is used to treat certain types of leukemia (blood cancer), bone marrow disorders, skin cancer and tumours of the stomach and digestive system.
The drug will be manufactured at the group’s Ahmedabad SEZ facility, it added.
At 1147 hours, Cadila Healthcare was quoting at Rs 355.70, up Rs 5.75, or 1.64 percent, on the BSE.",The drug will be manufactured at the group’s Ahmedabad SEZ facility.,"Cadila Healthcare share price touched 52-week high of Rs 378, rising 8 percent intraday on April 9 after the company received final approval from the US drug regulator for a blood cancer drug.

Zydus Cadila has received final approval from the US Food and Drug Administration to market Imatinib Mesylate Tablets, 100 mg and 400 mg, as per a company release.

This medication is used to treat certain types of leukemia (blood cancer), bone marrow disorders, skin cancer and tumours of the stomach and digestive system.

The drug will be manufactured at the group’s Ahmedabad SEZ facility, it added.

At 1147 hours, Cadila Healthcare was quoting at Rs 355.70, up Rs 5.75, or 1.64 percent, on the BSE.",https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-share-price-hits-52-week-high-on-usfda-nod-for-cancer-drug-5125901.html
14,"April 09, 2020 09:59 AM IST",2,Sandip Das,Ajanta Pharma share price jumps 8% on US FDA nod for cholesterol drug,"Share price of Ajanta Pharma jumped over 8 percent intraday on April 9 after the company received US FDA approval for Cholestyramine Powder.
It is used to lower high levels of cholesterol in the blood.
The stock hit a new 52-week high level of Rs 1,550 per share and was quoting at Rs 1,479.80, up Rs 114.45, or 8.38 percent.
It was trading with volumes of 3,681 shares, compared to its five day average of 4,407 shares, a decrease of -16.47 percent.
Its share price zoomed over 41 percent in the last 15 days.",Ajanta Pharma received US FDA nod for Cholestyramine Powder. It is used to lower high levels of cholesterol in blood.,"Share price of Ajanta Pharma jumped over 8 percent intraday on April 9 after the company received US FDA approval for Cholestyramine Powder. It is used to lower high levels of cholesterol in the blood.

The stock hit a new 52-week high level of Rs 1,550 per share and was quoting at Rs 1,479.80, up Rs 114.45, or 8.38 percent. It was trading with volumes of 3,681 shares, compared to its five day average of 4,407 shares, a decrease of -16.47 percent. Its share price zoomed over 41 percent in the last 15 days.

Pharmaceutical sales in March registered an 8.9 percent growth primarily on account of panic buying of medicines in the chronic categories.

Ajanta Pharma has committed Rs 6 crore to fight COVID-19 pandemic with Rs 2 crore been directly contributed to Prime Minister CARES Fund and the rest Rs 4 crore being spent on providing ventilators, thermal thermometers, sanitizers and protective gears such as latex gloves, gammex gloves, N-95 masks, PPE Kits, etc. to the government of Maharashtra, BMC and other agencies.",https://www.moneycontrol.com/news/business/stocks/ajanta-pharma-share-price-jumps-8-on-us-fda-nod-for-cholesterol-drug-5125061.html
15,"April 09, 2020 11:14 AM IST",1,Nishant Kumar,Hindalco shares jump 5% after Novelis receives clearance for Aleris acquisition,"Shares of Hindalco Industries climbed 5 percent in morning trade on BSE on April 9, buoyed by reports that Novelis has received the final regulatory clearance for the Aleris acquisition.
Novelis, the wholly-owned subsidiary of Hindalco Industries, has received the final regulatory clearance needed to complete its acquisition of Aleris.
JPMorgan said the acquisition of Aleris in the new economic environment may be earnings dilutive in the short-term.
On the other hand, Kotak Institutional Equities has a 'buy' recommendation on Hindalco with a target price of Rs 225.
""The Aleris acquisition would increase Hindalco’s debt by $2.2 billion in the interim till they divest the Lewisport plant, which in the current environment could take 9-12 months.","Novelis, the wholly-owned subsidiary of Hindalco Industries, has received the final regulatory clearance needed to complete its acquisition of Aleris. The European Commission (EC) has approved the Liberty House Group as a suitable buyer of the Duffel facility.","Shares of Hindalco Industries climbed 5 percent in morning trade on BSE on April 9, buoyed by reports that Novelis has received the final regulatory clearance for the Aleris acquisition.

Novelis, the wholly-owned subsidiary of Hindalco Industries, has received the final regulatory clearance needed to complete its acquisition of Aleris. The European Commission (EC) has approved the Liberty House Group as a suitable buyer of the Duffel facility.

As per a report by CNBC TV18, JPMorgan has an 'overweight' call on Hindalco with a reduced target price of Rs 170 from Rs 195 earlier.

JPMorgan said the acquisition of Aleris in the new economic environment may be earnings dilutive in the short-term. ""We ascribe a negative equity value of Rs 30 per share for the Aleris transaction,"" said JPMorgan.

JPMorgan expects a sharp volume and margin cuts at Novelis and lower EPS by 30 percent.

On the other hand, Kotak Institutional Equities has a 'buy' recommendation on Hindalco with a target price of Rs 225.

""The Aleris acquisition would increase Hindalco’s debt by $2.2 billion in the interim till they divest the Lewisport plant, which in the current environment could take 9-12 months. We estimate net debt/EBITDA to increase to 4.4 times in FY2021E given earnings hit led by COVID-19,"" Kotak said.

""With interest coverage of 2.5 times and FCF generation, we see the near-term spike in leverage manageable. Nonetheless, increase in leverage is discomforting given downside risk to earnings in FY2021E if COVID-19 led disruptions extend beyond one quarter,"" Kotak added.

The brokerage believes the stock is pricing in the uncertainty at current at 0.5 times P/B (ex-goodwill) FY2022E versus historic mean of 1.1 times and in line with 2008/2015 trough of 0.4 times.

Kotak finds risk-reward attractive at 4 times EV/EBITDA FY2022E versus historic mean of 6.5 times.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hindalco-shares-jump-5-after-novelis-receives-clearance-for-aleris-acquisition-5125601.html
16,"April 09, 2020 11:39 AM IST",1,Sunil Matkar,GRM Overseas locked in 5% upper circuit as operations commence,"Shares of GRM Overseas were locked in a 5 percent upper circuit on April 9 following commencement of plant operation.
At 1050 hours IST, it was trading at Rs 171.95 on the BSE, up Rs 8.15 or 4.98 percent.
The basmati rice maker on April 8 in its BSE filing said the plant operators have been restarted.
The company is equipped with three milling plants, each having a capacity of 20 tons per hour.
It sells basmati rice under its brands - Himalaya, Jaipure and 7 Express.","The stock has been consistent gainer after March 25, rising 44.5 percent till today.","Shares of GRM Overseas were locked in a 5 percent upper circuit on April 9 following commencement of plant operation.

The stock has been a consistent gainer after March 25, rising 44.5 percent till April 9. However, it had fallen more than 40 percent in the last four months.

At 1050 hours IST, it was trading at Rs 171.95 on the BSE, up Rs 8.15 or 4.98 percent. It has a market capitalisation of Rs 63.44 crore.

The basmati rice maker on April 8 in its BSE filing said the plant operators have been restarted.

The company is equipped with three milling plants, each having a capacity of 20 tons per hour. It sells basmati rice under its brands - Himalaya, Jaipure and 7 Express.

To ensure the safety of employees and workmen, the company had temporarily shut down the operations of plants situated at various states and closed down all the offices and warehouses from March 30.",https://www.moneycontrol.com/news/business/markets/grm-overseas-locked-in-5-upper-circuit-as-operations-commence-5125671.html
17,"April 09, 2020 11:13 AM IST",2,Sandip Das,Astron Paper share price spikes 10% after nod to restart production at Bhuj,"Astron Paper & Board Mill share price spiked almost 10 percent after the company received permission from the Gujarat government to commence production for its unit at Bhuj.
""We would like to inform you that we have been received permission from the government of Gujarat regarding the commencement of Unit-2 located at Bhuj, Gujarat.
Balaram Papers Private Limited, wholly-owned subsidiary company also received permission to commence operation.
It gained 13 percent in the last 7 days and was quoting at Rs 30, up Rs 2.65, or 9.69 percent.
It has touched an intraday high of Rs 30.05 and an intraday low of Rs 29.10.","The stock witnessed a spurt in volume by more than 1.39 times and was trading with volumes of 9,269 shares.","Astron Paper & Board Mill share price spiked almost 10 percent after the company received permission from the Gujarat government to commence production for its unit at Bhuj.

""We would like to inform you that we have been received permission from the government of Gujarat regarding the commencement of Unit-2 located at Bhuj, Gujarat. Unit-1 (PM-1 and 2) located at Halvad, District- Morbi, Gujarat remain shut during this lockdown period. Balaram Papers Private Limited, wholly-owned subsidiary company also received permission to commence operation. Hence, we have partially started production with a bare minimum strength of men power and with conditions/directions/ guideline issued by Ministry of Health and Family Welfare Govt of India and by Government of Gujarat with respect to preventive measures taken for this COVID-19,"" the company said in a filing to the exchanges.

The stock witnessed a spurt in volume by more than 1.39 times and was trading with volumes of 9,269 shares, compared to its five-day average of 4,923 shares, an increase of 88.27 percent.

It gained 13 percent in the last 7 days and was quoting at Rs 30, up Rs 2.65, or 9.69 percent. It has touched an intraday high of Rs 30.05 and an intraday low of Rs 29.10.",https://www.moneycontrol.com/news/business/stocks/astron-paper-share-price-spikes-10-after-nod-to-restart-production-at-bhuj-5125471.html
18,"April 08, 2020 05:28 PM IST",1,Rakesh Patil,"Slideshow | Sensex ends below 30,000; here are the top 10 gainers on April 8","Wipro shares rallied 4 percent as the company's board plans to meet on April 15 to consider and approve the condensed audited standalone and consolidated financial results under IndAS for the quarter and year ended March 31, 2020.","On April 8, Sensex slipped below 30,000 in a volatile session.","Wipro shares rallied 4 percent as the company's board plans to meet on April 15 to consider and approve the condensed audited standalone and consolidated financial results under IndAS for the quarter and year ended March 31, 2020.",https://www.moneycontrol.com/news/business/stocks/slideshow-sensex-ends-below-30000-here-are-the-top-10-gainers-on-april-8-5120541.html
19,"April 09, 2020 10:40 AM IST",1,Sandip Das,ICICI Bank share price jumps 3% after Kotak maintains 'buy' call,"The share price of ICICI Bank jumped almost 4 percent intraday on April 9 after research and broking firm Kotak Institutional Equities maintained its “buy” call on the stock but cut target to Rs 490 from Rs 615 per share.
The bank continued to be the top pick for Kotak, a CNBC-TV18 report said.
… this would add immense convenience to our customers as it allows them to bank while they are on social media,"" ICICI Bank Executive Director Anup Bagchi said in a release.
ICICI Bank is one of the largest private banks in the country with 5,275 branches and a loan book of Rs 6,35,654 crore.
ICICI Bank has put all loans and credit facilities into two categories, depending on the impact of the coronavirus outbreak.",Kotak is of the view that the bank is well-positioned to come through this period with a lower degree of stress.,"The share price of ICICI Bank jumped almost 4 percent intraday on April 9 after research and broking firm Kotak Institutional Equities maintained its “buy” call on the stock but cut target to Rs 490 from Rs 615 per share. The bank continued to be the top pick for Kotak, a CNBC-TV18 report said.

The underlying conditions provided a favourable testing ground for the bank, which was well-positioned to come through the period with a lower degree of stress, Kotak said.

Amid the ongoing lockdown, the bank has launched its services on messaging platform WhatsApp, a move that will allow customers to avail banking services 24x7 without the need to visit a branch.

""Our retail customers can execute a host of their banking requirements on their own, without visiting a branch. … this would add immense convenience to our customers as it allows them to bank while they are on social media,"" ICICI Bank Executive Director Anup Bagchi said in a release.

ICICI Bank is one of the largest private banks in the country with 5,275 branches and a loan book of Rs 6,35,654 crore. It trades at attractive valuations and trades less than 1-time adjusted book and holds many subsidiary companies which can create additional value, said A K Prabhakar, Head - Research at IDBI Capital.

ICICI Bank has put all loans and credit facilities into two categories, depending on the impact of the coronavirus outbreak. For all credit card dues, standard interest rates of the card variant will be levied. The interest rate specified at the time of availing of the EMI facility would be levied for all EMI transactions.

The stock, which has gained 16 percent in the last 15 days, was quoting at Rs 330.75, up Rs 11.75, or 3.68 percent. It has touched an intraday high of Rs 336.15 and an intraday low of Rs 326.30.

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/icici-bank-share-price-jumps-3-after-kotak-maintains-buy-5125331.html
20,"April 09, 2020 01:29 PM IST",0,Kshitij Anand,This fund manager shares mantra for picking sectors for post-COVID-19 world,"Q) We have already seen a big casualty in the form of IndiaNivesh Securities broking arm shutting down the operations.
In the long term, markets will eventually reflect the inherent strength and value of the businesses comprising the market.
It helps to keep in mind that “In the short term the markets are a voting machine but in the long term a weighing machine”.
What are your views on earnings, markets, flows, as well as demand?
For investors, near quarter earnings growth does not change the fair value of good businesses by anywhere close to the magnitude of price corrections we have seen in the market.","With the low cost of money globally and various reforms carried out in the past, India should be able to attract more external capital","A) There is a lot of grey area and a lot of varied definitions of what comprises ESG and a company faring well on ESG scores by one criterion might have much lower scores by another.

Q) Do you think companies in the ESG space could get attention?

A) Such periods of high volatility, uncertainty and disruption do impact the smaller/vulnerable firms across industries and lead to higher degrees of consolidation. It is also a sign of a competitive/dynamic industry structure. I think it is no different within the financial services industry.

Q) We have already seen a big casualty in the form of IndiaNivesh Securities broking arm shutting down the operations. Do you think this could just be the starting?

These will include leading names in the private banking and insurance segment. Demand for various consumer discretionary items across segments such as passenger vehicles, AC, jewelry amongst others will get deferred but eventually, they will all come back. Market leaders in these segments should do well.

A) Many quality businesses run by good management, addressing large-sized structural opportunities and which have grown profitably in the past will continue to do so in the future across industries.

Q) We have seen massive wealth erosion in most of the top-quality stocks in FY20, and as we step into FY21 some of those names could give multibagger returns if someone is investing in them now. Which are the sectors that could lead the way?

But since there can be more volatility and remain so for an uncertain period, an investor can choose his/her approach basis discussion with his financial advisor. We think a mix of lump sum and staggered approach might be fine in the current circumstances.

In the long term, markets will eventually reflect the inherent strength and value of the businesses comprising the market. The recent ~35% correction brings valuations to attractive levels given that fair value of businesses have not got impaired anywhere close to what the prices are suggesting.

The global flows, in turn, are being determined more by factors such as fear. It helps to keep in mind that “In the short term the markets are a voting machine but in the long term a weighing machine”.

If they are unallocated/under-allocated to equity, given risk profile, this is a wonderful opportunity to correct that imbalance. The short term is expected to be fairly volatile and global flows will determine this volatility.

A) Investors should look at an allocation into equities only from within what they have kept aside as an investment/savings pool. These are good times to refresh this asset allocation.

Q) Smart investors might be looking to buy the dip – what would you advise – lump sum or staggered approach in direct equities or mutual funds?

Many quality businesses run by good management, addressing large-sized structural opportunities and which have grown profitably in the past will continue to do so in the future across industries will bounce back, Gaurav Misra, Senior Fund Manager- Equity, Mirae Asset Investment Managers India, said in an interview with Moneycontrol’s Kshitij Anand.

Thus, India’s leading tobacco company might be ranked higher on ESG scores (by some rating methodology) than some well-managed consumer companies but get excluded by other ESG ratings (on basis of the sector).Similarly, India’s leading power utility is spending billions of dollars to reduce its NOX/SO2 emissions to be at par with gas-based plants and further improve its ESG score.

While predominantly thermal it is moving towards a larger share of Renewable’s organically and through acquisitions. Yet it is getting penalised for being a “thermal power (coal-based)” producer.

The thought behind a greater focus on sustainable aspects of environment and society, is important in the long term for everyone. Good governance which should include among other things, minority shareholder interest (through better risk controls, capital allocation, etc), was always important for us.

Q) What are your expectations from FY21? What are your views on earnings, markets, flows, as well as demand?

A) My expectation for FY21 is fluid and will depend on:

1) The timelines on how successfully India and other countries are able to contain the spread of COVID 19 and the concomitant development of drugs and vaccines, if any.

2) The appropriateness, efficacy, and optimality of various monetary and fiscal measures announced by the government.

In the short term, there is a partial/complete cessation of activities barring a few sectors such as agriculture, government administration/healthcare, utilities, telecom/internet, etc. This will lead to a sharp contraction of near term (next 1-3 quarters) GDP and pull-down corporate revenues and earnings as well.

In the short period, it is important that the supply shock is minimised by ensuring that supply and production chains across essential goods (including farming activity) and other segments (when opened up) are intact and functioning, otherwise, problems will get amplified.

India was emerging from a combination of cyclical and structural slowdown. The auto sector was in a cyclical downturn for over 4 quarters and expected to turnaround during the year.

Sectors such as real estate are to emerge from a structural transformation post demonetisation and RERA, while the banking sector was emerging from asset quality issues. In a way the starting point for India is advantageous.

We are coming from a low but improving base of overall activity and the coronavirus is an external shock to the Indian system.

Since the cause of the problem is external to India and it is not a structural problem or one of our own making, one can be hopeful that recovery could be fast (if healthcare and monetary/fiscal interventions are successful) as well.

However, given the novel nature of the virus, the pandemic problem could persist/spread for longer. In that scenario the recovery as and when it starts will be slower and gradual. A longer pandemic episode could hurt more firms and create more job losses.

Thus, it is still a very fluid situation and we are not sure on the magnitude of earnings that might be cut for FY21. For investors, near quarter earnings growth does not change the fair value of good businesses by anywhere close to the magnitude of price corrections we have seen in the market.

Hence in a way a lot of the expected medium-term weakness and possibly more has already been discounted by the markets.

Since the markets have corrected by over 35%, valuations on all parameters are at attractive levels. The Market Cap to GDP as well as the overall Price/book is now at a level it was during the Global Financial Crisis of 2008-9.

Historically, Indian markets have been found at the current valuation range only about 5% of the time. The bond and earnings yield gap are also at a maximum post the GFC. These are attractive entry levels for an investor looking for absolute/relative returns.

Of course, the markets can correct more but I cannot predict that. On the other hand, in periods of uncertainty and weak economic cues – strong well-run businesses tend to be more immune and gain market share at the cost of weaker firms.

Lastly, major economies have undertaken a lot of monetary/fiscal easing. This will help global economies on the upside when it starts. The monetary expansion will also lead to some money coming back to attractive emerging markets such as India.

Domestic money inflows, especially through the SIP route, have held up well in all recent bouts of volatility. I expect this to continue and it shows the better understanding investors have of the underlying volatility and investment horizon expected from this asset class.

Q) Once the lockdown is over and we (the whole world) come out of COVID-19, what will be the new normal which the world will be looking at in investments, insurance, food habits, consumption etc.?

A) Ultimately, India will retain its structural-demographic advantage. With the low cost of money globally and various reforms carried out in the past, India should be able to attract more external capital.

There could be an increasing trend towards greater sourcing from countries beyond China and India could attract more FDI in select industries as one of the alternate manufacturing hubs in the world.

There could be a greater move towards online shopping of financial-investment/insurance products, other services – such as education, higher levels of work from home, as well as for online shopping.

There could be an increasing shift toward robotic manufacturing. Typically, we would expect more movement towards the organised sector on the criterion of quality and safety in segments such as food staples. Many of these trends were underway post GST and demonetisation.

Maybe some trends such as the extensive use of Ola/Uber are reversed as people prefer their own vehicles on safety grounds. Deeper shifts in consumer behaviour will depend on the duration of the lockdown and the pandemic.

Additionally, there could be a strengthening of the country’s medical infrastructure and capacity.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/this-fund-manager-shares-mantra-for-picking-sectors-for-post-covid-19-world-5126051.html
21,"April 09, 2020 10:48 AM IST",1,Nishant Kumar,"Titan share price up 3%, company says Q4 growth broadly in line","Titan Company share price climbed over 3 percent in the morning trade on BSE on April 9, a day after the company said its growth in Q4FY20 was mostly in line but the coronavirus outbreak had hurt sales.
""The quarter commenced well with the growth largely in line with our targets till the beginning of March.
As per the BSE filing, the company's revenue for the division declined by 5 percent due to lost sales in March.
The diamond-studded activation in the quarter did well and wedding jewellery sales continued to be good till the disruption, said the company.
The company said its watches and wearables division grew by 1 percent despite the significant loss of sales in the month of March.",The company said its watches and wearables division grew by 1 percent despite the significant loss of sales in the month of March.,"Titan Company share price climbed over 3 percent in the morning trade on BSE on April 9, a day after the company said its growth in Q4FY20 was mostly in line but the coronavirus outbreak had hurt sales.

""The quarter commenced well with the growth largely in line with our targets till the beginning of March. However, sales started dipping sharply in March, particularly in the watches segment, due to COVID-19,"" the company said in a regulatory filing on April 8, referring to the respiratory disease caused by the coronavirus.

As per the BSE filing, the company's revenue for the division declined by 5 percent due to lost sales in March. Revenue growth of January and February month was at about 16.5 percent.

The diamond-studded activation in the quarter did well and wedding jewellery sales continued to be good till the disruption, said the company.

During the year, the division added 40 Tanishq stores, 1 Zoya store and 8 Mia stores for the year to date on a net basis, with the retail space addition being nearly 1,51,000 sq ft, said the company.

The company said its watches and wearables division grew by 1 percent despite the significant loss of sales in the month of March.

In the eyewear segment, growth was subdued in the quarter primarily due to the decline in trade channel but the disruption in March led to a 20 percent decline in revenues for the quarter. Growth for January and February months was flat, said the company.

Brokerage firm Motilal Oswal Financial Services has a “neutral” view on the stock, with a target price of Rs 1,320 and said that even though its rating on the stock is neutral, its longer-term topline and earnings opportunity remain attractive.

As per the brokerage, the coronavirus disruption was expected to strongly impact the business performance of the company, especially due to its extensive presence in malls, which were shut down even before the 21-day lockdown was announced.

Even after the lockdown ends, the footfall in malls is likely to be low as people will continue to maintain social distancing.

""It would be interesting to hear the management commentary on the road ahead. We would prefer to wait and watch in the current scenario, as there is no clarity on when the lockdown will be lifted. We are yet to incorporate the impact of the lockdown in our estimates,"" Motilal Oswal said.

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/titan-share-price-up-3-company-says-q4-growth-broadly-in-line-5124891.html
22,"April 09, 2020 11:38 AM IST",0,,Coronavirus pandemic | NSE gives more time to brokers for submission of reports,"The National Stock Exchange (NSE) has relaxed compliance requirements for brokers to submit reports pertaining to client funding and net worth certificates in the wake of prevailing coronavirus pandemic.
However, the due date for submitting the quarterly report on the incidence of cyber-attacks and threats will remain unchanged — 15 days after the end of the quarter, NSE said in a circular.
The exchange has given time till April 30 to brokers for submitting reports on client funding, artificial intelligence (AI) and machine learning (ML) applications and quarterly compliance certificate.
Also, reports on system or cyber audit can now be submitted till July 31.
In view my of the ongoing lockdown, the due dates for submitting these reports have been extended, the exchange said.",The National Stock Exchange (NSE) has relaxed compliance requirements for brokers to submit reports pertaining to client funding and net worth certificates in the wake of prevailing coronavirus pandemic.,"The National Stock Exchange (NSE) has relaxed compliance requirements for brokers to submit reports pertaining to client funding and net worth certificates in the wake of prevailing coronavirus pandemic.

However, the due date for submitting the quarterly report on the incidence of cyber-attacks and threats will remain unchanged — 15 days after the end of the quarter, NSE said in a circular.

The exchange has given time till April 30 to brokers for submitting reports on client funding, artificial intelligence (AI) and machine learning (ML) applications and quarterly compliance certificate.

The due dates for submitting the report on AI and ML applications and quarterly compliance certificate was April 15, while the same for client funding was April 7.

Further, NSE has extended time by one month, till June 30, for submission of the report on risk-based supervision, audit as well as net worth certificate for members for the half year ending March 2020. These reports were required to be submitted at the end of May.

Also, reports on system or cyber audit can now be submitted till July 31. Earlier, it was required to be submitted by June 30.

Besides, the exchange has given relaxation of one month till May 31 for submitting compliance certificates on margin trading for half year ending March 2020.

In view my of the ongoing lockdown, the due dates for submitting these reports have been extended, the exchange said.",https://www.moneycontrol.com/news/business/coronavirus-pandemic-nse-gives-more-time-to-brokers-for-submission-of-reports-5125501.html
23,"April 09, 2020 10:01 AM IST",2,Rakesh Patil,Cipla share price hits 52-week high on final approval from US FDA,"Cipla share price touched a 52-week high of Rs 589.95, rising 15 percent in the early trade on April 9 after the company received final approval from the United States Food and Drug Administration (US FDA).
The company has received final approval for its Abbreviated new drug application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (USFDA), as per company release.
Albuterol Sulfate Inhalation Aerosol is the first AB-rated generic therapeutic equivalent version of Merck Sharp & Dohme Corp’s Proventil HFA Inhalation Aerosol.
Proventil HFA Inhalation Aerosol and its authorized generic equivalent had US sales of approximately USD 153 million for the 12-month period ending February 2020.
The entire Albuterol Sulfate HFA Inhalation Aerosol market had US sales of approximately USD 2.8 billion for the 12-month period ending February 2020, according to IQVIA (IMS Health).","There were pending buy orders of 110,157 shares, with no sellers available.","Cipla share price touched a 52-week high of Rs 589.95, rising 15 percent in the early trade on April 9 after the company received final approval from the United States Food and Drug Administration (US FDA).

The company has received final approval for its Abbreviated new drug application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (USFDA), as per company release.

Albuterol Sulfate Inhalation Aerosol is the first AB-rated generic therapeutic equivalent version of Merck Sharp & Dohme Corp’s Proventil HFA Inhalation Aerosol. It is used for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms, it added.

Proventil HFA Inhalation Aerosol and its authorized generic equivalent had US sales of approximately USD 153 million for the 12-month period ending February 2020. The entire Albuterol Sulfate HFA Inhalation Aerosol market had US sales of approximately USD 2.8 billion for the 12-month period ending February 2020, according to IQVIA (IMS Health).

“We are pleased to receive the final approval for generic Albuterol MDI from the USFDA. This further strengthens our presence in the US market,"" said Umang Vohra, MD and Global CEO, Cipla Limited.

""We will continue to build on our portfolio of drug-device combinations in the respiratory space to serve the unmet needs of our patients across markets,” he added.

We are planning shipments in a staggered manner. We are also ensuring that we do our bit by donating the product in this time of need, the company said.

At 09:40 hrs, Cipla was quoting at Rs 589.95, up Rs 76.95, or 15 percent on the BSE.

There were pending buy orders of 110,157 shares, with no sellers available.",https://www.moneycontrol.com/news/business/stocks/cipla-share-price-hits-52-week-high-on-final-approval-from-us-fda-5125071.html
24,"April 09, 2020 02:30 PM IST",2,Sunil Matkar,M&M shares surge 10% after CRISIL reaffirms rating,"Mahindra and Mahindra share price has gained for the fourth consecutive session, rising 10 percent intraday on April 9 after CRISIL reaffirmed its rating.
The stock rallied 31 percent in four straight sessions and one of the reasons for the rally was also the company's decision to stop injecting money into SsangYong Motor Company (SYMC).
It was trading at Rs 355.05, up Rs 28.50 or 8.73 percent on the BSE at 1345 hours IST.
M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long term rating at AAA/Stable and short term rating at A1+ for the company's bank facilities.
The rating agency also reaffirmed its rating on the company's Rs 475 crore and Rs 500 crore non-convertible debentures at AAA/Stable, while the rating on commercial paper, which has been enhanced to Rs 1,000 crore from Rs 500 crore earlier, has also been reaffirmed at A1+, it added.",M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long term rating at AAA/Stable and short term rating at A1+ for company's bank facilities.,"Mahindra and Mahindra share price has gained for the fourth consecutive session, rising 10 percent intraday on April 9 after CRISIL reaffirmed its rating.

The stock rallied 31 percent in four straight sessions and one of the reasons for the rally was also the company's decision to stop injecting money into SsangYong Motor Company (SYMC).

It was trading at Rs 355.05, up Rs 28.50 or 8.73 percent on the BSE at 1345 hours IST.

M&M in its BSE filing on April 9 said CRISIL has reaffirmed its long term rating at AAA/Stable and short term rating at A1+ for the company's bank facilities.

The rating agency also reaffirmed its rating on the company's Rs 475 crore and Rs 500 crore non-convertible debentures at AAA/Stable, while the rating on commercial paper, which has been enhanced to Rs 1,000 crore from Rs 500 crore earlier, has also been reaffirmed at A1+, it added.

""The ratings continue to reflect M&M's leadership in the Indian tractor industry and healthy market position in light commercial vehicles (LCVs). The ratings also factor in a strong financial risk profile, supported by a robust balance sheet with low leverage and high financial flexibility,"" CRISIL said in its note.

These strengths are partially offset by exposure to cyclicality inherent in the farm equipment (tractor) and automotive (auto) segments, exposure to risks pertaining to acquisitions and investments in subsidiaries/joint ventures (JVs), and decline in market share in the utility vehicle (UV) space over the last few years, it added.

According to the rating agency, the outbreak of the novel coronavirus (COVID-19) is expected to affect each of the major segments over the near term - both in terms of disruption of the supply chain, and/or end-demand.

""Nevertheless, M&M's strong capital structure and liquidity position, along with the benefit of diversification of its business profile supports its credit profile,"" CRISIL said.

Meanwhile, on April 3, M&M in its special board of directors meeting, reviewed investment in SsangYong Motor Company and took a decision that it will not be able to inject any fresh equity into SYMC and has urged SYMC to find alternate sources of funding.

""However, with a view to enable SYMC to have continuity of business operations, whilst they are exploring alternate sources of funding, the board has authorised the M&M management to consider a special one-time infusion of up to 40 billion KRW ($32 million) over the next three months,"" company said.

Moreover, M&M said it would make every effort to continue to support all other non-fund initiatives that are currently in place to help SYMC reduce capex, save costs and secure funds.

The board had received the request from the management and labour union of SsangYong Motor Company for fresh injection of equity from M&M to help the company fund 500 billion KRW ($406 million) of requirements over the next three years.",https://www.moneycontrol.com/news/business/markets/mm-shares-surge-10-after-crisil-reaffirms-rating-5126831.html
0,"April 07, 2020 03:38 PM IST",2,Rakesh Patil,Granules India share price gains 12% on EU GMP approval,"Granules India share price added 12 percent intraday on April 7 after its facility in Andhra Pradesh's Visakhapatnam received EU good manufacturing practice approval.
The approval for Unit-V, high potent API and Finished Formulations manufacturing facility, which was audited in January, will be valid for threeAt 1445 hours, Granules India was quoting at Rs 156.75, up Rs 15.70, or 11.13 percent, on the BSE.
The share touched its 52-week high of Rs 188.85 on February 19, 2020 and 52-week low of Rs 84.25 on July 26, 2019.
Currently, it is trading 17 percent below its 52-week high and 86.05 percent above its 52-week low.",The EU nod for the company's Visakhapatnam facility will be valid for three years.,"Granules India share price added 12 percent intraday on April 7 after its facility in Andhra Pradesh's Visakhapatnam received EU good manufacturing practice approval.

The approval for Unit-V, high potent API and Finished Formulations manufacturing facility, which was audited in January, will be valid for three

At 1445 hours, Granules India was quoting at Rs 156.75, up Rs 15.70, or 11.13 percent, on the BSE.

The share touched its 52-week high of Rs 188.85 on February 19, 2020 and 52-week low of Rs 84.25 on July 26, 2019.

Currently, it is trading 17 percent below its 52-week high and 86.05 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/granules-india-share-price-gains-12-on-eu-gmp-approval-5116561.html
1,"April 07, 2020 04:55 PM IST",0,Sandip Das,Winners & Losers: 10 stocks that moved the most on April 7,"HDFC Bank | Shares jumped over 10 percent after the bank's advances aggregated to approximately Rs 9,930 billion as of Q4 FY20, a growth of around 21 percent as compared to Rs.
8,194 billion as of 31 March 2019, it said in a regulatory filing.",IndusInd Bank and HDFC Bank from the banking space were the top gainers while Dr Reddy's Labs and Lupin rallied from the pharma space.,"HDFC Bank | Shares jumped over 10 percent after the bank's advances aggregated to approximately Rs 9,930 billion as of Q4 FY20, a growth of around 21 percent as compared to Rs. 8,194 billion as of 31 March 2019, it said in a regulatory filing.",https://www.moneycontrol.com/news/business/stocks/winners-losers-10-stocks-that-moved-the-most-on-april-7-5116961.html
2,"April 08, 2020 01:25 PM IST",2,Nishant Kumar,Cadila share price surges 15% on USFDA approval for Perphenazine tablets,"Cadila Healthcare share price surged 15 percent in intraday trade on BSE on April 8, a day after the company said it received approval from the US drug regulator for Perphenazine tablets.
""Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg,"" the company said in a release.
This medication is for the treatment of schizophrenia and for the control of severe nausea and vomiting in adults.
Zydus Cadila presents itself as an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.
The BSE has sought clarification from Cadila Healthcare after an article on abplive.com on April 7 said ""COVID 19 - Cadila Healthcare claims to make coronavirus medicine"".",The drug is for the treatment of schizophrenia and controlling severe nausea and vomiting in adults.,"Cadila Healthcare share price surged 15 percent in intraday trade on BSE on April 8, a day after the company said it received approval from the US drug regulator for Perphenazine tablets.

""Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg,"" the company said in a release.

This medication is for the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. The drug will be manufactured at the group’s manufacturing facility at Baddi.

The group now has 284 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04, said the release.

Zydus Cadila presents itself as an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

The BSE has sought clarification from Cadila Healthcare after an article on abplive.com on April 7 said ""COVID 19 - Cadila Healthcare claims to make coronavirus medicine"".

A response from the company is awaited.

At 1305 hours, the stock, which has been in the green since April 3, was trading at Rs 351.90, up 12.61 percent.",https://www.moneycontrol.com/news/business/markets/cadila-share-price-surges-15-on-usfda-approval-for-perphenazine-tablets-5120841.html
3,"April 08, 2020 08:10 AM IST",0,Priyanka Roshan,"In pics | Stocks in the news: Maruti Suzuki, Wipro, VA Tech Wabag, Adani Green, IndusInd Bank",Indiabulls Housing Finance: Rating agency ICRA downgraded the outlook on the long-term rating to negative due to the heightened risk from its investment in Yes Bank's additional tier 1 bonds and loans given to companies belonging to the former promoters of the bank.,"IndusInd Bank, Sudarshan Chemical are also among the stocks in the news today.",Indiabulls Housing Finance: Rating agency ICRA downgraded the outlook on the long-term rating to negative due to the heightened risk from its investment in Yes Bank's additional tier 1 bonds and loans given to companies belonging to the former promoters of the bank.,https://www.moneycontrol.com/news/business/stocks/in-pics-stocks-in-the-news-maruti-suzuki-wipro-va-tech-wabag-adani-green-indusind-bank-5118491.html
4,"April 08, 2020 11:24 AM IST",1,Nishant Kumar,Adani Green Energy shares jump 5% after forming JV with TOTAL,"Shares of Adani Green Energy jumped almost 5 percent in morning trade on BSE on April 8, a day after the company said it received Rs 3,707 crore for the formation of the joint-venture (JV) with a French firm TOTAL.
""TOTAL S.A. (TOTAL), through its step-down subsidiary has invested approximately Rs 3,707 crore for a 50 percent partnership with Adani Green in a JV,"" a regulatory filing by the company on April 7 said.
Adani Green Energy, part of the diversified Adani Group, is one of the largest renewable companies in India.
TOTAL is a major energy player that produces and markets fuels, natural gas and low-carbon electricity.
Shares of Adani Green traded 3.08 percent up at Rs 163.90 on BSE around 11:15 hours.","Adani Green Energy, part of the diversified Adani Group, is one of the largest renewable companies in India. TOTAL is a major energy player that produces and markets fuels, natural gas and low-carbon electricity.","Shares of Adani Green Energy jumped almost 5 percent in morning trade on BSE on April 8, a day after the company said it received Rs 3,707 crore for the formation of the joint-venture (JV) with a French firm TOTAL.

""TOTAL S.A. (TOTAL), through its step-down subsidiary has invested approximately Rs 3,707 crore for a 50 percent partnership with Adani Green in a JV,"" a regulatory filing by the company on April 7 said.

""Through the establishment of the joint venture, both partners aim to adhere to the highest standards of governance and strengthen the foundation of the partnership between the two groups. The closing of the transaction in the current environment reinforces the strength of the relationship between the partners and further underscores the robust climate commitment of both partners,"" the BSE filing added.

Adani Green Energy, part of the diversified Adani Group, is one of the largest renewable companies in India. TOTAL is a major energy player that produces and markets fuels, natural gas and low-carbon electricity.

Shares of Adani Green traded 3.08 percent up at Rs 163.90 on BSE around 11:15 hours.",https://www.moneycontrol.com/news/business/markets/adani-green-energy-shares-jump-5-after-forming-jv-with-total-5120141.html
5,"April 08, 2020 12:14 PM IST",1,,Adani Green Energy shares jump 5% after Total SA deal,"Shares of Adani Green Energy gained 5 per cent on Wednesday after Total SA said it has invested Rs 3,707 crore in a solar energy joint venture with the domestic firm.
The scrip jumped 4.90 per cent to Rs 166.80 on the BSE.
On the NSE, it gained 4.97 per cent to Rs 166.85.
Total SA on Tuesday said it has invested Rs 3,707 crore to set up 50:50 joint venture with Adani Green Energy Ltd (AGEL) through its step-down subsidiary.
The French energy firm had last year picked up a 50 per cent stake in the 5 million tonnes per year LNG import terminal that the Adani Group is building at Dhamra in Odisha's Bhadrak district.","Total SA on Tuesday said it has invested Rs 3,707 crore to set up 50:50 joint venture with Adani Green Energy Ltd (AGEL) through its step-down subsidiary.","Shares of Adani Green Energy gained 5 per cent on Wednesday after Total SA said it has invested Rs 3,707 crore in a solar energy joint venture with the domestic firm. The scrip jumped 4.90 per cent to Rs 166.80 on the BSE.

On the NSE, it gained 4.97 per cent to Rs 166.85.

Total SA on Tuesday said it has invested Rs 3,707 crore to set up 50:50 joint venture with Adani Green Energy Ltd (AGEL) through its step-down subsidiary.

The closing of the transaction in the current environment reinforces the strength of the relationship between the partners and further underscores robust climate commitment of both partners, it stated.

The French energy firm had last year picked up a 50 per cent stake in the 5 million tonnes per year LNG import terminal that the Adani Group is building at Dhamra in Odisha's Bhadrak district.",https://www.moneycontrol.com/news/business/stocks/adani-green-energy-shares-jump-5-after-total-sa-deal-5120371.html
6,"April 08, 2020 02:27 PM IST",1,Rakesh Patil,"West Coast Paper, Emami Paper start production partially; shares price locked at upper circuit","West Coast Paper Mills and Emami Paper share price locked at 5 percent upper circuit on April 8 after the company started production, albeit partially, at its Dandeli unit.
""We have partially started production at paper and duplex board division, Dandeli with a bare minimal strength of staff/labour, company said in the release.
Also, Emami Paper Mills has obtained special permission from the District Magistrate and started partial operation of manufacturing facilities at Balasore (Odisha).
Emami Paper Mills was quoting at Rs 56.95, up Rs 2.70, or 4.98 percent and West Coast Paper Mills was quoting at Rs 143.30, up Rs 6.75, or 4.94 percent on the BSE.
West Coast Paper Mills touched a 52-week high of Rs 297 and a 52-week low of Rs 99.90 on 30 May 2019 and 25 March 2020, respectively.","The share touched its 52-week high Rs 297.00 and 52-week low Rs 99.90 on 30 May, 2019 and 25 March, 2020, respectively.","West Coast Paper Mills and Emami Paper share price locked at 5 percent upper circuit on April 8 after the company started production, albeit partially, at its Dandeli unit.

""We have partially started production at paper and duplex board division, Dandeli with a bare minimal strength of staff/labour, company said in the release.

The production has started with strict adherence to the conditions, guidelines/instructions of Ministry of Health & Family Welfare Govt of India and Department of Health & Family Welfare, Govt. of Karnataka with regard to the preventive measures taken for combating COVID -19, it added.

Also, Emami Paper Mills has obtained special permission from the District Magistrate and started partial operation of manufacturing facilities at Balasore (Odisha).

Emami Paper Mills was quoting at Rs 56.95, up Rs 2.70, or 4.98 percent and West Coast Paper Mills was quoting at Rs 143.30, up Rs 6.75, or 4.94 percent on the BSE.

West Coast Paper Mills touched a 52-week high of Rs 297 and a 52-week low of Rs 99.90 on 30 May 2019 and 25 March 2020, respectively.

Currently, it is trading 51.75 percent below its 52-week high and 43.44 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/west-coast-paper-starts-production-partially-share-price-locked-at-upper-circuit-5121261.html
7,"April 07, 2020 09:30 PM IST",-2,,"Debt-laden DHFL not to make any payment to lenders, bond","Dewan Housing Finance Corporation (DHFL) on Tuesday said it will not make any interest or principal payment to lenders as well as bondholders as the company is under resolution process.
The Corporate Insolvency Resolution Process (CIRP) was initiated against the debt-ridden company as per the provisions of the Insolvency and Bankruptcy Code, 2016 with effect from December 3, 2019.
The non-banking finance company (NBFC) further said that it is under moratorium and dues to lenders and bond holders will remain in abeyance until the CRIP is completed.
Of this secured debt is Rs 74,054 crore and Rs 9,818 crore is unsecured.
Stock of DHFL closed 4.97 per cent up at Rs 9.50 apiece on the BSE.",Dewan Housing Finance Corporation (DHFL) on Tuesday said it will not make any interest or principal payment to lenders as well as bondholders as the company is under resolution process.,"Dewan Housing Finance Corporation (DHFL) on Tuesday said it will not make any interest or principal payment to lenders as well as bondholders as the company is under resolution process.

The Corporate Insolvency Resolution Process (CIRP) was initiated against the debt-ridden company as per the provisions of the Insolvency and Bankruptcy Code, 2016 with effect from December 3, 2019.

DHFL said all the rated debt papers of the company are carrying default grade ratings and disclosures on the same have been made to the exchanges.

The creditors of the company were duly informed about commencement of the CIRP and were requested to submit their claims to the company in the prescribed manner as per the provisions of the Code.

The amounts to be received towards the dues by the creditors will be based on a resolution plan to be approved in due course by the NCLT, Mumbai, DHFL said in a regulatory filing.

The non-banking finance company (NBFC) further said that it is under moratorium and dues to lenders and bond holders will remain in abeyance until the CRIP is completed.

The company is in moratorium under Section 14 of the Code since November 29, 2019 under Rule 5(b)(i) of Insolvency and Bankruptcy (Insolvency and Liquidation Proceedings of Financial Service Providers and Application to Adjudicating Authority) Rules 2019.

""...it has not made and shall not be making payment of interest or principal to any of the lenders of the company including the NCD holders under all ISINs till approval and implementation of resolution plan and till then any payments to the lenders or NCD holders will continue to remain in abeyance subject to the CIRP process,"" Dewan Housing Finance said.

International Securities Identification Number (ISIN) is a 12-character unique alphanumeric code used for uniform identification of a security.

The company has made a series of debt defaults after the crisis unfolded and was superseded by the RBI in late November last year on concerns over its corporate governance and defaults, and appointed an administrator.

As of July 2019, the beleaguered home financier owed Rs 83,873 crore to banks, the National Housing Board, mutual funds and bondholders/retail bondholders. Of this secured debt is Rs 74,054 crore and Rs 9,818 crore is unsecured.

Stock of DHFL closed 4.97 per cent up at Rs 9.50 apiece on the BSE.",https://www.moneycontrol.com/news/business/stocks/debt-laden-dhfl-not-to-make-any-payment-to-lenders-bond-5119731.html
8,"April 08, 2020 01:39 PM IST",1,Sunil Matkar,"Sudarshan Chemical shares jump 11% after Roha plant opens, India Ratings upgrades outlook","Shares of Sudarshan Chemical Industries rallied 11 percent intraday on April 8 after India Ratings revised its outlook on the company to ""positive"" from ""stable"".
Another reason for the rally could be the recommencement of production at Roha plant, Maharashtra.
""India Ratings and Research has revised the company's outlook to""positive"" from ""stable"" while affirming its long-term issuer rating at A+,"" the company said in its BSE filing.
The rating agency revised the outlook to positive on company's unsecured loans, non-fund-based working capital limits, fund-based working-capital limits, term loans and term deposits while affirming earlier ratings.
Further, the company said as it had received the necessary permission to restart Roha site and transport material.","Company said as it served the essential industries of food packaging and personal care, it had received necessary permission to restart Roha site and transport material.","Shares of Sudarshan Chemical Industries rallied 11 percent intraday on April 8 after India Ratings revised its outlook on the company to ""positive"" from ""stable"".

Another reason for the rally could be the recommencement of production at Roha plant, Maharashtra.

The stock rallied 5.67 percent in the previous session, taking the two-day gains to over 17 percent. It was trading at Rs 386.25, up Rs 16.75 or 4.53 percent on the BSE at 13:12 hours.

""India Ratings and Research has revised the company's outlook to""positive"" from ""stable"" while affirming its long-term issuer rating at A+,"" the company said in its BSE filing.

The rating agency revised the outlook to positive on company's unsecured loans, non-fund-based working capital limits, fund-based working-capital limits, term loans and term deposits while affirming earlier ratings.

""The outlook revision reflects India Ratings' expectation of sustenance of the company's strong credit profile over the medium term, driven by the strategy growth in its profitability amid a supportive demand environment,"" company said.

""The revenues growth is likely to be underpinned by the increased capacity of existing products and the launch of new products. The margins are expected to remain resilient due to an improved product mix, backward integration, cost optimization, and higher operating leverage,"" it added.

Further, the company said as it had received the necessary permission to restart Roha site and transport material.

""Production capacities and deliveries will ramp up gradually based on availability of raw material, manpower and transport infrastructure within the conditions stipulated by the letter granting permission,"" it added.

The company's manufacturing facilities at Roha and Mahad and offices had temporarily suspended due to pandemic of novel coronavirus (COVID-19) since March 26.",https://www.moneycontrol.com/news/business/markets/sudarshan-chemical-shares-jump-11-after-roha-plant-opens-india-ratings-upgrades-outlook-5120951.html
9,"April 08, 2020 03:31 PM IST",1,Kshitij Anand,MSCI re balancing: Morgan Stanley says 26 stocks to benefit from the rejig,"D-Street welcomed some good news from Morgan Stanley amid the mayhem seen in the equity market due to the outbreak of COVID-19.
Morgan Stanley came out with a report suggesting that India’s weight is likely to increase in the emerging market index, a report authored by Ridham Desai, and Sheela Rathi.
Over the next few months, Morgan Stanley expects MSCI to rebalance MSCI India weights to reflect this change.
Combined with this flow, Morgan Stanley expects active inflow to the tune of $5.7 billion taking the combined expected inflow to around $7 billion.
There are 26 stocks that are likely to benefit the most from this regime.","Over the next few months, Morgan Stanley expects MSCI to rebalance MSCI India weights to reflect this change.","Indian market posted its best percentage gain since May 2009 on April 7.

D-Street welcomed some good news from Morgan Stanley amid the mayhem seen in the equity market due to the outbreak of COVID-19.

Morgan Stanley came out with a report suggesting that India’s weight is likely to increase in the emerging market index, a report authored by Ridham Desai, and Sheela Rathi.

From April 1, 2020, India moved into a new regime on foreign limits whereby the FPI limit has been increased to the sector foreign limit. Over the next few months, Morgan Stanley expects MSCI to rebalance MSCI India weights to reflect this change.

MSCI India's weight in Emerging Market (EM) is likely to rise by 55bps and India's foreign inclusion factor (FIF) is likely to rise from 0.39 to 0.42 that could result in an incremental $1.3 billion of passive inflows.

Combined with this flow, Morgan Stanley expects active inflow to the tune of $5.7 billion taking the combined expected inflow to around $7 billion.

There are 26 stocks that are likely to benefit the most from this regime. The names include L&T, Asian Paints, Bajaj Finance, Nestle India, Divi’s Laboratories, Britannia Industries, Shree Cement, Tata Steel, and Bharti Infratel, the report highlighted.",https://www.moneycontrol.com/news/business/markets/msci-re-balancing-morgan-stanley-says-26-stocks-to-benefit-from-the-rejig-5121611.html
10,"April 08, 2020 12:57 PM IST",1,Sunil Matkar,Wipro shares gain 4% ahead of March quarter earnings next week,"Shares of IT company Wipro rallied 4 percent intraday on April 8 ahead of its Q4 FY20 earnings.
The company will announce its March quarter earnings next week.
The board will also consider the condensed audited consolidated financial results under IFRS for same periods, it added.
""The financial results would be finally approved by the board of directors on the evening of the same day.""
The stock was trading at Rs 196.15, up Rs 4.25 or 2.21 percent on the BSE at 12:28 hours.","Company said the board would also mull recommendation of final dividend, if any, for FY20.","Shares of IT company Wipro rallied 4 percent intraday on April 8 ahead of its Q4 FY20 earnings. The company will announce its March quarter earnings next week.

Wipro on Tuesday said the meeting of the board of directors would be held on April 15 to consider and approve the condensed audited standalone and consolidated financial results under IndAS for the quarter and year ended March 31, 2020.

The board will also consider the condensed audited consolidated financial results under IFRS for same periods, it added. ""The financial results would be finally approved by the board of directors on the evening of the same day.""

The company said the board would also mull recommendation of final dividend, if any, for FY20.

Hence the trading window for dealing in the securities of the company has been closed from March 16, 2020, till the close of trading hours of April 17, 2020, it added.

The leading global IT company said after the results announcement, the senior management would discuss its performance for the quarter and answer questions via conference call on the same day at 19:15 hours.

Brokerages largely expect the IT companies to be impacted by COVID-19.

""Second half of Q4FY20 witnessed varying levels of COVID-19 disruption across most of the core markets of IT companies like the US, Europe and even India, but most of our coverage companies did a reasonable job in controlling the damage by resorting to options like ‘work from home’,"" said Motilal Oswal.

According to the brokerage, Wipro may report a 4.3 percent decline in Q4 profit and 0.6 percent degrowth in revenue QoQ. IT services dollar revenue degrowth could be 1 percent and EBIT margin may contract 22bp QoQ.

The stock was trading at Rs 196.15, up Rs 4.25 or 2.21 percent on the BSE at 12:28 hours.",https://www.moneycontrol.com/news/business/markets/wipro-shares-gain-4-ahead-of-march-quarter-earnings-next-week-5120741.html
11,"April 07, 2020 03:23 PM IST",1,Sunil Matkar,Shilpa Medicare locked in upper circuit on UK nod for anti-cancer drug,"Shilpa Medicare shares were locked in 5 percent upper circuit on April 7 after the pharma company received the UK health regulator’s approval for its anti-cancer drug Imatinib.
After losing more than 52 percent in over a month, the stock has gained nearly 16 percent in April so fa.
Its United Kingdom-based subsidiary Koanaa Healthcare ot the nod of the Medicines and Healthcare products Regulatory Authority (MHRA) for Imatinib oral solution.
The drug should be available in the UK in the second quarter of 2020 and would be supplied from its UK-based manufacturing facility LM Pharmaceuticals, the company said.
The worldwide market is approximately $1.6 billion and in UK is approximately $104.4 million as per IQVIA MAT Q4 2019 data, it said.","According to the company, the drug is expected to be available in the UK in the second quarter of 2020.","Shilpa Medicare shares were locked in 5 percent upper circuit on April 7 after the pharma company received the UK health regulator’s approval for its anti-cancer drug Imatinib.

After losing more than 52 percent in over a month, the stock has gained nearly 16 percent in April so fa. It was trading at Rs 282.95, up 4.99 percent on the BSE at 1512 hours.

Its United Kingdom-based subsidiary Koanaa Healthcare ot the nod of the Medicines and Healthcare products Regulatory Authority (MHRA) for Imatinib oral solution.

""The approval of Imatinib Oral Solution represents a major step forward in treatment options for cancers in paediatric and geriatric patients, patients with swallowing difficulties and also offers dose titration across the patient population,"" said the company in its BSE filing.

The drug should be available in the UK in the second quarter of 2020 and would be supplied from its UK-based manufacturing facility LM Pharmaceuticals, the company said.

The worldwide market is approximately $1.6 billion and in UK is approximately $104.4 million as per IQVIA MAT Q4 2019 data, it said.",https://www.moneycontrol.com/news/business/markets/shilpa-medicare-locked-in-upper-circuit-on-uk-nod-for-anti-cancer-drug-5116641.html
12,"April 08, 2020 07:12 AM IST",1,Nishant Kumar,Hot Stocks | Three pharma stocks to bet on in the short term,"On the technical front, some positive divergences on secondary oscillators can be seen on daily charts which point at further short-covering in days to come.
Traders can accumulate the stock in the range of Rs 3,550-3,500 for the upside target of Rs 4,170 with a stop loss below Rs 3,100.
Traders can accumulate the stock in the range of Rs 10,200-10,500 for the upside target of Rs 12,350 with a stop loss below Rs 8,950.
Abbott India | Buy | LTP: Rs 16,689 | Target price: Rs 19,050 | Stop loss: Rs 14,240 | Upside: 14%Since February 2020, this stock has been seen trading in a downward sloping channel and tested Rs 12,500.
Traders can accumulate the stock on dips in the range of Rs 16,200-16,000 for the upside target of Rs 19,050 with a stop loss below Rs 14,240.","On the higher side, 8,850 should act as an immediate hurdle for Nifty, above which short-covering can get extended and Nifty can move towards 9,200 levels as well.","Shitij Gandhi

After a long weekend, bulls made a great comeback on April 7 as the Indian market posted sharp gains with Nifty and Bank Nifty indices gaining up to 10.5 percent in a single trading session, tracking positive cues from global markets.

On the derivative front, heavy open interest buildup was seen at 8,500 put strike which should act as immediate support for the Nifty.

On the technical front, some positive divergences on secondary oscillators can be seen on daily charts which point at further short-covering in days to come.

On the higher side, 8,850 should act as an immediate hurdle for Nifty, above which short-covering can get extended and Nifty can move towards 9,200 levels as well.

Bank Nifty is also forming a higher bottom pattern on daily charts and above 19,250 levels, the follow-up buying can be seen which could take the index towards 20,000 levels once again.

Here are three stock recommendations for the next 3-4 weeks:

Dr. Reddy's Laboratories | Buy | LTP: Rs 3,599.95 | Target price: Rs 4,170 | Stop loss: Rs 3,100 | Upside: 16%

This stock has given a sharp breakout above Rs 3,250 and breached three-year high on the charts with prices surpassing above Rs 3,550 level.

On the technical front, a breakout can be seen above the neckline of the inverted head and shoulder pattern on the daily charts.

Additional volumes along with a rise in price suggest fresh long build-up in the prices which could move the stock towards more highs in the coming days.

Traders can accumulate the stock in the range of Rs 3,550-3,500 for the upside target of Rs 4,170 with a stop loss below Rs 3,100.

GlaxoSmithKline Consumer Healthcare | Buy | LTP: Rs 10,550.75 | Target price: Rs 12,350 | Stop loss: Rs 8,950 | Upside: 17%

The stock has been consistently moving higher on the broader charts with the formation of a higher high and higher bottom pattern.

At the current juncture, a fresh breakout has been observed on the charts as the stock price has moved above the psychological level of Rs 10,000 and hit a fresh 52-week high of Rs 10,700.

Additionally, the stock has also formed an inverted head and shoulder pattern on daily charts and given breakout above the neckline of the pattern formation.

Traders can accumulate the stock in the range of Rs 10,200-10,500 for the upside target of Rs 12,350 with a stop loss below Rs 8,950.

Abbott India | Buy | LTP: Rs 16,689 | Target price: Rs 19,050 | Stop loss: Rs 14,240 | Upside: 14%

Since February 2020, this stock has been seen trading in a downward sloping channel and tested Rs 12,500.

However, it took support at its 100-days exponential moving average on the daily charts and at the current juncture, formed a rounding bottom pattern with prices once again surpassing above its short and long-term moving averages.

The broader structure is still positive for the stock as it hit a fresh 52-week high of Rs 16,899 in Tuesday’s session.

Traders can accumulate the stock on dips in the range of Rs 16,200-16,000 for the upside target of Rs 19,050 with a stop loss below Rs 14,240.

(The author is Senior Technical Analyst at SMC Global Securities)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-three-pharma-stocks-to-bet-on-in-the-short-term-5117811.html
13,"April 08, 2020 12:52 PM IST",1,Rakesh Patil,Galaxy Surfactants partially resumes plant operations; share price rises 6%,"Galaxy Surfactants share price rose over 6 percent intraday on April 8 after the company partially resumed the operations.
We have partially resumed our operations at our plants with effect from April 6, 2020, the company said in a press release.
The share price rose 21 percent in the last one year.
The share touched its 52-week high Rs 1,790.00 and 52-week low Rs 975.00 on 11 February 2020 and 24 March 2020, respectively.
Currently, it is trading 32.38 percent below its 52-week high and 24.15 percent above its 52-week low.",The share price rose 21 percent in last 1-year.,"Galaxy Surfactants share price rose over 6 percent intraday on April 8 after the company partially resumed the operations.

We have partially resumed our operations at our plants with effect from April 6, 2020, the company said in a press release.

We are taking necessary preventive measures like social distancing, temperature testing, providing masks to workers etc. to avoid any infection due to COVID-19, it added.

At 12:36 hrs, Galaxy Surfactants Ltd was quoting at Rs 1,210.45, up Rs 41.10, or 3.51 percent on the BSE.

The share price rose 21 percent in the last one year.

The share touched its 52-week high Rs 1,790.00 and 52-week low Rs 975.00 on 11 February 2020 and 24 March 2020, respectively.

Currently, it is trading 32.38 percent below its 52-week high and 24.15 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/galaxy-surfactants-partially-resumes-plant-operations-share-price-rises-6-5120711.html
14,"April 08, 2020 09:37 AM IST",1,Rakesh Patil,Va Tech Wabag share price rises 5% on securing water treatment contract in Bahrain,"Va Tech Wabag share price rose 5 percent in the early trade on April 8 after the company secured a contract in Bahrain.
The company has secured 4.5 million Bahraini Dinar (approximately Rs 900 million) order from Ministry of Works, Municipalities Affairs and Urban Planning (MoW) in the Kingdom of Bahrain, as per BSE release.
The order includes operation, maintenance and management of the Madinat Salman Sewage Treatment Plant (STP) and Long Sea Outfall for a period of 5 years.
ICRA has revised its long term fund based facilities rating of the company to ICRA A (Negative) from ICRA A+ (Negative).
At 09:20 hrs, Va Tech Wabag was quoting at Rs 81.80, up Rs 3.80, or 4.87 percent on the BSE.",ICRA has revised its long term fund based facilities rating of the company to ICRA A (Negative) from ICRA A+ (Negative).,"Va Tech Wabag share price rose 5 percent in the early trade on April 8 after the company secured a contract in Bahrain.

The company has secured 4.5 million Bahraini Dinar (approximately Rs 900 million) order from Ministry of Works, Municipalities Affairs and Urban Planning (MoW) in the Kingdom of Bahrain, as per BSE release.

The order includes operation, maintenance and management of the Madinat Salman Sewage Treatment Plant (STP) and Long Sea Outfall for a period of 5 years.

""In line with our growth strategy, this new order to our strong O&M order book across the globe provides annuity income which helps us with improved cash flow and better revenue predictability,” said Deep Raj Saxena, CEO – Middle East and Africa Cluster.

ICRA has revised its long term fund based facilities rating of the company to ICRA A (Negative) from ICRA A+ (Negative).

At 09:20 hrs, Va Tech Wabag was quoting at Rs 81.80, up Rs 3.80, or 4.87 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/va-tech-wabag-share-price-rises-5-on-securing-water-treatment-contract-in-bahrain-5119381.html
15,"April 08, 2020 12:06 PM IST",1,Rakesh Patil,Maruti Suzuki share price rises 8% despite fall in production in March,"Maruti Suzuki India share price rose 8 percent intraday on April 8 even after the company reported weak production numbers for the month of March.
The company's total production in March 2020 fell 47 percent to 92,540 units from 136,201 units in the year-ago.
Its passenger cars production declined to 69,854 units from 101,807 units, YoY.
At 11:25 hrs, Maruti Suzuki India was quoting at Rs 4,838.65, up Rs 289.05, or 6.35 percent on the BSE.","Its passenger cars production declined to 69,854 units from 101,807 units, YoY.","Maruti Suzuki India share price rose 8 percent intraday on April 8 even after the company reported weak production numbers for the month of March.

The company's total production in March 2020 fell 47 percent to 92,540 units from 136,201 units in the year-ago.

Its passenger cars production declined to 69,854 units from 101,807 units, YoY.

At 11:25 hrs, Maruti Suzuki India was quoting at Rs 4,838.65, up Rs 289.05, or 6.35 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/maruti-suzuki-share-price-rises-8-despite-fall-in-production-in-march-5120261.html
16,"April 08, 2020 01:51 PM IST",1,Kshitij Anand,"Keep an eye on ESG stocks, could grow big post COVID-19: Lav Chaturvedi","The Nifty ESG Index has been outperforming the benchmark Nifty for more than a year, and we believe ESG stocks should continue to see traction and should grow in a big way post-Covid-19, Lav Chaturvedi, ED & CEO at Reliance Securities, said in an interview with Moneycontrol’s Kshitij Anand.
Notably, there are dedicated onshore or offshore funds, which invest only on ESG stocks, as these stocks also carry relatively low regulatory interferences.
The Nifty ESG Index has been outperforming the benchmark Nifty for more than a year.
We believe the ESG stock should continue to see traction and will grow in a big way post-COVID-19.
A) The market was factoring in higher teen growth for FY21, which looks very difficult, given the current COVID-19 pandemic.","ESG sector has been gaining prominence for the last couple of years especially since topics such as global warming, climate change impact, etc. have gained momentum across the globe.","The Nifty ESG Index has been outperforming the benchmark Nifty for more than a year, and we believe ESG stocks should continue to see traction and should grow in a big way post-Covid-19, Lav Chaturvedi, ED & CEO at Reliance Securities, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt:

Q) What would you advise – lump sum or staggered investing approach, direct equities or mutual funds?

A) Lump-sum investment is usually advisable in a scenario when most of the risks appear to be factored in the valuations and you have a broad judgment about the quantum of risk.

During the current pandemic, the situation is extremely uncertain with regards to both containment of the crisis and subsequent recovery process.

Hence, we would advise the investors to adopt a staggered investment approach over 6 to 12 months horizon and use every dip as an opportunity to increase the investments commensurating with individual risk appetite and investment objectives.

Q) IndiaNivesh Securities' broking arm shut its operations. Do you think this could just be the starting?

A) As they say, no crisis should go waste. Our industry has experienced the Karvy episode before, and now it is IndiaNivesh. I think the industry will be up for some serious consolidation.

This could be either because of an aggressive business model or un-sustainable operating leverage. Either way, there will be consolidation and optimization of industry players. Robust risk management and customer-centricity would be a key differentiator.

Q) A lot has been talked about and spoken about COVID-19 hotspots. But where are the hotspots in terms of investment in the current scenario?

A) One can always find hotspots irrespective of situations. In the context of the current scenario, potential opportunities could be in Consumer Staples, Telecom, Healthcare and OMCs as hotspots.

Based upon how quickly we come out of lockdown with calibrated lifting up, we may see healthy recovery in sectors like Retail, Hospitality, Cement, Paints, Automobile, and Specialty Chemicals, etc.

Q) Do you think companies in the ESG space could get attention, and could probably turn out to be big winners once this (COVID-19) is over?

A) ESG sector has been gaining prominence for the last couple of years especially since topics such as global warming, climate change impact, etc. have gained momentum across the globe.

Notably, there are dedicated onshore or offshore funds, which invest only on ESG stocks, as these stocks also carry relatively low regulatory interferences.

The Nifty ESG Index has been outperforming the benchmark Nifty for more than a year. We believe the ESG stock should continue to see traction and will grow in a big way post-COVID-19.

Q) With the starting of April we also start a new financial year – what is your expectations from the FY21? What are your views on earnings, markets, flows, as well as demand?

A) The market was factoring in higher teen growth for FY21, which looks very difficult, given the current COVID-19 pandemic. In case the lockdown is not extended, the economy should come back on track over a couple of quarters.

But it is too uncertain to predict anything as of yet. We are likely to see a sharp earnings downgrade for FY21 and based upon the calibrated lifting up of lockdown and subsequent recovery there might be earnings growth in the range of 5-10 percent for FY21, which still looks to be decent given the current situation.

Q) Once the lockdown is over and we (the whole world) come out of COVID-19 --- what will be the new normal which the world will be looking at in investments, insurance, food habits, consumption, etc.?

A) Social distancing will be a new normal. The economy that so far has been focusing on sharing (Uber, WeWork, etc.) will now take a more balanced approach and will embrace distancing as a business proposition.

Focus on healthcare will grow. Also, work from home and less travel will become a new normal across sectors. This may have an impact on rental yields etc.

From the investors' perspective, they will keep looking for a better value proposition with a low degree of uncertainty. As soon as the COVID-19 crisis gets over, we believe the sectors, which have been battered badly and have the potential to revive faster will be lapped up by the investors.

Q) We have seen massive wealth erosion in most of the top-quality stocks in FY20, and as we step into FY21 some of those names could give multibagger returns if someone is investing in them now. Could you highlights 3-5 such stocks that hold that potential?

A) As we all know during these uncertain times, there are certain quality stocks that got hammered and have the potential to generate hefty returns once dust settled and economy begun to recover.

Stocks like ICICI Bank, Maruti Suzuki, Hero MotoCorp and UltraTech Cement, etc. can potentially generate relatively better returns in the large-cap space.",https://www.moneycontrol.com/news/business/markets/keep-an-eye-on-esg-stocks-could-grow-big-post-covid-19-lav-chaturvedi-5117821.html
17,"April 07, 2020 09:32 PM IST",2,Sunil Matkar,UBS Principal Capital buys Rs 197cr worth shares of IndusInd Bank,"Singapore-based investment banking firm UBS Principal Capital Asia has acquired up 0.85 percent stake in private sector lender IndusInd Bank on April 7.
As per April 7 bulk deal data available on the National Stock Exchange, UBS has acquired 53,83,066 equity shares of the bank at Rs 367 per share.
IndusInd Bank was the biggest gainer among Nifty stocks, rallying 22.56 percent to close at Rs 383.85 on the NSE.
One of primary reasons was withdrawal of deposits from select private banks (including IndusInd Bank), especially after the Yes Bank fiasco.
The IndusInd Bank management in its analyst call highlighted that it will make higher provisions towards some of the stressed accounts and guided to increase provision coverage to more than 60 percent by FY20.","IndusInd Bank was the biggest gainer among Nifty stocks, rallying 22.56 percent to close at Rs 383.85 on the NSE","Singapore-based investment banking firm UBS Principal Capital Asia has acquired up 0.85 percent stake in private sector lender IndusInd Bank on April 7.

As per April 7 bulk deal data available on the National Stock Exchange, UBS has acquired 53,83,066 equity shares of the bank at Rs 367 per share.

The total deal value stood at Rs 197.55 crore and could be one of reasons for stellar rally in the stock price.

IndusInd Bank was the biggest gainer among Nifty stocks, rallying 22.56 percent to close at Rs 383.85 on the NSE.

The stock had fallen nearly 80 percent in the last three-month period, which was quite a big correction compared to Nifty Bank (down 46 percent), Nifty (down 34 percent) and Nifty Private Bank (down 49 percent), following concerns around asset quality and strength of funding franchise.

One of primary reasons was withdrawal of deposits from select private banks (including IndusInd Bank), especially after the Yes Bank fiasco.

The COVID-19 outbreak has further impacted growth/asset quality prospects in the select business segments.

Motilal Oswal estimates credit cost to remain elevated over the next few quarters while lowering its business growth assumptions. It has cut its price target on the counter to Rs 800/share while maintaining its buy call in a report dated March 31.

The IndusInd Bank management in its analyst call highlighted that it will make higher provisions towards some of the stressed accounts and guided to increase provision coverage to more than 60 percent by FY20.

It has introduced planning cycle-5 with strong focus on reducing deposit concentration and increasing granularity of liabilities through retail deposits. Also, focus will be on building a granular asset book.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/ubs-principal-capital-buys-rs-197cr-worth-shares-of-indusind-bank-5118451.html
18,"April 08, 2020 11:37 AM IST",-1,,Coronavirus pandemic | Rating firm Crisil postpones AGM due later this month,"Credit rating firm Crisil on Wednesday said it has postponed its annual general meeting, which was scheduled for later this month, due to the coronavirus pandemic.
The company's 33rd annual general meeting (AGM) was to be held on April 21.
The company will announce a new date for the AGM in due course, it said.
In view of the above, the e-voting processes for the AGM and the dividend payment date would also stand postponed, it said.
Shares of Crisil on Wednesday was trading at Rs 1,251.95 apiece on the BSE, up 2.54 per cent from the previous close.","Credit rating firm Crisil on Wednesday said it has postponed its annual general meeting, which was scheduled for later this month, due to the coronavirus pandemic","Credit rating firm Crisil on Wednesday said it has postponed its annual general meeting, which was scheduled for later this month, due to the coronavirus pandemic. The company's 33rd annual general meeting (AGM) was to be held on April 21.

""The prevailing lockdown and restrictions on mass congregations in Mumbai, which commenced on March 21, 2020 in view of the COVID-19 pandemic, constrained the company from fully completing the dispatch of physical copies of the annual report to our shareholders,"" Crisil said in a regulatory filing.

It also said the current circumstances do not allow a smooth and safe conduct of the AGM and in the safety of all stakeholders, in keeping with government advisories on COVID-19, the board of directors has decided to postpone the AGM.

The company will announce a new date for the AGM in due course, it said.

In view of the above, the e-voting processes for the AGM and the dividend payment date would also stand postponed, it said.

However, the book closure announced earlier by the company for the purpose of determining the entitlement of shareholders for the final dividend will remain unchanged on April 7 and 8 (Tuesday and Wednesday).

""Accordingly, the dividend, when approved by the members at the rescheduled AGM of the company, will be made payable to those members whose names appear on the register of members as on the aforesaid book closure date,"" the ratings agency said.

Shares of Crisil on Wednesday was trading at Rs 1,251.95 apiece on the BSE, up 2.54 per cent from the previous close.",https://www.moneycontrol.com/news/business/coronavirus-pandemic-rating-firm-crisil-postpones-agm-due-later-this-month-5120221.html
19,"April 08, 2020 01:00 PM IST",1,,Breezing through COVID-19 storm! This retail stock owned by Radhakishan Damani can be a multibagger,"Veteran stock market investor Radhakishan Damani-led Avenue Supermarts seems to be breezing through the coronavirus storm.
Avenue Supermarts, which operates the supermarket chain DMart, has been on the analysts' radar for its strong fundamentals.
Some experts place it in the category of a multibagger amid the COVID-19 lockdown being a top retail player.
Currently, the company has 196 DMart stores and expects to open 30 stores every year through its cluster approach.
The infusion of funds would provide Avenue Supermarts the ammunition to enhance its store expansion pace, resulting in higher revenue and profitability.","At a time when most of the midcaps are reeling under pressure, DMart stands out with an outperformance of more than 20 percent, so far, in 2020.","Veteran stock market investor Radhakishan Damani-led Avenue Supermarts seems to be breezing through the coronavirus storm. The stock, locked in 5 percent upper circuit six times since March, has rallied more than 23 percent in 2020.

Avenue Supermarts, which operates the supermarket chain DMart, has been on the analysts' radar for its strong fundamentals.

Some experts place it in the category of a multibagger amid the COVID-19 lockdown being a top retail player. It is also among the top picks for many domestic brokerages.

A K Prabhakar, Head, Research, IDBI Capital in an interview to Moneycontrol placed Avenue Supermart in the category of multibaggers of the future. The company had been growing at 25 percent in the last few years, he said.

“We think the company is pulling consumers away from unorganised stores due to high discounting and now, delivery to home on the minimum charge would help the company grow in the next few years around those levels,” he said.

DMart is focused on value retailing and offers a wide range of fast-moving consumer products, general merchandise, and apparel.

Currently, the company has 196 DMart stores and expects to open 30 stores every year through its cluster approach.

It offers significant discounts compared to e-commerce, modern trade (~6%) and general trade (~18%), which would drive revenue growth, say experts.

“The DMart chain offers a considerable amount of discount when compared to e-commerce platforms. The operating margin is higher compared to its peers due to the company’s low-cost structure,” Angel Broking said in a note.

The brokerage firm expects DMart to report consolidated revenue/PAT CAGR of 18% and 26%, respectively, over FY2019-22E. It has an accumulate rating on the stock, which is also in top picks category with a target price of Rs 2,395.

Consistent growth and profitability

One of the big factors that make the stock a good buy on dips is that it has delivered consistent performance over the years, which is a positive sign.

At a time when most of the midcaps are reeling under pressure, DMart stands out with an outperformance of over 20 percent, so far, in 2020.

Experts say that the coronavirus outbreak impact will be minimal on Avenue Supermart due to its non-discretionary nature of the business and a capital-efficient business model.

Over the years, DMart has been able to maintain consistent profitability and remains an exceptional performer in its peer group.

“Given the robust store operating metrics, DMart has progressively enhanced its return ratios despite being CAPEX intensive. We expect the impact of the virus to be limited owing to the non-discretionary nature of the business,” ICICIDirect said in a research note.

“In a bid to reduce promoter stake to 75%, the company had successfully concluded qualified institutional placement (QIP) placement worth Rs 4,100 crore. Incremental cash-flow infusion in the company is expected to significantly shore up store addition pace with foray into newer geographies. DMart has a capital-efficient business model generating superior RoCE of 23% and fixed asset turnover ratio of 4.1x,” it said.

The infusion of funds would provide Avenue Supermarts the ammunition to enhance its store expansion pace, resulting in higher revenue and profitability.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/breezing-through-covid-19-storm-this-retail-stock-owned-by-radhakishan-damani-can-be-a-multibagger-5120601.html
20,"April 08, 2020 10:51 AM IST",-1,Kshitij Anand,In midst of a storm: 270 stocks in BSE 500 with high FII exposure face selling pressure,"The Indian market has plunged more than 30 percent from its recent high, and much of the selling was seen in foreign institutional investors (FII) heavy stocks.
There are more than 270 stocks in the S&P BSE 500 index in which foreign investors hold more than 10 percent stake as of data collated from December quarter.
More than 95 percent stocks in the S&P BSE 500 index in which FIIs hold majority stake have given negative returns so far in the year 2020.
There are as many as 54 stocks out of 270 in the S&P BSE 500 index where FIIs hold majority stake and they have plunged more than 50 percent in the same period.
In our opinion, instead of focusing only on FII heavy stocks, the prudent approach here would be to stay with fundamentally sound stocks and accumulate them in a staggered manner,” he said.","FII ownership should not be looked in isolation when making an investment call. FIIs could be selling due to varied reasons; hence, it is not just limited to the fundamentals of the company.","The last two months have been painful for investors as well as traders. The Indian market has plunged more than 30 percent from its recent high, and much of the selling was seen in foreign institutional investors (FII) heavy stocks.

There are more than 270 stocks in the S&P BSE 500 index in which foreign investors hold more than 10 percent stake as of data collated from December quarter.

More than 95 percent stocks in the S&P BSE 500 index in which FIIs hold majority stake have given negative returns so far in the year 2020. There are as many as 54 stocks out of 270 in the S&P BSE 500 index where FIIs hold majority stake and they have plunged more than 50 percent in the same period.

Stocks that fell more than 50 percent include names like Gayatri Projects, Vedanta, RBL Bank, JustDial, Ujjivan Financial Services, Adani Power, HEG, and M&M Financial Services, etc. among others.

FIIs have been net sellers in Indian markets for over Rs 60,000 cr in the cash segment of the Indian equity markets. They pulled out more than Rs 12000 cr in February, and over Rs 5,000 crore in January, data from Moneycontrol.com showed.

“The outbreak of Coronavirus across the globe has impacted the sentiments of investors worldwide. It has led to a sharp correction in the 54 stocks mentioned as they either belong to the sectors that are highly cyclical or are facing company-specific issues,” Ajit Mishra, VP Research Religare Broking told Moneycontrol.

“Further, given the heightened selling pressure by the FIIs in the past one month, the decline in the prices has aggravated. In our opinion, instead of focusing only on FII heavy stocks, the prudent approach here would be to stay with fundamentally sound stocks and accumulate them in a staggered manner,” he said.

Note: The tables given are for reference only and not a buy or sell recommendations

Due to poor macro environment and fears of recession looming, selling pressure was seen in stocks across largecap, midcap as well as smallcap. Selling pressure was not just limited to India but it was across the world.

“Equity Funds saw over $50 billion flow out during the quarter and Bond Funds set weekly and monthly outflow records on their way to their biggest quarterly outflow since 3Q13,” EPFR Global said which tracks institutional and individual investor flows in global markets.

“FII heavy stocks have underperformed the index as Sensex has slipped approx 30% recently in comparison to stocks which have fallen 50%, whereas investors are concerned it is advisable to invest money in fundamentally sound companies rather than just following FIIs, if the company you invested in is fundamentally sound one can hold the position,” Ritesh Asher – Chief Strategy Officer (CSO) at KIFS Trade Capital told Moneycontrol.

“Fundamentally strong companies such as HUL, Navin Florine, Granules India have so far effectively saved themselves from the heat of macro factors taking place,” he said.

What should investors do?

The next big question in front of investors what should they do if they have stocks in which FIIs are heavily invested. Does it make sense to reduce the holding? Or what are the other factors which should be looked at before pressing buy or a sell button?

Well, experts feel that FII ownership should not be looked in isolation when making an investment call. FIIs could be selling due to varied reasons; hence, it is not just limited to the fundamentals of the company.

It would be wise to first understand the qualitative and quantitative aspects of the company before taking any decision related to buying or selling the stock.

“Investors should look at both quantitative as well as qualitative factors before investing. They should see that the company has prudent management, strong corporate governance, comfortable valuation and healthy financials with long term growth visibility, lower debt to equity ratio and sound balance sheet,” says Mishra.

Asher of KIFS Trade Capital is of the view that investors should not worry about FIIs based data if they have invested in the correct stock, because in the past few weeks DIIs managed to absorb the sell-off made by FIIs.

“As mentioned previously, investors should go through the study of stocks they are planning to invest in like what does the company do, is it financially strong, who is the management, are there any corporate governance issues, product line, vision & mission, valuation, etc before taking any decision to buy or sell a particular stock,” he said.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/in-midst-of-a-storm-270-stocks-in-bse-500-with-high-fii-exposure-face-selling-pressure-5116091.html
21,"April 08, 2020 11:02 AM IST",1,Rakesh Patil,L&T gains nearly 4% after subsidiary wins contract from IOC,"Larsen and Toubro gained nearly 4 percent intraday on April 8 after the company's subsidiary won a contract from Indian Oil Corporation.
L&T Hydrocarbon Engineering, a wholly-owned subsidiary of the company, has been awarded a Large Project by Indian Oil Corporation Limited (IOCL).
The engineering, procurement, construction and commissioning (EPCC) contract is for setting up a new 9 MMTPA Atmospheric & Vacuum Distillation Unit (AVU) and allied facilities (EPCC-1 Package) for Barauni Refinery Capacity Expansion Project at IOCL's Barauni Refinery, Bihar.
The capacity of Barauni Refinery is being augmented from the current installed capacity of 6.0 MMTPA to 9.0 MMTPA.
At 10:44 hrs, Larsen & Toubro was quoting at Rs 815.85, up Rs 14.20, or 1.77 percent on the BSE.",Company's wholly owned subsidiary of the company has been awarded a Large Project by Indian Oil Corporation Limited (IOCL),"Larsen and Toubro gained nearly 4 percent intraday on April 8 after the company's subsidiary won a contract from Indian Oil Corporation.

L&T Hydrocarbon Engineering, a wholly-owned subsidiary of the company, has been awarded a Large Project by Indian Oil Corporation Limited (IOCL).

The engineering, procurement, construction and commissioning (EPCC) contract is for setting up a new 9 MMTPA Atmospheric & Vacuum Distillation Unit (AVU) and allied facilities (EPCC-1 Package) for Barauni Refinery Capacity Expansion Project at IOCL's Barauni Refinery, Bihar.

The capacity of Barauni Refinery is being augmented from the current installed capacity of 6.0 MMTPA to 9.0 MMTPA.

At 10:44 hrs, Larsen & Toubro was quoting at Rs 815.85, up Rs 14.20, or 1.77 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/lt-gains-nearly-4-after-subsidiary-wins-contract-from-ioc-5120041.html
22,"April 08, 2020 12:40 PM IST",-2,Kshitij Anand,Pain in auto sector likely to continue for another 6 to 8 months: Paras Bothra,"The pain for the auto sector is likely to continue for another 6 to 8 months if the lockdown period is extended.
The sales numbers of all auto OEMs for March have been terrible though it was expected, Paras Bothra, President of Equity Research, Ashika Stock Broking, said in an interview with Moneycontrol’s Kshitij Anand.
Q) What is your take on the auto sales numbers - do you think the pain is likely to continue in the sectors, and it is best to stay away?
A) The pain for the auto sector is likely to continue for another 6 to 8 months if the lockdown period is extended.
The sales numbers of all auto OEMs for March have been terrible though it was expected.","While valuation indicators suggest that the bottom is near the previous levels, nevertheless, one shouldn’t forget that this crisis is, after all, a healthcare crisis that morphed into a financial one.","The pain for the auto sector is likely to continue for another 6 to 8 months if the lockdown period is extended. The sales numbers of all auto OEMs for March have been terrible though it was expected, Paras Bothra, President of Equity Research, Ashika Stock Broking, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) The market is nervous as the number of coronavirus cases in India has been accelerating and there might be the possibility of another round of lockdown to contain the community spread.

As testing increased to around 10,000 tests per day, the number of coronavirus cases escalated to over 4,000, which is alarming. If the lockdown is extended beyond April around the world, the economic activity will slump and we could experience a deeper recession than 2009.

FPIs remained net sellers during March and pulled out nearly Rs 62,000 crore from equity markets. In the face of economic uncertainty, FPIs are pulling out the money from risky assets and parking it into safe havens like the US treasury. This is creating panic selling in the Indian markets.

From the economic perspective, with 87 percent of the workforce in the informal sector, the pain for lockdowns will be severely felt by India which will trigger unemployment and will squeeze the overall consumption demand.

A slowdown in demand will result in sharp cuts in corporate earnings growth in the coming quarters.

A) The pandemic was a health crisis that has now transformed into a financial crisis. Thus, the need of the hour is to find a cure.

The market is unlikely to see structural relief rally till then.

Other macro factors at this point of time are not so relevant except the massive stimulus package announced by the government to support the ailing economy and RBI’s monetary easing.

Q) What is your take on the auto sales numbers - do you think the pain is likely to continue in the sectors, and it is best to stay away?

A) The pain for the auto sector is likely to continue for another 6 to 8 months if the lockdown period is extended. The sales numbers of all auto OEMs for March have been terrible though it was expected.

Thus, the revivals in sales numbers will be delayed given the current economic uncertainties caused by the health crisis. So, it is better to stay away from auto stocks at current market volatility.

A) As we know, ""cash is king"" in times of crisis and provides a cushion. Companies that have a strong balance sheet and strong cash flows and thus have significant cash per share will be protected from the downside.

Q) What should be the trading strategy of the coming week?

A) Domestic markets will track global market movements and the spread of the virus in both India and globally.

The developments with regards to viruses are very dynamic in nature and evolving and thus it is always better to stay invested in FMCG, healthcare, utilities & telecom stocks as defensive bets in this market.

A) While valuation indicators suggest that the bottom is near the previous levels, nevertheless, one shouldn’t forget that this crisis is, after all, a health crisis that morphed into a financial one.

Besides, never in history, economies have been completely shut down choking economic activity. Thus, unless the virus and the spread of the epidemic is contained, there are always risks of the further downside and it could be too early to call the market bottom till the time the cure is invented.

COVID-19 is an unprecedented event, unknown and unknowable at this point in time. The uncertainty of it has led to a crash in the markets world across and the ferocity and pace of the price damage is unthinkable.

Bear markets are always brutal and engulf all of the market participants with fear and make them behave irrationally. A patient investor can only look at the widening gap between value and price with incremental fall and gradually initiate buy in times of extreme fear in companies of his choice, provided the choices are fair in the first place.

Markets never go broke, companies do, and it displays the collective sentiment of the herd from extreme optimism to extreme pessimism from time to time.

The historical valuation metrics reflects the degree of correction from a historical standpoint and gives a good reference point to judge the severity of the fall and the degree of value emerging with incremental decline if at all, from hereon, whether be it P/E or P/B or Earning yield to Bond yield or Mcap to GDP. If there is “Panic” today, the “Unwinding” of it is also inevitable.

Nothing stays permanent in space and time and the pendulum of market and emotion swings both ways. Stay Fit & Stay Healthy and introspect in silence the irrationality to arrive at a fair decision.

Q) What are your views on the financial space? Does it look like the smart money is moving from financials towards defensives' names?

A) Financials are likely to be under pressure given the fact that even considering hypothetically the crisis is solved today itself, it will take the economy a significant amount of time to restart and get back to working at the previous levels.

The fall out of the same is rising NPAs and dismal intermittent credit growth. Thus, at this present moment, defensives are clear favourites.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/pain-in-auto-sector-likely-to-continue-for-another-6-to-8-months-paras-bothra-5116621.html
23,"April 08, 2020 09:12 AM IST",0,Kshitij Anand,Explained: 6 ways to deal with fall in trading volumes,"Stock options are the worst affected.
Avoid illiquid stock options, and try to stick to index.
3) Higher impact costs for larger ordersIf there are 2 offers at 100, 2 stocks can be bought at 100.
Big traders have higher impact costs nowHow to deal with this:Stick to liquid contracts.
Avoid less liquid stock options.","In the last few days, trading volumes have fallen across segments, causing havoc among traders. In this article, we will examine the effects of this, and what precautions we can take to decrease our risks.","Abid Hassan

In the last few days, trading volumes have fallen across segments, causing havoc among traders. In this article, we will examine the effects of this, and what precautions we can take to decrease our risks:

1) Wider bid-offer spreads increasing costs

Bid-offer spreads have increased in the futures and options segment. This is lower on liquid contracts of Nifty and Bank Nifty futures, at the money options, and out of the money options.

In the illiquid contracts: in the money strikes and far dated futures and options are affected. Stock options are the worst affected.

How to deal with this:

Trade contracts which you know you will get exit from. Use limit orders instead of market orders. Avoid illiquid stock options, and try to stick to index.

2) Whipsaw takes out stop-losses

Volumes absorb volatility. As volumes are low, the volatility has spiked. This means in the whipsaw happening around supports and resistances, stop losses are getting hit.

How to deal with this:

Reduce the position size. Keep deeper stops that can accommodate the volatility.

3) Higher impact costs for larger orders

If there are 2 offers at 100, 2 stocks can be bought at 100. But, if liquidity is low, one offer is at 100 and another at 101. This makes the price 100.5. This extra 0.5 is the impact cost. Big traders have higher impact costs now

How to deal with this:

Stick to liquid contracts. Use limit orders instead of market orders.

Low liquidity causes gaps and sudden surges. Stop losses can be missed, leading to unlimited losses. An unusually higher number of holidays in India in April exacerbates the effects of this as India catches up with news from the overseas markets which remain open.

How to deal with this:

Systematic stop-loss orders should be kept in the trading terminal. Retail investors can consider moving from futures and naked options selling to risk defined strategies such as option spreads.

Most options have lower liquidity now. We already covered the bid-offer and impact costs. There is a bigger risk specific to options. Exiting options to book profit or loss has become difficult, and traders are getting stuck in positions.

This is especially dangerous in stock options which are delivery-settled, which needs higher capital and costs more.

How to deal with this:

Stick to liquid and cash-settled contracts like an index. Avoid less liquid stock options. Square off stock option positions before expiry.

Illiquid options are showing absurd prices, IVs, etc. This leads to incorrect decisions on premiums, break evens, Greeks, etc.

How to deal with this:

Sanity checks any option price you see. Double-check the bid-offer spreads. Stick to liquid options. Avoid illiquid times like the opening hours.

(The author is Co-Founder and CEO at Sensibull)

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/explained-6-ways-to-deal-with-fall-in-trading-volumes-5117791.html
24,"April 08, 2020 11:07 AM IST",2,Nishant Kumar,IndusInd Bank share price jumps 15% after UBS buys stake,"A day after logging a strong gain of 22.60 percent, the share price of IndusInd Bank surged 15 percent in the morning trade on BSE on April 8 after UBS Principal Capital Asia bought 53,83,066 shares of the private lender.
Singapore-based investment banking firm UBS Principal Capital Asia acquired a 0.85 percent stake in IndusInd Bank on April 7.
One of the primary reasons was the withdrawal of deposits from select private banks, including IndusInd Bank, following the Yes Bank fiasco.
The bank's deposits increased 4 percent year on year (YoY) to Rs 2.02 lakh crore in Q4FY20 as against Rs 1.94 lakh crore a year ago.
Shares of IndusInd Bank were trading 9.80 percent up at Rs 421.70 on BSE at 1055 hours.","As per April 7 bulk deal data available on the National Stock Exchange, UBS acquired 53,83,066 equity shares of the bank at Rs 367 per share.","A day after logging a strong gain of 22.60 percent, the share price of IndusInd Bank surged 15 percent in the morning trade on BSE on April 8 after UBS Principal Capital Asia bought 53,83,066 shares of the private lender.

Singapore-based investment banking firm UBS Principal Capital Asia acquired a 0.85 percent stake in IndusInd Bank on April 7.

As per April 7 bulk deal data available on the National Stock Exchange, UBS acquired 53,83,066 equity shares of the bank at Rs 367 per share.

The total deal value stood at Rs 197.55 crore and could be one of the reasons for the stellar rally in the stock price.

The stock had fallen nearly 80 percent in the last three-month period, a big correction compared to the Nifty Bank (down 46 percent), Nifty (down 34 percent) and Nifty Private Bank (down 49 percent), following concerns over asset quality and strength of funding franchise.

One of the primary reasons was the withdrawal of deposits from select private banks, including IndusInd Bank, following the Yes Bank fiasco.

The coronavirus outbreak has further impacted growth and asset quality prospects in select business segments.

Meanwhile, the bank reported strong business operations for the quarter ended March 31, 2020.

As per a BSE filing of April 6, the bank's net advances grew 13 percent year-on-year (YoY) to Rs 2.09 lakh crore as on March 31 compared with Rs 1.86 lakh crore a year ago.

The bank's deposits increased 4 percent year on year (YoY) to Rs 2.02 lakh crore in Q4FY20 as against Rs 1.94 lakh crore a year ago.

Retail deposits and deposits from small business customers jumped 34 percent YoY to Rs 62,587 crore as on March 31 as against Rs 46,651 crore on March 31, 2019.

Liquidity coverage ratio for the quarter stood at 112.18 percent compared with 111.39 percent on March 31, 2019.

CASA ratio, however, declined marginally and stood at 40.5 percent YoY against 43.1 percent in the previous year's same period.

Shares of IndusInd Bank were trading 9.80 percent up at Rs 421.70 on BSE at 1055 hours.",https://www.moneycontrol.com/news/business/markets/indusind-bank-share-price-jumps-15-after-ubs-buys-stake-5120051.html
0,"April 07, 2020 08:57 AM IST",0,Sandip Das,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","According to the pivot charts, the key support level for Nifty is placed at 7,974.22 followed by 7,864.63.
If the index moves up, key resistance levels to watch out for are 8,274.97 and 8,466.13.
The important pivot level, which will act as crucial support for the index, is placed at 16,819.63, followed by 16,389.96.
On the upside, key resistance levels are placed at 18,002.53 and 18,755.77.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​","Mitessh Thakkar of mitesshthakkar.com recommends buying Apollo Hospitals with a stop loss of Rs 1,174, target at Rs 1,235 and CESC with a stop loss of Rs 412, target at Rs 450.","Benchmark indices have nosedived for the seventh consecutive week ended April 3 amid worries over increasing COVID-19 infected cases globally and rating downgrade on fear of NPA pressure in banking & financials sector due to lockdown. Subdued auto sales data for March and rally in oil prices also hit sentiment.

The BSE Sensex tanked 2,224.64 points or 7.46 percent to 27,590.95 and the Nifty50 fell 576.45 points or 6.66 percent to 8,083.80 for the week, taking total seven-week loss to 33 percent each.

The market breadth was in favour of bulls for last three straight sessions during the passing week, which experts feel indicated that supressed valuations in quality stocks attracted buying interest at lower levels hoping that the worst might have discounted by the market.

According to the pivot charts, the key support level for Nifty is placed at 7,974.22 followed by 7,864.63. If the index moves up, key resistance levels to watch out for are 8,274.97 and 8,466.13.

The important pivot level, which will act as crucial support for the index, is placed at 16,819.63, followed by 16,389.96. On the upside, key resistance levels are placed at 18,002.53 and 18,755.77.

In an interview to CNBC-TV18, top market experts recommend which stocks to bet on for good returns:

Ashwani Gujral of ashwanigujral.com

Buy Apollo Hospitals with a stop loss of Rs 1,160, target at Rs 1,250

Buy Sun Pharma with a stop loss of Rs 360, target at Rs 410

Buy Cipla with a stop loss of Rs 440, target at Rs 475

Sell IndusInd Bank with a stop loss of Rs 325, target at Rs 300

Sell ICICI Bank with a stop loss of Rs 300, target at Rs 278

Sudarshan Sukhani of s2analytics.com

Buy ACC with a stop loss of Rs 945, target at Rs 985

Buy Biocon with a stop loss of Rs 280, target at Rs 302

Buy Cipla with a stop loss of Rs 435, target at Rs 468

Buy TCS with a stop loss of Rs 1,600, target at Rs 1,720

Mitessh Thakkar of mitesshthakkar.com

Buy Apollo Hospitals with a stop loss of Rs 1,174, target at Rs 1,235

Buy CESC with a stop loss of Rs 412, target at Rs 450

Buy GAIL India with a stop loss of Rs 79, target at Rs 88

Buy HDFC with a stop loss of Rs 1,475, target at Rs 1,580

The views and investment tips expressed by investment experts are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/top-buy-and-sell-ideas-by-ashwani-gujral-sudarshan-sukhani-mitesh-thakkar-for-short-term-68-5114581.html
1,"April 07, 2020 02:31 PM IST",0,Priyanka Roshan,In pics | Top 10 bottom-up stocks based on fundamentals amid COVID-19 crisis,"Ultratech Cement | While near-term volume growth outlook is muted, as demand recovers in 2HFY21, Ultratech is well positioned to leverage on it with current utilization (FY20e) at 74 percent and pan India presence, the brokerage said.
",Here is the list of 10 stocks that Macquarie suggests.,"Ultratech Cement | While near-term volume growth outlook is muted, as demand recovers in 2HFY21, Ultratech is well positioned to leverage on it with current utilization (FY20e) at 74 percent and pan India presence, the brokerage said. (Image: Moneycontrol)",https://www.moneycontrol.com/news/business/stocks/in-pics-top-10-bottom-up-stocks-based-on-fundamentals-amid-covid-19-crisis-5113671.html
2,"April 07, 2020 09:51 AM IST",1,Sandip Das,Lupin share price jumps 3% on launch of generic drug; Morgan Stanley sees target of Rs 948,"The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement.
The tablets are generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets, 180 mg and 360 mg, Lupin said.
The stock price fell over 54 percent in the last one month and was quoting at Rs 225.95, up Rs 6.40, or 2.92 percent.
Global research firm Morgan Stanley has an overweight call on the stock with a target of Rs 948 per share, according to a report by CNBC-TV18.
Brokerage firm Motilal Oswal has a buy rating on the stock with a target at Rs 815.","The tablets are generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets, 180 mg and 360 mg, Lupin said.","Share price of Lupin jumped over 3 percent in the morning trade on April 7 after the company launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market. The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement.

Company's alliance partner Concord Biotech Ltd had received approval from the United States Food and Drug Administration (USFDA) earlier for the product, it added.

The tablets are generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets, 180 mg and 360 mg, Lupin said.

The stock price fell over 54 percent in the last one month and was quoting at Rs 225.95, up Rs 6.40, or 2.92 percent. It has touched an intraday high of Rs 230.00 and an intraday low of Rs 225.75.

Global research firm Morgan Stanley has an overweight call on the stock with a target of Rs 948 per share, according to a report by CNBC-TV18. Brokerage firm Motilal Oswal has a buy rating on the stock with a target at Rs 815. While the near-term outlook may be subdued, the broking house remains positive on the company due to limited price erosion in the base business, robust ANDA pipeline and better-than-industry growth in the branded domestic formulation (DF).

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/lupin-share-price-jumps-3-on-launch-of-generic-drug-morgan-stanley-sees-target-of-rs-948-5114691.html
3,"April 07, 2020 08:00 AM IST",0,Priyanka Roshan,"In pics | Stocks in the news: Tata Motors, IDBI Bank, Godrej Properties, Bharat Gears, Raymond, Dhampur Sugar, Indiabulls Housing",Mahindra & Mahindra: The company said that it will not be able to inject any fresh equity in-unit SsangYong Motor.,"HCL Infosystems, HCC, Omaxe, TVS Electronics, A2Z Infra Engineering  are also among the stocks that are in the news",Mahindra & Mahindra: The company said that it will not be able to inject any fresh equity in-unit SsangYong Motor.,https://www.moneycontrol.com/news/business/stocks/in-pics-stocks-in-the-news-idbi-bank-raymond-dhampur-sugar-mills-5107171.html
4,"April 07, 2020 10:56 AM IST",2,Kshitij Anand,"Sensex jumps over 2,400 points; 4 factors which fuelled the rally","Indian market opened with a strong gap on the upside on April 7 which fuelled a 2500-point rally in Sensex, while the Nifty50 reclaimed 8,800 levels in intraday trade.
Eventually, Sensex closed 2476 points, or 8.97 percent, higher at 30,067.21 while Nifty settled 708 points, or 8.76 percent, up at 8,792.20.
The current price action could be categorized into a trading rally and investors should not mistake it with a market bottom which could well be some time away.
“I describe today’s move as a trading rally or some kind of a pullback and this is something which will keep on happening in a bear market,” he said.
Value buying at lower levels:The Indian market has fallen by about 30 percent from its recent high has put benchmark indices in an oversold zone.","Sectorally, the action was seen in healthcare, IT, Realty, Bankex, Telecom, and Auto stocks which are trading with gains of over 4 percent each.","Indian market opened with a strong gap on the upside on April 7 which fuelled a 2500-point rally in Sensex, while the Nifty50 reclaimed 8,800 levels in intraday trade.

Eventually, Sensex closed 2476 points, or 8.97 percent, higher at 30,067.21 while Nifty settled 708 points, or 8.76 percent, up at 8,792.20.

All sectoral indices closed with healthy gains, with BSE Bankex and Energy indices logging gains of 10.70 percent and 10.02 percent, respectively.

The current price action could be categorized into a trading rally and investors should not mistake it with a market bottom which could well be some time away.

“Market sold off aggressively and value is beginning to emerge in a lot of pockets especially the one which got rapidly sold off, but we have to keep in mind that the economic recovery is still some time away and in the meantime we could see some of these trading rallies,” Nilesh Shah - MD & CEO - Envision Capital said in an interview with CNBC-TV18.

“I describe today’s move as a trading rally or some kind of a pullback and this is something which will keep on happening in a bear market,” he said.

We have collated a list of 4 factors which probably fuelled optimism on D-Street:

Rally in Asian markets:

Asian markets rallied on strong price action seen on Wall Street after initial reports suggest that the coronavirus crisis may be levelling off in New York and receding in Europe.

Japan’s Nikkei rose 2% and has erased most of last week’s losses after Prime Minister Shinzo Abe promised a massive $991 billion economic stimulus package - equal to 20% of GDP, said a Reuters report.

MSCI’s broadest index of Asia-Pacific shares outside Japan pared early gains, but rose almost 1%, it said.

India may get $1.3-bn passive flow: Morgan Stanley

With India swiftly responding to the delay in notifying sector-wise limits for investment in stocks by overseas investors, analysts at Morgan Stanley now expect MSCI to rebalance MSCI India weight in the emerging market (EM) index, Business Standard reported quoting a report from Morgan Stanley.

“To reflect this change along with removing the DR (depository receipts) in the foreign ownership limit (FOL) calculation. As a result, they estimate $1.3 billion in passive inflows into the Indian equities spread across a bunch of stocks,” the report added.

India lifts restrictions on 24 drug exports amid coronavirus

The government has lifted restrictions on the export of 24 pharmaceutical ingredients and medicines made from them, the government said in a statement, Reuters reported.

It had imposed the restrictions last month as the coronavirus outbreak disrupted global supply chains. Paracetamol, a common pain reliever, and its formulations were not included in the list of drugs freed up for export.

The 26 active pharmaceutical ingredients and medicines accounted for 10% of all Indian pharmaceutical exports and include several antibiotics, such as tinidazole and erythromycin, the hormone progesterone and Vitamin B12, added the report.

Pharma stocks have been gaining of late as industry experts and brokerages believe that the sector is better placed to navigate the crisis during COVI-19 outbreak even though the challenges faced by it are all same.

Value buying at lower levels:

The Indian market has fallen by about 30 percent from its recent high has put benchmark indices in an oversold zone.

""In a bearish scenario, sector leaders with relatively stronger balance sheets, higher earnings visibility, strong cash flows, and management with a good track record should be preferred. Investors should avoid companies with high leverage,"" Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC told Moneycontrol.

""Good quality companies in small-ticket consumer discretionary sector which have corrected can bounce back. The demand destruction they have seen is temporary and they can see long term growth due to low penetration and rising per-capita income. Private banks have seen a sharp correction but those with a strong liability franchise and high-quality assets may gain market share. Also, insurance companies should continue to see secular growth,"" he said.",https://www.moneycontrol.com/news/business/markets/sensex-jumps-over-1000-points-4-factors-which-could-be-fuelling-the-rally-5114821.html
5,"April 07, 2020 11:46 AM IST",-1,Kshitij Anand,Macquarie sees at least 3 months for business to be normal post lockdown,"In the first scenario which is also the base case – Macquarie sees a 1-month lockdown followed by 3 months to business as usual.
In the bear case scenario, there could be 2-months of lockdown followed by more gradual 6 months to normal.
Even though agriculture is a pain point, Macquarie does not expect a significant impact on HDFC Bank’s overall asset quality.
Cipla: Target Rs 535Key positives are steady growth visibility, recalibrated capital allocation, and attractive valuations, according to Macquarie.
Petronet LNG: Target Rs 325The core thesis on PLNG has not changed despite a volatile macro backdrop, and Macquarie sees a short sharp volume recovery post lockdown.",Macquarie has made wholesale cuts across their coverage which are in the range from a moderate 5 percent to some cases ~80 percent.,"The Indian government ordered a nation-wide lockdown on March 25, 2020, for an initial period of 21-days which could get extended to 1-2 months, Macquarie Research highlighted said in a report authored by Aditya Suresh.

In the report, Macquarie has taken a granular look at two scenarios that could emerge in the near future. In the first scenario which is also the base case – Macquarie sees a 1-month lockdown followed by 3 months to business as usual.

In the bear case scenario, there could be 2-months of lockdown followed by more gradual 6 months to normal.

Macquarie has made wholesale cuts across their coverage which are in the range from a moderate 5 percent to some cases ~80 percent. Sectors that look better placed are staples, IT, and pharma.

The report highlights the top 10 Macquarie India research ideas based on certain fundamental parameters such as Book value per share growth is greater than 10 percent, or there is an EPS growth of more than 10 percent, etc. among others.

HDFC Bank: Target Rs 1,499

Even in the bear case scenario if we assume the loan growth/credit costs post COVID-19 to be 12%/2.3% for FY21E (base 21%/1.3%), the stock still offers an upside of ~30 percent today.

“We consider credit cost of 2.3% to be excessive as ~80% of the unsecured loans is towards salaried employees which in our view would have a better ability to repay in these testing times,” said the report.

Valuations at 2.1x FY22E P/BV for a ~2 percent ROA provides a favourable risk-reward with limited downside risk. Even though agriculture is a pain point, Macquarie does not expect a significant impact on HDFC Bank’s overall asset quality.

Successful execution of the strategy of the new CEO has yielded success with the company’s organic growth rate being faster than the industry now. Even with a single-digit revenue decline in FY21E (due to global growth shocks), EPS decline would be less than 10 percent (due to margin resilience) against an 18 percent drop in share price in the last 1 month.

The stock has a strong net cash balance sheets (US$3.4bn) and a dividend yield of 4.7 percent. The target price if Rs830 is set at 17x FY22 EPS with ~30 percent upside.

HUL: Target Rs 2563

Macquarie is of the view that home care can benefit in the near term on account of stockpiling which we see normalizing in the next 2-3 months. Out of home consumption like color cosmetics and skincare can take a hit.

“We see long term positive trends in some of the categories like personal wash and packaged/nutrition foods. We believe the GSK merger provides a strong platform to grow the food portfolio. We believe the merger would be EPS accretive (~9%) from the first year, FY21,” said the note.

Superior portfolio constructs, strong distribution and investments in digital infrastructure will help consolidate market share. Macquarie values HUR at 50x FY22E.

ICICI Bank: Target Rs 684

Even if we factor a loan growth/credit costs of 8.5%/2.7% for FY21E in the bear case scenario (post-COVID) the stock offers an upside of ~50 percent today. “We have assumed credit costs to be higher than the GFC level credit cost,” said the note.

Though there will be job losses due to COVID-19, Macquarie believes that the delinquencies in the retail portfolio will be contained and will be fairly lower than the GFC levels as this time around banks has majorly lent to internal customers.

Valuations at ~1.5x FY22E P/BV for 1.5% ROA is very compelling and can offer reasonable upside from the current levels, added the note.

HCL Technologies: Target Rs 727

In the current volatile global macro environment, Macquarie is of the view that HCL has low exposure to BFSI (21% of revenues) and a diversified business mix with software: services mix of 35:65.

UltraTech Cement: Target Rs 3952

Given near term earnings uncertainty, Macquarie focus on asset-based valuation – Ultratech trades at US$128/ton, which is 5 years low and a mere 5-10 percent above replacement cost.

Given the fact that the company has over 20 percent market share, along with diversified geographical presence, strong brand and distribution network, the stock warrants a sustainable premium.

Dr Reddy’s Laboratories: Target Rs 3324

Macquarie is of the view that the market is discounting Dr Reddy’s steadfast focus on creating ex-US growth avenues (refer Fig) and better productivity. It expects ongoing efforts on rationalising costs and improving asset utilisation to boost cash generation.

GAIL India is trading at about 50 percent below our fundamental bear case valuation. Macquarie value GAIL’s gas transmission division and listed investments together at US$9bn EV or ~20% above today’s price.

Cipla: Target Rs 535

Key positives are steady growth visibility, recalibrated capital allocation, and attractive valuations, according to Macquarie. The FY21/22E EBITDA margins are higher than Street led by factoring in a higher upside from Cipla’s focus on profitable growth.

Cipla’s key strengths, its strong branded franchises in India and South Africa, are growing at a healthy pace.

Petronet LNG: Target Rs 325

The core thesis on PLNG has not changed despite a volatile macro backdrop, and Macquarie sees a short sharp volume recovery post lockdown. We continue to see PLNG as a steady compounder with – 10+ percent EPS CAGR, driven by: (a) Dahej expansion ramp-up, (b) Kochi ramp-up, (c) tariff compounding, (d) income on growing net cash position.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/macquarie-sees-at-least-3-months-for-business-to-be-normal-post-lockdown-5112001.html
6,"April 07, 2020 10:11 AM IST",2,Nishant Kumar,"PNB Housing Finance shares hit 5% upper price band as the firm eyes raising $100 mn from JICA, Citibank","As per the press release, the company has signed an agreement with JICA to raise USD 75 million and with Citibank for USD 25 million.
This would be JICA's first debt funding in the housing finance sector in the country,” the company's managing director Sanjaya Gupta said.
The company claimed, as on March 31, 2020, it had maintained sufficient liquidity of around Rs 7,588 crore.
It had additional sanctioned but undrawn lines of Rs 3,994 crore and had serviced all its committed liabilities to date without exercising the moratorium option.
Shares of the company traded 3.09 percent higher at Rs 166.60 on BSE around 09:45 hours IST.","As per the press release, the company has signed an agreement with JICA to raise USD 75 million and with Citibank for USD 25 million.","Shares of PNB Housing Finance hit their 5 percent upper price band at Rs 169.65 in early trade on BSE on April 7, a day after the company said it had signed an agreement with Japan International Cooperation Agency (JICA) and Citibank to raise $100 million (about Rs 762 crore) for providing loans in the affordable housing segment.

As per the press release, the company has signed an agreement with JICA to raise USD 75 million and with Citibank for USD 25 million.

“We express our gratitude to JICA and Citi for partnering with us in their journey towards improving the lives of low-income households and promoting sustainable economic growth in India. This would be JICA's first debt funding in the housing finance sector in the country,” the company's managing director Sanjaya Gupta said.

Its CFO Kapish Jain said these are long-term loans of five years that would further help in balancing the company's asset-liability management (ALM) position.

The company claimed, as on March 31, 2020, it had maintained sufficient liquidity of around Rs 7,588 crore. It had additional sanctioned but undrawn lines of Rs 3,994 crore and had serviced all its committed liabilities to date without exercising the moratorium option.

Shares of the company traded 3.09 percent higher at Rs 166.60 on BSE around 09:45 hours IST.",https://www.moneycontrol.com/news/business/markets/pnb-housing-finance-shares-hit-5-upper-price-band-as-the-firm-eyes-raising-100-mn-from-jica-citibank-5114811.html
7,"April 07, 2020 09:04 AM IST",1,,Diamonds in the Dust: Axis Bank to weather COVID-19 storm barring some temporary bruising,"To view the full content of this article, you have to be a Pro:Already a Moneycontrol Pro subscriber?
Or Open in AppNot a Moneycontrol Pro subscriber yet?
Subscribe to Moneycontrol Pro:What's included:",We would recommend adding Axis Bank gradually amid deep cuts in the market,"To view the full content of this article, you have to be a Pro:

Already a Moneycontrol Pro subscriber? Or Open in App

Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:







What's included:",https://www.moneycontrol.com/news/business/moneycontrol-research/diamonds-in-the-dust-axis-bank-to-weather-covid-19-storm-barring-some-temporary-bruising-5114141.html
8,"April 07, 2020 07:19 AM IST",-1,Kshitij Anand,'Keep trades limited and protected amid COVID-19; deploy Nifty Modified Put Butterfly spread',"The carnage was worse in Bank Nifty as it dropped a whopping 13 percent in the week gone by.
FMCG and Pharma as it attracted fresh long interest.
Apart from that about 30 percent of the stocks witnessed unwinding divided equally between Long Unwinding and Short Covering.
The only sector to witness the unusual unwinding this week was Cement led by the unwinding of interest in ACC and Grasim.
However, considering the unpredictability of the pandemic it makes sense to keep the trades limited and protected.","Considering the unpredictability of the pandemic, it makes sense to keep the trades limited and protected. Hence, Modified Butterfly on monthly series options is advised.","Shubham Agarwal

After a sombre start to April, the Nifty50 tried to stage a comeback in the next session but got pulled deeper into the trenches amid uncertainty regarding the impact of COVID-19.

The index settled with a loss of 6 percent for the week ended April 3.

The carnage was worse in Bank Nifty as it dropped a whopping 13 percent in the week gone by. The diversity of impact in the returns is a little more painful when associated with the open interest (OI) activity in futures.

The reaction of traders in the futures segment was quite predictable as far as Bank Nifty is concerned which added over 13 percent in OI.

On the other hand, despite the fact that it’s the first week of April expiry, Nifty lost interest in futures especially later in the week, which was out of ordinary.

Aggregate futures attracted fresh directional interest in the first week augmenting itself by around 5 percent. What was more interesting to see was at least initiation of a bit of positivity.

As the participants soak the bitterness of the impact of the global pandemic, there were pockets in the now called essential sectors viz. FMCG and Pharma as it attracted fresh long interest.

Apart from that about 30 percent of the stocks witnessed unwinding divided equally between Long Unwinding and Short Covering. And finally, over 50 percent of the stocks added shorts.

Slicing it down further, FMCG added longs led by HUL, UBL, Dabur and Colgate Palmolive. Falling crude oil prices sparked the Oil PSUs with long additions in BPCL and HPCL. Pharma was one sector that added almost secular longs.

The only sector to witness the unusual unwinding this week was Cement led by the unwinding of interest in ACC and Grasim.

India VIX has dropped by 15 points this week to the level of 55.

Even though these are super elevated levels, it is better than the week before.

The increment in implied volatility has also taken a toll on liquidity, which could start getting restored if the implied volatility cools off.

Composition wise too, a lot of interest is now seen in the farther strikes, which because of the fatter premiums looks fairly attractive.

This is visible in Nifty as low as 6,100 strikes have also added a significant amount of interest. However, considering the unpredictability of the pandemic it makes sense to keep the trades limited and protected. Hence, Modified Butterfly on monthly series options is advised.

Modified Put Butterfly is a 4-legged strategy where 1 lot of Put close to current underlying level is bought against that 2 lots of lower strike Puts are sold and 1 more lot of Put is bought but closer to the Put sold strike.

This keeps the lower but constant profits in case of a downward breakout. This is a risk-averse and a universal strategy.",https://www.moneycontrol.com/news/business/markets/keep-trades-limited-and-protected-amid-covid-19-deploy-nifty-modified-put-butterfly-spread-5109241.html
9,"April 07, 2020 10:52 AM IST",1,Sandip Das,"D-Street Buzz: Banks rally led by IndusInd Bank, stock jumps 15%; Motilal Oswal retains buy on HDFC Bank","Sensex is up 1,125.29 points or 4.08 percent at 28716.24, and the Nifty jumped 321.15 points or 3.97 percent at 8404.95.
All sectoral indices are trading in the green with Bank Nifty spiking 5 percent in the morning session.
Morgan Stanley has maintained an overweight stance on the stock with target of Rs 525 per share.
The other gainers included Axis Bank which spiked 8 percent followed by HDFC Bank, ICICI Bank, Kotak Mahindra Bank and Federal Bank.
Motilal Oswal maintains a buy on HDFC Bank with a revised target of Rs 1,150 per share, an upside on 41 percent and has a buy also on IndusInd Bank with target of Rs 800 per share, an upside of 155 percent.","IndusInd Bank was the top gainer followed by Axis Bank, HDFC Bank, ICICI Bank and Kotak Mahindra Bank.","The Indian stock market surged on April 7 tracking its Asian peers on hopes of the coronavirus spread having peaked in key global centres.

Sensex is up 1,125.29 points or 4.08 percent at 28716.24, and the Nifty jumped 321.15 points or 3.97 percent at 8404.95.

All sectoral indices are trading in the green with Bank Nifty spiking 5 percent in the morning session.

The top gainers included IndusInd Bank which zoomed 15 percent. The private sector lender and its promoter the Hinduja Group initiated talks with sovereign wealth funds and pension funds, including Canada’s CPPIB and Singapore’s GIC Pte Ltd, to raise as much as USD 500 million. Morgan Stanley has maintained an overweight stance on the stock with target of Rs 525 per share.

The other gainers included Axis Bank which spiked 8 percent followed by HDFC Bank, ICICI Bank, Kotak Mahindra Bank and Federal Bank.

HDFC Bank reported a 7.41 percent increase in aggregate deposits during the January-March period to Rs 11.46 lakh crore, which was 24 percent higher as compared to March 31 last year.

Motilal Oswal maintains a buy on HDFC Bank with a revised target of Rs 1,150 per share, an upside on 41 percent and has a buy also on IndusInd Bank with target of Rs 800 per share, an upside of 155 percent.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-banks-rally-led-by-indusind-bank-stock-jumps-15-motilal-oswal-retains-by-on-hdfc-bank-5115011.html
10,"April 07, 2020 10:24 AM IST",2,Nishant Kumar,"D-Street Buzz: Pharma stocks shine; Cadila, Laurus Labs, Biocon shares jump up to 15%","Most pharma stocks were trading with strong gains in morning trade on April 7, keeping their sectoral index on BSE in the higher territory.
Shares of Morepen Labs, Cadila, Laurus Labs, Hikal, Lupin, Biocon and Sun Pharma were trading with strong gains.
""With China resuming supplies of raw materials, potential disruption in manufacturing is now no longer a concern.
""The India pharma market growth continues on expected lines – high single-digit.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","Brokerages do not see a meaningful adverse impact of the lockdown, which is in its second week, on the earnings of pharma players.","Most pharma stocks were trading with strong gains in morning trade on April 7, keeping their sectoral index on BSE in the higher territory.

Around 1:15 hours, the BSE Healthcare index was 5.20 percent up at 13,039.55. Shares of Morepen Labs, Cadila, Laurus Labs, Hikal, Lupin, Biocon and Sun Pharma were trading with strong gains.

Pharma stocks have been gaining of late as industry experts and brokerages believe that the sector is better placed to navigate the crisis during COVI-19 outbreak even though the challenges faced by it are all same.

""We remain confident on the strong demand scenario from both domestic and export markets. Also, believe that these disruptions would not be meaningful from a full-year earnings perspective as the benefits of weaker currency could bridge the gap,"" brokerage firm Centrum Broking said in a report.

Centrum says the export market will experience some price increases amid shortages and demand increase for generic drugs. However, it expects some impact on the Q1FY21 Indian pharmaceutical market (IPM) growth.

Brokerages do not see a meaningful adverse impact of the lockdown, which is in its second week, on the earnings of pharma players.

""With China resuming supplies of raw materials, potential disruption in manufacturing is now no longer a concern. There has been inflation in select raw material supplies but the same should only have a minor impact on gross margins during the quarter,"" brokerage Nirmal Bang said.

""The India pharma market growth continues on expected lines – high single-digit. In the US, we could see marginal benefit coming from dollar appreciation and a potential increase in the stocking at the wholesaler level which should be offset by currency depreciation in emerging markets due to declining crude prices.""

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-pharma-stocks-shine-cadila-laurus-labs-biocon-shares-jump-up-to-15-5115001.html
11,"April 07, 2020 02:19 PM IST",2,Sandip Das,"D-Street Buzz: 450 stocks hit upper circuit on BSE; HDFC Bank, RIL most active","The other gainers included Axis Bank which spiked 17 percent followed by HDFC Bank, ICICI Bank, Kotak Mahindra Bank and Federal Bank.
The top gainers included Cadila Healthcare, Dr Reddy's Labs, Cipla, Divis Labs, Sun Pharma, Aurobindo Pharma and Torrent Pharma.
452 stocks have hit upper circuit on BSE including SpiceJet, Rail Vikas Nigam, IRCTC, Jubilant Life, Balrampur Chini, Maruti Suzuki and Graphite India among others.
30 stocks have hit 52-week high on BSE including names like Torrent Pharma, Dr Reddy's Labs, Hindustan Unilever, IPCA Labs and GSK Consumer among others.
The most active stocks included HDFC Bank, Reliance Industries, Bajaj Finance, ICICI Bank and Axis Bank.","452 stocks have hit upper circuit on BSE including SpiceJet, Rail Vikas Nigam, IRCTC, Jubilant Life, Balrampur Chini, Maruti Suzuki and Graphite India among others.","The Indian stock market is trading at day's high with Sensex up 2,150.92 points or 7.8 percent at 29741.87, and the Nifty spiked 617.80 points or 7.64 percent at 8701.60.

All sectoral indices are trading in the green with Bank Nifty and the pharma index spiking 10 percent each in the afternoon session.

The top gainers included IndusInd Bank which zoomed 21 percent. The private sector lender and its promoter the Hinduja Group initiated talks with sovereign wealth funds and pension funds, including Canada’s CPPIB and Singapore’s GIC Pte Ltd, to raise as much as USD 500 million. Morgan Stanley has maintained an overweight stance on the stock with target of Rs 525 per share.

The other gainers included Axis Bank which spiked 17 percent followed by HDFC Bank, ICICI Bank, Kotak Mahindra Bank and Federal Bank.

HDFC Bank reported a 7.41 percent increase in aggregate deposits during the January-March period to Rs 11.46 lakh crore, which was 24 percent higher as compared to March 31 last year.

Motilal Oswal maintains a buy on HDFC Bank with a revised target of Rs 1,150 per share, an upside on 41 percent and has a buy also on IndusInd Bank with target of Rs 800 per share, an upside of 155 percent.

The pharma index surged 10 percent hitting a 1-month high as industry experts and brokerages believe that the sector is better placed to navigate the crisis during COVID-19 outbreak even though the challenges faced by it are all same.

""We remain confident on the strong demand scenario from both domestic and export markets. Also, believe that these disruptions would not be meaningful from a full-year earnings perspective as the benefits of weaker currency could bridge the gap,"" brokerage firm Centrum Broking said in a report.

The top gainers included Cadila Healthcare, Dr Reddy's Labs, Cipla, Divis Labs, Sun Pharma, Aurobindo Pharma and Torrent Pharma.

452 stocks have hit upper circuit on BSE including SpiceJet, Rail Vikas Nigam, IRCTC, Jubilant Life, Balrampur Chini, Maruti Suzuki and Graphite India among others.

30 stocks have hit 52-week high on BSE including names like Torrent Pharma, Dr Reddy's Labs, Hindustan Unilever, IPCA Labs and GSK Consumer among others.

The most active stocks included HDFC Bank, Reliance Industries, Bajaj Finance, ICICI Bank and Axis Bank.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-450-stocks-hit-upper-circuit-on-bse-hdfc-bank-ril-most-active-5116351.html
12,"April 07, 2020 07:05 AM IST",2,Nishant Kumar,"Hot Stocks | Sun Pharma, Just Dial can give up to 14% return 3-4 weeks","In the recent past, financial stocks have been facing terrible selloff and last week too, we saw tremendous underperformance from this space.
Moreover, it would be unfair not to mention the stupendous rally in pharma stocks on the last day of the week.
Just Dial | Buy | LTP: Rs 300.50 | Target price: Rs 342 | Stop loss: Rs 284.20 | Upside: 14 percentThis stock has corrected sharply in the recent turmoil and posted its all-time low of Rs 250 in the last week of March.
Although the market environment does not suit positions on the long side, we are advising this stock with strict stop losses.
One can look to buy for a target of Rs 342 in the coming weeks.","Last week, India VIX cooled off considerably from a 12-year high, which is the only sign of relief because it indicates the possibility of volatility reducing.","Sameet Chavan

During the previous week, the proceedings started with a strong cut on Monday and despite some pullback in the following session markets once again resumed their downward trajectory.

Eventually, the truncated week ended with nearly seven percent cut from the previous weekly close.

As we all know, markets are being driven by fear and till the coronavirus pandemic does not subside, the pain is likely to stay in the market.

Traders are advised not to create aggressive bets, especially leveraged positions in such kind of environment.

Last week, India VIX cooled off considerably from a 12-year high, which is the only sign of relief because it indicates the possibility of volatility reducing and thereby, shrinking the overall range of the market.

It would be important to see how things pan out over the weekend with respect to coronavirus.

As far as levels are concerned, 8,000 followed by 7,800 would be seen as immediate supports, whereas on the higher side, if the market has to see some relief, the Nifty needs to surpass 8,300-8,400 convincingly.

In the recent past, financial stocks have been facing terrible selloff and last week too, we saw tremendous underperformance from this space.

Moreover, it would be unfair not to mention the stupendous rally in pharma stocks on the last day of the week. It has been the safe-haven space for traders and investors in the recent meltdown and now it increases the possibility of the multi-year pain ending for this basket.

Here are two stock recommendations for the next 3-4 weeks:

Sun Pharma | Buy | LTP: Rs 376.45 | Target price: Rs 404 | Stop loss: Rs 357 | Upside: 7 percent

The entire pharma space has been the knight in the shining armour for the market participants in the recent carnage.

This laggard sector has not only showed reluctance to fall but also saw a stupendous rally in the last few sessions, especially on last Friday.

It would be too early to comment on this, but we may see early signs of revival for this basket after the underperformance of nearly five years.

Sun Pharma gave a decisive breakout from key short-term moving averages along with sizable volumes.

Just Dial | Buy | LTP: Rs 300.50 | Target price: Rs 342 | Stop loss: Rs 284.20 | Upside: 14 percent

This stock has corrected sharply in the recent turmoil and posted its all-time low of Rs 250 in the last week of March.

Looking at the last few days’ price action, it appears that the correction has halted for a while.

On April 1, we saw the first sign of strength as prices managed to close above the 5-day exponential moving average for the first time in the last few weeks.

In addition, the RSI-smoothed oscillator has confirmed a positive crossover in extreme oversold territory.

Hence, we expect the stock to give some relief in the next few days.

Although the market environment does not suit positions on the long side, we are advising this stock with strict stop losses.

One can look to buy for a target of Rs 342 in the coming weeks. The stop loss can be placed at Rs 284.20.

(Chief Technical & Derivatives Analyst at Angel Broking)

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-sun-pharma-just-dial-can-give-up-to-14-return-3-4-weeks-5106541.html
13,"April 07, 2020 12:00 PM IST",-1,Nishant Kumar,Bajaj Finance shares tank 6%; brokerages cut estimates keep mixed views,"The company’s liquidity position remains very strong,"" Bajaj Finance said.
Deposit book stood at Rs 21,400 crore as of March 31, 2020, compared to Rs 13,193 crore as of March 31, 2019.
The mix of the retail and corporate book stood at 72:28, Bajaj Finance said.
On the other hand, Kotak Institutional Equities has upgraded Bajaj Finance to a 'buy' from a 'sell' with a target price of Rs 2,700 from Rs 3,850 earlier.
Kotak said Bajaj Finance has built a solid data-driven lending engine that has helped it to read early warning indicators, toggle across segments and channels.","Brokerage firm Emkay Global Financial Services has downgraded the company to 'hold' from 'buy', revising the target price to Rs 2,331 from Rs 3,570 earlier.","Shares of Bajaj Finance tanked about 6 percent to hit their fresh 52-week low of Rs 2,083 on BSE on April 7 even as a day ago the company said despite a 10 days loss, the company continued to grow its assets, new loans, new customer acquisition and franchise in a steady manner during Q4.

In a BSE filing on April 6, the company said its customer franchise as of March 31, 2020, stood at 4.26 crore as compared to 3.45 crore as of March 31, 2019. During the March quarter of FY20, the company had acquired 19 lakh new customers.

New loans booked during Q4FY20 were 60 lakh as compared to 58 lakh in Q4FY19 and assets under management (AUM) stood at Rs 1,47,600 crore as of March 31, 2020, as compared to Rs 1,15,888 crore as of March 31, 2019, the company claimed.

""The company continues to remain well capitalised with the capital adequacy ratio (CRAR) of approximately 25 percent as of March 31, 2020. Consolidated liquidity surplus stood at Rs 15,800 crore as of March 31, 2020. The company’s liquidity position remains very strong,"" Bajaj Finance said.

Deposit book stood at Rs 21,400 crore as of March 31, 2020, compared to Rs 13,193 crore as of March 31, 2019. The mix of the retail and corporate book stood at 72:28, Bajaj Finance said.

Moreover, the company said it is assessing the adequacy of provisioning for identified large accounts and will consider enhancing provisions for these accounts. It is also considering one-time accelerated provisioning for COVID-19 to further strengthen its provisioning standards.

Brokerages trim estimates, keep mixed views

Brokerage firm Emkay Global Financial Services, in a report on April 6, said it had downgraded the company to 'hold' from 'buy', revising the target price to Rs Rs 2,331 from Rs 3,570 earlier.

""We downgrade Bajaj Finance to 'hold' from 'buy' and revised the target price to Rs 2,331 from Rs 3,570, corresponding to nearly 3.2 times P/B FY22E, considering elevated uncertainties around growth and asset quality. With management’s rising focus on recoveries and managing asset quality, growth will take a back seat at least for a few quarters,"" Emkay Global said.

Emkay is of the view that as the whole world is facing a recession due to the COVID-19 outbreak, India would not be an exception.

""With nearly 63 percent of lending to retail customers, nearly 91 percent business in urban and semi-urban areas and nearly 39 percent portfolio under the consumer durable segment, Bajaj Finance is the most vulnerable to the current scenario of lockdowns,"" Emkay said.

Also, with an average asset maturity of 24 months, the decline in disbursements would have a faster impact on growth resulting in speedy AUM rundown, Emkay added.

Brokerage firm Motilal Oswal Financial Services has a 'neutral' view on the stock with a target price of Rs 2,625.

Motilal has cut its earnings estimate by 42 percent and 25 percent for FY21 and FY22E, respectively, to factor in the lower AUM growth and a sharp rise in credit cost, whose impact was partially negated by the opex cut.

Motilal expects AUM growth to slow down from 27 percent in FY20 to 8 percent in FY21, but revert to 20 percent in FY22.

""While we believe stock price correction (55 percent from peak) and current valuations (2.9 times FY22E BV) largely factor in the moderate economic growth and the resultant impact on earnings, near-term volatility may remain high as earnings have significant linkages to the prevailing COVID-19 situation,"" Motilal Oswal said.

Motilal Oswal believes that segments like two-wheeler financing, SME and loan against property will witness asset quality stress in FY21E. The brokerage estimates credit costs to jump from 2.5 percent in FY20 to 4 percent in FY21 and then moderate to 3.1 percent by FY22E.

On the other hand, Kotak Institutional Equities has upgraded Bajaj Finance to a 'buy' from a 'sell' with a target price of Rs 2,700 from Rs 3,850 earlier.

""We believe that increased risk to Bajaj Finance’s consumer and SME book from the current lockdown and on the back of an economic slowdown is priced in, post the recent sharp stock correction,"" said Kotak in a report on April 7.

""We significantly increase our credit cost estimates for FY2021E, slowdown our medium-term growth forecasts in the backdrop of increasing uncertainty and raise our cost of equity assumptions to reflect increased business risks in the current environment,"" it said.

Kotak said Bajaj Finance has built a solid data-driven lending engine that has helped it to read early warning indicators, toggle across segments and channels.

Kota believes that Bajaj will sail through these challenging times even as it may have to face rough weather in the near-term.

""The stock is down from its rich multiples, that assumed uninterrupted high-growth, to reflect current challenges. We believe that this is a good opportunity for long-term investors, many of whom, have believed in the story but were not comfortable to enter at higher levels, an approach similar to ours,"" Kotak said.

Kotak has reduced its estimates by 16-39 percent for FY2021-22E reflecting lower growth and higher credit costs; PBT before provisions stands reduced by 12-14 percent.

After the reduction, Kotak expects Bajaj to resume 19-20 percent RoE by FY2022E. The RoE decline in FY2021E (14 percent) will be sensitive to write-offs in the lending book, Kotak said.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/bajaj-finance-shares-tank-6-brokerages-cut-estimates-keep-mixed-views-5115041.html
14,"April 07, 2020 02:13 PM IST",2,Sunil Matkar,"AU Small Finance Bank gains 5% after Q4 deposits rise 34%, NPA remain stable","Shares of AU Small Finance Bank gained 5 percent intraday on April 7 after the company reported a 34 percent increase in its deposits with stable asset quality performance.
As per its unaudited partial results, the bank's deposits grew by 9 percent to Rs 26,163 crore in the quarter ended March 2020, against Rs 23,865 crore in December ended quarter, while the year-on-year increase was 34 percent.
""During FY20, the bank continued its thrust on building a granular, retail, low-cost deposit franchise,"" AU SFB said in its BSE filing.
Total balance sheet assets at the end of March quarter were Rs 42,346 crore, registering 29 percent year-on-year and 10 percent QoQ growth.
During Q4FY20, the bank sold PSL certificate amounting to Rs 5,710 crore and for FY20, the aggregate PSL Certificate sold amounting Rs 15,505 crore, it said.",,"Shares of AU Small Finance Bank gained 5 percent intraday on April 7 after the company reported a 34 percent increase in its deposits with stable asset quality performance.

As per its unaudited partial results, the bank's deposits grew by 9 percent to Rs 26,163 crore in the quarter ended March 2020, against Rs 23,865 crore in December ended quarter, while the year-on-year increase was 34 percent.

""During FY20, the bank continued its thrust on building a granular, retail, low-cost deposit franchise,"" AU SFB said in its BSE filing.

Disbursements for FY20 rose around 17 percent over FY19 led by higher around 28 percent growth in retail disbursements, it added.

Total balance sheet assets at the end of March quarter were Rs 42,346 crore, registering 29 percent year-on-year and 10 percent QoQ growth.

Retail assets under management grew by 38 percent YoY and 7 percent sequentially to Rs 26,131 crore at the end of March quarter.

Total loan assets reached to Rs 31,133 crore with an annual growth of around 28 percent and sequential growth of 4 percent, company said.

On a sequential basis, the bank's gross NPA ratio stood at 1.9 percent in March quarter against 1.88 percent in December quarter, while net NPA ratio improved to 0.97 percent from 1.01 percent in quarter ended December 2019.

The provisional coverage ratio improved to 49 percent in the January-March quarter, from 46.80 percent in the December quarter, while the liquidity coverage ratio stood at around 137 percent as of March 2020.

On March 31, 2020, the bank said it had surplus liquidity of Rs 4,900 crore.

During Q4FY20, the bank sold PSL certificate amounting to Rs 5,710 crore and for FY20, the aggregate PSL Certificate sold amounting Rs 15,505 crore, it said.

The stock was trading at Rs 473.45, up 1.38 percent on the BSE at 1340 hours IST.",https://www.moneycontrol.com/news/business/markets/au-small-finance-bank-gains-5-after-q4-deposits-rise-34-npa-remain-stable-5116381.html
15,"April 07, 2020 10:27 AM IST",0,Kshitij Anand,Every crisis is an opportunity! Utilise current scenario to re-organise portfolio,"The 45-year veteran investor from Mumbai said it felt similar to 2008, when the news of an impending global financial crisis, made the rounds.
Based on the sound advice given by Krishna, Arjun decided to make opportune use of the global crisis and added quality stocks to his equity portfolio at attractive valuations.
Analyse your financial standing and risk appetite:Portfolio re-organising is a task that must be done with due diligence.
Before getting started, analyse your financial standing and reflect on one of the core tenets of investing – your risk appetite.
At the same time, the current volatility offers a perfect opportunity to scout quality stocks at attractive valuations to add to your portfolio for meaningful gains in the long run.","Individual investors should remember that every crisis is an opportunity. The present situation is no different, should you choose to wisely seize it and use it to your advantage.","A few days ago, history repeated itself for Arjun. It was the day that benchmark indices recorded their single-biggest fall, just as the World Health Organization (WHO), declared COVID-19 a global pandemic.

Gains made painstakingly over the years were wiped clean within seconds. The 45-year veteran investor from Mumbai said it felt similar to 2008, when the news of an impending global financial crisis, made the rounds.

Like many other worried investors who lost their hard-earned money in the market tumble of 2008, Arjun was ready to hurriedly cut his losses and exit the capital markets, had it not been for his friend and financial advisor, Krishna.

Based on the sound advice given by Krishna, Arjun decided to make opportune use of the global crisis and added quality stocks to his equity portfolio at attractive valuations.

This helped him diversify his holdings further and enhanced his investments manifold, in the long-term. And just as he recalled the 2008 crisis, Arjun also recalled Krishna’s valuable advice and sought to do something similar now when markets in India and across the globe, have corrected stocks to extremely attractive valuations.

At a time when Morgan Stanley has warned of a global recession — with global rating agencies slashing their FY21 GDP forecast for India — here’s how you, as an investor, can use this volatility to take stock of your portfolio and reorganise it.

Analyse your financial standing and risk appetite:

Portfolio re-organising is a task that must be done with due diligence. Before getting started, analyse your financial standing and reflect on one of the core tenets of investing – your risk appetite.

With no expert view that can precisely predict the bottom, it is up to you to gauge your risk appetite accurately.

For instance, if you are in your late 30s with a family and liabilities to shoulder, calculate how much money you can redirect from long-term goals such as retirement to maintain current liquidity.

Similarly, if you are in your early 20s and have a high tolerance to risk, be more moderate in your expectations.

Remain invested in good quality stocks:

Crises like these, in my opinion, strongly test the true character of investors. It separates the veterans of volatility from the amateurs seeking to experiment.

If you have consistently invested in fundamentally-sound stocks, make sure to remain invested. Indian markets have overcome such crises in the past and have rewarded those who had the patience to wait out the storm.

At the same time, the current volatility offers a perfect opportunity to scout quality stocks at attractive valuations to add to your portfolio for meaningful gains in the long run.

Several high-value stocks would be trading at lower valuations and you should lap them up as soon as you can. Also, if you have invested in mutual funds through Systematic Investment Plans (SIPs), do not discontinue them, as that would be a mistake.

With dropping NAVs, your SIPs would fetch more units now, averaging out the cost of buying. Staying invested now would yield higher dividends in the long run.

Provision for liquidity:

In such uncertain times, liquidity is a major concern. With a slump in economic activities, most businesses have come to a standstill and companies are staring at losses.

Lay-offs can’t be ruled out. This brings me to another essential aspect of wealth management and asset allocation — building an emergency corpus.

Having an emergency corpus ensures that you can bank on it to take care of your daily needs and liabilities, without dipping into your savings or compromising on your earmarked capital for various investment milestones. Check your portfolio and make adequate provisions for this corpus, if not done so already.

Consider liquid funds that invest in securities with short-term maturities like 91 days that offer higher returns as compared to a savings account. Redemption is quick and easy and is processed within one (T+1) working day.

In conclusion:

Amid all the gloom and doom, the Reserve Bank of India (RBI) has made several big-bang announcements to infuse much-needed liquidity worth Rs. 1 lakh [1] crore, through long-term repo operations (LTROs).

These measures should help the Indian economy in combating adverse impacts of COVID 19, spur consumption and instil confidence amongst investors.

However, as individual investors, do remember that every crisis is an opportunity. The present situation is no different, should you choose to wisely seize it and use it to your advantage.

(The author is Head, Edelweiss Wealth Management)

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. Not sure which mutual funds to buy? Download moneycontrol transact app to get personalised investment recommendations.",https://www.moneycontrol.com/news/business/markets/every-crisis-is-an-opportunity-utilise-current-scenario-to-re-organise-portfolio-5109211.html
16,"April 07, 2020 12:04 PM IST",2,Rakesh Patil,Cadila Healthcare share price surges 15% on USFDA approval,"Cadila Healthcare share price added 15 percent intraday on April 7 after the company received final approval from the USFDA to market Perphenazine Tablets.
Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg, as per the company release.
This medication is indicated for the treatment of schizophrenia and for the control of severe nausea and vomiting in adults.
The group now has 284 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.
At 11:46 hrs, Cadila Healthcare was quoting at Rs 311.80, up Rs 36.75, or 13.36 percent on the BSE.",The drug will be manufactured at the group’s formulation manufacturing facility at Baddi.,"Cadila Healthcare share price added 15 percent intraday on April 7 after the company received final approval from the USFDA to market Perphenazine Tablets.

Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg, as per the company release.

This medication is indicated for the treatment of schizophrenia and for the control of severe nausea and vomiting in adults.

The drug will be manufactured at the group’s formulation manufacturing facility at Baddi.

The group now has 284 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.

At 11:46 hrs, Cadila Healthcare was quoting at Rs 311.80, up Rs 36.75, or 13.36 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-share-price-surges-15-on-usfda-approval-5115471.html
17,"April 07, 2020 07:27 AM IST",-1,Kshitij Anand,COVID-19 is an 'external health shock' which can get morphed into a ‘financial crisis',"It poses an existential crisis not only to human life but also to the world economy.
There are mainly three stakeholders in an economy - households, businesses, and the government.
Now the entry of COVID-19 brought the existential crisis for the households who were forced to remain indoors and practice social distancing.
To some extent, these packages also ensure the prevention of widespread bankruptcies in the private sector which is essential to prevent the current crisis from getting morphed into an economic crisis.
The only silver lining, seems to be in this entire episode, is the fact that it is still a health crisis and not yet a full-blown financial crisis.","Though the recession is given for the year 2020, global policymakers are doing their best to keep their key stakeholders afloat in their economies through stimulus packages.","Mazhar Mohammad

The world had a little idea of how dangerous an unknown virus, which was later named COVID – 19, can turn out to be. It poses an existential crisis not only to human life but also to the world economy.

This unknown little beast has brought down the global economies to a grinding halt.

There are mainly three stakeholders in an economy - households, businesses, and the government. Households own labour and capital which they submit to businesses.

Then businesses by making use of this labour and capital churn out goods and services. In this process, businesses pay money to the households who again create demand for goods and services.

In between some part of the wealth is shared with the governments in the form of taxes who again spend this money on welfare schemes. This flow of money keeps the economy rolling across the world.

Now the entry of COVID-19 brought the existential crisis for the households who were forced to remain indoors and practice social distancing. This has upset the business activity and stopped the production of goods and services.

Unusually, this not only led to the supply shock but also in course of time creates low demand as households run out of money.

In turn, the revenues for the government will also come down as households and businesses can’t contribute anything in the form of taxes to the government.

What can be the economic cost of COVID–19:

The global economy right now is in an unprecedented situation, which is worse than in the times of the great depression of 1929 and world wars as ‘households’ across the globe are locked down due to the life-threatening virus.

The historical statistics related to US Economy suggest that during the great depression of 1929 – 1933 the GDP of US Economy was contracted by 30 percent whereas unemployment rate peaked at 20 percent and in the last global financial crisis of 2008 US GDP was contracted by 8.4 percent (annualised) in the 4th quarter of 2008.

As COVID -19 crisis, as of now, appears to be still on the mid path without a nearby solution, the fear is that the world economy may slip into depression kind of scenario if liquidity taps opened by the world central bankers to provide rescue measures dry up before finding a medical solution.

Though at this juncture it will be very difficult to project to what extent there can be economic damage to the global economy it will be worthwhile to look at the damage suffered by the dragon economy which recently opened up from lockdown.

It already started experiencing defaults on retail loans as many individuals are finding themselves out of jobs and money. World Economic Forum expects sharp cuts in the growth of Chinese Economy as economists’ estimates only a growth of 2 percent against the targeted growth rate of 6 percent for the year 2020.

It can easily get translated into reality as the ‘worlds factory’ is open but its shoppers are still struggling with lockdowns in Europe, the USA, and Asia.

Its business activity in the last two months seems to be significantly down as pointed out by certain economic indicators as shown in the table below:

Though the recession is given for the year 2020, global policymakers are doing their best to keep their key stakeholders afloat in their economies through stimulus packages.

In this regard USA whose GDP is roughly around $21.6 trillion came out with a massive relief program through a special act on last 25th March v.i.z CARES ACT – Corona Virus Aid, Relief and Economic Security Act which facilitated a $2 trillion stimulus package to provide aid to states, industry, and workers.

This stimulus amounts to 10 percent of its GDP. Similarly, Germany and the UK also announced stimulus packages which is equivalent of 5 percent of their respective GDPs.

To some extent, these packages also ensure the prevention of widespread bankruptcies in the private sector which is essential to prevent the current crisis from getting morphed into an economic crisis.

CARES ACT also sets up a $500 billion lending program for small businesses and health care sectors with incentives for businesses to keep employees on the payroll.

The only silver lining, seems to be in this entire episode, is the fact that it is still a health crisis and not yet a full-blown financial crisis.

Hence, as long as it remains health crisis and if a medical solution is found in the near term before policymakers run out of their liquidity weapons then sooner than later the economic activity shall find its feet firmly on the ground with quick rebounding capacity as Households will be no longer on social isolation mode.

(The author is Chief Strategist – Technical Research & Trading Advisory, Chartviewindia.in)

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-is-an-external-health-shock-which-can-get-morphed-into-a-financial-crisis-5109701.html
18,"April 07, 2020 12:04 PM IST",2,Sandip Das,"Tata Power share price jumps 5% on bagging Rs 1,730-crore NTPC project","The share price of Tata Power Company jumped 5 percent intraday on April 7 after the company got a Rs 1,730-crore project from NTPC.
Tata Power Solar Systems, a wholly-owned subsidiary of Tata Power, received the Letter of Award to build the 300 MW CPSU-II for NTPC at an all-inclusive price of Rs 1,730.16 crore.
The order book of Tata Power Solar now stands at around Rs 8,541 crore, the company said in a filing to the exchanges.
The stock, which slipped 28 percent in the last month, was quoting at Rs 31.70, up Rs 1.50, or 4.97 percent.
It has touched an intraday high of Rs 31.80 and an intraday low of Rs 30.80.",Tata Power Solar Systems has received the Letter of Award to build the 300 MW CPSU-II for NTPC.,"The share price of Tata Power Company jumped 5 percent intraday on April 7 after the company got a Rs 1,730-crore project from NTPC.

Tata Power Solar Systems, a wholly-owned subsidiary of Tata Power, received the Letter of Award to build the 300 MW CPSU-II for NTPC at an all-inclusive price of Rs 1,730.16 crore.

The commercial operation date (COD) for this grid-connected solar photovoltaic project is September 2021. The order book of Tata Power Solar now stands at around Rs 8,541 crore, the company said in a filing to the exchanges.

""It is projects like these which demonstrate the trust in Tata Power’s project management and execution skills. This order is a motivation for us to continue focusing on delivering the best to our customers, as per their expectations,"" Tata Power CEO & MD Praveer Sinha said.

The stock, which slipped 28 percent in the last month, was quoting at Rs 31.70, up Rs 1.50, or 4.97 percent. It has touched an intraday high of Rs 31.80 and an intraday low of Rs 30.80.",https://www.moneycontrol.com/news/business/stocks/tata-power-share-price-jumps-5-on-bagging-rs-1730-crore-ntpc-project-5115391.html
19,"April 07, 2020 12:47 PM IST",1,Rakesh Patil,L&T share price rises 5% on order win from Indian Army,"Larsen & Toubro (L&T) share price rose 5 percent intraday on April 7 after the company bagged an order from the Indian Army.
The Smart World, a communication business of L&T Construction, has secured a large order from the army to establish a first-of-its-kind Unified Network Management System to manage, support and operate the countrywide Armed Forces Network under the Network for Spectrum (NFS), the company said in the release.
The value of the contract is between Rs 2,500-5,000 crore and is to be implemented in 18 months followed by three years of warranty and seven years of AMC, it added.
""The order involves creating a centralised network monitoring, management and control system for all the seven layers under NFS which interconnects 414 defence stations,"" said L&T CEO and Managing Director SN Subrahmanyan said.
At 1230 hours, Larsen & Toubro was quoting at Rs 808.80, up Rs 33.95, or 4.38 percent, on the BSE.","The Smart World, a communication business of L&T Construction, has secured the order valued between Rs 2,500 and Rs 5,000 crore.","Larsen & Toubro (L&T) share price rose 5 percent intraday on April 7 after the company bagged an order from the Indian Army.

The Smart World, a communication business of L&T Construction, has secured a large order from the army to establish a first-of-its-kind Unified Network Management System to manage, support and operate the countrywide Armed Forces Network under the Network for Spectrum (NFS), the company said in the release.

The value of the contract is between Rs 2,500-5,000 crore and is to be implemented in 18 months followed by three years of warranty and seven years of AMC, it added.

""The order involves creating a centralised network monitoring, management and control system for all the seven layers under NFS which interconnects 414 defence stations,"" said L&T CEO and Managing Director SN Subrahmanyan said.

At 1230 hours, Larsen & Toubro was quoting at Rs 808.80, up Rs 33.95, or 4.38 percent, on the BSE.",https://www.moneycontrol.com/news/business/stocks/lt-share-price-rises-5-on-order-win-from-indian-army-5115851.html
20,"April 07, 2020 12:48 PM IST",0,Kshitij Anand,'To dodge the COVID-19 bullet investors should follow these 3 simple rules',"To dodge the COVID-19 bullet, investors could take shelter in cash-rich companies that may sustain in lockdown better than other companies, Vishal Wagh, Research Head, Bonanza Portfolio Ltd, said in an interview with Moneycontrol’s Kshitij Anand.
Many investors, Mutual Funds and even many institutions are stuck with their longer-term holding which is bleeding more than 20-25 percent.
The current lockdown scenario also forced many corporates to generate liquid cash for payment of overheads, as well as wages.
Invest in safer stock like ITC, Abbot India, and SanofiA) Every shock in the market creates an opportunity for longer-term investors.
Currently, stocks that are getting affected due to lockdown and getting in cheaper rates should be zeroed for investment.",Every shock in the market creates an opportunity for longer-term investors. No one currently in positions to comment on the bottom as Corona spread is getting wider with every passing day.,"To dodge the COVID-19 bullet, investors could take shelter in cash-rich companies that may sustain in lockdown better than other companies, Vishal Wagh, Research Head, Bonanza Portfolio Ltd, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) In current volatility and stretched margin norms by SEBI, retailers are hardly able to participate. Many investors, Mutual Funds and even many institutions are stuck with their longer-term holding which is bleeding more than 20-25 percent.

Many margin calls are getting triggered. The fear factor in this market may lead to a further sell-off and liquidation of portfolio and redemption of Mutual Funds.

The current lockdown scenario also forced many corporates to generate liquid cash for payment of overheads, as well as wages.

A) Volatility is a very common factor since correction has started. So, intraday moves of 3-5 percent in Nifty cannot be ignored in the next couple of weeks.

At the same time, India VIX has corrected by around 35 percent from the top. It shows that the market will be volatile but it will remain within a range.

As far as options data is concerned, the strike of 8,000 and 9,000 in April monthly expiry has seen the highest open interest, combining both put and call together.

Whereas, the total premium is 8,000 Strike is 960 and 9,000 strike is 1122. So, a broader range for the market will be 7,040 on the lower side and on the higher side 10,250.

In short, Nifty may retest the current low at the same time it has the potential to see sharp recovery and 9,000 levels can be tested easily.

On the other hand, fall of more than 7-8 percent in USDINR has seen inflows in the Indian market historically. So, long term investors may get a good opportunity to invest; whereas, for the traders, there will plenty of opportunities with low risk and reward ratio due to higher-stop loss.

A) The sales number will remain lower only on the back of the lockout and March ending. Even post-lockout, the economy will take at least a couple of months to get back on track and slowdown in the auto sector may continue.

A) 1. Cash-rich companies may sustain lockdown better way than other companies;2. It will provide them with the opportunity to go for a strategic investment plan so that exponential growth can be achieved;

3. Corporate benefits like dividend and buy-back can be easily done.

A) The strategy should be to:

1. Invest in defensive sectors like Pharma and FMCG;2. Avoid high beta stocks;3. To invest in Gold for Hedging against uncertainty.

4. Invest in safer stock like ITC, Abbot India, and Sanofi

A) Every shock in the market creates an opportunity for longer-term investors. No one currently is in a position to comment on the bottom as the disease continues to spread globally.

Currently, stocks that are getting affected due to lockdown and getting in cheaper rates should be zeroed for investment. Stocks like INOX, Indigo are few of those.

A) Due to global slowdown and lockout, the small scale industry will get affected adversely. So, the problem of NPA may worsen in the coming quarters.

Unemployment may spurt if the current situation does not come under control. All these thing will create pressure on the financial sector. It is better to switch to the defensive for shelter in this current scenario.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/to-dodge-the-covid-19-bullet-investors-should-follow-these-3-simple-rules-5111091.html
21,"April 07, 2020 10:12 AM IST",2,Sandip Das,Manali Petro share price surges 16% after resumption of Propylene Glycol production,"The share price of Manali Petrochemicals jumped more than 16 percent intraday on April 7 after the company resumed production of Propylene Glycol at both its plants.
The stock price jumped more than 18 percent in the last three days and was quoting at Rs 12, up Rs 1.71, or 16.62 percent.
It has touched an intraday high of Rs 12.10 and an intraday low of Rs 11.50.
The plant operations have been shut down from March 27, 2020 on account of the 21-day lockdown to break the chain of the coronavirus infections.
It was trading with volumes of 17,164 shares, compared to its five day average of 20,941 shares, a decrease of 18.04 percent.",Operations have been shut since March 27 following the 21-day nationwide lockdown.,"The share price of Manali Petrochemicals jumped more than 16 percent intraday on April 7 after the company resumed production of Propylene Glycol at both its plants.

The stock price jumped more than 18 percent in the last three days and was quoting at Rs 12, up Rs 1.71, or 16.62 percent. It has touched an intraday high of Rs 12.10 and an intraday low of Rs 11.50.

The plant operations have been shut down from March 27, 2020 on account of the 21-day lockdown to break the chain of the coronavirus infections.

It was trading with volumes of 17,164 shares, compared to its five day average of 20,941 shares, a decrease of 18.04 percent.",https://www.moneycontrol.com/news/business/stocks/manali-petro-share-price-surges-16-after-resumption-of-propylene-glycol-production-5114841.html
22,"April 07, 2020 09:54 AM IST",2,Rakesh Patil,Godrej Properties share price up 10% on Q4 sales growth,"Godrej Properties share price rose 10 percent in early trade on April 7 after the company reported 100 percent sequential growth in its Q4FY20 booking.
In the Q4 of FY20, the company's bookings stood at Rs 2,380 crore representing QoQ growth of 100 percent and YoY growth of 10 percent, the company said in a release.
The company has sold over 3,000 homes in the fourth quarter, meanwhile, the number of homes sold and the value of homes sold were the highest the company has achieved in any quarter.
The Q4 sales included over 500 homes sold in the second half of March as the company focused on digital sales tools to sustain operations despite the lockdown.
At 09:38 hrs Godrej Properties was quoting at Rs 662.65, up Rs 55.55, or 9.15 percent on the BSE.",The company launched 17 new projects and phases in FY20 including 6 launches in Q4.,"Godrej Properties share price rose 10 percent in early trade on April 7 after the company reported 100 percent sequential growth in its Q4FY20 booking.

In the Q4 of FY20, the company's bookings stood at Rs 2,380 crore representing QoQ growth of 100 percent and YoY growth of 10 percent, the company said in a release.

The company has sold over 3,000 homes in the fourth quarter, meanwhile, the number of homes sold and the value of homes sold were the highest the company has achieved in any quarter.

The Q4 sales included over 500 homes sold in the second half of March as the company focused on digital sales tools to sustain operations despite the lockdown.

Also, the company launched 17 new projects and phases in FY20 including 6 launches in Q4.

The company's total booking value for FY20 is up 11 percent YoY at Rs 5,915 crore with residential sales increasing by 14 percent YoY to Rs 5,840 crore comprising of over 7,300 homes sold, it added.

At 09:38 hrs Godrej Properties was quoting at Rs 662.65, up Rs 55.55, or 9.15 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/godrej-properties-share-price-up-10-on-q4-sales-growth-5114761.html
23,"April 07, 2020 01:59 PM IST",2,Kshitij Anand,Heads up! Smart money moving from financials to FMCG & pharma,"Experts feel that the smart money seems to be moving out of financials into defensive sectors such as FMCG and pharma.
If we look at the data from March to April 3, Nifty Bank underperformed Nifty50 while Nifty FMCG, as well as Nifty Pharma, outperformed.
The Nifty50 plunged by about 28 percent since March while NiftyBank plunged by about 40 percent.
The Nifty FMCG was down over 9 percent while the Nifty Pharma fell nearly 3 percent, data from AceEquity showed.
Most of the stocks in the NiftyBank index fell 20-70 percent that include names like Kotak Mahindra Bank, Bank of Baroda, ICICI Bank, Axis Bank, RBL Bank, and IndusInd Bank.","Most of the stocks in the NiftyBank index fell 20-70 percent that include names like Kotak Mahindra Bank, Bank of Baroda, ICICI Bank, Axis Bank, RBL Bank, and IndusInd Bank.","The Indian market has broken crucial support levels in March as benchmark indices slipped in bear territory. One of the big contributors to the fall were financials, which hold approximately 25 percent weight in the index, followed by technology and Oil & Gas.

Experts feel that the smart money seems to be moving out of financials into defensive sectors such as FMCG and pharma. If we look at the data from March to April 3, Nifty Bank underperformed Nifty50 while Nifty FMCG, as well as Nifty Pharma, outperformed.

The Nifty50 plunged by about 28 percent since March while NiftyBank plunged by about 40 percent. The Nifty FMCG was down over 9 percent while the Nifty Pharma fell nearly 3 percent, data from AceEquity showed.

The worst fear which has clouded the outlook for the financial sector in the near term is fall in economic activity which could seriously impact the debt servicing ability of borrowers.

According to a report by ICRA, stressed assets are likely to spike which could well lead to a rise in reported NPAs that would be visible only over the next few quarters

“SME and retail segments to be more affected than corporate segments. Resumption of timely repayments after moratorium remains suspect, especially for the unorganized segments with limited alternative funding avenues,” said the report.

Most of the stocks in the NiftyBank index fell 20-70 percent that include names like Kotak Mahindra Bank, Bank of Baroda, ICICI Bank, Axis Bank, RBL Bank, and IndusInd Bank.

“Financials are likely to be under pressure given the fact that even considering hypothetically the crisis is solved today itself, it will take the economy significant time to restart & get back to working at the previous levels,” Paras Bothra, President of Equity Research, Ashika Stock Broking told Moneycontrol.

“The fall out of the same is rising NPAs and dismal intermittent credit growth. Thus, at this present moment defensives are clear favorites,” he said.",https://www.moneycontrol.com/news/business/markets/heads-up-smart-money-moving-from-financials-to-fmcg-pharma-5115481.html
24,"April 07, 2020 02:35 PM IST",2,Rakesh Patil,Cosmo Films share price rises over 9% after 2 plants open partially,"Cosmo Films share price rose over 9 percent intraday on April 7 after two of its Maharashtra plants resumed partial operations.
The company’s plants in Waluj and Shendra resumed partial operations in accordance with the permission from concerned authorities to facilitate supply of packaging material for essential items, the company said in a release.
At 1409 hours, Cosmo Films was quoting at Rs 220.20, up Rs 16.25, or 7.97 percent, on the BSE.
The share touched its 52-week high Rs 357.00 and 52-week low Rs 186.30 on February 26, 2020, and August 5, 2019, respectively.
Currently, it is trading 38.32 percent below its 52-week high and 18.2 percent above its 52-week low.","The share touched its 52-week high Rs 357.00 and 52-week low Rs 186.30 on February 26, 2020, and August 5, 2019, respectively.","Cosmo Films share price rose over 9 percent intraday on April 7 after two of its Maharashtra plants resumed partial operations.

The company’s plants in Waluj and Shendra resumed partial operations in accordance with the permission from concerned authorities to facilitate supply of packaging material for essential items, the company said in a release.

At 1409 hours, Cosmo Films was quoting at Rs 220.20, up Rs 16.25, or 7.97 percent, on the BSE.

The share touched its 52-week high Rs 357.00 and 52-week low Rs 186.30 on February 26, 2020, and August 5, 2019, respectively.

Currently, it is trading 38.32 percent below its 52-week high and 18.2 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/cosmo-films-share-price-rises-over-9-after-2-plants-open-partially-5116421.html
0,"April 05, 2020 09:00 AM IST",-1,Kshitij Anand,"Market in a bottomless pit, value buying is still some time away: Gaurav Garg","A. COVID-19 has been the major cause of the decline seen in the markets due to its economic impact.
The current situation has made the market a bottomless pit and thus it is bleeding institutions by diminishing its holding value.
The popular notion of value buying still holds, but it may be a while before that phase starts.
However, the current situation is not very promising as we can see a continuous rise in COVID cases and it is difficult to say if the bottom is here or not.
The strategy involves a high level of experience in the market as one has to look at the historic prices of stocks and current market conditions especially during the economic slowdown or unstable conditions.","For Nifty, 7,800 and 7,500 will act as support levels and 8,700 and 9,000 will be the resistance levels, Gaurav Garg, Head of Research, at CapitalVia Global Research Limited - Investment Advisor, has told Moneycontrol.","The novel coronavirus pandemic, due to its economic impact, has been the major cause of decline seen in the markets. The popular notion of value buying still holds, but it may be a while before that phase starts, Gaurav Garg, Head of Research, at CapitalVia Global Research Limited - Investment Advisor, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpts of the interview:

Q. Another volatile week for Indian Markets with 8,055 as a base. What is causing panic in the markets – is institutional selling causing panic in the markets? What are the other factors contributing to this bloodbath on D-Street?

A. COVID-19 has been the major cause of the decline seen in the markets due to its economic impact. The current situation has made the market a bottomless pit and thus it is bleeding institutions by diminishing its holding value.

As a result, it has become imperative for institutions to loosen the baggage. The popular notion of value buying still holds, but it may be a while before that phase starts.

Due to the ongoing lockdown across the country, economic implications have been substantial, which is leading to an economic slowdown and affecting almost all sectors and without any concrete sign of recovery, selling pressure may exist.

Q. What are your views on the month of April? Will we be able to see some green on the screen? Earnings will be delayed what are other data points to look for?

A. The situation in April may continue to be the same without any development in COVID-19 cases as this will not reduce panic in the country.

Any affirmative approach by the government for aiding the economy may be perceived positively on the street. Auto sales figures may help to make informed decisions by investors.

Q. India’s M-Cap-to-GDP ratio has slipped below FY09-levels or below 2008 crisis do you think a bottom is near? It is at the lowest since 2006. It will be difficult to say that we are near the bottom but a good multibagger opportunity for the next five years if one invests now.

A. In the current crisis, the economic slowdown has taken a toll on Midcap stocks since they are not always cash-rich like bluechip companies, such prolonged shutdown and halted economic activity deeply affects the earnings of the mid-cap.

This situation, however, has a silver lining, it gives the opportunity to buy at lower levels for holding on a long term time frame. However, the current situation is not very promising as we can see a continuous rise in COVID cases and it is difficult to say if the bottom is here or not.

Once this pandemic issue resolves, economic activity can be seen gaining momentum basically due to increased consumption and therefore a judicious investment can be made for the next five years.

Q. What is your take on the auto sales numbers-do you think the pain is likely to continue in the sectors, and it is best to stay away?

A. The Supreme Court has ordered the automakers to clear their BS-IV inventory before April 1, but many of the automakers had failed to do so due to the nation-wide lockdown from March 24.

Although few automakers are saying that the sales figures for March 2020 should not be compared with March 2019 since the situations have been completely different.

The sales of Maruti Suzuki India Ltd, Hyundai Motor India Ltd, Mahindra & Mahindra Ltd (M&M), Tata Motors Ltd and Toyota Kirloskar India Pvt. Ltd has seen a decline of more than 40 percent on a YoY basis.

The automobile industry which largely depends on the domestic and international supply chain for spare parts has been disrupted due to the lockdown. With day by day increasing cases in India the sales of April might be much worse than March figures.

Q. This is one advice which is echoed on D-Street is that one should stay with cash-rich companies. Do you agree with the statement, if yes how will it help in dodging the COVID-19 bullet?

A. Before investing in a cash-rich company one has to go through the cash and cash equivalents which are one of the key metrics to identify the company’s financial soundness.

As an investor, one has to identify the reason behind the excess cash. A company may start investing in research and development or to acquire new business, etc.

But, during the economic slowdown, the cash-rich companies are most likely to wait for the right opportunity and invest selectively based on the assessment of a business, future growth, demand and supply of that industry.

Q. What is the trading strategy for the coming week?

A. With the continuation of the turmoil in Indian benchmarks indexes, one can opt for the “Buy Low Sell High” strategy. The strategy involves a high level of experience in the market as one has to look at the historic prices of stocks and current market conditions especially during the economic slowdown or unstable conditions.

Given the global scenarios on the COVID-19 pandemic, the market still looks downside. For Nifty, 7,800 and 7,500 will act as support levels and 8,700 and 9,000 will be the resistance levels.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/market-in-a-bottomless-pit-value-buying-is-still-some-time-away-gaurav-garg-5107871.html
1,"April 04, 2020 08:44 AM IST",1,Kshitij Anand,Small & mid-caps outperform! 49 stocks in BSE500 buck trend in short week,"As many as 65 stocks in the S&P BSE 500 index were down 10-30 percent.
Sectors which saw buying interest were healthcare, pharma, consumption as well as oil & gas stocks thanks to steep fall in crude oil prices.
There are as many as 49 stocks in the S&P BSE 500 index which have outperformed in a truncated week.
The S&P BSE Mid-cap index was down a little over 3 percent while the S&P BSE Small-cap index saw a dip of nearly a percent for the week ended April 3.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.",The fear factor in this market may lead to a further sell-off and liquidation of portfolio and redemption of mutual funds,"As many as 65 stocks in the S&P BSE 500 index were down 10-30 percent. This includes names such as TVS Motor, Future Consumer, Kotak Mahindra Bank, PVR, Bandhan Bank, Bharat Forge, Dalmia Bharat, ICICI Bank, MindTree, Maruti Suzuki, Bajaj Finance, Eicher Motors, Infosys and HDFC Bank.

Sectors which saw buying interest were healthcare, pharma, consumption as well as oil & gas stocks thanks to steep fall in crude oil prices. Selling pressure was evident in financials including public and private banks, IT, and metal stocks.

There are as many as 49 stocks in the S&P BSE 500 index which have outperformed in a truncated week. These include names such as Inox Wind, Sun Pharma, Ipca Laboratories, Lupin, Delta Corp, Sobha, Graphite India, and KRBL, data from AceEquity showed.

The S&P BSE Mid-cap index was down a little over 3 percent while the S&P BSE Small-cap index saw a dip of nearly a percent for the week ended April 3.

Indian markets closed in the red for the seventh consecutive week. The S&P BSE Sensex fell by over 7 percent while the Nifty50 was down by 6.6 percent for the week ended April 3, but broader markets relatively outperformed in the same period.

Institutional selling, rise in coronavirus (COVID-19) cases across the world, as well as financial stocks because an extended period of lockdown in India could lead to large non-performing asset (NPA) in the banking as well as non-banking financial companies (NBFC) space.

“In current volatility and stretched margin norms by SEBI, retailers are hardly able to participate. Many investors, mutual funds (MFs) and even many institutions are stuck with their longer-term holding which is bleeding more than 20-25 percent,” Vishal Wagh, Research Head, Bonanza Portfolio told Moneycontrol.

“Many margin calls are getting triggered. The fear factor in this market may lead to a further sell-off and liquidation of portfolio and redemption of MFs. Current lockdown scenario is also forcing many corporates to generate liquid cash for payment of overheads, and wages,” he said.

Volatility is likely to continue for the month of April as well, suggest experts. The coming week is a truncated one which has only three trading sessions. The market will remain shut on Monday (April 6) on account of Mahavir Jayanti, and on April 10 which is a Good Friday.

INDIA VIX cooled off considerably from a 12-year high, which is the only sign of relief. It indicates a possibility of volatility reducing and thereby shrinking the overall range in the market.

“Today, the market is clearly driven by fear and sentiments, and till the time, things with respect to coronavirus pandemic does not subside, the pain is likely to stay in the market,” Sameet Chavan, Chief Analyst-Technical and Derivatives, Angel Broking told Moneycontrol.

“Traders are advised not to create aggressive bets especially leveraged positions in such kind of environment. As far as levels are concerned, 8,000 followed by 7,800 would be seen as immediate supports; whereas on the higher side, if the market has to see some relief, the Nifty needs to surpass 8,300-8,400 convincingly,” he said.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/small-mid-caps-outperform-49-stocks-in-bse500-buck-trend-in-short-week-5107291.html
2,"April 03, 2020 06:06 PM IST",0,Kshitij Anand,The Market Podcast | Indices yet to hit bottom; seek solace in pharma and consumption stocks,"However, it staged a follow-through day on March 31, 2020.
It relies on a follow-through day (FTD), a device identified by historical research.
That big gain on rising volume is a follow-through day, which confirms that a new uptrend is underway.
A follow-through day can’t pick the exact day when a market bottoms, but it can get you close to the bottom.
Hence, a follow-through day should be used in conjunction with other indicators to provide firm evidence.",A follow-through signal doesn’t mean investors should go and buy with abandon. It just gives you the go-ahead to choose high-quality stocks with strong sales and EPS growth as they break out of their bases.,"Selling pressure by foreign institutional investors is likely to continue for some more time on Dalal Street but investors can look for opportunities in this market fall, Mayuresh Joshi, Head of Equity Research India, William O'Neil India said in a special ‘Market Podcast’ with Moneycontrol.

Earnings hit is going to be very severe for a lot of industries facing the heat whether it is aviation, hospitality stocks or movie exhibitors, and most likely these stocks are going to feel the pinch in terms of downgrades, said Joshi.

He advises investors to bucket in two groups. Till that time COVID-19 led uncertainty remains, pharma and consumption stocks which have leadership positions have certain elements of a margin of safety.

“And, as the curve starts falling and we move past Q1, these high beta co-related sectors and stocks which have leadership positions will come into focus again,” says Joshi.

Have we made a bottom? Track Follow Through Day

In recent times, the Nifty50 has corrected by over 33 percent from its all-time high of 12,431. However, it staged a follow-through day on March 31, 2020.

If history is to be believed, this may not be the bottom of the market. Joshi expects the index to make another one or more lower lows.

It is difficult to identify the start of a major stock market uptrend if you are relying on headlines and news. By the time reporters figure out what’s going on in the stock market, the best part is over.

MarketSmith India, a research report by William O'Neil India has defined set of rules to identify the upturn in the market. It will remove any personal judgment. It relies on a follow-through day (FTD), a device identified by historical research.

A follow-through day occurs if a benchmark index (Nifty in our case) delivers a strong gain (1.5% or higher) on a volume higher than the previous session. That big gain on rising volume is a follow-through day, which confirms that a new uptrend is underway.

A follow-through day can’t pick the exact day when a market bottoms, but it can get you close to the bottom. The most powerful follow-throughs usually occur on the fourth to the seventh day of an attempted rally.

There will be cases in which confirmed rallies fail. A few large institutional investors, who have large funds, can run up the market on any particular day and create an impression of a follow-through.

Hence, a follow-through day should be used in conjunction with other indicators to provide firm evidence. One of the other indicators is simply to check if there are fundamentally good stocks breaking out of sound bases.

A follow-through signal doesn’t mean investors should go and buy with abandon. It just gives you the go-ahead to choose high-quality stocks with strong sales and EPS growth as they break out of their bases.

(Tune in to the podcast for more)

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/podcast/the-market-podcast-indices-yet-to-hit-bottom-seek-solace-in-pharma-and-consumption-stocks-5105721.html
3,"April 03, 2020 02:21 PM IST",2,Sunil Matkar,RBL Bank cracks over 15% on forecast of higher provisions in credit card biz,"Shares of private sector lender RBL Bank plunged more than 15 percent intraday on April 3 after the management forecast rise in provisions from credit card business in the first quarter of FY21.
The stock has corrected more than 80 percent in one year due to higher provisions for bad loans, withdrawal of deposits after Yes Bank crisis, etc.
It was trading at Rs 114, down Rs 17.35 or 13.21 percent on the BSE at 13.47 hours IST.
We will see a rise in provisions on credit card business in Q1FY21,"" Vishwavir Ahuja, Managing Director & CEO at RBL Bank told CNBC-TV18.
RBL Bank in its BSE filing on March 1 said wholesale advances have been reflecting de-growth and retail advances are reflecting healthy growth during January-March quarter FY20.","The stock has corrected more than 80 percent in last one year due to higher provisions for bad loans, withdrawal of deposits after Yes Bank crisis etc.","Shares of private sector lender RBL Bank plunged more than 15 percent intraday on April 3 after the management forecast rise in provisions from credit card business in the first quarter of FY21.

The stock has corrected more than 80 percent in one year due to higher provisions for bad loans, withdrawal of deposits after Yes Bank crisis, etc. It was trading at Rs 114, down Rs 17.35 or 13.21 percent on the BSE at 13.47 hours IST.

""Microfinance book was in good shape through March, but disbursals in microfinance will be a concern going ahead. We will see a rise in provisions on credit card business in Q1FY21,"" Vishwavir Ahuja, Managing Director & CEO at RBL Bank told CNBC-TV18.

Current spending in credit card business dropped to 40 percent, he said, adding but the net income of the bank is the highest in any quarter for Q4FY20.

The bank has managed to maintain its operating profit & liquidity position, he said, adding the revenue-generating and earning capacity remained strong.

On the deposits, Ahuja said the government deposits were in very low-single-digit now from a peak of 9 percent. ""We expect deposits to stabilise in the coming quarters.""

The Reserve Bank of India suddenly on March 5 put Yes Bank under 30-day moratorium period and set the withdrawal limit up to Rs 50,000 per person. This hit other small-medium private sector lenders as well.

""Maharashtra, particularly, withdrew money from some private banks. We have seen a decline in our wholesale book,"" Ahuja said, adding two-thirds of liability base is from retail customers.

RBL Bank in its BSE filing on March 1 said wholesale advances have been reflecting de-growth and retail advances are reflecting healthy growth during January-March quarter FY20.

The retail:wholesale advance mix approximately is 55:45.

""Asset quality position in legacy book consistent with guidance given in Q3 FY20; there is no material change. There was some increase in slippage in SME (wholesale) and retail largely on account of stress and inability to collect in the last few days because of the lockdown. However, overall, we expect lower slippages QoQ,"" said RBL which expects to increase provision coverage ratio sequentially.

The bank said it has strong operating performance during the quarter ended March 2020, reflecting franchise strength of the bank and its strong earning capacity despite economic slowdown and shutdown in the last few days.

""Net interest margin was at an all-time high. Net interest income growth was higher in Q4 than advances and balance sheet growth,"" it added.",https://www.moneycontrol.com/news/business/markets/rbl-bank-cracks-over-15-on-forecast-of-higher-provisions-in-credit-card-biz-5104931.html
4,"April 05, 2020 02:40 PM IST",-1,,Torrent Pharma says promoters haven't pledged shares,"Torrent Pharma has said that its promoters have not pledged any equity shares they hold in the company for any purpose, and a surveillance action by stock exchanges was not warranted.
The company was commenting on reports of the National Stock Exchange shortlisting five companies, including Torrent Pharmaceuticals, with higher levels of pledged shares by promoters for surveillance action.
""The promoters of Torrent Pharma have not pledged any equity shares they hold in Torrent Pharma for any purpose,"" the company said in an email.
Further, such an obligation is created in respect of loans raised by Torrent Pharma for the purposes of its business.""
The National Stock Exchange had last week stated that it has shortlisted five companies, including Torrent Pharmaceuticals, with higher levels of pledged shares by promoters for surveillance action.","The promoters are obligated to hold a minimum 26 per cent shares and management control of Torrent Pharma during the period of loans the company has taken, it said.","Torrent Pharma has said that its promoters have not pledged any equity shares they hold in the company for any purpose, and a surveillance action by stock exchanges was not warranted. The promoters are obligated to hold a minimum 26 per cent shares and management control of Torrent Pharma during the period of loans the company has taken, it said.

The company was commenting on reports of the National Stock Exchange shortlisting five companies, including Torrent Pharmaceuticals, with higher levels of pledged shares by promoters for surveillance action.

""The promoters of Torrent Pharma have not pledged any equity shares they hold in Torrent Pharma for any purpose,"" the company said in an email.

Promoters, it said, ""are obligated by virtue of certain covenants/negative covenants agreed by Torrent Pharma in the loan agreements executed with various lenders that the promoters shall continue to hold management control (inter-alia holding at least 26 per cent of the equity share capital of Torrent Pharma or otherwise) during the period such loans are outstanding.

Further, such an obligation is created in respect of loans raised by Torrent Pharma for the purposes of its business.""

Torrent said a pledge of shares is a security interest in favour of lenders and can be enforced by sale of such shares in event of default.

On the other hand, the covenants/negative covenants agreed under various loan agreements obligate the promoters not to sell a specified portion of their shares so long as a loan given to the company is outstanding.

""It may be noted that recently SEBI expanded the disclosure requirements (effective from 01-Oct-19) in respect of promoters shares which are subject to any kind of encumbrance by specifically including the requirement to disclose covenant/negative covenants/non-disclosure undertaking given in respect of promoters holding in a listed company. In this context the foregoing disclosure was made by promoter of Torrent Pharma,"" it said.

This, it said, was made abundantly clear in the disclosures filed with the stock exchange at various point in time.

""Considering there is no pledge on the promoters' holding in Torrent Pharmaceuticals Ltd, we believe surveillance action is not warranted,"" the firm said, asking NSE to revisit and remove the surveillance action on the stock.

The National Stock Exchange had last week stated that it has shortlisted five companies, including Torrent Pharmaceuticals, with higher levels of pledged shares by promoters for surveillance action.

The exchange will levy a minimum margin of 35 per cent on the respective shares, including on stocks in the derivatives segment.",https://www.moneycontrol.com/news/business/stocks/torrent-pharma-says-promoters-havent-pledged-shares-5109531.html
5,"April 03, 2020 02:24 PM IST",2,Nishant Kumar,ITC shares jump 10% even as company denies acquisition of Sunrise Food,"Shares of ITC jumped almost 10 percent in intraday trade on BSE on April 3 after reports emerged that the company was looking to acquire spice maker Sunrise Food.
ITC, however, in a BSE filing on April 2 denied any such development.
""We would like to inform that the company has not entered into an exclusivity agreement for the acquisition of Sunrise Foods Private Limited,"" the regulatory filing by ITC said.
Meanwhile, Domino’s Pizza, in partnership with ITC Foods, has launched “Domino’s Essentials”.
Shares of ITC traded 6.76 percent up at Rs 177.60 while those of Jubilant FoodWorks were 6.03 percent down at Rs 1,300 on BSE around 14:10 hours.",,"Shares of ITC jumped almost 10 percent in intraday trade on BSE on April 3 after reports emerged that the company was looking to acquire spice maker Sunrise Food.

ITC, however, in a BSE filing on April 2 denied any such development.

""We would like to inform that the company has not entered into an exclusivity agreement for the acquisition of Sunrise Foods Private Limited,"" the regulatory filing by ITC said.

Meanwhile, Domino’s Pizza, in partnership with ITC Foods, has launched “Domino’s Essentials”.

Jubilant FoodWorks, in a BSE filing on April 2 said the delivery infrastructure of Domino’s will be leveraged to help customers order everyday grocery essentials offered by ITC Foods, India’s most trusted packaged staple brand.

""This first-of-its-kind, unique partnership between a QSR and an FMCG company is aimed at serving the community at large by ensuring uninterrupted supply of essential items without them having to step outside the safety of their homes,"" the BSE filing by Jubilant said.

As per the filing, a combo pack of Aashirvaad Atta and Spices including chili, coriander and turmeric powder will be available on Domino’s app starting today. This service will be available for consumers first in Bengaluru and then in the cities of Noida, Mumbai, Kolkata, Chennai and Hyderabad.

Shares of ITC traded 6.76 percent up at Rs 177.60 while those of Jubilant FoodWorks were 6.03 percent down at Rs 1,300 on BSE around 14:10 hours.",https://www.moneycontrol.com/news/business/markets/itc-shares-jump-10-even-as-company-denies-acquisition-of-sunrise-food-5105121.html
6,"April 05, 2020 03:35 PM IST",-2,,Coronavirus pandemic | FPIs pull out record Rs 1.1 lakh cr in March amidst COVID-19 mayhem,"Foreign portfolio investors (FPIs) have net withdrawn a record Rs 1.1 lakh crore from the Indian markets in March as the coronavirus pandemic dented investor sentiment worldwide.
According to latest depositories data, FPIs pulled out a net Rs 61,973 crore from equities and Rs 56,211 crore from the bond market in March, taking the cumulative net outflow to Rs 1,18,184 crore.
Besides, in just two trading sessions of April, FPIs have withdrawn a net sum of Rs 6,735 crore from the domestic markets.
Out of this, Rs 3,802 crore were pulled out from equities and Rs 2,933 crore from the debt segment.
""The sell-off in March is mostly driven by quant funds, hedge funds, and risk parity funds,"" Harsh Jain, co-founder and COO at Groww said.",This is also the highest withdrawal ever since the FPI data has been made available by the National Securities Depository Ltd.,"Foreign portfolio investors (FPIs) have net withdrawn a record Rs 1.1 lakh crore from the Indian markets in March as the coronavirus pandemic dented investor sentiment worldwide.

According to latest depositories data, FPIs pulled out a net Rs 61,973 crore from equities and Rs 56,211 crore from the bond market in March, taking the cumulative net outflow to Rs 1,18,184 crore.

The outflow of funds in March comes after six consecutive months of investment by FPIs since September 2019.

This is also the highest withdrawal ever since the FPI data has been made available by the National Securities Depository Ltd.

Besides, in just two trading sessions of April, FPIs have withdrawn a net sum of Rs 6,735 crore from the domestic markets. Out of this, Rs 3,802 crore were pulled out from equities and Rs 2,933 crore from the debt segment.

""The sell-off in March is mostly driven by quant funds, hedge funds, and risk parity funds,"" Harsh Jain, co-founder and COO at Groww said.

Terming the fund outflow as ""unparalleled"", Himanshu Srivastava, senior analyst manager research, Morningstar India, said that with fear over the degree of impact that COVID-19 could leave on the global economy, foreign investors stormed out of the emerging markets, with India among the worst hit.

""The intensity of the situation could be gauged from the fact that even during the financial crisis of 2008, FPIs sold net assets worth USD 9.3 billion in the Indian markets while in March 2020, they have been net sellers to the tune of USD 16.5 billion,"" he added.

Regarding the future of FPI flows, Srivastava said these are unprecedented scenarios and with risk-taking going off the table, emerging markets like India may most likely witness a prolonged period of net outflows till the time situation on the coronavirus front stabilizes.

Jain said: ""RBI raised the limit FPIs can invest in corporate bonds to 15 per cent on March 30th. While this is encouraging, it is unlikely to drive investments immediately. The government's plan for easing out the lockdown after 15th April and other boosts like economic aid is crucial at this point in time.""",https://www.moneycontrol.com/news/business/coronavirus-pandemic-fpis-pull-out-record-rs-1-1-lakh-cr-in-march-amidst-covid-19-mayhem-5109621.html
7,"April 06, 2020 01:52 PM IST",1,Sunil Matkar,Don't wait for bottom as uncertainty persists; look at these 18 quality picks,"Moneycontrol has collated a list of 18 stocks which have strong fundamentals and can deliver solid returns in the longer term.
Bajaj Finance: The stock could correct further but the current scenarios present a good opportunity to accumulate the quality franchise.
The monetisation across digital platform continued to remain robust as the digital segment has continued to display strong growth.
We believe news heavy events will help the company to maintain growth momentum in broadcasting revenues in the medium term.
With no major capex, we expect the company to continue paying high dividends (already paid Rs 20 per share in FY20).",Hence every expert on the street advised buying quality stocks in a gradual manner instead of bulk purchases and waiting for the market bottom which no one has found yet in the history.,"History suggests that the market always creates great opportunity once in every decade, whether it was 2000's IT boom, 2008's global financial crisis or the latest novel coronavirus or COVID-19-led crash.

In IT boom, the Nifty50 fell around 48 percent in more than one-and-half-year (from 1,732 to 898 levels), while the correction of more than a year in the global financial crisis was 58 percent from the peak (6,287 to 2,617 levels). In the COVID-19-led sell-off, the index corrected around 38 percent from its peak (12,430 levels) if we take the lowest level seen on March 23 and currently the fall was 33 percent (from record high seen in January till April 3, 2020).

""It is a Déjà vu (a feeling of having already experienced the present situation) all over again as markets have a tendency, once in a decade, of creating declines of high magnitude and velocity in a very short span of time. This always leaves the investors in an iffy kind of a situation as to whether the world is coming to an end,"" ICICI Direct said.

But in the following years, especially once the dust settles down, every recovery has given hefty returns provided one should pick the right time and right opportunities. Just to explain the reality of multibagger - the Nifty50 has taken nearly four years to rally around 4,900 points but it lost those same gains in just over 2 months due to COVID-19 that has taken nearly 65,000 lives with around 12 lakh infected cases worldwide.

In fact, the virus deliberately forced the major parts of the world to go for lockdown and as a result, raised fears of recession as well as depression which worried investors the most.

In large-mid-to-smallcaps, 80-90 percent stocks corrected sharply with the majority falling in the range of 30-90 percent during the phase of turmoil.

Hence, every expert on the Street advised buying quality stocks in a gradual manner instead of bulk purchases and waiting for the market bottom which no one has found yet in history.

""We believe that as more time passes, COVID curve will flatten across the countries as it has in China and South Korea. Even Italy has started to show some indications of flattening of the COVID curve. Moreover, the chances for finding a cure will keep rising. Thus the current challenges also present with one of the biggest opportunity to accumulate assets at reasonable valuations,"" Axis Securities said.

Moneycontrol has collated a list of 18 stocks which have strong fundamentals and can deliver solid returns in the longer term.

Brokerage: Axis Securities

Titan Company: It has consistent growth and valuations have become attractive. Demand scenario will revive sooner than later.

United Breweries: It is one of the best consumption themes with solid long-term growth potential. The stock correction provides a good entry point.

Eicher Motors: It has solid premiumisation potential and has been a consistent value creator.

Kotak Mahindra Bank: It is one of the best franchises with consistent returns and the current valuations are reaching the stressed zone.

Bajaj Finance: The stock could correct further but the current scenarios present a good opportunity to accumulate the quality franchise.

ICICI Bank: The stock has seen deep correction but will be solid when the market bounces back. The stock will quickly erase the losses as it has a strong retail book.

Bharti Airtel: The business impact on account of COVID-19 will be limited. It is a good stock for capital protection and long-term growth.

Maruti Suzuki India: Low fuel prices and lower interest rates which all will work well for Maruti. The stock will see a solid bounce-back as the market revives.

Brokerage: ICICI Direct

Hero MotoCorp: It is an industry leader in the domestic 2-W segment with a market share of around 35 percent with its core motorcycle segment market share at around 50 percent. However, the company is likely to witness near-term headwinds in terms of a rebound in volumes amidst COVID-19 outbreak and more than anticipated price increase on account of BS-VI transition (more than 10 percent).

From a broader perspective, however, it possesses capital-efficient business model realising more than 25 percent return on capital employed (RoCE) on a consistent basis and offers an attractive dividend yield of around 5 percent.

Heidelberg Cement: It is one of the few companies in the cement space, which despite having a regional presence, possesses a strong balance sheet and retail presence. HCIL, like most other cement companies, would be facing volume disruption in the near term. However, they would be able to withstand the same comfortably owing to cost leadership, strong promoter backup and low D/E of 0.3x. Post the sharp correction in the stock price, HCIL is now available at attractive valuations.

Wipro: In the near term, the company may face revenue pressure due to exposure to affected verticals like energy vertical, lockdown, pricing pressure and a slowdown in discretionary spend. However, post H2FY22, we expect IT spending to improve and grow at a healthy pace in FY22.

In addition, digital acceleration, gains in market share led by automation and pick-up in execution could drive large deal wins. The recent correction in the stock price factors in most of the near term negatives and is trading at an attractive valuation.

Tech Mahindra: In H1FY21, the company may face revenue and margin pressure led by COVID-19 lockdown, pricing pressure, delay in deal ramp-ups and slowdown in discretionary spend. However, we expect IT service spending to improve post H2FY21 and a revival in FY22. Further, the company's leadership in telecom vertical will make it a key beneficiary of vendor consolidation in the segment and 5G opportunities. Enterprise business segment will also benefit from improved competencies, sharper market positioning and success in large deals.

Bharat Electronics: COVID-19 will have an impact as some projects may get delayed but the anticipated medical devices order from government amid COVID-19 outbreak and likely operational relaxation by respective state governments to aerospace and defence firms from India Lockdown may lead to some cushion in FY21.

Overall, strong order book of Rs 51,300 crore (which is 4x book to bill ratio) continues to provide strong revenue visibility. BEL currently exhibits attractive valuations, has always paid consistent dividends, commands a debt-free balance sheet and generates strong cash flow from operations (CFO) yield.

KSB: Historically, the company maintained DPS to tune of Rs 5-6/share, which provides a dividend yield of 1.5 percent. Further, the company is making FCF/share to the tune of Rs 12-15 proving FCF yield of around 3-3.5 percent. Moreover, the company has been generating other income to the tune of Rs 40 crore on cash of Rs 207 crore.

Based on CY22 estimates, the earnings yield of the company is well over the 10-year G Sec yields. Historically, a positive spread of equity over bond yield provides a better investment opportunity. Hence, we expect downside in KSB from present levels to be limited.

Gujarat Pipavav: Gujarat Pipavav was expected to see major disruptions during March and April, as most of the services on the GPPL port are meant for the Far East (China in particular), which saw disruption due to the annual Chinese new year and then the COVID-19 crisis.

However, faster than expected ramp-up in the Chinese container ports (workers allowed to return to the port, factories restarting), would lead to clear the backlog of cargoes and de-bottlenecking of the global EXIM cargo movement (re-positioning of containers stranded at the Chinese ports).

The increased container movement between the Far East and India would lead to a higher capacity utilisation for GPPL (with a favourable product mix of EXIM cargo compared to coastal cargo movement).

Kewal Kiran Clothing: Though the near term revenue growth would be impacted owing to the impact of COVID-19 (closure of stores due to national lockdown), however over the longer term the management is looking to achieve double-digit revenue growth and has alluded at a possibility of dilution in margin profile to a range of 18-19 percent.

Despite the same, KKCL remains one of the most profitable branded apparel players having a robust balance sheet with cash & investments worth around Rs 270 crore. We expect the working capital days to inch up in the near term owing to liquidity stress faced by the Multi Brand Outlets (MBO) channel.

However, with the company having robust cash & investments, we do not foresee a significant increase in working capital debt. The debt/equity ratio is comfortably placed at 0.2x.

Mahanagar Gas: Although the company's sales volumes are expected to decline in the range of around 30 percent in the near term due to lockdown amid COVID-19 outbreak, we expect the steady volume growth once normalcy is restored.

Going ahead, we estimate total volume at 3.4 mmscmd for FY22 with volume growth at 7.3 percent CAGR for the next two years. Low gas prices and strong pricing power will help MGL to report healthy margins of Rs 14.6/scm in FY22. On account of attractive valuations, strong return ratios and favourable government policies, we expect MGL to be a beneficiary of India's growing CGD sector.

TV Today: TV Today has maintained its leadership in the Hindi news segment with Aaj Tak and India Today has seen an increase in market share, over the past five quarters. The monetisation across digital platform continued to remain robust as the digital segment has continued to display strong growth. We believe news heavy events will help the company to maintain growth momentum in broadcasting revenues in the medium term. Another attractive feature is the dividend yield. With no major capex, we expect the company to continue paying high dividends (already paid Rs 20 per share in FY20).

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/dont-wait-for-bottom-as-uncertainty-persists-look-at-these-18-quality-picks-5109861.html
8,"April 04, 2020 09:17 AM IST",1,Kshitij Anand,April 2020 could reasonably be better as markets are deeply oversold: Umesh Mehta,"Institutional selling is not a big worry at the moment as Foreign Institutional Investors (FII)/Foreign Portfolio Investors (FPI) selling is actually cooling off now.
Given that the markets are deeply oversold, April 2020 could reasonably be better and consolidate at or around current levels.
Maruti Suzuki saw a decline of 47 percent while TVS Motor’s sales more than halved in March 2020 which indeed is abnormal.
Nonetheless, this ratio acts as one of the indicators to channelise investors to remain invested at current levels.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","The Nifty50 has retraced 61 percent from lows of 7,500 to highs of 9,050. Therefore, 8,000-8,200 levels should act as a support zone for a bounce-back rally which can take Nifty50 to 8,800-9,000 levels","A. Institutional selling is not a big worry at the moment as Foreign Institutional Investors (FII)/Foreign Portfolio Investors (FPI) selling is actually cooling off now. However, the big worry is uncertainty and the estimated time our economy would take to recover, in addition to how long this lockdown type situation prevails in combating the pandemic situation.

In addition to the above, another big worry is of the United States economy which is still not under complete lockdown and the number of infected cases is multiplying.

If in the future the US decides on a complete lockdown in order to contain the virus, then the global economic repercussions may be catastrophic as the US is the world’s largest consumer and a trickle-down effect on other economies would be first-hand.

A. The only data point investors and traders are currently tracking is the chart of rising coronavirus (COVID-19) cases in India and not the charts related to the stock market.

Given that the markets are deeply oversold, April 2020 could reasonably be better and consolidate at or around current levels.

A. The current situation is considered under abnormal periods and it is expected that the worst is largely priced in. Maruti Suzuki saw a decline of 47 percent while TVS Motor’s sales more than halved in March 2020 which indeed is abnormal.

Once the lockdown is over, how soon the demand picks up is a bigger worry. Hence, it is expected that the government soon come up with the most awaited scrappage policy which would act as a trigger for the automobile sector.

And, this at the current juncture, makes the sector a high-risk, and high-reward bet.

A. Investors should stay away from consensus views. At this point in time, cash-rich, debt-free companies are largely available in the FMCG sector and they are still trading at record high valuations making them a very crowded trade.

Instead, the ones with risk appetite should bet on financials, automobile, cement, paints sector wherein the demand only maybe temporarily postponed as compared to severe demand destruction for the long haul.

A. The Nifty50 has retraced 61 percent from lows of 7,500 to highs of 9,050. Therefore, 8,000-8,200 levels should act as a support zone for a bounce-back rally which can take Nifty50 to 8,800-9,000 levels. It is advisable for traders to keep a stop loss below 8,000.

Q. India’s Mcap-to-GDP ratio has now slipped below FY09 levels or below the 2008 financial crisis – do you think a bottom is near? It is at its lowest since FY06. It will be difficult to say that we are near the bottom but what is a good multi-bagger opportunity for the next five years if someone invests now?

A. India Inc saw a robust investment momentum from private equity in 2018 for the second consecutive year with a total investment of $26.3 billion (BAIN & Company: India Private Equity Report 2019).

Hence, the true market-cap to GDP ratio is slightly blurred as the PE inflows are not considered in the market-cap.

Nonetheless, this ratio acts as one of the indicators to channelise investors to remain invested at current levels. One may note that these indicators do not assist in the short term timing of the market and investors should not just jump and buy solely on the fact that the ratio is so attractive.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/april-2020-could-reasonably-be-better-as-markets-are-deeply-oversold-umesh-mehta-5107451.html
9,"April 03, 2020 03:43 PM IST",-1,Sunil Matkar,"JB Chemicals, Solara Active, Strides tank 6-10% as USFDA requests withdrawal of Ranitidine","""As a result of this immediate market withdrawal request for all Ranitidine products, Solara has stopped further manufacturing and distribution ofRanitidine API for the US market,"" said Solara Active in its BSE filing.
Strides said it has approval for Rx and OTC Ranitidine tablets for the US market, and it currently commercializes only the Rx product in the US.
Consequently, Strides submitted the requested data to the USFDA and until test results were available, Strides voluntarily suspended the sales of ranitidine Rx tablets in September 2019, the company said.
Subsequently, Strides said it announced the relaunch of Ranitidine tablets in the US market.
Solara Active said Ranitidine API was amongst its top 10 APIs for company and contributed around 7 percent to its total revenues.","Ranitidine is an Rx and OTC drug used as an H2 (histamine-2) receptor blocker, which decreases the amount of acid created by the stomach.","Shares of JB Chemicals, Solara Active and Strides Pharma Science were down 6-10 percent intraday on April 3 after the US health regulator requested all manufacturers to withdraw all prescription (Rx) and over-the-counter (OTC) Ranitidine drugs from the US market immediately.

This latest step is based on their ongoing investigation of the N-Nitrosodimethylamine (NDMA) impurity in Ranitidine medications.

As per a statement from the US Food and Drug Administration, the agency has determined that the NDMA impurity in some Ranitidine formulation products increases over time and when stored at higher than room temperatures it may result in consumer exposure to unacceptable levels of NDMA impurity.

""As a result of this immediate market withdrawal request for all Ranitidine products, Solara has stopped further manufacturing and distribution of

Ranitidine API for the US market,"" said Solara Active in its BSE filing.

The company further said it would engage with its formulation partners to understand the next steps and additional data that it needs to generate for supporting their product's relaunch to the market in an extended period.

Ranitidine is an Rx and OTC drug used as an H2 (histamine-2) receptor blocker, which decreases the amount of acid created by the stomach.

Strides said it has approval for Rx and OTC Ranitidine tablets for the US market, and it currently commercializes only the Rx product in the US.

In September 2019, following a citizen petition filed in the US by an online pharmacy, the USFDA had learned that some ranitidine medications contain NDMA at low levels and FDA issued a statement alerting patients of NDMA found in samples of Ranitidine. The agency, then, did not announce any intention to recall the product and requested all Ranitidine manufacturers to conduct laboratory testing to examine levels of NDMA in Ranitidine, recommending the use of an LC-HRMS testing protocol.

Consequently, Strides submitted the requested data to the USFDA and until test results were available, Strides voluntarily suspended the sales of ranitidine Rx tablets in September 2019, the company said.

In November 2019, USFDA announced the Laboratory testing and analysis2 of Ranitidine and advised the acceptable NDMA limits. In the summary of test results provided by USFDA, Strides' Ranitidine tablets were found to be within the acceptable limits for NDMA of 96 nanograms(ng) per day or 0.32 parts per million (ppm) which was also considered reasonably safe by most of the regulators for human ingestion based on lifetime exposure.

Subsequently, Strides said it announced the relaunch of Ranitidine tablets in the US market. The company also tested the NDMA content for all its commercial batches and its product met and continued to meet the FDA recommended NDMA specification limit of NMT 0.32 ppm within the labelled expiration date.

Meanwhile, JB Chemicals said it continued to market Rantac, the formulation of Ranitidine, in India. The company has taken steps to ensure that the NDMA in the product is within the acceptable limits.

Further, the company said it has not yet launched this product in the US market.

Solara Active said Ranitidine API was amongst its top 10 APIs for company and contributed around 7 percent to its total revenues. ""Solara does not foresee any significant impact on its growth trajectory and continues to maintain a positive outlook for the future.""

JB Chemicals was trading at Rs 455, down 9.86 percent, Solara was down 4.37 percent at Rs 434.70 and Strides Pharma was down 5.09 percent at Rs 309.70 on the BSE at 1458 hours IST.",https://www.moneycontrol.com/news/business/markets/jb-chemicals-solara-active-strides-tank-6-10-as-usfda-requests-withdrawal-of-ranitidine-5105501.html
10,"April 05, 2020 08:02 AM IST",0,Sandip Das,"Gainers & Losers: 10 stocks that moved most last week; ITC, RBL Bank, Lupin top charts","Lupin, up 17 percentShare price of Lupin jumped over 17 percent in the week after the company received received an EIR from the USFDA.
We will see a rise in provisions on credit card business in Q1FY21,"" Vishwavir Ahuja, Managing Director & CEO at RBL Bank told CNBC-TV18.
Total two-wheeler sales during the month stood at 1,33,988 units as against 3,10,885 units in March 2019, down 56.9 percent.
Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.
Shitij Gandhi Technical Analyst at SMC Global Securities has a sell on the stock with target price at Rs 5,000.","Experts suggest that 7,800 would be a crucial level to watch out for. If it breaks, then it could touch 2020's lows.","While Sensex tanked 674 points to 27,590, the Nifty closed at 8,083, down 170 points on April 3. Indian markets will remain shut on April 6 on account of a public holiday.

Experts suggest that 7,800 would be a crucial level to watch out for. If it breaks, then it could touch 2020's lows.

""Technically speaking, the Nifty needs to sustain above 7,800 levels in the current leg of downswing to retain a positive bias which will subsequently give a life line to the bulls,"" Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory, Chartviewindia.in told Moneycontrol.

Follow our LIVE blog for the latest updates on the novel coronavirus pandemic and its impact

Here are the top 10 stocks that moved the most last week:

Top gainers

Balrampur Chini, up 39 percent

Share price of Sakthi Sugars surged over 39 percent for the week as investors bet on demand for the commodity remaining strong despite the ongoing 21-day lockdown. Hopes of sugar producers in Uttar Pradesh securing permission from the state government to manufacture hand sanitisers also boosted sentiment.

Lupin, up 17 percent

Share price of Lupin jumped over 17 percent in the week after the company received received an EIR from the USFDA.

The company has received an establishment inspection report (EIR) from the USFDA for its Aurangabad, India facility. Lupin received an establishment inspection report from the US drug regulator. The company received the EIR for its Inhalation Research Center located at Coral Springs, Florida. The facility was inspected by the Food and Drug Administration between February 19 and February 26, on behalf of the UK Medicines and Healthcare products Regulatory Agency for Lupin’s generic Fostair application to the UK regulator.

Morgan Stanley initiated an overweight call on the stock with target of Rs 948 per share. Brokarage firm Motilal Oswal has a buy rating on the stock with target at Rs 815. While near-term outlook may be subdued, the broking house remain positive on the company.

Cipla, up 16 percent

Cipla share price added over 16 percent in the week gone by after the pharma company announced the successful completion of Phase-3 clinical study for a generic version of GSK's Advair Diskus. ""This is an important milestone and is a testament to Cipla's strong respiratory capabilities and will go a long way in strengthening our respiratory franchise in the US,"" Umang Vohra, MD and Global CEO said.

""Cipla will now file the product with the USFDA (another three-four months). Being a complex product and based on past experience with other players (Mylan, Hikma, Sandoz), it is highly likely that the approval pathway will be longer than the usual one-year cycle,"" said Emkay. The brokerage has a buy call on the stock with a target at Rs 522, implying a 26 percent potential upside.

ITC, up 13 percent

Share price of tobacco manufacturer ITC was up 13 percent for the week after reports emerged that the company was looking to acquire spice maker Sunrise Food.

ITC, however, in a BSE filing on April 2 denied any such development. ""We would like to inform that the company has not entered into an exclusivity agreement for the acquisition of Sunrise Foods Private Limited,"" the regulatory filing by ITC said.

Top losers

RBL Bank, down 32 percent

Shares of private sector lender RBL Bank plunged more than 32 percent after the management forecast rise in provisions from credit card business in the first quarter of FY21. ""Microfinance book was in good shape through March, but disbursals in microfinance will be a concern going ahead. We will see a rise in provisions on credit card business in Q1FY21,"" Vishwavir Ahuja, Managing Director & CEO at RBL Bank told CNBC-TV18.

Current spending in credit card business dropped to 40 percent, he said, adding but the net income of the bank is the highest in any quarter for Q4FY20. The bank has managed to maintain its operating profit & liquidity position, he said, adding the revenue-generating and earning capacity remained strong. ""Maharashtra, particularly, withdrew money from some private banks. We have seen a decline in our wholesale book,"" Ahuja said, adding two-thirds of liability base is from retail customers.

IndusInd Bank, down 28 percent

IndusInd Bank share price shed over 28 percent this week as the bank is looking to raise as much as $500-750 million in 'confidence capital' from global firms, attempting to allay investor's fears after the novel coronavirus (COVID-19) outbreak, The Economic Times reported.

The private lender, backed by the Hinduja family, also saw an outgo of one-tenth of its deposits after Yes Bank went through a crisis. Global private equity (PE) funds such as Blackstone, Apax Partners, General Atlantic (GA), Advent, TPG, Carlyle and others have been contacted, the report said.

Moneycontrol could not independently verify the report.

IndusInd Bank has asked Morgan Stanley and Citi to approach PE players, the report said, adding that the promoters are considering diluting their stake by 5-10 percent, subject to approval by The Reserve Bank of India (RBI). The bank is looking at three-to-four investor who have “patient long-term money to invest,” sources told the publication.

Investors will most probably negotiate board seats and other affirmative rights, which the bank’s promoter family and management will take into consideration, the report added.

TVS Motor Company, down 21 percent

Share price of TVS Motor Company fell 21 percent after the company reported a 55.5 percent decline in total sales in March at 1,44,739 units. The company, which primarily makes two-wheelers and three-wheelers, had sold 3,25,323 units in March 2019, TVS Motor Company said in a statement. ""There has been a huge impact on the company's production and sales this month because of COVID-19 lockdown across the country,"" it added.

Total two-wheeler sales during the month stood at 1,33,988 units as against 3,10,885 units in March 2019, down 56.9 percent. Domestic two-wheeler sales stood at 94,103 units last month as compared to 2,47,694 units in March 2019, a decline of 62 percent, it added. Total exports declined 34.3 percent to 50,197 units last month as compared with 76,405 units in March 2019.

Ashish Chaturmohta of Sanctum Wealth Management has a sell recommendation on the stock with target of Rs 235. He is of the view that the stock is in long-term downtrend forming lower top and lower bottom on the weekly chart. It has broken major support zone of Rs 340-320 with high volumes and long body bearish candle, indicating selling pressure.

Kotak Mahindra Bank, down 18 percent

Share price of private sector lender Kotak Mahindra Bank fell 18 percent this week after the bank talked of increased risk and cost due to extended moratorium and warned of default if recovery was delayed.

While addressing conference call, the country's fourth-largest private sector lender said it was seeing problems in unsecured personal loans such as credit cards and consumer durables, especially from customers who are fence-sitters and have the ability to pay but not the will. ""Extra efforts are required to remind them through calls,"" it said.

""Defaults are expected to rise due to which recovery will be delayed. The bank is focusing to protect balance sheet rather than looking for balance sheet or income statement growth,"" said the lender.

Maruti Suzuki, down 17 percent

Auto major Maruti Suzuki share price shed 17 percent after the country’s top car maker reported a 47 percent fall in sales for March. The company sold 83,792 vehicles in March against 1,58,076 units in year-ago period. Shares of Maruti ended 1.03 percent lower. Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.

Shitij Gandhi Technical Analyst at SMC Global Securities has a sell on the stock with target price at Rs 5,000. He is of the view that the stock after consolidating in the range of Rs 7,000 to Rs 7,500 levels has given a sharp breakdown below its 200-days exponential moving average on the daily charts and went below Rs 5,000 levels to mark its 52-week low of Rs 4,803 on March 13.

On the lines of General Motors and Ford in the US, India’s automotive giant Maruti Suzuki is stepping in to help produce critical medical equipment and supplies. Car market leader Maruti Suzuki will assist three different companies in producing ventilators, masks, and protective clothing the Delhi-based company informed on March 28.

Eicher Motors, down 14 percent

Eicher Motors share price was down 14 percent this week after the company declared its sales figures for the month of March. Eicher Motors on April 1, 2020, said its total two-wheeler sales declined 41 percent to 35,814 units in March 2020 as against 60,831 units in March 2019. On a month-on-month basis, total Royal Enfield sales declined 43.63 percent in March 2020 from 63,536 units in February 2020.

Total two-wheeler exports jumped 33 percent to 3,184 units in March 2020 compared with 2,397 units in March 2019. Along with other auto manufacturers, Eicher Motors is also feeling heat from the lockdown due to coronavirus.

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/gainers-itc-rbl-bank-lupin-top-charts-5107571.html
11,"April 03, 2020 04:01 PM IST",2,Sunil Matkar,OnMobile Global share price up 20% ahead of share buyback decision,"Shares of OnMobile Global were locked in 20 percent upper circuit on April 3, as the company plans a share buyback.
The stock closed at Rs 18.06, up Rs 3.01, or 20 percent, on the BSE, taking to 28 percent the gains of the two last sessions.
""The meeting of the board of directors will be held on April 9 to consider a proposal of buyback of equity shares of the company,"" the mobile entertainment company told BSE.",The stock has rallied 28 percent in the last two sessions.,"Shares of OnMobile Global were locked in 20 percent upper circuit on April 3, as the company plans a share buyback.

The stock closed at Rs 18.06, up Rs 3.01, or 20 percent, on the BSE, taking to 28 percent the gains of the two last sessions.

""The meeting of the board of directors will be held on April 9 to consider a proposal of buyback of equity shares of the company,"" the mobile entertainment company told BSE.",https://www.moneycontrol.com/news/business/markets/onmobile-global-share-price-up-20-ahead-of-share-buyback-decision-5105671.html
12,"April 04, 2020 11:13 AM IST",0,Kshitij Anand,"Market & Meditation: Strong mental health helps one achieve financial goals, says Arun Thukral","Arun ThukralYoga has helped me to a great extent at various junctures in my personal as well as professional life.
To recollect the market journey over the years and even my personal investing journey, I clearly remember the tech/new economy stocks crash in early 2000 as well as during the 2008 sub-prime crisis.
There was a huge fall during those times, and on both these occasions, the market bounced back strongly.
Strong mental health helped one to achieve financial goals.
I have been through this investing journey for over 30 years and witnessed severe market falls and then recoveries.","These eight limbs are Yama, Niyama, Aaasan, Pranayam, Pratyahara,  Dharna, Dhyan and Samadhi and not just aasanas which is only one part out of eight","Arun Thukral

Yoga has helped me to a great extent at various junctures in my personal as well as professional life. To recollect the market journey over the years and even my personal investing journey, I clearly remember the tech/new economy stocks crash in early 2000 as well as during the 2008 sub-prime crisis.

There was a huge fall during those times, and on both these occasions, the market bounced back strongly. However, overall the bear market period back then for months was quite painful and most of the retail investors who could not handle the stress booked losses and decided not to come back for many years.

Those who could actually come out and thrived were investors who could handle these stressful occasions. Keeping their head intact and acting rationally helped them maintain their balance. At the end of the day, “handling stress” became the differentiator.

Strong mental health helped one to achieve financial goals. Needless to add that yoga and meditation techniques surely helped.

To talk about techniques, I normally practice “reflection” a form of mediation every morning and recollect previous day's events in chronological order without judging them. Over a period of time, one starts to get the benefits of this and it helps to be more aware or mindful about oneself.

At the subconscious level, one starts taking the right decisions as clarity emerges while practicing any kind of meditation technique.

I have been through this investing journey for over 30 years and witnessed severe market falls and then recoveries. There is no point in becoming extra anxious or extremely bullish or excited, and this realisation has come through yoga/meditation.

I have also come to realise that yoga is a way of life and one has to look at Ashtang Yoga (eight limbs) and not just physical aasanas. Most of the time when you talk about yoga, people relate this only with physical aasanas.

These eight limbs are Yama, Niyama, Aaasan, Pranayam, Pratyahara, Dharna, Dhyan and Samadhi and not just aasanas which is only one part out of eight.

To be successful in your journey, you need to be in the right state of mind or 'Chitta' are it is called in yoga.

Investing is not different and one has to reach that level of Chitta to be successful. Ekagra Chitta which is the focused mind is a desirable state whereas Nirudh Chitta is the highest point.

Happy Investing!

The author is market expert and author of Yogi on Dalal Street

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/market-meditation-strong-mental-health-helps-one-achieve-financial-goals-says-arun-thukral-5107521.html
13,"April 03, 2020 01:45 PM IST",1,Sunil Matkar,Experts name 10 safe bets as valuations seem attractive amid market turmoil,"Some experts argue market valuations are attractive now, but the recovery might not be immediate given the lockdown in India and major parts of the world.
Private bank's rural market share is 15 percent while the urban market share is 33 percent.
HDFC Bank continues to gain market share both on assets and the liability side of the business.
Its deposit market share has reached to 7.3 percent in FY19 from 5.1 percent in FY15, however, its incremental deposit market share gain was 9.1 percent (highest in the industry) during the same period.
Trent’s strong balance sheet, strong business positioning and stores expansion plan make it attractive for long term investment.",Vineeta Sharma of Narnolia Financial Advisors said the sharp fall in valuation was an opportunity for prudent long term equity investors.,"There has been a real carnage on the Street in the last one-and-half-month as sentiment was hurt due to the outbreak of coronavirus and fears of resultant economic damage.

The rise of cases in developed nations - United States and Europe - worried investors the most. FIIs started pulling out money from emerging markets like India. As a result, we saw the biggest monthly outflow in March (Rs 65,816 crore)

Sensex and Nifty plunged over 33 percent from their record highs seen in January. Many stocks hit their respective multi-year lows.

Some experts argue market valuations are attractive now, but the recovery might not be immediate given the lockdown in India and major parts of the world.

""As far as value buying is concerned, the market itself is in the value zone. Most of the fundamentally strong stocks are available at almost five-year low valuations,"" Sundar Sanmukhani, Head of Fundamental Research Desk at Choice Broking told Moneycontrol.

""Our recommendation to the investors is to stick to quality fundamental stocks, which have minimal impact from the lockdown and can rapidly revive post that,"" he said. He is cautious on the equity market performance in the near term.

Vineeta Sharma, Head of Research at Narnolia Financial Advisors also said the sharp fall in valuation was an opportunity for prudent long term equity investors. ""Idea is to identify businesses where long-term competitive moat exit, the balance sheet is strong to tide short term pain and there is a secular business growth potential for the future.""

Here is the list of 10 stocks which experts feel are safe quality bets in the current market turmoil:

Expert: A K Prabhakar, Head - Research at IDBI Capital

ICICI Bank

It is one of the largest private bank with 5,275 branches network and loan book of Rs 6,35,654 crore. It trades at attractive valuations and trades less than 1-time adjusted book. It holds many subsidiary companies which can create additional value.

Avenue Supermarts (D-Mart)

Company is growing at 25 percent in the last few years and we think company is pulling consumer away from unorganised stores due to high discounting and now delivery to home on minimum charge would help the company grow in next few years around those levels.

HDFC Life Insurance

Life insurance as business is growing 15 percent CAGR in last 17 years in private sector and for next 10 years similar growth looks possible. Company grows faster than peers and has better margin and this correction gives better entry point.

Bharti Airtel

Now duopoly in telecom between Jio and Airtel would give pricing power to both these companies.

Muthoot Finance

Gold NBFC is safest in this crisis situation with NIM around 15 percent and loan book of around Rs 38,000 crore. It has one of lowest NPAs for high margin business.

Expert: Vineeta Sharma, Head of Research, Narnolia Financial Advisors

HDFC Bank

Over the last ten years, PSU banks have lost market share to more nimble and better managed private banks from 81 percent in 2009 to 66 percent in 2019. Private bank's rural market share is 15 percent while the urban market share is 33 percent. We remain confident that there is more room for large scale private banks to take away PSUs' market share as the formalization of the economy increases.

HDFC Bank continues to gain market share both on assets and the liability side of the business. Its deposit market share has reached to 7.3 percent in FY19 from 5.1 percent in FY15, however, its incremental deposit market share gain was 9.1 percent (highest in the industry) during the same period.

Currently the bank is focused to tap the rural opportunity offering retail products and banking services to the citizens across the country.

Trent

The Indian retail apparel industry is highly unorganized. Trent runs retail stores - Westside, Zudio, Star, Landmark, Zara and Massimo Dutti. The company has more than 97 percent own brand portfolio for Westside which is the largest contributor to revenues. Led by differentiated product offerings & store experience, Trent has accelerated the store expansion program in FY19 and operates more than 270 stores across more than 70 cities in India.

Focused on the speed of delivering the latest fashion each week and committed to faster store opening to scale up the reach, Trent revenues are expected to grow at 25 percent CAGR for the next 3 years. Trent’s strong balance sheet, strong business positioning and stores expansion plan make it attractive for long term investment. The company presently trades at 4 times EV/Sales.

Apollo Hospitals Enterprises

Apollo Hospitals is the largest hospital network in India with 70 hospitals, 10,000+beds and 10,000+ doctors. The healthcare services comprise 55 percent of the revenues. The Pharmacy chain has 3,428 outlets across 20 states & 4 union territories and comprises 39 percent of the revenues. The other business contributes 6 percent of the revenues. Apollo is highly competitive compared to other destinations for medical tourists while offering similar standards and quality care at a substantially lower cost (around 65-90 percent savings versus US).

The company plans to bring down the debt to Rs 2,500-2,600 crore (net debt/EBITDA <2.5x) post completion of the pharmacy restructuring exercise. We expect the healthcare business to grow at a CAGR of 12 percent and the pharmacy business to grow at a CAGR of 17 percent for the next 3 years leading to sustained margin expansion and ROCE improvement. The company presently trades at 1.78 times FY20 EV/Sales.

Tata Elxsi

Tata Elxsi offers electronic, software development and system design services to automotive and aerospace industries. The company works with leading car manufacturers and suppliers, in developing electronics and software for powertrain, infotainment, connectivity, active safety, and comfort and convenience. The software which comprised 2 percent in the total value of the car in 2002 has reached 10 percent and is expected to reach 40 percent by 2030.

The company has also diversified into Medical business which will be fastest-growing segment within Tata ELXSI. It now contributes 8 percent and growing at double-digit QoQ. We expect in the next two years to at least contribute 22 percent of overall revenue. The company has cash balance of Rs 500 crore in the book and is planning to go for M&A.

HDFC AMC

Penetration of mutual fund products in India is only a fraction of the global average. Mutual Fund industry is well-poised for strong growth due to rising awareness amongst investors. Also, rising penetration of the internet and smartphones is contributing to the ease and speed of financial services in India.

Promoted by Housing Development Finance Corporation (HDFC) and Standard Life Investments Limited (SLI), HDFCAMC has strong corporate governance and is built on the trust of investors. HDFC AMC is India’s largest and most profitable mutual fund manager with Rs 3.8 trillion in assets under management. The company has huge operating leverage as most of the costs are fixed. Secular business growth ahead and efficient operation makes it an investment candidate.

Disclaimer: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

""Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.""",https://www.moneycontrol.com/news/business/markets/experts-name-10-safe-bets-as-valuations-seem-attractive-amid-market-turmoil-5102101.html
14,"April 06, 2020 01:09 PM IST",2,Kshitij Anand,"Story in a chart: Long build-up seen in ITC, buy for a target of Rs 210","Jay PurohitITC seems to be ready to take a u-turn after the fall in price halted around the reversal zone of a Bullish Butterfly pattern on the weekly chart and started rebounding in the last few days.
The fall was supported by the huge short formation in the futures segment.
At the current juncture, the stock is comparatively light on positions and marginal long build-up is seen in the current bounce which is a positive sign for the counter.
Looking at the overall chart structure and derivatives data, we are expecting a bounce in the stock towards Rs 210 levels in the coming weeks.
Thus, any dip toward 173 shall be used as a buying opportunity with a stop-loss of Rs 160.","At the current juncture, the stock is comparatively light on positions and marginal long build-up is seen in the current bounce which is a positive sign for the counter.","Jay Purohit

ITC seems to be ready to take a u-turn after the fall in price halted around the reversal zone of a Bullish Butterfly pattern on the weekly chart and started rebounding in the last few days. The stock rose nearly 7 percent on April 3.

We are witnessing a double-bottom kind of formation on the daily chart. RSI oscillator started moving northward from the oversold territory on both daily and weekly scale, which is a sign of relief for the bulls.

The stock had a strong bear phase in the last one year and corrected by more than 50 percent. The fall was supported by the huge short formation in the futures segment.

The open interest has reached to highest ever level of 16.91 crore on March 6 but, we witnessed a good amount of unwinding in the stock in the later fortnight of the March series, indicating that traders gradually exited their short positions.

At the current juncture, the stock is comparatively light on positions and marginal long build-up is seen in the current bounce which is a positive sign for the counter.

Looking at the overall chart structure and derivatives data, we are expecting a bounce in the stock towards Rs 210 levels in the coming weeks. Thus, any dip toward 173 shall be used as a buying opportunity with a stop-loss of Rs 160.

(The author is a technical and derivatives analyst at Motilal Oswal Financial Services)

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/story-in-a-chart-long-build-up-seen-in-itc-buy-for-a-target-of-rs-210-5109661.html
15,"April 06, 2020 11:45 AM IST",-2,Sandip Das,"'Nifty can fall towards crucial support of 7,800-7,700'","Furthermore, prices are trading below 5 days DMA placed around 8400, down move towards earlier crucial support 7800/7700 can continue which can extend to swing low 7500.
We recommend a buy in Bharti Infratel around Rs 152 keeping a stop loss Rs 135, for target of Rs 188.
The appearance of emerging cup and handle pattern where handle is about to construct near the line of parity on daily chart indicates up side movement in the coming sessions.
Daily momentum indicator RSI seems to be taking support from its falling line while being trading in an oversold region on daily chart also creating positive rhythm in the scrip.
Furthermore, declining histogram in MACD adds the conviction of buying the scrip around Rs 585 for the target of Rs 650 with stop loss of Rs 550 marks.","As long as the index is trading below 20 DMA, one should opt for sell on rise strategy.","Shabbir Kayyumi

Formation of the weekly candle is a small red candle for Nifty, it is continuous 8th week of lower closing. The index had given a bounce back earlier but it could not sustain above 5 WMA and is now trading below 5 DMA. India VIX index has started cooling off after making the highest mark of 86 in the month of March and currently sustaining below 55 marks which suggests contraction of volatility under process and ideal scenario to go towards normal daily ATR.

Recently index touched the lower Bollinger Band placed around 7520 and sustaining above it indicates retracement of prices towards middle band or 20 DMA which is standing around 8900 marks. As long as the index is trading below 20 DMA, one should opt for sell on rise strategy.

Furthermore, prices are trading below 5 days DMA placed around 8400, down move towards earlier crucial support 7800/7700 can continue which can extend to swing low 7500. 7500 interestingly is 50% retracement mark from low of 2008 (2252) and high of 2020 (12430).

For the banking index, majority of the oscillators are in oversold zone and a relief rally towards 20000 levels is expected.

Below are the top 3 stocks which can give up to 23 percent return:

Bharti Infratel: Buy around Rs 152 | Target: Rs 188 | Stop loss: Rs 135 | Upside: 23%

The scrip has formed a cup and handle on the daily charts and is undergoing consolidation in the longer time frame. It is on the verge of resuming its prior trend. The momentum indicator MACD has crossed the signal line indicating a start of a trend. The RSI too is above its key 40 mark indicating positive momentum on its side. We recommend a buy in Bharti Infratel around Rs 152 keeping a stop loss Rs 135, for target of Rs 188.

Biocon: Buy around Rs 285 | Target: Rs 320 | Stop loss: Rs 268 | Upside: 12%

Daily chart of the stock reveals that demand is increasing and supply is diminishing as stock is taking support from line of parity showing a rebound from its lower levels. Prices are consolidating above the formation of the morning star candlestick pattern showing strength from bottom. With the chart looking attractive and decent volume participation witnessed, we recommend a buy around Rs 285 in this stock for an upside target of Rs 320, keep a stop loss of Rs 268.

Infosys: Buy around Rs 585 | Target: Rs 650 | Stop loss: Rs 550 | Upside: 11%

The stock bottomed out near the Rs 509-515 zones and it has been consolidating for last few days on daily chart. The appearance of emerging cup and handle pattern where handle is about to construct near the line of parity on daily chart indicates up side movement in the coming sessions.

Daily momentum indicator RSI seems to be taking support from its falling line while being trading in an oversold region on daily chart also creating positive rhythm in the scrip. Furthermore, declining histogram in MACD adds the conviction of buying the scrip around Rs 585 for the target of Rs 650 with stop loss of Rs 550 marks.

The author is Head of Technical Research at Narnolia Financial Advisors Ltd.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/nifty-can-fall-towards-crucial-support-of-7800-7700-5108831.html
16,"April 05, 2020 09:42 AM IST",1,Sunil Matkar,"Bet on these 33 stocks having low financial leverage, strong competitive positioning","As a result, Indian equity benchmarks crashed 35 percent from record high levels seen in January and investors lost around Rs 52 lakh crore of wealth in two-and-half-month.
LKP expects NBFCs to remain challenged despite liquidity-easing measures announced by the Reserve Bank of India (RBI), due to wider credit spreads and asset quality concerns.
The Centre announced welfare measures worth Rs 1.7 lakh crore, while the RBI announced a Rs 3.7 lakh crore liquidity stimulus package.
But most experts feel that these measures being announced globally amid such crisis, generally help in the long term rather than the short term.
Along with equity, oil hit the most due to lockdown-led low demand across the world.","FIIs pulled out Rs 65,817 crore from Indian equities in March alone. The financial sector was hit the most as the lockdown impacts collection efficiency of MFI, NBFC, HFC, SFB and banks.","The market had taken nearly four years to rally from 7,511 levels in March 2016 to hit record high of 12,430 on the Nifty50 in January 2020. But it took only two months to lose those gains and reach the levels of 2016 again.

It was a complete devastation of every asset class in a short span of time by the novel coronavirus or COVID-19 pandemic, which reportedly started from China — the world's second largest economy — and spread to other parts of the world in a couple of months.

The pandemic has forced several parts of world to go for complete lockdown. Confirmed cases have surged past 12 lakh with over 64,000 deaths worldwide. As a result, Indian equity benchmarks crashed 35 percent from record high levels seen in January and investors lost around Rs 52 lakh crore of wealth in two-and-half-month.

""These are unprecedented times - haven't seen anything like this in four decades because it is more of a crisis of confidence than a financial crisis,"" said LKP Research.

FIIs pulled out Rs 65,817 crore from Indian equities in March 2020 alone, while financial sector hit the most due to lockdown that impacts collection efficiency of MFI, NBFC, HFC, SFB and Banks.

LKP expects NBFCs to remain challenged despite liquidity-easing measures announced by the Reserve Bank of India (RBI), due to wider credit spreads and asset quality concerns. Lenders to segments like commercial vehicle, SME and self employed groups would face challenges, it feels.

The Centre announced welfare measures worth Rs 1.7 lakh crore, while the RBI announced a Rs 3.7 lakh crore liquidity stimulus package. But most experts feel that these measures being announced globally amid such crisis, generally help in the long term rather than the short term.

Along with equity, oil hit the most due to lockdown-led low demand across the world. International benchmark Brent crude futures crashed 68 percent from 2020's high seen in January and the fall of price below the production cost hit the oil producing countries very hard, but it was a boon for India.

""The biggest oil shock with two low cost oil producing countries flooding the market is in our view a worry for the USA in an election year at a time when the Pandemic is devastating its economy,"" said LKP.

India being a large importer of oil would save more than 1 percent of its GDP and companies consuming oil and having a certain degree of pricing power in its products stand to gain, it added.

The brokerage feels the impact of lockdown is a major risk for REITs due to fall in rental income, industrials and capital goods due to labour dislocation, hotels due to non-occupancy, multiplexes, aviation, logistics, transportation, etc.

""Job losses would in our view impact consumer discretionary sector as consumers defer and postpone purchases,"" it said.

As a result, selling was seen across sectors, with Auto, Bank, Metals, Realty and Media losing around 45-47 percent. Infra, IT and Energy were down 28-31 percent.

Hence, like every expert, LKP also feels it is an opportunity to accumulate quality stocks. The brokerage has advised accumulating in tranches, as business leaders having low financial leverage and strong competitive positioning in the below mentioned sectors are likely to gain after the COVID-19 crisis:

SBI, ICICI Bank, HDFC Life, Bharti Airtel, CONCOR, Finolex Industries, HDFC, JK Paper, HUL, Colgate Palmolive, Bharat Electronics, Cipla, United Spirits, among others, are included in its stock picks list.

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/bet-on-these-33-stocks-having-low-financial-leverage-strong-competitive-positioning-5108921.html
17,"April 05, 2020 09:31 AM IST",1,Sunil Matkar,Story in a chart: 'Cup and Handle' pattern in Coal India suggests buying opportunity,"Shabbir KayyumiThe Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community.
In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal.
A Cup & Handle reversal pattern forms after a downtrend, and its completion marks a trend reversal to uptrend.
In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle.
Profit bookingTarget as per Cup & Handle pattern is calculated by adding height of Cup to neckline which comes to Rs 165.","Cup and Handle patterns are an integral part of technical analysis. But, successful traders combine these techniques with technical indicators and other forms of technical analysis to maximize their odds of success.","Shabbir Kayyumi

The Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community.

In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal. A Cup & Handle reversal pattern forms after a downtrend, and its completion marks a trend reversal to uptrend.

In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle. A trendline is drawn by connecting these highest points of the two peaks, which is called as 'Neckline'. This trend line is the most important component of C & H pattern.

Why to buy Coal India?

C & H patterns are an integral part of technical analysis, but successful traders combine these techniques with technical indicators and other forms of technical analysis to maximize their odds of success.

Coal India is having a strong resistance line standing around Rs 142 levels indicating strong bullish breakout only above these levels. Recent formation of Cup and Handle pattern will give a breakout on a close above Rs 142 mark which suggests buying in the stock for higher targets of Rs 165. Volume can also add further insight while trading these patterns. Decent volume participation while giving breakout is also giving support to C & H pattern.

Figure 1. Cup & Handle pattern and Buy signal on Coal India

> A close above neckline (Rs 142) of Cup & Handle pattern is indicating trend reversal to uptrend.> Short-term moving average 20 DMA (Rs 138) defines short-term trend is providing support to buyers as prices are sustained and trading around it.> Mid-term moving average 50 DMA (Rs 132) defines mid-term trend is very well augur with bulls as prices are sustained and trading above it.

> Decent volume participation while pattern breakout will also give additional confirmation.

Profit booking

Target as per Cup & Handle pattern is calculated by adding height of Cup to neckline which comes to Rs 165. However, one can book profits near previous swing high which is around Rs 162.

Stop loss

Entire bullish view negates on breaching of Handle on closing basis and one should exit from long position. In case of Coal India, it is placed around Rs 127 levels.

Conclusion

We recommend buying Coal India above Rs 142 with a stop loss of Rs 127 for higher targets of Rs 165 as indicated in above chart.

(The author is Head - Technical Research at Narnolia Financial Advisors Ltd.)

Disclosure: Narnolia Financial Advisors/Analyst (s) does/do not have any holding in the stocks discussed but these stocks may have been recommended to clients in the past. Clients of Narnolia Financial Advisors Ltd. may be holding aforesaid stocks. The stocks recommended are based on our analysis which is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/story-in-a-chart-cup-and-handle-pattern-in-coal-india-suggests-buying-opportunity-5108711.html
18,"April 06, 2020 04:06 PM IST",2,Sunil Matkar,"' NBFCs/HFCs' eligible for moratorium on term loans, buy these 3 stocks for 31-102% return'","Among others, Axis Bank, ICICI Bank, M&M Financial, SBI, HDFC, Indiabulls Housing, HDFC Bank, Kotak Mahindra Bank, IndusInd Bank were also caught in a bear trap, falling 2-9 percent.
But after discussions with management of various NBFC/HFC, brokerage Emkay cleared that the moratorium is applicable to NBFC/HFCs as well.
""Term loans obtained from banks by all NBFCs/HFCs are fully eligible under the moratorium and our discussions suggest that many NBFCs/HFCs would avail the same.
But NBFCs/HFCs are not eligible for deferment of interest on working capital loans,"" it said.
Technically, the brokerage feels not allowing NBFCs/HFCs to defer their term loans during the current crisis would completely deteriorate the entire liquidity measures undertaken by the RBI.",Emkay feels housing finance companies (HFCs) are better placed compared to asset finance companies (AFCs).,"Share prices of non-banking finance companies/housing finance companies, as well as banks, were hit hard on April 3 after a media report indicated that NBFCs/HFCs are not eligible for a three-month moratorium on term loans borrowed and are liable to pay regularly.

Reports further stated that the only option open for NBFCs/HFCs would be a separate LTRO (long-term repo operation) window through which banks can infuse sufficient liquidity in order to smoothen bond market transactions.

Nifty Bank index plunged 5.27 percent and Financial Service index dropped 4.25 percent on Friday. Shriram Transport and Cholamandalam Investment fell the most, down 16 percent and 12 percent.

Among others, Axis Bank, ICICI Bank, M&M Financial, SBI, HDFC, Indiabulls Housing, HDFC Bank, Kotak Mahindra Bank, IndusInd Bank were also caught in a bear trap, falling 2-9 percent.

But after discussions with management of various NBFC/HFC, brokerage Emkay cleared that the moratorium is applicable to NBFC/HFCs as well.

""Term loans obtained from banks by all NBFCs/HFCs are fully eligible under the moratorium and our discussions suggest that many NBFCs/HFCs would avail the same. But NBFCs/HFCs are not eligible for deferment of interest on working capital loans,"" it said.

Technically, the brokerage feels not allowing NBFCs/HFCs to defer their term loans during the current crisis would completely deteriorate the entire liquidity measures undertaken by the RBI.

During the recent monetary policy meet (March 25-27), the RBI has offered a moratorium of three months to all term loan borrowers, who are likely to be impacted by the lockdown and social distancing during the COVID-19 outbreak.

""Since the deferment is available from banks, NBFCs with an elevated share of bank borrowings (Cholamandalam Investment, M&M Financial, Shriram Transport) may opt for a similar deferment from banks and are relatively safeguarded. However, NBFCs with a higher share of bond market borrowings (LIC Housing) could raise incremental money from the LTRO window at the cost of margins,"" Emkay said.

Its assessment suggests that NBFCs with relatively stronger liability franchise (HDFC, Bajaj Finance) would anyhow be better placed, as their ability to raise funds at lower costs would aid margin disruptions.

After further discussions with management, Emkay indicated that the only unclear aspect of this entire exercise is the rating downgrade of securitized pool of assets of such NBFCs and HFCs.

""As per management, the pool of assets, including such deferred loans, should be exempted from downgrade as the said restructuring mandate is from the RBI,"" the brokerage said.

""In case of ratings downgrade of such pools, NBFCs would suffer further margin pressure due to elevated discounting by pool buyers. Also, many financial institutions may opt to stay away from the securitization of these assets,"" it added.

NBFCs/HFCs are confident of resolving this issue with the RBI and SEBI soon.

Hence, considering above parameters, Emkay feels housing finance companies (HFCs) are better-placed than asset finance companies (AFCs) as the overall impact of the deferment would be more visible in AFCs since recoveries are better among large-ticket secured loans.

HDFC remained its preferred pick with safer asset composition (salaried mortgages), longer maturity duration (72 months) and superior collection efficiency (99 percent digital).

""Cholamandalam Investment has high preference followed by Bajaj Finance post the recent correction; however, elevated discretionary exposure (including auto) and shorter maturity duration keep us cautious. We prefer M&M Financial Services the least due to rising delinquencies and low coverage,"" said the brokerage which advised buying HDFC (with a target of Rs 1,971, potential upside of 31.4 percent), Cholamandalam Investment (Rs 253, potential upside of 102.4 percent), Bajaj Finance (Rs 3,137, upside of 42 percent).

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/nbfcshfcs-eligible-for-moratorium-on-term-loans-buy-these-3-stocks-for-31-102-return-5112011.html
19,"April 06, 2020 10:02 AM IST",-1,Kshitij Anand,"Buying fear: This Warren Buffett indicator hints a bottom, but are we there yet?","Warren Buffett once said, ""Be fearful when others are greedy and greedy when others are fearful"".
One thing is certain that there is a lot of fear in equity markets across the globe.
Experts feel that investors should deploy a staggered approach while investing in equity markets because the slide could still continue.
Warren Buffett described this ratio (Market cap to GDP ratio) as the ""best single measure"" of where valuations stand at any given moment in one of his articles back in 2001 with Fortune magazine.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.",The bottom could be some time away because we have fallen just 30 percent in 2 months while history suggests that bottom formation has taken anywhere between 10-27 months.,"The Indian market has fallen nearly 30 percent from its all-time high seen in January, which indicates we are now in a bear market. But, is it time to buy the fear? Maybe not.

Warren Buffett once said, ""Be fearful when others are greedy and greedy when others are fearful"". One thing is certain that there is a lot of fear in equity markets across the globe. Institutional investors are selling equities to either raise cash or fund margin calls.

But, can we say that we have made a bottom? And, this would be the best time to invest? Experts feel that investors should deploy a staggered approach while investing in equity markets because the slide could still continue.

The COVID-19 outbreak which is a global pandemic is likely to have severe economic fallout for many countries,xc including India. Global rating agencies have warned that the world economy is likely to slip into a recession in 2020.

“Given the uncertainty, one may not be in a full “Greed-on” mode, but certainly it is time to loosen the purse strings. In numerical terms, valuations are at least 10 percent more favourable vis-a-vis 2 weeks ago,” Rakesh Parekh, Head - Portfolio Management, JM Financial Services told Moneycontrol News.

“Globally, we have gone through multiple viruses scares over the last two decades. And, the experience has been that while business disruptions lead to near-term pressure on earnings and cash flows, good quality solid businesses adjust and rebound quickly as things begin to settle down. Since stocks are cheaper, it is a good idea to start deploying cash,” he said.

Where is the bottom?

Yes, it is time to buy the fear but in a staggered way because the bottom could still be some time away. Although, India’s market capitalisation/GDP ratio has declined swiftly from 79 percent as on FY19 to 54 percent (FY20E GDP) – much below its long-term average of 75 percent and closer to the levels last seen during FY05 and FY09 – makes it attractive.

The Nifty is trading at a 12-month forward RoE of 15 percent, above its long-term average of 14.5 percent, Motilal Oswal said in a note.

Warren Buffett described this ratio (Market cap to GDP ratio) as the ""best single measure"" of where valuations stand at any given moment in one of his articles back in 2001 with Fortune magazine.

The ratio acts as a good barometer when it comes to studying market valuations, but experts differ that we have made a bottom – although, we might be trading at levels last seen during the 2008 financial crisis. The ratio is at its lowest level since FY06.

“The current situation is not very promising as we can see a continuous rise in COVID cases and it is difficult to say if the bottom is here or not,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor told Moneycontrol.

“Once this pandemic issue resolves, economic activity can be seen gaining momentum basically due to increased consumption and therefore a judicious investment can be made for next 5 years,” he said.

This ratio acts as one of the indicators to channelize investors to remain invested at current levels. But, one may note that these indicators do not assist in the short term timing of the market and investors should not just jump and buy solely on the fact that the ratio is so attractive, suggest expert.

The other reason which makes experts believe that the bottom could be some time away is the fact that we have fallen just 30 percent in 2 months while history suggests that bottom formation has taken anywhere between 10-27 months.

“The final bottom in the four previous falls took 10-27 months versus less than three months in the ongoing fall,” said a CLSA report.

VK Sharma, Head PCG & Capital Markets Strategy, HDFC Securities told that the market cap to GDP ratio today is around 0.53, which matches that of December end 2008.

“While the Nifty, in the current bear market has fallen 39.57 percent to its low, in 2008 it had fallen as much as 61 percent,” he said.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/buying-fear-this-warren-buffett-indicator-hints-a-bottom-but-are-we-there-yet-5109881.html
20,"April 03, 2020 04:23 PM IST",-1,Kshitij Anand,"Taking Stock: COVID-19, selloff in financials weigh on D-St: Nifty holds 8,000 levels","Financials hold 30-40 percent weightage in the index and any fall in top names leads to sharp selloff.
The broader markets were better off, as the S&P BSE Midcap index fell 1.1 percent while the S&P BSE Smallcap index was down just 1.03 percent.
Top Nifty losers include Titan Company, IndusInd Bank, ICICI Bank, and Axis Bank.
Stocks & sectorsSectorally, the S&P BSE Bankex was down 5.3 percent, followed by the S&P BSE Finance index that fell 4.3 percent and the S&P BSE Auto index that was down 2.9 percent.
Action was seen in the S&P BSE Healthcare index, which was up 3.5 percent followed by the S&P BSE Oil & Gas index that rose 2.03 percent and the FMCG index was up 0.84 percent.",Bank stocks suffer huge losses after Moody's Investors Service changed the outlook for the banking system from stable to negative.,"Another spike in global coronavirus infections that crossed one-million mark and relentless selling by institutional investors weighed on sentiment on April 3, as the Sensex plunged more than 600 points and the Nifty just about holding the crucial 8,000 level.

Let’s look at the final tally on D-Street: the Sensex tanked 674 points to 27,590, while the Nifty closed at 8,083, down 170 points. Indian markets will remain shut on Monday on account of a public holiday.

Financials led the fall on D-Street as selling pressure on some of the top quality names continued. Financials hold 30-40 percent weightage in the index and any fall in top names leads to sharp selloff.

Most bank stocks suffered huge losses in intraday trade on BSE on April 3 after Moody's Investors Service changed the outlook for the banking system to negative from stable, underscoring the impact f the disruptions caused by the viral outbreak.

Sectorally, selling pressure was seen in the Bankex followed by finance, consumer durables, auto and consumer discretionary.

The broader markets were better off, as the S&P BSE Midcap index fell 1.1 percent while the S&P BSE Smallcap index was down just 1.03 percent.

""The Indian markets opened and stayed negative, with reduced volatility. A ratings downgrade for the banking sector due to the impact of Covid-19 and ensuing stressed asset concerns, impacted the financial stocks,” Vinod Nair, Head of Research at Geojit Financial Services, said.

“FIIs were net sellers to the tune of Rs 1,100 crore on April 1 and show no signs of reversal. Markets are trading in uncertainty regarding the spread of the virus in India, as hope emerged of infections peaking in some of the worst affected global markets,” he said.

Top Nifty gainers include GAIL India, ITC, Cipla, and Sun Pharma.

Top Nifty losers include Titan Company, IndusInd Bank, ICICI Bank, and Axis Bank.

Stocks & sectors

Sectorally, the S&P BSE Bankex was down 5.3 percent, followed by the S&P BSE Finance index that fell 4.3 percent and the S&P BSE Auto index that was down 2.9 percent.

Action was seen in the S&P BSE Healthcare index, which was up 3.5 percent followed by the S&P BSE Oil & Gas index that rose 2.03 percent and the FMCG index was up 0.84 percent.

Volume spike of more than 100% was seen in stocks like ITC, Cipla, Apollo Hospitals, Lupin and Torrent Pharma.

Long buildup was seen in stocks like Torrent Pharma, IGL, HPCL and MRF.

Short buildup was seen in stocks like JSPL, Cummins India, RBL Bank, Shriram Transport, and PVR.

More than 200 stocks hit a fresh 52-week low. These include Shree Cements, Eicher Motors, Maruti Suzuki, ICRA, PVR, and Supreme Industries.

Stocks in news

Banking stocks led the fall, with the NiftyBank falling nearly 1,000 points, weighed down by losses in RBL Bank, Axis Bank, IndusInd Bank, ICICI Bank and Bandhan Bank.

ITC: Shares jumped nearly 7 percent in intraday trade on BSE after reports said the company was looking to acquire spice maker Sunrise Food.

RBL Bank: Shares of the private sector lender plunged more than 15 percent intraday after the management forecast rise in provisions from credit card business in the first quarter of FY21.

Cipla: The stock gained over 8 percent after the pharma company announced the successful completion of Phase-3 clinical study for a generic version of GSK's Advair Diskus.

Lupin: The share price rose 14 percent after the company received an establishment inspection report (EIR) from the USFDA for its Aurangabad, India facility.

Technical View

The Nifty formed a bearish candle on the daily charts.

Technically speaking, the Nifty needs to sustain above 7,800 levels in the current leg of downswing to retain a positive bias, which will subsequently give a lifeline to the bulls.

In case the Nifty closes below 7,610, then weakness will be confirmed, which will open up more downsides below 7,511 with initial targets of 7,341, Mazhar Mohammad, Chief Strategist – Technical Research &Trading Advisory, Chartviewindia.in, said.

On the rebound from 7800 initially, downside target shall be towards 8,600.

For the time, traders are advised to remain neutral and wait for stability, said Mohammad.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/taking-stock-covid-19-selloff-in-financials-weigh-on-d-st-nifty-holds-8000-levels-5104421.html
21,"April 04, 2020 07:39 AM IST",1,Kshitij Anand,Lucky 7: HDFC Securities picks fundamentally strong stocks for your portfolio,"On the charts, the Nifty50 has fallen from 12,152 to 7511 and on bounces the retracement levels could be 9270-9846.
Substantial debt-funded capex or acquisitions or inability to improve the EBITDA margins leading to the higher net adjusted leverage are some concernsHPCL is an integrated refining and marketing company and has substantial oil marketing operations.
Coronavirus outbreak has impacted industry demand and HPCL has to face volatility in oil prices.
The sharp drop in global crude prices in the last few weeks (correction in oil prices from ~US$45/bbl to US$22-25/bbl) provided respite to OMCs will allow the OMCs to raise margins.
Rural demand has been weak due to lower-income, recovery in demand would take another two to three quarters.",In the interim we may see values dip sharply again and again based on over discounting of fundamental deterioration or technical reasons like large selling by FPIs due to risk aversion,"It is a difficult time for investors who might be seeing the value of their portfolios go down on a daily basis, but traders who trade both on the long and short side could have a gala time even if volatility index goes on a rollercoaster ride, HDFC Securities said in a report. However, they must follow money management rules by keeping strict stop losses and try to square up the trade the same day as far as possible. Close “While we do not want to sound alarmist for the sake of it, we have tried to interpret the possibilities objectively. The long term fair value of most well-managed companies will not change materially based on lower earnings or cash flows of a few quarters,” said the report. related news 'They are brave': Briton, 99-year old Tom Moore, raises millions for health workers

Coronavirus pandemic: How India’s most populated states are tackling COVID-19 crisis

In Pics | Here's what top corporate leaders have to say on lockdown extension The report further added that in the interim we may see values dip sharply again and again based on over discounting of fundamental deterioration or technical reasons like large selling by FPIs due to risk aversion. Hence, changing asset allocation, raising cash in the interim and redeploying later at lower levels (in same/different stocks based on a fresh evaluation) may help overcome the anxiety during deep selloffs (and its consequent impact on wealth effect). The hard truth is that the ultimate winners out of this turmoil may not be the same as those in your current portfolio. The three-week lockdown to contain the COVID-19 outbreak will mean that 75 percent of the economy will be shut down, resulting in a direct output loss of more than 4 percent. On the charts, the Nifty50 has fallen from 12,152 to 7511 and on bounces the retracement levels could be 9270-9846. In the best-case scenario, it could rise to 10294. “It could later fall again and in case we are able to contain the virus by April end (first scenario), then we could form a higher bottom at 7842-8160,” said the report. It further added that in case the virus lingers on beyond this date (second scenario), then we could breach the low of 7511 and go towards 6825-6357. HDFC Securities said that currently, they are not including any financials in their recommendations. Here are top 7 stocks from IT, consumption, oil & gas as well as from healthcare space: Apollo Hospitals Enterprises:



Apollo Hospital Enterprise Ltd (AHEL) is Asia’s one of the leading integrated healthcare service providers having presence in Hospital, Pharmaceutical, Primary Care & Diagnostic Clinics; Telemedicine units, Health Insurance Services, Global Projects Consultancy, Colleges of Nursing and Hospital Management and a Research Foundation, epidemiological studies, stem cell & genetic research.

This stock fallen over 25 percent in the last one month due to Corona Virus fears in India despite the fact that Hospital's business will be unaffected by the virus scare; if at all it may benefit out of it.

On account of increased pricing, better occupancy, and improved case mix, AHEL witnessed improvement in its hospital and pharmacy segment's profitability. Substantial debt-funded capex or acquisitions or inability to improve the EBITDA margins leading to the higher net adjusted leverage are some concerns

HPCL is an integrated refining and marketing company and has substantial oil marketing operations. It is the third-largest oil refining and marketing company in India. It owns and operates two refineries, one in Mumbai with a 7.5 million metric tonnes per annum (MMTPA) capacity and another one in Visakhapatnam with 8.3 MMTPA capacity.

Coronavirus outbreak has impacted industry demand and HPCL has to face volatility in oil prices. The stock has fallen by about 37 percent since Nov 2019 highs.

Crude oil prices have recently fallen to their lowest in nearly three months after the failed decision of production cut by OPEC nations, stoking fears about global economic growth. Trade tiff of the US with China has led to fears of further slowing down of the global economy which could impact crude oil demand and hence its prices.

The sharp drop in global crude prices in the last few weeks (correction in oil prices from ~US$45/bbl to US$22-25/bbl) provided respite to OMCs will allow the OMCs to raise margins.

Now onwards, normative margins could be restored allowing HPCL to be the largest beneficiary as its earnings are highly sensitive to changes in the marketing margins.

Hindustan Unilever Limited is engaged in fast-moving consumer goods businesses comprising home and personal care, foods and refreshments. The Company's segments are Soaps and Detergents, which include soaps, detergent bars, detergent powders, detergent liquids, and scourers.

HUL lost over 340 basis points to 38.9 percent in the skin cleansing category over the past two years dragged by a sharp decline in two of its largest brands— Lux and Lifebuoy — that together accounts for a quarter of the market.

The beauty care category was impacted by delayed winter for skincare and pricing correction in soaps, and the Personal wash market also declined in Q3. Rural demand has been weak due to lower-income, recovery in demand would take another two to three quarters.

However, HUL has undertaken various measures such as partnering with banks and financial partners and offering additional credit to wholesalers in rural markets to ease out liquidity concerns in trade channels.",https://www.moneycontrol.com/news/business/markets/lucky-7-hdfc-securities-picks-fundamentally-strong-stocks-for-your-portfolio-5103611.html
22,"April 06, 2020 11:48 AM IST",1,Kshitij Anand,'SBI Life Insurance could turn out to be a multibagger in the next 5 years',"I would recommend investors accumulate SBI Life Insurance in this downtrend for better than market returns in the next 5 years, VK Sharma, Head PCG & Capital Markets Strategy, HDFC Securities, said in an interview with Moneycontrol’s Kshitij Anand.
I would recommend investors accumulate SBI Life Insurance in this downtrend for better than market returns in the next 5 yearsA) The results would obviously be delayed and will not be good.
As and when we see a plateauing out of those numbers, markets should bounce back.
A) The auto sector numbers were worse than expected, even counting the lockdown.
Pharma stocks, which had lost the tag of ""safe"" stocks, have partially got it back, courtesy of the virus.",SBI Life Insurance is something that I would like to recommend for investors to accumulate in this downtrend for better than market returns in the next 5 years.,"I would recommend investors accumulate SBI Life Insurance in this downtrend for better than market returns in the next 5 years, VK Sharma, Head PCG & Capital Markets Strategy, HDFC Securities, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) Rising numbers of infections in the US, the fall of the US Indices, fear arising out of the super spreader event of Nizamuddin, is making the markets sulk.

We have handled the virus issue better than the US, UK or any other European countries and would have been celebrating the fall in the new infections after April 6 but that was not to be. Our vigil has now been extended.

A) This is very interesting.

Yes, the market cap to GDP ratio today is around 0.53, which matches that of December end 2008. While the Nifty, in the current bear market has fallen 39.57 percent to its low, in 2008 it had fallen as much as 61 percent.

I would recommend investors accumulate SBI Life Insurance in this downtrend for better than market returns in the next 5 years

A) The results would obviously be delayed and will not be good.

The only thing going for the markets is that the positions are very light in the April series. In fact, we have started the April series with an Open Interest (OI) of just 240 crore shares in stock futures.

This is the lowest since October 2015. The number is 54 percent lower than the all-time high seen in February 2018 and 43 percent lower than the last series.

In fact, the Nifty50 has fallen in all the past four series, something that only happened way back in 2002. But when that happened, the 5th series closed in positive.

The main data to be diced and sliced are the new infection numbers. As and when we see a plateauing out of those numbers, markets should bounce back.

A) The auto sector numbers were worse than expected, even counting the lockdown.

The sector has had no reprieve from the courts on liquidating their BS-IV inventory. They will get only 10 days after the lockdown is relaxed to sell their ware.

A) Cash-rich companies are great companies to back in uncertain times. As they do not carry the baggage of the interest on the debt, they will fare better in tough times.

Usually, they are available at a higher end of the PE spectrum but the current downturn has lowered all boats. So it’s a good time.

A) For the coming week, unless the tide turns in the infection numbers, one should stick to what is working and that is Pharma. There are trading plays possible in the sector.

A) Yes, the money is moving to Pharma and FMCG sector. Pharma stocks, which had lost the tag of ""safe"" stocks, have partially got it back, courtesy of the virus.

While the finance boys have been hit badly, but the better-managed ones will emerge stronger after the turmoil settles.

So, there is still a lot of time for these stocks to turnaround. Top banks with low NPAs and good margins should be picked again when the tide turns.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/sbi-life-insurance-could-turn-out-to-be-a-multibagger-in-the-next-5-years-5109161.html
23,"April 03, 2020 01:45 PM IST",1,Sunil Matkar,Cipla share price up 8% on successful completion of Phase-3 clinical study of asthma drug,"The share price of Cipla gained 8.3 percent intraday on April 3 after the pharma company announced the successful completion of Phase-3 clinical study for a generic version of GSK's Advair Diskus.
It was trading at Rs 443.30, up Rs 29.75, or 7.19 percent, on the BSE at 1307 hours.
""...announced the successful completion of Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalation powder (100/50 mcg),"" the pharmaceutical company said in a BSE filing.
Fluticasone propionate and salmeterol inhalation powder 100/50 mcg, 250/50 mcg and 500/50 mcg are generic versions of GSK's Advair Diskus.
The brokerage has a buy call on the stock with a target at Rs 522, implying a 26 percent potential upside.","Fluticasone propionate and salmeterol inhalation powder 100/50 mcg, 250/50 mcg and 500/50 mcg are generic versions of GSK's Advair Diskus.","The share price of Cipla gained 8.3 percent intraday on April 3 after the pharma company announced the successful completion of Phase-3 clinical study for a generic version of GSK's Advair Diskus.

The stock has gained 19 percent in the last week after hitting a six-year low following the selloff triggered by the coronavirus outbreak. It was trading at Rs 443.30, up Rs 29.75, or 7.19 percent, on the BSE at 1307 hours.

""...announced the successful completion of Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalation powder (100/50 mcg),"" the pharmaceutical company said in a BSE filing.

Fluticasone propionate and salmeterol inhalation powder 100/50 mcg, 250/50 mcg and 500/50 mcg are generic versions of GSK's Advair Diskus.

It is used in treating asthma in patients 4 years and older. It is also used in the long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flareups.

""This is an important milestone and is a testament to Cipla's strong respiratory capabilities and will go a long way in strengthening our respiratory franchise in the US,"" Umang Vohra, MD and Global CEO said.

According to IQVIA (IMS Health), Advair Diskus and its generic equivalents had US sales of approximately $2.9 billion for the 12-month period ending February 2020.

""Cipla will now file the product with the USFDA (another three-four months). Being a complex product and based on past experience with other players (Mylan, Hikma, Sandoz), it is highly likely that the approval pathway will be longer than the usual one-year cycle,"" said Emkay.

The brokerage has a buy call on the stock with a target at Rs 522, implying a 26 percent potential upside.

The brokerage said it was unlikely that generic Advair's would be launched by FY22, hence the same was not a part of its estimates.

At present, Mylan's Wixela Inhub is the only generic in the market. Mylan received product approval in January 2019 and launched the drug at a 70 percent discount.

""Sandoz has shelved off the generic Advair project after the USFDA rejected its application, while Hikma's (partnered with Vectura) application is currently under review (had received a CRL in the first review cycle). Among Indian generics, Lupin, partnered with Celon, is currently in the development stages,"" said Emkay.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/cipla-share-price-up-8-on-successful-completion-of-phase-3-clinical-study-of-asthma-drug-5104691.html
24,"April 03, 2020 02:53 PM IST",2,Nishant Kumar,"D-Street Buzz: Banking stocks plunge; shares of RBL Bank, IndusInd Bank, ICICI Bank crack up to 15%","As per a report by CNBC-TV18, Moody's expects a deterioration in banks' asset quality due to disruption in economic activity from the coronavirus outbreak.
around 14:40 hours IST, Nifty Bank index was down over 5 percent, with shares of RBL Bank, ICICI Bank, IndusInd Bank, Axis Bank and Bandhan Bank among top losers, falling between 7-15 percent.
""We have factored a lockdown of 30-45 days in our revised estimates and cut individual banks’ loan growth in FY21 by 3-5 percent and taken deterioration in asset quality.
""We believe the impact on asset quality would be the least for HDFC Bank, Kotak Mahindra Bank, and DCB Bank, but it would be relatively high for IndusInd Bank,"" Phillip Capital said.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","As per a report by CNBC-TV18, Moody's expects a deterioration in banks' asset quality due to disruption in economic activity from the coronavirus outbreak.","Most Bank stocks suffered strong losses in intraday trade on BSE on April 3 after global brokerage Moody's Investors Service changed the outlook for the banking system to negative from stable, underscoring the negative impact due to disruptions caused by the outbreak of COVID-19.

As per a report by CNBC-TV18, Moody's expects a deterioration in banks' asset quality due to disruption in economic activity from the coronavirus outbreak.

Stating that asset quality will deteriorate, Moody's said a sharp decline in economic activity and a rise in unemployment will lead to a deterioration of household and corporate finances, which in turn will result in increases in delinquencies.

around 14:40 hours IST, Nifty Bank index was down over 5 percent, with shares of RBL Bank, ICICI Bank, IndusInd Bank, Axis Bank and Bandhan Bank among top losers, falling between 7-15 percent.

Mihir Vora - Chief Investment Officer - Max Life Insurance said in an interview with CNBC-TV18 that because of the prolonged lockdown there are fears that the retail and SME loan might start turning a bit sour so the concerns that there may be a rise in NPAs are keeping the financial stocks under pressure.

Many brokerages have highlighted that the lockdown of the domestic and global economies due to the COVID-19 threat will have a meaningful impact on banks’ loan-book growth.

""We have factored a lockdown of 30-45 days in our revised estimates and cut individual banks’ loan growth in FY21 by 3-5 percent and taken deterioration in asset quality. Our earnings revisions are down between 10 percent and 35 percent,"" said brokerage firm Phillip Capital.

The uncertain outlook and the country-wide lockdown has made banks vulnerable to a new leg of asset-quality crisis, with the most uncertain part being the lockdown period and the time that the economy would take to return to normalcy.

""We believe the impact on asset quality would be the least for HDFC Bank, Kotak Mahindra Bank, and DCB Bank, but it would be relatively high for IndusInd Bank,"" Phillip Capital said.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-banking-stocks-plunge-shares-of-rbl-bank-indusind-bank-icici-bank-crack-up-to-15-5105131.html
0,"April 03, 2020 12:39 PM IST",1,Sandip Das,Aurobindo Pharma share price gains 4% despite calling off deal with Sandoz,"The share price of Aurobindo Pharma gained almost 5 percent intraday on March 3 after the company said on April 2, the USD 900 million deal to acquire Sandoz Inc's US-based generic oral solids and dermatology businesses has been mutually called-off.
Holzkirchen-based Sandoz is a leading player in generic pharmaceuticals and biosimilars and a division of Swiss drug major Novartis.
""This decision was taken as approval from the US Federal Trade Commission for the transaction was not obtained within anticipated timelines,"" Aurobindo Pharma said in a regulatory filing.
The acquisition was to be made through its wholly-owned subsidiary Aurobindo Pharma USA Inc.
The deal was expected to close in 2019 following the completion of customary closing conditions, including US Federal Trade Commission clearances.",Credit Suisse has downgraded the stock to underperform from neutral and has slashed target from Rs 450 to Rs 345 per share as USFDA approvals may remain weak.,"The share price of Aurobindo Pharma gained almost 5 percent intraday on March 3 after the company said on April 2, the USD 900 million deal to acquire Sandoz Inc's US-based generic oral solids and dermatology businesses has been mutually called-off.

Holzkirchen-based Sandoz is a leading player in generic pharmaceuticals and biosimilars and a division of Swiss drug major Novartis.

""This decision was taken as approval from the US Federal Trade Commission for the transaction was not obtained within anticipated timelines,"" Aurobindo Pharma said in a regulatory filing.

The acquisition was to be made through its wholly-owned subsidiary Aurobindo Pharma USA Inc.

The deal was expected to close in 2019 following the completion of customary closing conditions, including US Federal Trade Commission clearances. Repeated delays, however, led to it being mutually terminated.

Global research firm Credit Suisse has downgraded the stock to underperform from neutral and has slashed target from Rs 450 to Rs 345 per share as USFDA approvals may remain weak. Growth in the absence of Sandoz acquisition is likely to be weak.

The stock witnessed a spurt in volume by more than 2.82 times and was trading with volumes of 471,071 shares, compared to its five day average of 142,930 shares, an increase of 229.58 percent.",https://www.moneycontrol.com/news/business/stocks/aurobindo-pharma-share-price-gains-4-despite-calling-off-deal-with-sandoz-5104331.html
1,"April 03, 2020 08:53 AM IST",0,Sandip Das,"Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term","The 30-share Sensex ended 1,203 points, or 4.08 percent, down at 28,265.31 while Nifty settled 344 points, or 4 percent, lower at 8,253.80.
The BSE Midcap and Smallcap indices remained better off than the benchmarks, down 2.18 percent and 1.06 percent, respectively.
According to the pivot charts, the key support level for Nifty is placed at 8,105.4, followed by 7,957.
The important pivot level, which will act as crucial support for the index, is placed at 17,782.07, followed by 17,355.83.
The views and investment tips expressed by investment experts are their own, and not that of the website or its management.","Ashwani Gujral of ashwanigujral.com recommends selling Kotak Mahindra Bank with a stop loss of Rs 1,200, target at Rs 1,080 and Tata Consultancy Services with a stop loss of Rs 1,730, target at Rs 1,660.","The 30-share Sensex ended 1,203 points, or 4.08 percent, down at 28,265.31 while Nifty settled 344 points, or 4 percent, lower at 8,253.80. The BSE Midcap and Smallcap indices remained better off than the benchmarks, down 2.18 percent and 1.06 percent, respectively.

Experts highlighted that the government's announcement regarding the cut in interest rates of several schemes such as PPF, Kisan Vikas Patra, NSC and small saving certificates indicates that the fiscal deficit will rise significantly and this has made the financial sector vulnerable. Rising coronavirus cases is already keeping markets on tenterhooks.

According to the pivot charts, the key support level for Nifty is placed at 8,105.4, followed by 7,957. If the index starts moving up, key resistance levels to watch out for are 8,495.15 and 8,736.5.

Nifty Bank closed 4.89 percent down at 18,208.35. The important pivot level, which will act as crucial support for the index, is placed at 17,782.07, followed by 17,355.83. On the upside, key resistance levels are placed at 18,894.67 and 19,581.04.

In an interview to CNBC-TV18, top market experts recommend which stocks to bet on for good returns:

Ashwani Gujral of ashwanigujral.com

Sell Kotak Mahindra Bank with a stop loss of Rs 1,200, target at Rs 1,080

Sell Tata Consultancy Services with a stop loss of Rs 1,730, target at Rs 1,660

Sell Infosys with a stop loss of Rs 615, target at Rs 570

Sell HDFC Bank with a stop loss of Rs 845, target at Rs 790

Buy Reliance Industries with a stop loss of Rs 1,060, target at Rs 1,120

Mitessh Thakkar of mitesshthakkar.com

Sell HCL Tech with a stop loss of Rs 426, target at Rs 400

Buy M&M Financial Services with a stop loss of Rs 148, target at Rs 159

Sell Infosys with a stop loss of Rs 623, target at Rs 580

Buy Bharat Electronics with a stop loss of Rs 67, target at Rs 75

Prakash Gaba of prakashgaba.com

Buy Ambuja Cement with a stop loss of Rs 150, target of Rs 170

Sell Infosys with a stop loss of Rs 620, target of Rs 570

Sell PVR with a stop loss of Rs 1,080, target of Rs 1,100

Sell SRF with a stop loss of Rs 2,710, target of Rs 2,500

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

The views and investment tips expressed by investment experts are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/top-buy-and-sell-ideas-by-ashwani-gujral-mitesh-thakkar-prakash-gaba-for-short-term-20-5103031.html
2,"April 01, 2020 12:51 PM IST",0,Kshitij Anand,Investors should rebalance their portfolio; largecaps a better play: Mahesh Patil,"Investors should rebalance their asset allocation.
Edited excerpt:A) Indian equity markets have fallen 30-35 percent from the recent peak in mid-Feb.
The sharp sell-off by FIIs is primarily from Quant funds, Hedge funds, Risk parity funds which had grown massively, some on leverage, when global liquidity was easy.
While the policy measures taken by our government and RBI came a bit late, they do provide some comfort to investors.
Wherever the equity component has gone down due to the fall in the market, investors should increase their equity exposure while maintaining a balanced allocation.","Small-ticket consumer discretionary sector which have corrected can bounce back. Private banks have seen a sharp correction, and insurance companies should continue to see secular growth.","Investors should rebalance their asset allocation. Wherever the equity component goes down due to the fall in the market, investors should increase their equity exposure while maintaining a balanced allocation, and there can be a slight tilt to large-caps at this time, Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt:

A) Indian equity markets have fallen 30-35 percent from the recent peak in mid-Feb. This is not just on the account of fundamental reasons but also due to high-intensity selling by foreign investors (FIIs) who have sold more than USD 8 billion in the past few weeks.

The sharp sell-off by FIIs is primarily from Quant funds, Hedge funds, Risk parity funds which had grown massively, some on leverage, when global liquidity was easy.

They had to forcefully unwind their positions amidst the high volatility as the VIX index touched record highs.

Also, global ETF flows indicate that investors are adding to positions in markets such as China, Japan, Korea, where COVID-19 has been seemingly peaked while reducing positions in other markets like India where the uncertainty remains.

DIIs, on the other hand, are mostly long-only and hence they would have deployed excess cash as the markets corrected sharply providing an attractive buying opportunity.

While the policy measures taken by our government and RBI came a bit late, they do provide some comfort to investors.

A) Yes, investors should rebalance their asset allocation. Wherever the equity component has gone down due to the fall in the market, investors should increase their equity exposure while maintaining a balanced allocation. There can be a slight tilt to large-caps at this time.

A) The large sell-off by FIIs due to increased volatility is largely over. Some amount of selling will continue until we see signs of flattening of the virus infection curve.

The domestic institutional investors (DIIs) on the other hand have seen good inflows in this month till date as investors and asset allocation funds move more money to equities seeing the markets at attractive levels.

They are providing some support for the market. However, if the lockdown is prolonged and the impact on the economy is much more severe, the savings will get impacted and the domestic flows could slow down.

This can put further pressure on our markets and we may re-test the recent lows if that happens.

While it is difficult to call a bottom at this point in time, the recent lows of the market should act as good support given that at those levels market fundamentals even on a trailing basis look very compelling.

A) The Indian government is tackling the COVID-19 situation in a step-by-step manner. The government has already announced a 21-day lockdown in an attempt to stop the spread of the virus.

They have announced relief measures worth Rs 1.7 lakh crore targeted to the low-income segment. The RBI also reduced rates by 75 bps, announced measures which will enhance liquidity in the system by 3.7 lakh crore, as well as a moratorium on loan and interest payments which should provide relief to a large swath of the population.

Overall, these measures should give some confidence to investors that India should be able to contain the virus sooner rather than later and that the government and RBI are working in a coordinated manner to cushion the impact on the economy.

However, in comparison to other economies like the US, Europe, and China, where a very large stimulus of almost 8-10% of GDP has been announced, we need to do more.

A large fiscal stimulus with targeted measures for various sectors that are bearing the brunt of the slowdown and which provides some relief to MSMEs as well is the need of the hour.

A) With the government announcing various measures to provide financial support to the low-income segment through its stimulus package, consumer staples should continue to see strong demand.

Small-ticket consumer discretionary segment may also do well. Retailing of consumer staples and small-ticket items should also benefit.

A) Good quality companies in small-ticket consumer discretionary sector which have corrected can bounce back. The demand destruction they have seen is temporary and they can see long term growth due to low penetration and rising per-capita income.

Private banks have seen a sharp correction but those with a strong liability franchise and high-quality assets may gain market share. Also, insurance companies should continue to see secular growth.

A) In a bearish scenario, sector leaders with relatively stronger balance sheets, higher earnings visibility, strong cash flows, and management with a good track record should be preferred. Investors should avoid companies with high leverage.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/investors-should-rebalance-their-portfolio-largecaps-a-better-play-mahesh-patil-5094591.html
3,"April 03, 2020 10:01 AM IST",1,Rakesh Patil,Lupin share price rises 3% as USFDA clears its Aurangabad facility,"Lupin share price rose more than 3 percent in early trade on April 3 after the company received an EIR from the USFDA.
The company has received an establishment inspection report (EIR) from the USFDA for its Aurangabad, India facility.
The inspection for the facility was carried out by the USFDA between February 10 and February 14 and concluded with no observations.
The share touched its 52-week high Rs 882.15 and 52-week low Rs 505.00 on 02 May, 2019 and 13 March, 2020, respectively.
Currently, it is trading 32.28 percent below its 52-week high and 18.29 percent above its 52-week low.","The inspection for the facility was carried out by the USFDA between February 10, 2020 and February 14, 2020 and concluded with no observations.","Lupin share price rose more than 3 percent in early trade on April 3 after the company received an EIR from the USFDA.

The company has received an establishment inspection report (EIR) from the USFDA for its Aurangabad, India facility.

The inspection for the facility was carried out by the USFDA between February 10 and February 14 and concluded with no observations.

“We are delighted with the receipt of the EIR for Aurangabad classifying the inspection as No Action Indicated. This takes us a step forward in our efforts of enhancing our compliance and quality standards across all our manufacturing sites,"" said Nilesh Gupta, Managing Director, Lupin.

""We continue to work with the USFDA to continuously improve our quality and compliance while providing important medicines to the US market”.

At 09:45 hrs Lupin was quoting at Rs 597.35, up Rs 18.15, or 3.13 percent on the BSE.

The share touched its 52-week high Rs 882.15 and 52-week low Rs 505.00 on 02 May, 2019 and 13 March, 2020, respectively.

Currently, it is trading 32.28 percent below its 52-week high and 18.29 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/lupin-share-price-rises-3-as-usfda-clears-its-aurangabad-facility-5103801.html
4,"April 01, 2020 11:52 AM IST",-2,Sunil Matkar,"Kotak Mahindra Bank plunges 10%, here are highlights of concall","Kotak Mahindra Bank share price fell more than 10 percent intraday on April 1 after the private lender talked of increased risk and cost due to extended moratorium and warned of default if recovery was delayed.
The bank is focusing to protect balance sheet rather than looking for balance sheet or income statement growth,"" said the lender.
The bank believes the economic recovery will take six to nine months if the coronavirus situation continued beyond a month (up to three-month time).
The Reserve Bank of India has given a three-month moratorium for the payment of loans after the lockdown.
Here are the highlights of Kotak Mahindra Bank's conference call, collated by KR Choksey:- The management foresees three types of scenarios.",The bank expects a lower recovery as customers who have the ability to pay will also hold back to enjoy the RBI moratorium and to have liquidity in difficult times.,"Kotak Mahindra Bank share price fell more than 10 percent intraday on April 1 after the private lender talked of increased risk and cost due to extended moratorium and warned of default if recovery was delayed.

The stock has plunged 31 percent in two months, as the 21-day lockdown to control coronavirus raised fears of defaults that could result in NPA pressure. The stock was trading at Rs 1,163.30 on the BSE, down Rs 133.05, or 10.26 percent, at 1058 hours.

While addressing conference call, the country's fourth-largest private sector lender said it was seeing problems in unsecured personal loans such as credit cards and consumer durables, especially from customers who are fence-sitters and have the ability to pay but not the will. ""Extra efforts are required to remind them through calls,"" it said.

""Defaults are expected to rise due to which recovery will be delayed. The bank is focusing to protect balance sheet rather than looking for balance sheet or income statement growth,"" said the lender.

The bank believes the economic recovery will take six to nine months if the coronavirus situation continued beyond a month (up to three-month time). ""The management sees urban areas more problematic than non-urban areas.""

The Reserve Bank of India has given a three-month moratorium for the payment of loans after the lockdown.

""The extended moratorium will increase the risk and costs for the banks due to the asset-liability mismatch,"" it said.

Here are the highlights of Kotak Mahindra Bank's conference call, collated by KR Choksey:

- The management foresees three types of scenarios. In the first scenario, the end of COVID-19 situation in 15-30 days' time (optimistic scenario) and everything will be normal in about two months.- Scenario Two, assumes this situation to continue beyond 1 month (up to three-month time) economic recovery will take six-nine months for recovery.- Scenario Three extends beyond three months, which is pessimistic. The company expects extended health problems and recovery, salary cuts and job loss. The management believes we are in Scenario Two.

- The management sees urban areas more problematic than non-urban areas.

- On the liability side, the banks witnessed an increase in customer deposits although not significant but better than expected. There was an uplift in saving deposits and a marginal increase in current and term came from existing customers, other private banks including Yes Bank (post moratorium) and small finance banks.- The bank doesn’t have too much government deposit exposure and hasn’t noticed a significant movement in these.

- On the assets front, the bank has been cautious about SME lending for the last one year. On the retail front, the bank will remain cautious but continue to grow home loans and unsecured loans, while on the wholesale front, the bank has been selective and not taken any concentrated bets.

- The management believes this situation will require geared up efforts towards recovery of non-performing loans (NPLs) and proper recovery infrastructure in place.- Retail borrowers are expected to repay EMIs on priority such as home loans, card loans and two-wheeler loans will be prioritized as compared to other personal loans.- Expecting lower recovery as customers who have the ability to pay will also hold back to enjoy RBI moratorium and to have liquidity in difficult times.- The bank is seeing a problem in unsecured personal loans, which include credit card, consumer durables and other personal loans, especially from the customers who are fence-sitters and have the ability to pay but are not willing. Extra efforts are required to remind them through calls.- The bank believes, if you are not the first to reach the customer; you will end up losing money.- Defaults are expected to rise due to which recovery will be delayed.

- The bank is focusing to protect the balance sheet rather than look for balance-sheet or income-statement growth.

- The management sees that in the present situation, the NBFC sector is more exposed to the solvency issue than the liquidity issue.- On the liquidity side, the BFSI sector will face issues with regards to ALM mismatch, tightening of liquidity. However, these are manageable with infused liquidity and reasonable support offered by the Centre.- The extended moratorium will increase the risk and costs for the banks due to ALM mismatch,

- In the case of the pessimistic scenario, the bank is expecting all the problems mentioned above to raise to the power of two or three.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/kotak-mahindra-bank-plunges-10-here-are-highlights-of-concall-5094751.html
5,"April 03, 2020 08:31 AM IST",-2,,"As expected, the auto numbers for March 2020 are terrible","To view the full content of this article, you have to be a Pro:Already a Moneycontrol Pro subscriber?
Or Open in AppNot a Moneycontrol Pro subscriber yet?
Subscribe to Moneycontrol Pro:What's included:",Passenger vehicle and two-wheeler segments may recover after the lockdown as people may prefer personal vehicles to public transport,"To view the full content of this article, you have to be a Pro:

Already a Moneycontrol Pro subscriber? Or Open in App

Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:







What's included:",https://www.moneycontrol.com/news/business/moneycontrol-research/as-expected-the-auto-numbers-for-march-2020-are-terrible-5099631.html
6,"April 01, 2020 11:06 AM IST",1,Rakesh Patil,"Slideshow | IndusInd Bank, L&T among 5 stocks that can return 12-123%","Benchmark indices on March 31 recovered most of the previous session's losses.
The Nifty finished near 8,600 level, while Sensex gained over 1,000 points.
All the sectoral indices ended in the green, while BSE Midcap and Smallcap indices added 2.5-3 percent.
Here are the top five picks from brokerages with 12-123 percent upside in medium to long term:",Here are the top five picks from brokerages with 12-123 percent upside in medium to long term:,"Benchmark indices on March 31 recovered most of the previous session's losses. The Nifty finished near 8,600 level, while Sensex gained over 1,000 points. All the sectoral indices ended in the green, while BSE Midcap and Smallcap indices added 2.5-3 percent. Here are the top five picks from brokerages with 12-123 percent upside in medium to long term:",https://www.moneycontrol.com/news/business/stocks/slideshow-indusind-bank-lt-among-5-stocks-that-can-return-12-123-5092121.html
7,"April 01, 2020 02:12 PM IST",1,Nishant Kumar,Coronavirus pain may linger; 10 stocks you can consider for your portfolio,"""We expect Dr Lal to outperform the industry growth and register revenue, EBITDA and PAT growth at CAGRs of 13.4 percent, 14.8 percent and 17.7 percent, respectively, over FY20-FY22E.
We expect free cash flow generation of nearly Rs 780 crore over the next two years,"" ICICI Securities said.
Seasoned portfolio and management experience led to higher than industry advances growth at nearly 24 percent CAGR in FY08-19.
""This could impact Q1FY21 revenue and EBITDA by Rs 220 crore and Rs 180 crore, respectively, which is equivalent to meager 1-2 percent.
""Alkem is one of the companies with higher exposure (two-thirds of the business) to the domestic formulation, which is a strong industry outperformer.",Brokerages and analysts are of the view that the pain caused by COVID-19 may linger and the market is factoring in the hit on earnings and economic fallout from coronavirus outbreak.,"The novel coronavirus has now spread to 178 countries. This black swan event has caused serious disruptions and brokerages and experts say the impact of the outbreak on the economy can't be measured precisely at this juncture.

Brokerages and analysts are of the view that the pain caused by the coronavirus may linger and the market is factoring in the hit on earnings and its economic fallout.

The coming few months are expected to be difficult, as global trade has dwindled and all financial markets have witnessed a meltdown.

Nobody knows when the pandemic will subside, what will be the magnitude of demand destruction and the extent to which asset prices will get reset across financial markets.

However, history show that financial markets discount such events at a rapid pace, sometimes overshooting on the downside.

At present, some of the best managed companies are available at attractive valuations. Brokerages advise one should accumulate companies (depending on their risk appetite and time horizon) which have gone through such challenging cycles and have come out much stronger.

Here are 10 stocks that look attractive to brokerages from long-term perspective:

Brokerage: ICICI Securities

Dr Lal Pathlabs | Buy

The company has consistently reported strong growth with incremental free cash flows in the normal course of business.

ICICI Sec said it was positive on the long-term outlook, considering the company’s strong brand franchise with sustainable growth, expansion potential, healthy FCFF generation and strong return ratios.

""We expect Dr Lal to outperform the industry growth and register revenue, EBITDA and PAT growth at CAGRs of 13.4 percent, 14.8 percent and 17.7 percent, respectively, over FY20-FY22E. We expect free cash flow generation of nearly Rs 780 crore over the next two years,"" ICICI Securities said.

""RoE and RoCE would remain strong at 24.3 percent and 22.9 percent, respectively, in FY22E whereas RoIC would move to 95.3 percent,"" it said.

HDFC Bank | Buy

HDFC Bank has efficiently focused on retail business and has garnered strong liability franchise to yield superior profitability over the years, said the brokerage.

Seasoned portfolio and management experience led to higher than industry advances growth at nearly 24 percent CAGR in FY08-19.

Enriched customer experience, a strong network of 5,345 branches and focus on digitisation has enabled the bank to build a strong liability franchise, with CASA comprising nearly 40 percent of deposits. Such high CASA limits cost of funds and thereby, enable to report superior NIM above 4 percent consistently, said the brokerage.

""Prudent asset quality has been core to the bank. The same has safeguarded the bank from NPA issues faced by the industry in recent fiscals. RoA at about 1.5 percent and RoE at 15-18 percent remain consistent for the bank with valuations expected to remain at a premium,"" ICICI Sec said.

Kotak Mahindra Bank | Buy

Kotak Mahindra Bank has built a network of 1,539 branches. Increased focus on retailisation of loans has enabled the bank to earn the best NIM in industry at 4.7 percent.

The savings rate was hiked by the bank to 6 percent in 2011, boosting savings deposits growth to Rs 2,39,354 crore by December 2019.

CASA ratio improved from 50.7 percent in December 2018 to 53.7 percent in December 19, which is the best in industry.

""Overall asset quality remained resilient with GNPA ratio at 2.46 percent in Q3FY20. The bank has no major exposure to IL&FS & other stressed assets. Going ahead, healthy business growth coupled with stable margins is expected to augur well for the bank,"" said ICICI Securities.

Titan | Buy

Titan Company is the market leader in the Indian jewellery market through its flagship brand Tanishq. The company also has a presence in watches and eyewear segments.

The company has also entered the online jewellery market by acquiring caratlane.com.

Volatility in gold prices, impact of coronavirus outbreak (closure of retail outlets due to a national lockdown) and reduced demand in discretionary spending are expected to impair consumer demand in the near term. However, the company is likely to recoup lost sales owing to pent up demand from H2FY21, ICICI Sec said.

The company has consistently exhibited ability to gain market share on a sustained basis amid a tough industry scenario. Robust balance sheet (more than 30 percent RoCE and virtually debt-free status) and asset-light distribution model have enabled it to outpace peers in terms of store addition.

It added 34 Tanishq stores for the nine months ended December 2019, which is equivalent to FY19 store addition, ICICI Sec said.

""Over the longer term, we expect Titan to be a key beneficiary as India’s gold market continues to strive towards regulation and standardisation,"" ICICI Sec said.

Dabur | Buy

Dabur India with a turnover of more than Rs 8,500 crore and earnings of more than Rs 1,400 crore has a strong portfolio of brands (Dabur Chyawanprash, Real, Hajmola, Vatika, Amla, Fem, Honey, Meswak, Dabur Red) with a focus largely on ayurvedic and healthcare offerings.

""With a wave of demand for the ayurvedic & natural products in addition to Coronavirus outbreak globally, staples segment including Dabur has been gaining significance especially its healthcare and home care categories such as Chyawanprash, honey, glucose, toothpaste, shampoos and hair oil,"" ICICI Sec said.

Dabur’s broad product portfolio provides a good play on Indian consumer goods spend by its strong presence in less-penetrated and high-growth categories.

The rural segment contributes around 45 percent of its sales, so it is well-placed to take advantage of the rural recovery.

Brokerage: Kotak Institutional Equities

Petronet LNG | Buy

Petronet LNG’s volumes have remained well above contracted levels historically and are expected to increase further with commissioning of Kochi pipeline post- lockdown and further expansion of Dahej.

""Our reverse valuation for Petronet LNG suggests the stock is trading at about 10 percent discount to NPV of long-term contracts, thereby pricing in materially lower off-take of volumes in the long run,"" said Kotak.

Kotak expects the company to continue paying higher dividends, pending investment in proposed overseas projects.

Lupin | Buy

""At this point, we see limited impact from COVID-19, with the lockdown impact on manufacturing and logistics likely to be smoothened out over the coming few weeks, though, we do see US FDA inspections for Somerset, Goa and Indore getting pushed back to H2FY21,"" Kotak said.

""We expect only a transient impact on domestic market performance with performance likely to be normalized from Q2FY21. However, we do expect a negative hit on EM sales given cross-currency exposure to South Africa (about Rs 600 crore revenues), as well as Brazil/Mexico (about Rs 600 crore revenues).""

However, the brokerage sees several levers to drive the EBITDA growth from FY2021, including market share gains in levothyroxine, gradual loss reduction in Solosec, as well as ProAir approval, with significant room to drive margin expansion through operating leverage.

The stock's valuation has also made it attractive at this juncture.

""Valuations remain compelling with the stock now trading at nearly 5 times FY2022 EV/EBITDA. At 15 times EBITDA multiple on FY2022, domestic segment accounts for entire market cap, with no value ascribed to the US. Nepexto approval underscores the significant optionality in the pipeline, including the inhalation basket (Fostair in the EU, Spiriva in the US) as well as biosimilars (Neulasta filing in FY2021),"" Kotak said.

Kansai Nerolac | Buy

""We upgrade Kansai Nerolac to buy; even as short-term demand collapses due to COVID-19, fundamentals of the company and the category are notably intact. Volume-led growth potential and stable/improving margin profile arising from rational competition,"" Kotak said.

Kotak cut FY2020-22E forecasts to factor in coronavirus impact, lower crude prices and weaker macros. The stock has corrected 35 percent in the past month notwithstanding significant RM tailwinds and it is trading at 24 times FY2022E PE, implying 40 percent valuation discount to APNT versus 15-20 percent historically.

Brokerage: Motilal Oswal Financial Services

Bharti Airtel | Buy

In the current environment, more tech-savvy data subscribers with higher ARPUs and longer-term recharges of 90 days may see a lower impact, Motilal Oswal said.

However, the rest of feature phone subscribers doing monthly recharges (one-third the ARPU of data subscribers), could see some marginal impact.

To protect these low income subscribers (80m), BHARTI has extended free incoming calls until April 17, 2020, with an additional Rs 10 talk-time.

""This could impact Q1FY21 revenue and EBITDA by Rs 220 crore and Rs 180 crore, respectively, which is equivalent to meager 1-2 percent. Against this, increased data consumption should see upgrades in recharge values, thus, mitigating the impact. In Q4FY20/Q1FY21, we currently estimate 13 percent/19 percent revenue growth on a QoQ basis,"" Motilal said.

Alkem | Buy

With the situation on account of the coronavirus outbreak intensifying, there has been a higher off-take of chronic set of medicines.

Further, with rising cases of cough/cold and respiratory illnesses, there is an increased requirement of antibiotics in the case of Alkem.

With the situation in China easing to some extent with reduced impact of COVID-19, manufacturing of KSM (key starting materials) and intermediates has resumed and moved toward normalcy.

""Alkem is one of the companies with higher exposure (two-thirds of the business) to the domestic formulation, which is a strong industry outperformer. It has lower exposure to US generics (nearly 25 percent), which is driven by new launches,"" Motilal said.

Motilal is positive on Alkem on the back of its industry outperformance track record in domestic formulation and better traction with minimal regulatory risk in US generics.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/coronavirus-pain-may-linger-10-stocks-you-can-consider-for-your-portfolio-5090761.html
8,"April 03, 2020 10:24 AM IST",-1,Kshitij Anand,50% of stocks we track are trading in bottom thirty percentile of valuations: Sahil Kapoor,"This has caused markets to de-rate aggressively and also price-in deeper earnings decline, probably split between these two aspects equally.
This has caused markets to de-rate in valuations and also discount a crack in earnings.
Alongside this, countries are also estimating the economic damage caused by lockdowns to provide equivalent or larger stimulus, so as to minimize hardships faced by citizens.
Healthcare, economic and social aspects, could very well benefit from a powerful dose of technology-led disruption.
More than 54 percent of the universe of stocks that we track, are trading in the bottom thirty percentile of valuations, nearing the total decimation last seen in the market crash of 2008.","Investors could see a sentiment shift once clarity and confidence emerge, of things getting under control, as markets are already offering lucrative valuations","This has caused markets to de-rate aggressively and also price-in deeper earnings decline, probably split between these two aspects equally.

This has caused markets to de-rate in valuations and also discount a crack in earnings. The accelerated decline in the stock markets in March’20 is probably because of the mounting uncertainty about the duration of the lockdown, globally.

Many governments in conjunction with their respective central banks have deployed a stimulus between 5-10 percent of GDP (estimating the loss in output), due to lockdown measures.

Alongside this, countries are also estimating the economic damage caused by lockdowns to provide equivalent or larger stimulus, so as to minimize hardships faced by citizens. This seems to be the consensus on which, markets are currently working.

The model which is being adopted now, both globally and in India, is to contain the spread, get to know the number of people infected, build healthcare capacity to match infection rates and reduce it to manageable levels.

India is facing a challenge from coronavirus, both socially and economically. Social distancing or suppression strategy, which is in force currently, is likely to yield benefits in slowing down the spread of the virus.

Historically, most economic crises have been caused by excesses in some segments of financial markets, which in turn, have percolated into the economy.

Either it is the central bank’s policy of raising short-term rates too fast or some hot sector crashing after a reality check on expectations or sometimes a reversion to the mean in overall valuations of the markets.

The current crisis, however, is a medical problem that is being tackled by voluntary quarantine that is resulting in a sharp contraction. It is flowing from the economy to markets and not the other way around.

This is also a reason given which, many people expect the economy to witness a sharp recovery, once we get a grip on the virus.

This can be the case, only if and when the lockdown is lifted and the economy is given enough support by the government, to come back online. This remains, a work in progress.

What could we do?

The solution lies in the usage of technology. India has an attractive array of options to use technology to find solutions. The deep penetration of Aadhar, mobile banking, and internet usage, could help authorities in mapping out a solution, containing the spread of the virus.

If we keep aside the moral question of the ‘surveillance state’, because the problem to tackle is about humanity as a whole, we have the required infrastructure to make effective changes.

In specific focus areas or high-risk clusters, the government can use data from mobile phones, social networks or Aadhar, to ascertain citizens’ movements and visit patterns to deploy healthcare professionals to target those who pose highest to lowest risk, in the current scenario.

This can help the government to trace, test and quarantine people in clusters and stop any possibility of community spreads. The government’s effort to get this crisis under control is like fighting a battle on multiple fronts. Healthcare, economic and social aspects, could very well benefit from a powerful dose of technology-led disruption.

Investors could see a sentiment shift once clarity and confidence emerge, of things getting under control, as markets are already offering lucrative valuations.

More than 54 percent of the universe of stocks that we track, are trading in the bottom thirty percentile of valuations, nearing the total decimation last seen in the market crash of 2008.

Such valuation levels should be utilized to up one’s equity preferences in small chunks, during the course of correction. In such times, investors should protect their emotional, financial and intellectual capital, by using a staggered approach to investing. The fruits of such poise in investing, usually are beneficial.

(The author is Chief Market Strategist, Edelweiss Wealth Management)

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/50-of-stocks-we-track-are-trading-in-bottom-thirty-percentile-of-valuations-sahil-kapoor-5103511.html
10,"April 01, 2020 11:19 AM IST",-2,Nishant Kumar,COVID-19 impact: Stormy clouds for aviation ahead; travel ban serious blow to earnings,"The aviation sector is approaching rough weather as the spread of novel coronavirus (COVID-19) has triggered travel restrictions and lockdown which will hit the airline players' revenue and margin significantly.
Brokerages are of the view that the industry will take longer than expected to recover fully from the disruption caused by COVID-19.
For March 2020, this should further weaken due to travel advisories and then a complete suspension of flights.
""Passenger growth of airlines is to fall sharply and register a negative 20-25 percent growth for FY21.
Centrum has a 'buy' recommendation on IndiGo, with a target price of Rs 1,340, and a 'reduce' rating on SpiceJet, with a target price of Rs 33.","CARE Ratings said that there seems to be turbulence and stormy clouds for the Indian aviation industry as airlines will be operating on sub-par capacity which will result in low ticket booking, fall in revenues and low passenger load factor (PLF).","The aviation sector is approaching rough weather as the spread of novel coronavirus (COVID-19) has triggered travel restrictions and lockdown which will hit the airline players' revenue and margin significantly.

Brokerages are of the view that the industry will take longer than expected to recover fully from the disruption caused by COVID-19.

""Even as the macros of the Indian aviation industry may be in favour of propelling its growth, the industry may not fully recover any time soon post the effects of the pandemic which has affected business operations, travel and tourism and economies world over,"" said CARE Ratings in a note on March 30.

Domestic air traffic growth has been muted at 3.6 percent year-on-year (YoY) to 13.39 crore pax over April 2019-February 2020 due to weak demand. For March 2020, this should further weaken due to travel advisories and then a complete suspension of flights.

The industry, which had already been struggling with the lack of travel demand, is likely to find it difficult to cope with the acute fall in revenue and may be forced to go for measures such as trimming of employee salaries which have already started, brokerages said.

As per brokerage firm Centrum Broking, airlines are taking steps to cut down on costs, for example, IndiGo announced salary cuts ranging from 5-20 percent and Go Air has implemented rotational leaves to employees without pay and. Air India has cancelled and reduced certain allowances it pays to its executive pilots, cabin crew and officers.

Also, as per Centrum, airlines are in talks with the lessors to explore any deferment on lease payments which will support their near term liquidity requirement.

However, going for the airline players is expected to get tougher.

CARE Ratings said that there seems to be turbulence and stormy clouds for the Indian aviation industry as airlines will be operating on sub-par capacity which will result in low ticket booking, fall in revenues and low passenger load factor (PLF).

""Passenger growth of airlines is to fall sharply and register a negative 20-25 percent growth for FY21. Passenger growth has been 13.7 percent during FY19 and 3.7 percent during FY20 (April-February),"" CARE said.

Freight operations may add support to overall traffic movement, CARE believes, but that is also likely to be subdued given the fall slowdown and shutdown of manufacturing units in most parts of the world and in the domestic economy due to the COVID-19 pandemic.

""In terms of capital expenditure airlines will be deferring or scaling back on CAPEX given the expected fall in the top line and bottom line of carries which means the purchase of airplanes or adding to the fleet sizes will not take place at least till 9-months-FY21,"" CARE said.

The fall in crude oil prices may also not help much as its benefit would be realised only once operations resume.

Centrum Broking said the interim cut of 11-12 percent in aviation turbine fuel (ATF) prices with effect from March 23 has a little impact with all operations suspended from March 25. Also, the rupee has depreciated by 5.8 percent in Q4FY20E which will increase outgo for dollar-based costs and also result in steep foreign exchange mark-to-market (fx MTM) losses on operating lease liabilities.

Centrum expects IndiGo’s RASK (revenue per available seat kilometre) yields to decline 2.5 percent YoY to Rs 3.5 and expect PAT loss of Rs 1,750 crore, primarily due to fx MTM loss of Rs 1,010 crore. It expects SpiceJet’s RASK yields to decline 3.6 percent YoY to Rs 3.9 and expect PAT loss of Rs 1,050 crore, primarily due to fx MTM loss of Rs 650 crore.

Centrum has a 'buy' recommendation on IndiGo, with a target price of Rs 1,340, and a 'reduce' rating on SpiceJet, with a target price of Rs 33.

There is a possibility of the lockdown being extended beyond April, which will lead to further earnings cuts. In this event, a relief package from the government (interest-free loans, lower taxes, etc) will be critical for the survival of airlines. Aircraft deliveries can also come under pressure as Boeing and Airbus have taken shut-downs, say experts and brokerages.

Brokerage firm Edelweiss Securities expects a weaker yield and passenger load factor (PLF) environment in the first half of FY21 as demand pain will linger.

""Factoring this, we cut FY21/22E EBITDAR 34 percent/18 percent for Indigo and 33 percent/6 percent for SpiceJet. With valuations turning reasonable at 8 times FY22E EV/EBITDAR post 40 percent correction since our downgrade and factoring near-term slowdown, we upgrade Indigo to ‘hold’ from ‘reduce’ with a revised target price of Rs 961 from Rs 1,297 earlier and maintain ‘buy’ on SpiceJet with a revised target price of Rs 79 from Rs 120 earlier,"" Edelweiss said.

Edelweiss added that even though valuations are lower after the recent correction, there is little room for upside at Indigo and advised that investors should avoid the sector at present.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-impact-stormy-clouds-for-aviation-ahead-travel-ban-serious-blow-to-earnings-5094531.html
11,"April 02, 2020 12:07 PM IST",-1,Kshitij Anand,Time to stay vigilant! Best opportunities come in times of crisis,"Investors should rebalance their asset allocation.
A) Broadly speaking selling had come from three sources - FIIs, margin unwinding by brokers and heavy short selling by hedge funds and traders.
b) Apart from asset allocation, the selection of investment should be scrutinized to reflect a new paradigm.
Always remember two things: “This too shall pass “ and “Best of the opportunities come in times of crisis, so stay vigilant”A) The essence of asset allocation is re-balancing.
We would suggest the following thing(s)a) Plan rebalancing of your asset allocation on March 31.b) Don’t rush – Take another 6 months to get to the ideal asset allocation.","Investors should stick to large-cap stocks which are most liquid, since there is a real risk that many mid and small-cap companies could become illiquid in the coming months.","Investors should rebalance their asset allocation. Wherever the equity component has gone down due to the fall in the market, investors should increase their equity exposure while maintaining a balanced allocation, and there can be a slight tilt to largecaps at this time, Sameer Kaul, MD & CEO, Trustplutus, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Q) What is your take on the market action amid heavy selling by FIIs? What is causing the panic on D-Street?

A) Broadly speaking selling had come from three sources - FIIs, margin unwinding by brokers and heavy short selling by hedge funds and traders.

We are seeing that the selling pressure by FIIs is abating and margin unwinding by brokers has also reduced substantially.

Therefore, we do not expect such sharp movements on a regular basis going forward. However, the market structure is weak, with share prices falling on modest volumes.

Buying activity by the DII and HNI segment which was till now absorbing FII sale volumes has also moderated.

A) Well, past trends indicate that markets usually retrace some of their losses in the immediate next month following an abnormal fall (like in October/ November 2008). That does give us hope for a positive April series.

However the lockdown will continue till April 15, and the situation is far from normal. At this point, investors should stick to largecap stocks which are most liquid, since there is a real risk that many mid and smallcap companies could become illiquid in the coming months. Liquidity at the bottom of the markets is always at a premium.

Currently, the bottom is placed at around 7,500 on the Nifty. At 7,500 selling abated and there was some buying witnessed across the board. However, markets have the tendency to retest the previous lows which investors should be careful about.

A) The packages announced by the RBI and the government are welcome and much appreciated by the markets. The government has taken steps to protect those at risk and most impacted.

The RBI has done more than what was expected. The government measures may have to be supplemented if the lockdown does not end by the deadline announced or if contagion spreads.

The RBI may also have to take further action specifically on the liquidity front.

Given that growth rates and inflation are likely to collapse, further interest rate cuts are also possible.

The most important policy actions have to happen after the lockdown ends led by massive government spending and a higher fiscal deficit.

A) The saying goes “Prepare and not Predict”. One of the best ways to behave rationally in a challenging time is to pre-commit to your strategy.

We as human beings are bad emotional time travellers, hence, it is always better to have a process-driven decision-making approach that includes a well-articulated Investment Policy Statement.

Once an investor adopts this process his or her approach should be the same in a bullish scenario or a bearish scenario.

Hence, while the checklist should be a logical output of an individual’s Investment Policy Statement, here are some general pointers to a checklist :

a) Investors should be conscious of facts that one should avoid.

b) Investors should not respond to prices & news flow and take a short term decision.

c) Investors should accept the fact that a lot of things we do not know and one should not invest in something that one does not understand.

d) Investors should not change their Investment framework mid-way.

a) Does your current portfolio represent changed facts and reality and is there a course correction required?

b) Apart from asset allocation, the selection of investment should be scrutinized to reflect a new paradigm.

c) Do you understand both qualitative and quantitative risks on the investment opportunity?

d) Does the investment opportunity provide liquidity at a short notice?

e) What is your time preference for the said investment?

Always remember two things: “This too shall pass “ and “Best of the opportunities come in times of crisis, so stay vigilant”

A) The essence of asset allocation is re-balancing.

We would suggest the following thing(s)

a) Plan rebalancing of your asset allocation on March 31.

b) Don’t rush – Take another 6 months to get to the ideal asset allocation. A lot of opportunities may emerge by then.

c) Plug the obvious gaps - We have found that most of the portfolios do not have the desired allocation to gold and international equities.

d) Retain liquidity in the portfolio.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/time-to-stay-vigilant-best-opportunities-come-in-times-of-crisis-5095911.html
12,"April 03, 2020 12:17 PM IST",1,Sunil Matkar,"Volatility to continue in Nifty, bet on these 5 stocks for 15-22% return: Ashish Chaturmohta","Ashish ChaturmohtaThe Nifty was in bear grip from the word go as frontline stocks faced pressure through the day on April 1.
Abbott India: Buy | CMP: Rs 15,613 | Stop loss: Rs 14,500 | Target: Rs 19,000 | Return: 22 percentThe stock touched a high of Rs 16,499 in February and then corrected to Rs 12,501.
PI Industries: Buy | CMP: Rs 1,195 | Stop loss: Rs 1,135 | Target: Rs 1,375 | Return: 15 percentThe stock touched all-time high of Rs 1,629 in February and declined to Rs 970.
TVS Motor: Sell | CMP: Rs 279 | Stop loss: Rs 295 | Target: Rs 235 | Return: 16 percentThe stock is in long-term downtrend forming lower top and lower bottom on the weekly chart.
Aurobindo Pharma: Sell | CMP: Rs 392 | Stop loss: Rs 416 | Target: Rs 320 | Return: 18 percentThe stock is in major downtrend forming lower top and lower bottom on the weekly chart.","VIX needs to move below 50 levels for some stability to return in the market, otherwise expect volatile moves to continue in the market.","Ashish Chaturmohta

The Nifty was in bear grip from the word go as frontline stocks faced pressure through the day on April 1. The Nifty closed at 8,254, down by 4 percent for the day. Broader market indices BSE Midcap and Smallcap outperformed the benchmarks, with a loss of 2.18 percent and 1.06 percent, respectively. Though the major indices were in negative, market breadth on NSE was slightly in favour of advances.

For the day, the index formed a Bearish Belt Hold line on the daily chart. The bounce-back rally faced resistance at 9,000. Now it has closed at support of 8,250, trading below it, decline towards 7,950 and then 7,500 levels. Immediate level is seen at 8,750 and then 9,000 levels.

On the upside, immediate resistance is seen at 8,700 and then 9,000. Overall, the Nifty is likely to trade in a broader range of 7,500 and 9,000 levels before the next directional move.

In Nifty April monthly expiry options, maximum open interest for Put is seen at strike price 8,000 followed by 7,500 and 7,000; while for Call maximum open interest is seen at 9,000 followed by 10,000. Nifty options distribution data is suggesting a wide range of 7,500 and 9,000 for now.

India VIX index, a measure of volatility, after touching 11-year high of 86.6 has seen some cooling off and is at 60 levels. VIX needs to move below 50 for some stability to return to the market, otherwise expect volatile moves to continue.

Here is the list of stock recommendations for 1-3 months time-frame:

ICICI Lombard General Insurance: Buy | CMP: Rs 1,106 | Stop loss: Rs 1,050 | Target: Rs 1,280 | Return: 16 percent

The stock has seen major decline from all-time high of Rs 1,440 in December to recent of Rs 805. The stock has taken support around previous lows and seen a bounce back. On the daily chart, the price has formed a short-term bullish inverted head and shoulders pattern between Rs 1,200 and Rs 800-odd levels.

Volumes have also been high, suggesting accumulation in stock at lower levels. Price has moved above 21-day exponential moving average, suggesting short-term trend change. Thus, the stock can be bought at current levels and on dips to Rs 1,085 with stop loss below Rs 1,050 for a target of Rs 1,280.

Abbott India: Buy | CMP: Rs 15,613 | Stop loss: Rs 14,500 | Target: Rs 19,000 | Return: 22 percent

The stock touched a high of Rs 16,499 in February and then corrected to Rs 12,501. Here price has taken support at 100-day moving average. Price has seen bounce back couple of times and is trading above short- term averages. Currently, the stock is at all-time high, indicating bullishness.

Volumes have been high, suggesting buying interest in the stock. Relative strength index has lows above oversold zone and now higher on daily chart. MACD has given positive crossover with its average and moved above equilibrium level of zero on daily chart. Thus, the stock can be bought at current levels and on dips to Rs 15,300 with stop loss below Rs 14,500 for a target of Rs 19,000.

PI Industries: Buy | CMP: Rs 1,195 | Stop loss: Rs 1,135 | Target: Rs 1,375 | Return: 15 percent

The stock touched all-time high of Rs 1,629 in February and declined to Rs 970. Here the stock has taken support at around 61.8 percent Fibonacci retracement of the major rise from Rs 676 to Rs 1,629. The stock has also taken support at 100-week moving average. Subsequently, it has seen bounce back thus respectively support level. Price has formed short-term double bottom on the daily chart between Rs 1,200 and Rs 970 levels i.e. at support. Thus, the stock can be bought at current levels and on dips to Rs 1,175 with stop loss below Rs 1,135 for a target of Rs 1,375.

TVS Motor: Sell | CMP: Rs 279 | Stop loss: Rs 295 | Target: Rs 235 | Return: 16 percent

The stock is in long-term downtrend forming lower top and lower bottom on the weekly chart. It has broken major support zone of Rs 340-320 with high volumes and long body bearish candle, indicating selling pressure. Price has given breakout on downside from Bollinger Band, with expansion of bands on weekly chart indicating continuation of trend in the direction of breakout.

The Average Directional Index (ADX) line, indicator of trend strength has up from equilibrium level of 20 with rising negative directional line on the weekly chart. Thus, the stock can be sold at current levels and on rise to Rs 284 with stop loss above Rs 295 for a target of Rs 235.

Aurobindo Pharma: Sell | CMP: Rs 392 | Stop loss: Rs 416 | Target: Rs 320 | Return: 18 percent

The stock is in major downtrend forming lower top and lower bottom on the weekly chart. The stock has had seen strong bounce back from Rs 389 to Rs 600 odd level. Fresh decline last month has broken low of Rs 389 and touched low of Rs 289. Recent bounce back is facing resistance around previous low area. The rally has been on below average volumes, indicating as relief and larger trend remains down. Price has moved below 21-day exponential moving average. Thus, the stock can be sold at current levels and on the rise to Rs 398 with stop loss above Rs 400 for a target of Rs 320.

The author is Head of Technical and Derivatives at Sanctum Wealth Management.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/volatility-to-continue-in-nifty-bet-on-these-5-stocks-for-15-22-return-ashish-chaturmohta-5101681.html
13,"April 03, 2020 10:28 AM IST",-2,Sandip Das,"COVID-19 impact | Ashok Leyland, Hero MotoCorp lead the fall in auto stocks; S&P downgrades Tata Motors","Ashok Leyland down 6%The share price of Ashok Leyland was down over 6 percent after the company reported a 90 percent decline in sales at 2,179 units in March.
Hero MotoCorp down 5%Hero MotoCorp share price shed 5 percent and was one of the top index losers.
Bajaj Auto down 3%Bajaj Auto share price fell over 3 percent after the company reported weak sales for March 2020.
Total two-wheeler sales fell 56.9 percent to 133,988 units in March 2020 as against 310,885 units in the year-ago period .
Domestic sales fell 47 percent year-on-year.","S&P Global Ratings downgraded Tata Motors stocks that shed 3 percent. Ashok Leyland, TVS Motor and Bajaj Auto fell 3-5 percent each.","The Indian market was trading in the red in the morning, with the Sensex down 390.01 points, or 1.38 percent, at 27875.30 and the Nifty had slipped 112.55 points, or 1.36 percent, to 8141.25.

The spread of coronavirus seemed to weigh on the market even as Prime Minister Narendra Modi, in a video message, hailed the people for adhering to the 21-day lockdown and requested their support to fight the outbreak.

Banks and autos took the maximum beating. The Nifty Auto was down more than 2.5 percent after automobile companies reported dismal March sales numbers with their manufacturing facilities locked down.

Ashok Leyland down 6%

The share price of Ashok Leyland was down over 6 percent after the company reported a 90 percent decline in sales at 2,179 units in March. The company sold 21,535 vehicles in the same month last year, Ashok Leyland said in a regulatory filing. Domestic sales stood at 1,787 units in March against 20,521 units in the year-ago period, a decline of 91 percent.

Hero MotoCorp down 5%

Hero MotoCorp share price shed 5 percent and was one of the top index losers. The country's largest two-wheeler maker reported a 42.4 percent decline sales at 3,34,647 units in March. The company had sold 5,81,279 units in the corresponding month of the previous year, Hero MotoCorp said in a statement.

Total motorcycle sales stood at 3,05,883 units against 5,35,943 units in March 2019, down 42.9 percent. Scooter sales declined 36.55 percent to 28,764 units compared with 45,336 vehicles in the year-ago month, it added.

Bajaj Auto down 3%

Bajaj Auto share price fell over 3 percent after the company reported weak sales for March 2020. The company's March sales were down 38 percent at 2,42,575 units against 3,93,351 vehicles in the year-ago period. Domestic sales fell by 55 percent at 1,16,541 units against 2,59,185 units, while exports were down 6 percent at 1,26,034 units versus 1,34,166 units, year on year.

In an interview to CNBC-TV18, Bajaj Auto said, ""The company would be able to service our export orders once the lockdown is over. Domestic demand will take a big knock in the first quarter of FY21. The company is paying vendors and meeting all payment obligations. It has not found a direct impact of crude prices on retail sales.""

Tata Motors down 3%

The share price Tata Motors was down 3 percent intraday after S&P Global Ratings downgraded the stock to more vulnerable to non-payment grade 'B', citing weaker-than-expected credit metrics owing to the disruptions and economic impact from the coronavirus pandemic, PTI reported.

On the other hand, Moody's Investors Service has placed Tata Motors' ratings on review for a possible downgrade. The review, which will be completed over the next 90 days, is on the Ba3 corporate family rating and Ba3 senior unsecured debt rating, Moody's said in a statement.

TVS Motor Company down 5%

The share price of TVS Motor Company shed 5 percent after the company's sales plunged 55.5 percent to 144,739 units in March 2020 as against 325,323 units in March 2019. Total sales were down by 42.85% in March compared with 253,261 units in February.

Total two-wheeler sales fell 56.9 percent to 133,988 units in March 2020 as against 310,885 units in the year-ago period . Domestic two-wheeler sales slumped 62 percent to 94,103 units in March 2020 as against sales of 247,694 units in March 2019. Three-wheeler sales declined 25.54 percent to 10,751 units in March 2020 from 14,438 units registered in March 2019.

Maruti Suzuki down 1.3%

Maruti Suzuki was down over a percent after the company could sell only 83,792 units March 2020 compared to 1,58,076 vehicles sold in the year-ago period.

The sales during March 2020 are not comparable with sales in March 2019 due to the suspension of operations with effect from March 22nd 2020, in line with national policy, said the company in a release.

Domestic sales fell 47 percent year-on-year. Sales in FY20 have fallen by 16 percent.

The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-impact-ashok-leyland-hero-motocorp-lead-the-fall-in-auto-stocks-sp-downgrades-tata-motors-5103661.html
14,"April 01, 2020 05:24 PM IST",-2,Nishant Kumar,"Auto stocks slip on weak March sales; Escorts, Maruti, Ashok Leyland worst hit","A majority of auto stocks ended in the red on April 1 following weak sales data for the previous month.
The relentless fall in sales continued in March as well and most automakers reported a steep decline in their numbers.
The company sold 83,792 vehicles in March against 1,58,076 units in year-ago period.
Hinduja group flagship firm Ashok Leyland reported a 90 percent decline in vehicle sales at 2,179 units.
The company sold 21,535 units in the same month last year, Ashok Leyland said in a regulatory filing.",Automobile companies have reported a steep drop in sales in March as well.,"A majority of auto stocks ended in the red on April 1 following weak sales data for the previous month.

The relentless fall in sales continued in March as well and most automakers reported a steep decline in their numbers.

The country’s top carmaker, Maruti Suzuki India, reported a 47 percent fall in sales for March. The company sold 83,792 vehicles in March against 1,58,076 units in year-ago period. Shares of Maruti ended 1.03 percent lower.

Hinduja group flagship firm Ashok Leyland reported a 90 percent decline in vehicle sales at 2,179 units. The company sold 21,535 units in the same month last year, Ashok Leyland said in a regulatory filing. Shares of the company closed 4.53 percent lower.

Eicher Motors’ total VECV sales plunged nearly 83 percent YoY. The stock closed 0.66 percent down.

Escorts’ tractor sales more-than-halved to 5,444 in March 2020 against 11,905 tractors sold in the same month last year. Shares of Escorts plunged 9.64 percent.

The BSE Auto index closed 1.54 percent lower, with TVS Motor (down 7.04 percent), MRF (down 5.22 percent), Motherson Sumi (down 5.08 percent) and Cummins (down 5.07 percent) as the top losers.

On the other hand, Hero MotoCorp (up 2.21 percent), Balkrishna Industries (up 1.64 percent), Bajaj Auto (up 1.12 percent), Amara Raja (up 0.19 percent) and Exide (up 0.11 percent) closed in the green.

A day after logging healthy gains, market benchmarks the Sensex and the Nifty were back in the negative territory on April 1, tracking weak global cues.

The 30-share Sensex ended 1,203 points, or 4.08 percent, down at 28,265.31 and the Nifty settled 344 points, or 4 percent, lower at 8,253.80. The BSE Midcap and Smallcap indices remained better off than the benchmarks, down 2.18 percent and 1.06 percent, respectively.

All sectoral indices ended in the red on BSE, with the BSE Bankex, IT and Teck falling over 5 percent each.",https://www.moneycontrol.com/news/business/markets/auto-stocks-slip-on-weak-march-sales-escorts-maruti-ashok-leyland-worst-hit-5096261.html
15,"April 01, 2020 12:47 PM IST",2,Sunil Matkar,"Yes Bank shares rally 10% after 'raising Rs 3,500 crore'","The share price of Yes Bank gained 10 percent intraday on April 1 after reports said that the private lender had raised Rs 3,500 crore from public sector banks.
Yes Bank had successfully raised Rs 3,500 crore on March 31 via certificates of deposits of nearly six-month maturity, The Economic Times reported.
Yes Bank likely offered an interest rate of 8.25 percent on its CDs.
Crisil on March 19 had assigned an A2 rating to the bank’s Rs 20,000-crore money market instrument, the report said.
Yes Bank earlier raised Rs 10,000 crore from the State Bank of India (SBI), other banks and financial institutions through the sale of equity under its reconstruction plan approved by the government and the Reserve Bank of India (RBI).","The bank on March 26 had said its board has approved a proposal to raise up to Rs 5,000 crore.","The share price of Yes Bank gained 10 percent intraday on April 1 after reports said that the private lender had raised Rs 3,500 crore from public sector banks.

The stock was trading at Rs 23.65, up Rs 1.20, or 5.35 percent, on the BSE at 1220 hours after falling 63 percent since March 18.

Yes Bank had successfully raised Rs 3,500 crore on March 31 via certificates of deposits of nearly six-month maturity, The Economic Times reported.

""Two large public sector banks 'flush with liquidity' are subscribers to Yes Bank's CDs and the process was completed within three working days,"" the newspaper quoted sources as saying.

Yes Bank likely offered an interest rate of 8.25 percent on its CDs. Crisil on March 19 had assigned an A2 rating to the bank’s Rs 20,000-crore money market instrument, the report said.

Moneycontrol could not independently verify the report. Yes Bank did not respond to queries, the report said.

The bank on March 26 had said its board has approved a proposal to raise funds up to Rs 5,000 crore.

The private lender informed the exchanges that it would raise the additional amount through shares, ADRs, GDRs or convertible bonds and it would be done in one or more tranches.

Yes Bank earlier raised Rs 10,000 crore from the State Bank of India (SBI), other banks and financial institutions through the sale of equity under its reconstruction plan approved by the government and the Reserve Bank of India (RBI).

The so-called reconstruction scheme, cleared by the Union Cabinet, took effect on March 13. After which the stock saw a sharp runup of 274 percent till March 18.

The bank on March 31 said CARE had withdrawn its rating for lender's short-term fixed deposits and certificate of deposit programme.

""The rating on certificate of deposit programme stands withdrawn as there is no amount outstanding against the rated amount. Also, the rating on the short-term fixed deposit programme has been withdrawn at the request of the bank as there is no outstanding deposits against the rating. The rating actions are in accordance with ICRA's policy on withdrawal and suspension,"" the rating agency said.",https://www.moneycontrol.com/news/business/markets/yes-bank-shares-rally-10-after-raising-rs-3500-crore-5095121.html
16,"April 03, 2020 12:00 PM IST",-1,Rakesh Patil,Cyient partners Hitachi Rail for signalling project but share price falls 2.5%,"Cyient share price declined 2.5 percent intraday on April 3 even after the company announced an agreement with Hitachi Rail for a series of project engineering services.
The agreement will help to accelerate the evolution of its signalling technology and expand and enhance its project execution capacity, it said.
Cyient will develop and operate a central delivery centre for Hitachi Rail in India, and a regional centre in the US.
These centres will be responsible for delivering engineering services for Hitachi’s global signalling projects that use proprietary interlocking platforms.
At 1131 hrs Cyient was quoting at Rs 229.20, down Rs 3.50, or 1.50 percent, on the BSE.",The agreement will help to accelerate the evolution of its signaling technology and expand and enhance its project execution capacity.,"Cyient share price declined 2.5 percent intraday on April 3 even after the company announced an agreement with Hitachi Rail for a series of project engineering services.

The agreement will help to accelerate the evolution of its signalling technology and expand and enhance its project execution capacity, it said.

""This agreement is a reflection of Cyient’s credibility in building global partnerships in safety critical industries such as rail transportation and is a testimony to the value and competitiveness we bring to our customers,"" Cyient CEO and MD Krishna Bodanapu said.

Cyient will develop and operate a central delivery centre for Hitachi Rail in India, and a regional centre in the US. These centres will be responsible for delivering engineering services for Hitachi’s global signalling projects that use proprietary interlocking platforms.

It will also provide software development and configuration support for Hitachi’s ATS product.

At 1131 hrs Cyient was quoting at Rs 229.20, down Rs 3.50, or 1.50 percent, on the BSE.",https://www.moneycontrol.com/news/business/stocks/cyient-partners-hitachi-rail-for-signalling-project-but-share-price-falls-2-5-5104151.html
17,"April 01, 2020 03:09 PM IST",-2,Sandip Das,"D-Street Buzz: Over 200 stocks hit 52-week low on BSE; IT, bank stocks tumble","Among the banking names, the top losers included Kotak Mahindra Bank which plunged over 9 percent followed by State Bank of India, HDFC bank, ICICI Bank and Axis Bank which fell 4-5 percent each.
Share price of Mindtree tumbled over 10 percent while that of Tech Mahindra fell over 9 percent.
239 stocks hit 52-week low on BSE including Jindal Steel & Power, PVR, TVS Motor Company, Cummins India, Future Retail, RBL Bank, Bharat Forge and Eicher Motors.
The most active stocks in NSE in terms of volumes included YES Bank which fell 6 percent.
Jindal Steel & Power Share price shed 16 percent and was one of the top metal losers.","277 stocks hit lower circuit on BSE including Future Retail, Future Consumer, Future Lifestyle, Suven Life Sciences and AU Small Finance Bank.","The Indian stock market continues trading deep in the red with Sensex down 1,305.80 points or 4.43 percent at 28162.69, and the Nifty plunged 371.75 points or 4.32 percent at 8226.

The sectors which fell the most included banks and IT which were down over 5 percent each.

Bank stocks tumbled as investors fear that the lockdown triggered by COVID-19 will have a serious impact on businesses across the sectors and they may see a rise in their bad loans due to this. ""We have factored a lockdown of 30-45 days in our revised estimates and cut individual banks’ loan growth in FY21 by 3-5 percent and taken deterioration in asset quality. Our earnings revisions are down between 10 percent and 35 percent,"" said brokerage firm Phillip Capital.

The uncertain outlook and the country-wide lockdown has made banks vulnerable to a new leg of asset-quality crisis, with the most uncertain part being the lockdown period and the time that the economy would take to return to normalcy. ""We believe the impact on asset quality would be the least for HDFC Bank, Kotak Mahindra Bank, and DCB Bank, but it would be relatively high for IndusInd Bank,"" Phillip Capital said.

Among the banking names, the top losers included Kotak Mahindra Bank which plunged over 9 percent followed by State Bank of India, HDFC bank, ICICI Bank and Axis Bank which fell 4-5 percent each.

IT stocks are also under pressure with the currency market closed on April 1 and April 2. Share price of Mindtree tumbled over 10 percent while that of Tech Mahindra fell over 9 percent. The other losers included TCS, Wipro, HCL Tech, Infosys and NIIT Tech.

India VIX fell 5.56 percent and was trading at 60.83 level.

239 stocks hit 52-week low on BSE including Jindal Steel & Power, PVR, TVS Motor Company, Cummins India, Future Retail, RBL Bank, Bharat Forge and Eicher Motors.

On the other hand, 277 stocks hit lower circuit on BSE including Future Retail, Future Consumer, Future Lifestyle, Suven Life Sciences and AU Small Finance Bank.

The most active stocks in NSE in terms of volumes included YES Bank which fell 6 percent. It was trading with volumes of 6,518,569 shares, compared to its five day average of 5,859,144 shares, an increase of 11.25 percent. Share price of State Bank of India was down 5 percent. It was trading with volumes of 2,132,550 shares, compared to its five day average of 4,301,738 shares, a decrease of -50.43 percent.

Jindal Steel & Power Share price shed 16 percent and was one of the top metal losers. It was trading with volumes of 1,762,797 shares, compared to its five day average of 562,473 shares, an increase of 213.40 percent. On the other hand, Ashok Leyland share price fell 3 percent and It was trading with volumes of 1,166,192 shares, compared to its five day average of 2,346,047 shares, a decrease of -50.29 percent.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-over-200-stocks-hit-52-week-low-on-bse-it-bank-stocks-tumble-5095921.html
18,"April 02, 2020 09:49 AM IST",-1,Kshitij Anand,On discount: 5 factors to consider while picking up beaten down stocks,"Well, beaten-down stocks might look attractive because they are available at a considerable discount when compared to the year-back level.
Investors should avoid companies with high leverage,” Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC told Moneycontrol.
At one glance, beaten-down stocks could look a better play looking at the valuations but, investors should also focus on factors that led to the fall in specific stocks.
Experts advise investors to commit to their own strategy in times of market turmoil just the ones which we are going through.
: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","In a bearish scenario, sector leaders with relatively stronger balance sheets, higher earnings visibility, strong cash flows, and management with a good track record should be preferred.","Indian market is down by about 30 percent from its peak of 12,420 recorded on January 20, and by about 23 percent in the financial year 20, but the big carnage happened in individual stocks.

As many as 175 stocks in the S&P BSE 500 index lost more than 50 percent of their value in the last 12-months that include names like Dalmia Bharat, VIP Industries, Axis Bank, JustDial, Reliance Infra, Reliance Capital, Dish TV, Vodafone Idea, as well as PNB Housing Finance.

Well, beaten-down stocks might look attractive because they are available at a considerable discount when compared to the year-back level. But, experts beg to differ.

Not every stock which witnessed selling pressure is an attractive buy. “In a bearish scenario, sector leaders with relatively stronger balance sheets, higher earnings visibility, strong cash flows, and management with a good track record should be preferred. Investors should avoid companies with high leverage,” Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC told Moneycontrol.

At one glance, beaten-down stocks could look a better play looking at the valuations but, investors should also focus on factors that led to the fall in specific stocks.

Investors should study the factors which led to the fall – is it because of structural changes in the industry, or is it company-specific issues or FII selling. They should also map the growth potential of the company’s product.

Experts advise investors to commit to their own strategy in times of market turmoil just the ones which we are going through. If you are a disciplined investor, chances are you would be able to invest money at the right time and punch out when things are not looking favourable.

“The saying goes “Prepare and not Predict”. One of the best ways to behave rationally in a challenging time is to pre-commit to your strategy,” Sameer Kaul, MD & CEO, Trustplutus told Moneycontrol.

“We as human beings are bad emotional time travelers and hence it is always better to have a process-driven decision-making approach that include(s) a well-articulated Investment Policy Statement. Once an Investor adopts this process his or her approach should be the same in a bullish scenario or a bearish scenario,” he said.

We spoke to Dinesh Rohira - Founder, CEO - 5nance.com, and here is a list of top 5 factors which he recommends investors to consider while picking beaten-down stocks:

Growth prospects:

In the current environment, there are some businesses that will benefit. These are the companies with products that have non-discretionary demand and low elasticity to price.

Management Dynamism:

Many companies that can change quickly with the times will be at an advantage. Adapting products and services to the environment is key, such that it can benefit consumers.

Valuations:

Across the board, valuations have become reasonable. Still, recent financials can have a bearing on the continuing performance. Sometimes very low valuations can also mean that poor fundamentals are expected to remain or further deteriorate.

De-leveraged Companies:

Companies with lower levels of debt are always in a better position to tide through tough times. They are the ones that have more capacity to survive and change according to the requirement.

Technologically Driven Businesses:

Many companies implement technology to their advantage. It is even more critical during such times as social distancing could mean more virtual dependence.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/on-discount-5-factors-to-consider-while-picking-up-beaten-down-stocks-5095471.html
20,"April 03, 2020 10:42 AM IST",1,Kshitij Anand,Last 10-year data suggests April belongs to bulls; will 2020 be different?,"Data from the last 10 years suggest that bulls got an upper hand seven times in the month of April.
On the other hand, Nifty fell three times in April in the last 10 years — in 2015 (Nifty down over 3 percent), 2012 (Nifty down 0.90 percent) and 2011 (Nifty down 0.6 percent).
After losing more than Rs 30 lakh crore of investor's wealth in March, traders and investors are hoping for some stability in markets.
FII Activity:Foreign institutional investors (FIIs) have pulled out more than Rs 65,000 crore from the cash segment of the Indian equity markets in March, as per provisional data.
On the other hand, mutual funds were mostly net sellers in the last ten years in the month of April.","Nifty50 jumped over 6 percent in April 2018, followed by 4.3 percent in April 2013 and over 1.48 percent in April 2016 — three of the biggest gains in April in the last 10 years.","March turned out to be an absolute disaster for the D-Street. The benchmark indices Sensex and Nifty50 dropped about 23 percent each and slipped into bear territory.

Now, as we step into April, investors are hopeful that the worst is behind us. But, given the continued exponential rise in COVID-19 cases in India and across the world, recovery may still be some time away despite a slew of measures undertaken by the central bankers around the globe.

Data from the last 10 years suggest that bulls got an upper hand seven times in the month of April.

Nifty50 jumped over 6 percent in April 2018, followed by 4.3 percent in April 2013 and over 1.48 percent in April 2016 — three of the biggest gains in April in the last 10 years.

On the other hand, Nifty fell three times in April in the last 10 years — in 2015 (Nifty down over 3 percent), 2012 (Nifty down 0.90 percent) and 2011 (Nifty down 0.6 percent).

Experts feel that the trend of the market will be driven by institutional activity, especially foreign investors who have pulled out more than Rs 60,000 crore from the cash segment of Indian markets and rise in coronavirus cases across the world including India.

“It is very tough to make a call for April after a brutal fall in March series because there are still lots of uncertainty about COVID-19 where the market has discounted almost worst-case scenario including a lockdown of 21-Days but if the situation further deteriorates from here then the market will again adjust itself in the downside,” Amit Gupta, Co-Founder & CEO, TradingBells told Moneycontrol.

“We can say that the April is going to be very choppy with moves on both sides, unlike March where the market has fallen vertically,” he said.

After losing more than Rs 30 lakh crore of investor's wealth in March, traders and investors are hoping for some stability in markets.

History suggests that markets have usually bounced back after steep moves on the downside. Hence, the swing low of 7,511 recorded on 24 March could act as a near-term bottom in April – only if there is no sudden spike in COVID-19 cases or selling from FIIs continues.

“Well, past trends indicate that in the months following an abnormal fall, markets usually retrace some of their losses in the immediate next month (like in October/ November 2008). That does give us hope for a positive April series,” Sameer Kaul, MD & CEO, Trustplutus told Moneycontrol.

“Currently, there is a bottom at a place at around 7,500 on the Nifty. At 7,500 selling abated and there was some buying witnessed across the board. However, markets have the tendency to retest the previous lows which investors should be careful about,” he said.

FII Activity:

Foreign institutional investors (FIIs) have pulled out more than Rs 65,000 crore from the cash segment of the Indian equity markets in March, as per provisional data.

“The large sell-off by FIIs due to increased volatility is largely over. Some amount of selling will continue until we see signs of flattening of the virus infection curve. DIIs, on the other hand, have seen good inflows in this month till date as investors and asset allocation funds move more money to equities seeing the markets at attractive levels,” Mahesh Patil, CO CIO Equities, Aditya Birla Sun Life Mutual Fund told Moneycontrol.

“However, if the lockdown is prolonged and the impact on the economy is much more severe, the savings will get impacted and the domestic flows could slow down,” he said.

If we look at the historical data, they have been mostly net buyers in the last 10 years in April. FIIs were net buyers of equities worth nearly Rs 20,000 crore in April 2019, followed by Rs 9,700 crore inflows in April 2010, and Rs 8,702 crore inflows recorded in April 2015.

On the other hand, mutual funds were mostly net sellers in the last ten years in the month of April. They pulled out more than Rs 5,000 crore in April 2019, followed by Rs 2,600 crore selloff in April 2014, and over Rs 1,600 crore in April 2010.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/last-10-year-data-suggests-april-belongs-to-bulls-will-2020-be-different-5099601.html
21,"April 03, 2020 09:47 AM IST",-1,Rakesh Patil,Bajaj Auto share price slips over 3%on weak March sales number,"Bajaj Auto share price slipped over 3 percent in the early trade on April 3 after the company reported weak sales for March 2020.
Domestic sales fell by 55 percent at 1,16,541 units against 2,59,185 units, while exports were down 6 percent at 1,26,034 units versus 1,34,166 units, year on year.
At 0924 hours, Bajaj Auto was quoting at Rs 1,993.50, down Rs 58.40, or 2.85 percent, on the BSE.
The share touched its 52-week high of Rs 3,315 February 3, 2020 and 52-week low of Rs 1,793.10 on March 24, 2020.
It is trading 40.07 percent below its 52-week high and 10.79 percent above its 52-week low.","Domestic sales of the company fell by 55 percent at 1,16,541 units against 2,59,185 units.","Bajaj Auto share price slipped over 3 percent in the early trade on April 3 after the company reported weak sales for March 2020.

The company's March sales were down 38 percent at 2,42,575 units against 3,93,351 vehicles in the year-ago period.

Domestic sales fell by 55 percent at 1,16,541 units against 2,59,185 units, while exports were down 6 percent at 1,26,034 units versus 1,34,166 units, year on year.

At 0924 hours, Bajaj Auto was quoting at Rs 1,993.50, down Rs 58.40, or 2.85 percent, on the BSE.

The share touched its 52-week high of Rs 3,315 February 3, 2020 and 52-week low of Rs 1,793.10 on March 24, 2020.

It is trading 40.07 percent below its 52-week high and 10.79 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/bajaj-auto-share-price-slips-over-3on-weak-march-sales-number-5103701.html
23,"April 03, 2020 12:00 PM IST",0,Sandip Das,"D-Street Buzz: Nifty Pharma outperforms led by Cipla, Lupin; ICICI Bank, Kotak Bank drag","Bank Nifty was down over 3 percent dragged by RBL Bank which tanked over 9 percent followed by ICICI Bank, IndusInd Bank, Kotak Mahindra Bank, State Bank of India, Bandhan Bank and Axis Bank.
Emkay Global Financial Services is of the view that Kotak Mahindra Bank has built a reasonably strong deposit franchisee, with its CASA at an industry high of 54%.
The other gainers included Lupin, Sun Pharma, Torrent Pharma, Biocon and Dr Reddy's Labs.
The top gainers included Sun Pharma, Mahindra & Mahindra, ONGC, ITC and Bajaj Finance while the top losers included IndusInd Bank, Kotak Mahindra Bank, ICICI Bank, Titan Company and Asian Paints.
The most active stocks included Reliance Industries, HDFC Bank, Bajaj Finance, ICICI Bank and Axis Bank.","The most active stocks included Reliance Industries, HDFC Bank, Bajaj Finance, ICICI Bank and Axis Bank.","COVID-19 continues to create havoc globally with stock markets continuing to remain under pressure. Sensex is down 453.93 points or 1.61 percent at 27811.38, and the Nifty shed 123.50 points or 1.5 percent at 8130.30.

All sectoral indices barring the pharma index are trading in the red. Banks along with the metal index fell the most down 3 percent each.

Bank Nifty was down over 3 percent dragged by RBL Bank which tanked over 9 percent followed by ICICI Bank, IndusInd Bank, Kotak Mahindra Bank, State Bank of India, Bandhan Bank and Axis Bank.

Emkay Global Financial Services is of the view that Kotak Mahindra Bank has built a reasonably strong deposit franchisee, with its CASA at an industry high of 54%. The deposit base remained largely disrupted and steady even as some peers faced a fall in deposits. It also cut its saving deposit rate in select buckets to protect NIMs. It has retained a hold rating with target of Rs 1290.

Metal stocks are also under pressure. The top losers included JSW Steel, Tata Steel, Jindal Steel & Power, Hindalco Industries, Coal India and NALCO.

Nifty Pharma is the outperforming sector, up over 4 percent led by Cipla which jumped 7 percent after the drug maker announced completion of Phase-3 clinical study for generic fluticasone propionate and salmeterol inhalation powder.

The other gainers included Lupin, Sun Pharma, Torrent Pharma, Biocon and Dr Reddy's Labs.

Global Research firm Morgan Stanley has a buy on Sun Pharma with target of Rs 449 per share and a buy on Lupin with target of Rs 761 per share. It upgraded Cipla to overweight on strong franchise and steady earnings growth outlook, a CNBC-TV18 report said.

India VIX fell 5.18 percent and was trading at 56.94 level.

The top gainers included Sun Pharma, Mahindra & Mahindra, ONGC, ITC and Bajaj Finance while the top losers included IndusInd Bank, Kotak Mahindra Bank, ICICI Bank, Titan Company and Asian Paints.

155 stocks hit 52-week low on BSE including RBL Bank, TVS Motor, PVR, JSW Steel, Phoenix Mills, Tata Power, Bharat Forge, Eicher Motors and Sun TV Network among others.

The most active stocks included Reliance Industries, HDFC Bank, Bajaj Finance, ICICI Bank and Axis Bank.

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-nifty-pharma-outperforms-led-by-cipla-lupin-icici-bank-kotak-bank-drag-5104011.html
24,"April 03, 2020 12:21 PM IST",1,Kshitij Anand,"'Asian Paints, Britannia may become the biggest wealth creators after COVID-19'","In the near-term, the market may reverse from a sharp bounce led by huge fiscal and monetary measures announced.
These measures will not be able to pick-up the economy in the short-term unless we see successful lockdown and reduction in the spread of COVID-19.
This stock market trend will continue to be challenging if the risk of recession remains after the 21-day lockdown.
Don’t be lured by low prices like new lows, 52-week low or a bounce in price during such consolidation period.
The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.",We had suggested increasing the mix of quality mid & small cap at the start of the year based on a promising outlook for 2020. This is unlikely to happen soon as the economy will have to bear a recession.,"Focus on domestic-oriented companies, businesses that stay safe and flourish during and after challenges. Solid business model and brands which are leaders in industry, products or niche segment, Vinod Nair, Head of Research at Geojit Financial Services, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Q) After an unforgettable March, do you think markets will be able to bounce back given the measures introduced by the govt?

A) To bounce back we need to see the number of infected cases coming down. In the near-term, the market may reverse from a sharp bounce led by huge fiscal and monetary measures announced.

These measures will not be able to pick-up the economy in the short-term unless we see successful lockdown and reduction in the spread of COVID-19.

A) The data suggests that we have entered a recession phase and the stock prices have factored that. This stock market trend will continue to be challenging if the risk of recession remains after the 21-day lockdown.

If the lockdown of 21-Days in India becomes successful and the domestic market opens then the second half of April will be promising. At the same time, recovery from a global lockdown will be encouraging.

A) Assuming that this health problem will be around more than three months, the total size of the fiscal, as well as monetary stimulus, is good enough as it accounts to about 4 percent of India's GDP.

The scheme has factored free food, an increase in cash in hand, job safety, loan, and various steps. The RBI announced monetary stimulus to increase financial liquidity and reduce risk in the system by providing a huge cut in interest rate and cash reserve ratio, moratorium and working capital interest deferment for three months, OMO and other relaxation which will provide liquidity of 3.2 percent of GDP, which is massive.

At the same time, the global economy needs to recover in those three months, else we are in a challenging situation.

A) This will be positive for defensive and staple business like FMCG, given the support to the rural and semi-rural economy. Banks will also benefit from the relaxation in the classification of NPA, higher incomes and reduction in interest cost. In general, any business that focuses on the domestic economy will benefit.

A) Here is a list of top three stocks which could turn out to be the biggest wealth creators:

Business operations are largely domestic and on account of the sharp fall in crude oil prices, the cost of the key raw materials has come down which would result in a significant improvement in margins for paint companies.

Furthermore, the companies are likely to pass the benefit to customers to set the brush for a revival in demand. Rising urbanisation and the government's stimulus measures will help to increase demand in the long term.

The packaged food (biscuit) industry is currently facing supply chain issues rather than demand issues due to lock down on account of COVID-19 pandemic.

Once the situation stabilises, we believe Britannia would be one of the major beneficiary considering the factors such as essential food category products, negligible dependence on exports (6%), strong distribution network (55 lakh outlets), negligible debt (D/E of 0.04x) & good cash position (Rs850 crore as on FY19) and strong return ratios (RoE of 24% and RoCE of 29% as on FY19).

It is at a sweet spot with almost no balance sheet stress unlike its competitors with good asset quality, lower exposure to stressed corporate lenders and low NPA below 0.5. Strong digital capabilities and high exposure in semi-urban and rural segments to add profitability once the economy is back to normalcy with CAR of 18.5.

A) Focus on domestic-oriented companies, businesses that stay safe and flourish during and after challenges. Solid business model and brands which are leaders in industry, products or niche segment.

Healthy track record of existence and ability to flourish under any cycle of the economy. Solid cash flow generation and lucrative dividend pay-out. A healthy balance sheet with zero/negligible net-debt.

Credible management, no pledging and strong shareholding of recognised institutions. Attractive valuation and parameters like business growth, margin, RoE, and RoI.

A) We had suggested increasing the mix of quality mid and smallcap at the start of the year based on a promising outlook for 2020. This is unlikely to happen anytime soon as the economy will have to suffer a recession.

Given the change in view, we suggest allocation of 30 percent for top private banks, top NBFCs and PSUB (not more than 5 finance stocks). The next 25 percent should be on consumption, chemicals and pharma.

Rest could be stock specific with a focus on IT, companies with management credentials, clean fundamentals, dividend history and a healthy business outlook with leadership qualities. Spread your investment in time, stocks and sectors.

Stick with quality stocks having leadership in sector, products or niche segment. Don’t be lured by low prices like new lows, 52-week low or a bounce in price during such consolidation period. Capitulation is not an opportunity to buy any type of stock.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/asian-paints-britannia-may-become-the-biggest-wealth-creators-after-covid-19-5100461.html
0,"March 31, 2020 02:42 PM IST",1,Rakesh Patil,Cyient share price rises nearly 7% on clearance to produce medical equipment for COVID-19,"Cyient share price rose nearly 7 percent intraday on March 31 after the company received clearance to produce medical equipment that is critical in the fight against COVID-19.
The company has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19, company said in a press release.
The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India, it added.
“We are proud to support our customers in the healthcare industry at this critical time.
At 14:19 hrs, Cyient was quoting at Rs 228.90, up Rs 11.35, or 5.22 percent on the BSE.",The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India,"Cyient share price rose nearly 7 percent intraday on March 31 after the company received clearance to produce medical equipment that is critical in the fight against COVID-19.

The company has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19, company said in a press release.

The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India, it added.

Cyient’s factory in Mysore, India, is dedicated to electronic manufacturing processes, including printed circuit board assemblies, cable harnesses, and box-builds that closely align with its core competence in electronic systems design, integration, and manufacturing services.

“We are proud to support our customers in the healthcare industry at this critical time. We will continue to do everything we can to help reduce the impact of this crisis on our customers’ operations as they focus on delivering the technology needed to fight Covid-19 at a national and global level,” said Rajendra Velagapudi, Senior Vice President and CEO, Cyient DLM.

At 14:19 hrs, Cyient was quoting at Rs 228.90, up Rs 11.35, or 5.22 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/cyient-share-price-rises-nearly-7-on-clearance-to-produce-medical-equipment-for-covid-19-5091401.html
1,"March 31, 2020 01:36 PM IST",0,Sunil Matkar,"Kotak upgrades these 2 auto battery makers, says replacement demand not priced yet","Kotak Institutional Equities has upgraded automobile battery manufacturers Exide Industries and Amara Raja Batteries to 'buy'.
""We expect near-term demand scenario to remain challenging for Amara Raja Batteries and Exide Industries given the 21-day nationwide lockdown the country is under.
However, we believe Amara Raja and Exide Industries are well-placed to recover some part of lost revenues as replacement demand will likely come back post the lockdown,"" said Kotak.
Automotive replacement segment forms 38-49 percent of total revenues and 55-70 percent of EBITDA for Exide and Amara Raja respectively.
Kotak believes the company will be able to retain most of the lower lead prices in the replacement segment, which will aid gross margins in the near-term.",Kotak slashed its price target for Amara Raja to Rs 650 (from Rs 780 earlier) and Exide Industries to Rs 165 (from Rs 180) due to cut in EPS estimates amid COVID-19-led impact.,"Kotak Institutional Equities has upgraded automobile battery manufacturers Exide Industries and Amara Raja Batteries to 'buy'.

The brokerage believes steep correction in the stock prices does not factor in the steady nature of automotive replacement demand.

Amara Raja shares rallied 8.5 percent and Exide Industries gained 4.3 percent on March 31, after falling 44 percent and 38 percent respectively in last more than two months due to coronavirus-led sell-off.

Also, the COVID-19 forced the government to announced 21-day lockdown last week, which will have a major impact on earnings of these companies.

""We expect near-term demand scenario to remain challenging for Amara Raja Batteries and Exide Industries given the 21-day nationwide lockdown the country is under. However, we believe Amara Raja and Exide Industries are well-placed to recover some part of lost revenues as replacement demand will likely come back post the lockdown,"" said Kotak.

Automotive replacement segment forms 38-49 percent of total revenues and 55-70 percent of EBITDA for Exide and Amara Raja respectively. Even during the 2008 global crisis, both Amara Raja and Exide Industries gross revenues grew by 17 percent YoY in FY2009 and 7 percent YoY in FY2010 mainly led by strong auto replacement segment demand.

""Also, organized players like Amara Raja and Exide Industries with strong balance sheets are benefitting from gaining market share from the unorganized segment,"" said the brokerage.

Hence, Kotak expects Amara Raja revenues to grow by 5 percent CAGR over FY2019-22 led by (1) 7-10 percent revenue CAGR in 2-wheeler and 4-wheeler replacement segment, (2) 13 percent revenue CAGR in e-rickshaw segment and (3) 5 percent revenue CAGR in railways segments.

In case of Exide Industries, the brokerage expects revenues to grow by 1 percent CAGR over FY2019-22 led by (1) 3-8 percent revenue CAGR in 2W and 4W replacement segment, (2) 12 percent revenue CAGR in the submarine and e-rickshaw segment and (3) 3 percent revenue CAGR in UPS segment.

However, Kotak slashed its price target for Amara Raja to Rs 650 (from Rs 780 earlier) and Exide Industries to Rs 165 (from Rs 180) due to cut in EPS estimates amid COVID-19-led impact.

The brokerage has cut Amara Raja's FY2021-22 EPS estimates by 13-16 percent led by (1) 10-12 percent cut in revenue growth assumptions mainly in the OEM and industrial segments and (2) 20-30 bps cut in EBITDA margin assumptions.

It has cut Exide Industries' FY2021-22 EPS estimates by 7-20 percent led by (1) 10-12 percent cut in revenue growth assumptions mainly in OEM and industrial segments and (2) 100 bps cut in EBITDA margin assumptions.

Kotak has reduced its EBITDA margin assumptions for Amara Raja by 20-30 bps and Exide Industries by 50-100 bps only over FY2020-22E due to (1) duopoly nature of the industry with high pricing power in the replacement segment (B2C business), which has a fragmented customer base and (2) steep decline in lead prices over the past three months given global growth concerns on account of coronavirus pandemic offset by negative operating leverage.

Lead prices have corrected by 10 percent YoY (in USD terms) and 7 percent YoY (in INR terms) in Q4FY20.

Kotak believes the company will be able to retain most of the lower lead prices in the replacement segment, which will aid gross margins in the near-term.

Amara Raja Batteries was up Rs 33.35 or 7.40 percent at Rs 483.90 and Exide Industries gained Rs 3.95 or 3.11 percent at Rs 130.80 on the BSE at 1306 hours IST.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/kotak-upgrades-these-2-auto-battery-makers-says-replacement-demand-not-priced-yet-5091071.html
2,"March 31, 2020 12:44 PM IST",-1,Nishant Kumar,"COVID-19 impact | Bumpy ride for autos; Hero Moto, M&M and Bajaj Auto top picks","Brokerages highlight that the industry sales volumes are down nearly 16 percent so far in FY20.
With half of March slated to be a washout, the quarter is another poor one,"" said ICICI Direct.
ICICI Direct expects industry volumes to decline sharply (nearly 40-50 percent) in Q1FY21E amid plant closures, accounting for at least two months of subnormal operations (one month of complete closure i.e.
Among ancillaries, ICICI Direct has a 'buy' rating to Exide Industries and 'hold' ratings to Apollo Tyres and Bharat Forge.
Tata Motors, Eicher Motors and Hero MotoCorp are its top picks from the sector.","SIAM's estimates had shown the present suspension of production activities at OEMs and ancillaries would cost the industry nearly Rs 2,300 crore per day in lost revenues, as per ICICI Direct report.","The domestic auto industry is going through a rough patch. The outbreak of COVID-19 will hit India's already struggling automobile sector significantly and brokerages warn that the sector may take longer than expected to recover from the blow.

Brokerages highlight that the industry sales volumes are down nearly 16 percent so far in FY20. The auto industry was readying for the transition for the upcoming switchover to BS-VI norms with effect from April 1, 2020, that needed intense deliberation and strategising in areas related to products, pricing, production & inventory management. The outbreak of coronavirus has come as a serious blow.

A report by brokerage firm ICICI Direct stated that SIAM's (Society of Indian Automobile Manufacturers) estimates had shown the present suspension of production activities at OEMs and ancillaries would cost the industry nearly Rs 2,300 crore per day in lost revenues.

""Q4FY20 (till March 15) was witness to production rationalisation at most OEMs as the focus remained firmly on the rundown of BS-IV stock. With half of March slated to be a washout, the quarter is another poor one,"" said ICICI Direct.

ICICI Direct expects industry volumes to decline sharply (nearly 40-50 percent) in Q1FY21E amid plant closures, accounting for at least two months of subnormal operations (one month of complete closure i.e. April 2020 and corresponding one month of gradual resumption of work i.e. May 2020).

""Our reworked estimates bake in another year of de-growth at the industry level in FY21E (-5 percent), after adjusting for some pent up recovery in the second half of FY21E. We see meaningful growth returning to the industry only in FY22E post normalisation of BS-VI environment, expected uptick in economic activity and consumer spending and build in nearly 10 percent volume increase for that year,"" ICICI Direct said.

For the latest updates, click here

As per the estimates of the brokerage firm Motilal Oswal Financial Services, in March 2020, wholesale volumes are estimated to decline nearly 37 percent, 40 percent and 68 percent year-on-year (YoY) for 2Ws, PVs and CVs, respectively, due to lockdown and BS-VI transition. Tractors volumes are expected to decline by about 16 percent YoY.

The stocks are now available at cheaper valuations and brokerages see it as an opportunity to buy quality stocks from the sector.

""Valuations appear attractive but given the uncertain macro environment and the threat of possible prolonged impact of coronavirus, we prefer stocks offering higher visibility of demand recovery, better competitive positioning, the scope of higher operating leverage and strong balance sheet,"" said Motilal Oswal.

As per Edelweiss Securities, after the sharp correction in stock prices, valuations have turned favourable despite the near-term uncertainty as the structural story is intact (demand as well as free cash flow generation) and pricing discipline will ensure benefits of easing commodities will be retained.

Stock recommendations from the sector

ICICI Direct said at this juncture, its preference from the sector are those business models that are capital efficient in nature (RoE, RoCE of more than 15 percent), possess healthy balance sheet (debt: equity less than 0.5 times) and are more domestic (India) centric in nature.

""We maintain our view that these businesses remain better placed to navigate the current downturn effectively and emerge stronger from it, leaving themselves primed for eventual recovery down the road. Among OEMs, we have valuation comfort and assign 'buy' ratings to Hero MotoCorp, Mahindra & Mahindra, Bajaj Auto and Ashok Leyland while assigning 'hold' rating to Maruti Suzuki, Tata Motors, Eicher Motors and Escorts,"" ICICI Direct said.

Among ancillaries, ICICI Direct has a 'buy' rating to Exide Industries and 'hold' ratings to Apollo Tyres and Bharat Forge.

Edelweiss Securities said it preferred stocks which have, or can have, strong product cycle and margin tailwinds.

Tata Motors, Eicher Motors and Hero MotoCorp are its top picks from the sector.

""We prefer Tata Motors which is a ‘buy’, as it is on the cusp of a strong product cycle. Moreover, the recent GBP depreciation will favour the company as it has a higher exposure to China and can benefit from its revival,"" Edelweiss said.

""Hero MotoCorp is a play on rural demand with attractive valuations. However, our structural concerns on its ability to gain market share in scooters, premium motorcycles and export persist,"" said Edelweiss.

""Eicher Motors' new product cycle can catapult, not only domestic volumes but also exports,"" said Edelweiss.

Follow our full coverage on coronavirus here

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-impact-bumpy-ride-for-autos-hero-moto-mm-and-bajaj-auto-top-picks-5086701.html
3,"March 31, 2020 10:17 AM IST",1,Sandip Das,"'Market still in bear grip; short-covering rally may take Nifty towards 8,960'","Moreover, a sustained trade below 8,260 could drag the index lower to levels of 8,080 and 7,800.
On the flip side, a trade beyond 8,450 can activate short-covering rallies taking Nifty higher to levels of 8,740 and 8,960.
Further, a sustained trade below Rs 313 may drag it lower to levels of Rs 280-265.
Tech Mahindra:On the weekly chart, Tech Mahindra has turned northwards after taking support at a major upward sloping trendline.
The stock may be bought in the range of Rs 526-529 for targets of Rs 565-590, keeping a stop loss below Rs 500.",A sustained trade below 8260 could drag the Index lower to levels of 8080 and 7800. On the flip side a trade beyond 8450 can activate short covering rallies taking Nifty higher to levels of 8740 and 8960.,"Aditya Agarwala

Nifty resumed its corrective wave following four days of pullback rally within a gigantic downtrend. Further, it is on the verge of a breakdown from a trend line support which could trigger expanded corrections suggesting that the bears are still controlling the market.

Moreover, a sustained trade below 8,260 could drag the index lower to levels of 8,080 and 7,800. On the flip side, a trade beyond 8,450 can activate short-covering rallies taking Nifty higher to levels of 8,740 and 8,960.

However, ADX indicator has risen above the Negative DI indicator which suggests that the selling has reached extreme oversold zone and VIX has also been cooling off from the peak of 86.64 indicating that wild volatile swings may halt.

ICICI Bank:

On the daily chart, ICICI Bank has broken down from a bearish flag pattern resuming its downward journey. Further, a sustained trade below Rs 313 may drag it lower to levels of Rs 280-265. Further, on the weekly chart, it is facing stiff resistance at the 200-WMA (weekly moving average) and has also broken down from trendline support confirming weakness.

Technical indicators are also favoring the bears. The stock may be sold in the range of Rs 317-314 for targets of Rs 280-265, keeping a stop loss above Rs 345.

Titan Company:

On the weekly chart, Titan Company has turned upwards after taking support at the previous swing low of Rs 732 which also happened to be the GAP support area formed in 2017 which is yet to be filled. Further, on the daily chart, it is trading back above its short term moving average i.e. 5-DMA after March 6, 2020 indicating intermediate bullishness. Moreover, it has also taken support at the 23.6 percent Fibonacci retracement level suggesting bullishness.

RSI has turned northward from the support zone of 30 which is favoring the bulls. The stock may be bought in the range of Rs 944-950 for targets of Rs 1050-1100, keeping a stop loss below Rs 880.

Tech Mahindra:

On the weekly chart, Tech Mahindra has turned northwards after taking support at a major upward sloping trendline. Further, it also took support at the 78.6 percent Fibonacci retracement level of the previous up move suggesting that bulls are supporting at the support zone.

On the daily chart, it has formed a bullish Engulfing pattern after a sustained downtrend and is also trading back above its 5-DMA. Further, RSI has formed a positive divergence which favors the bullish view developing currently. The stock may be bought in the range of Rs 526-529 for targets of Rs 565-590, keeping a stop loss below Rs 500.

The author is Senior Technical Analyst - Institutional Equities at YES Securities

: The views and investment tips expressed by investment expert on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/market-still-in-bear-grip-short-covering-rally-may-take-nifty-towards-8960-5089881.html
4,"March 31, 2020 10:49 AM IST",-2,Nishant Kumar,"IndusInd Bank deposits shrink by 10-11%, brokerages see tough road ahead","Some reduction in wholesale, possibly attributable to stock price fall is also a reason behind the fall in deposits.
We have enhanced a deposit category by 25 bps to accelerate this,"" IndusInd Bank said.
The stock price has corrected steeply in recent days, owing to concerns about asset quality and strength of funding franchise.
IIFL believes this will force IndusInd Bank to cut back growth and impact NIMs.
ICICI Securities has a “buy” recommendation on IndusInd Bank but with a target price of Rs 1,268 against Rs 1,796 earlier.","Some reduction in wholesale, possibly attributable to stock price fall is also a reason behind the fall in deposits.","Shares of IndusInd Bank hit 15 percent lower circuit at Rs 349.85 in the early trade on BSE on March 31, a day after the private lender said its deposits were down by around 11 percent.

Of the total fall in deposits since Q3FY20, 70 percent was through state government deposits and 30 percent was via corporate deposits.

""Deposits fell 10-11 percent and almost two-third of reduction is on account of government-related accounts – this is largely related to general private sector bank stance. This will also result in lower CASA ratio, but reduce our dependency on this category for deposits in future,"" IndusInd Bank said in a regulatory filing on BSE on March 30.

Some reduction in wholesale, possibly attributable to stock price fall is also a reason behind the fall in deposits. The retail reduction is least, the bank said and claimed that deposits are more stable and flows recommenced while NIMs are also expected to remain stable.

""Deposit traction will rebuild in April. The bank has an aggressive deposit retailisation strategy in place. LCR-based retail deposit base growing more than 40 percent, significantly ahead of peers. We have enhanced a deposit category by 25 bps to accelerate this,"" IndusInd Bank said.

The stock price has corrected steeply in recent days, owing to concerns about asset quality and strength of funding franchise.

The coronavirus outbreak has further impacted growth and asset-quality prospects in the select business segments.

Tough road ahead

The bank said it has replaced the bulk of these deposits by CDs and borrowings. This, as per brokerage firm Emkay Global, should inch up funding cost in the near-term, weighing in on margins.

Besides, the brokerage said the bank plans to focus on retail deposits (via expanding branches), which will take time to build and thus credit growth will be calibrated, tracking deposit momentum and not vice versa, as it happened in the past.

""The bank has seen deterioration in asset quality due to corporate slippage, which we believe will accelerate after the recent lockdown, led by stress in retail and SME and some lumpy corporate stress (for e.g., Vodafone). Thus, we build in higher NPAs at 3.1 percent/LLP (loan loss provision) at 170 bps in FY21E,"" Emkay Global said.

The bank plans to rebalance its book towards consumer banking, which should lead to margin or RoA expansion in the long run, Emkay said.

The bank has said cards, personal loans, real estate and loan against property (LAP) are showing early signs of disruption, while diamond and CV portfolios are well-tested across cycles with higher customer vintage and should bounce back as normalcy returns.

Moreover, the bank believes that the RBI moratorium of three months should help manage this temporary disruption unless the situation worsens.

Emkay Global said that near-term growth and asset quality pain will weigh on stock performance, but the new MD’s strategy to focus on retailisation of assets and liabilities should help the bank in the long run.

The brokerage has a “buy” recommendation on the stock, with a revised target price of Rs 630, valuing the bank at 1.1 times FY21E ABV/1 time FY22E ABV. Emkay said the key risks to its call are higher-than-expected NPA formation and a further deceleration in loan growth.

Brokerage firm Motilal Oswal Financial Services, too, has a “buy” on the stock, with a target price of Rs 800.

""We estimate credit cost to remain elevated over the next few quarters while lower our business growth assumptions. We thus cut our FY20 and FY21 earnings by 13 percent and 22 percent, respectively, and estimate the bank to deliver FY21E RoA and RoE of 1.7 percent and 14.3 percent, respectively. We reduce our target price to Rs 800 which corresponds to 1.3 times forward ABV,"" Motilal Oswal said.

IIFL Securities, too, has a “buy” call on the stock, with a target price of Rs 650.

IIFL said that while the fall in deposits has been replaced by other sources, it exposes the bank’s tight liquidity situation.

IIFL believes this will force IndusInd Bank to cut back growth and impact NIMs. IndusInd is in the process of accelerating stressed-asset recognition and provisions too.

""Given this and the Covid-19 related impact, we downgrade profits by 6.5/26/14 percent for FY20/21/22ii, respectively. We believe IndusInd Bank would trade at 1 time FY22ii BVPS due to uncertain growth and profitability outlook for now,"" IIFL Securities said.

ICICI Securities has a “buy” recommendation on IndusInd Bank but with a target price of Rs 1,268 against Rs 1,796 earlier.

""Despite some concerns on stressed telecom account, higher vehicle book and uncertainty around COVID-19, we believe IndusInd Bank is a good value proposition given it is trading at 0.9 timrs P/ABV FY21E,"" ICICI Securities said.

ICICI said the impact on asset quality may be for a short term. However, it will be important to track borrowers' behaviour after the completion of moratorium period, it said. As per the brokerage, working capital loans and unsecured loans like personal loans and credit cards are at higher risk of default.

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/indusind-bank-deposits-shrink-by-10-11-brokerages-see-tough-road-ahead-5090091.html
5,"March 31, 2020 10:28 AM IST",1,Sandip Das,"Lupin share price jumps 3% after Morgan Stanley's overweight call, raises target to Rs 948/sh","Share price of pharmaceutical company Lupin was up 3 percent intraday on March 31 after Morgan Stanley initiated an overweight call on the stock with target of Rs 948 per share.
Brokarage firm Motilal Oswal has a buy rating on the stock with target at Rs 815.
It has upgraded Lupin to outperform from sell and raised the target to Rs 660 from Rs 600 per share.
The stock was quoting at Rs 576.90, up Rs 16.80, or 3 percent.
It has touched an intraday high of Rs 589.00 and an intraday low of Rs 568.90.","Broking firms Morgan Stanley, CLSA and Motilal Oswal have a bullish stance on the stock with target up to Rs 948 per share.","Share price of pharmaceutical company Lupin was up 3 percent intraday on March 31 after Morgan Stanley initiated an overweight call on the stock with target of Rs 948 per share.

Lupin received an establishment inspection report from the US drug regulator. The company received the EIR for its Inhalation Research Center located at Coral Springs, Florida. The facility was inspected by the Food and Drug Administration between February 19, 2020 and February 26, 2020 on behalf of the UK Medicines and Healthcare products Regulatory Agency for Lupin’s generic Fostair application to the UK regulator.

""The receipt of the EIR with satisfactory VAI status validates our commitment towards ensuring the highest levels of quality and CGMP compliance at all our sites,"" said Vinita Gupta, CEO of Lupin.

Brokarage firm Motilal Oswal has a buy rating on the stock with target at Rs 815. While near-term outlook may be subdued, the broking house remain positive on the company due to limited price erosion in the base business, robust ANDA pipeline and better-than-industry growth in branded domestic formulation (DF).

It expect 23 percent earnings CAGR over FY19-22E, led by limited competition products in US generics and improved operating leverage in the DF segment.

Broking house CLSA has reiterated its bullishness on the pharma space. According to CLSA, the pharma earnings are relatively secure in a market rife with fear of a slowdown as the pharma offers stable revenue/profit streams from a secure domestic market. It has upgraded Lupin to outperform from sell and raised the target to Rs 660 from Rs 600 per share.

The stock was quoting at Rs 576.90, up Rs 16.80, or 3 percent. It has touched an intraday high of Rs 589.00 and an intraday low of Rs 568.90. It was trading with volumes of 22,432 shares, compared to its five day average of 174,696 shares, a decrease of -87.16 percent.

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/lupin-share-price-jumps-3-after-morgan-stanleys-overweight-call-raises-target-to-rs-948sh-5090001.html
6,"March 31, 2020 10:41 AM IST",1,Kshitij Anand,"HDFC Bank, ITC among 10 stocks that could benefit from stimulus package","According to Emkay Global, the lockdown of the nature we are going through should shave off Rs 2.3 lakh crore from GDP every week it is continued.
We spoke to various experts and collated a list of stocks that are likely to benefit the most from the stimulus package announced by the govt.
Expert: ICICIdirectHDFC Bank:HDFC Bank has efficiently focused on retail business and has garnered strong liability franchise to yield superior profitability over the years.
Such high CASA limits the cost of funds and thereby enables to report of superior NIM above 4 percent consistently.
The same has safeguarded the bank from NPA issues faced by the industry in recent fiscals.",Experts feel that the coming few months are expected to be difficult as all financial markets have witnessed a swift meltdown thereby opening up opportunities for long term investors to dip in.,"The Finance Minister and the Reserve Bank of India (RBI) last week unleashed a slew of measures to cushion the impact of the economic slowdown caused by the COVID-19 outbreak.

Indian market which is now in the bear phase will find it difficult to get back on its feet in the near to medium term but stock-specific action is likely to continue.

Within a couple of days of the announcement of the 21-day lockdown across the country, the govt. and the RBI have made some major announcements to cushion the impact of the economic crash.

Various economists and analysts suggest that the COVID-19 outbreak will significantly impact the Indian economy. UBS forecasts India's GDP growth could be 2.5 percent, while in a more severe pandemic scenario it could be negative, at -0.2 percent on a YoY basis in FY21.

According to Emkay Global, the lockdown of the nature we are going through should shave off Rs 2.3 lakh crore from GDP every week it is continued.

“Although the govt's Rs1.7-lakh crore package (0.83% of GDP) addresses some of the most basic issues, it pales in comparison with both the scale of the problem and what is being done by other countries,” it said.

The noteworthy measures include free food grains and pulses, cash transfers to widows, elderly and women, and free LPG for three months.

Indeed, the RBI's announcement of loan moratorium should be seen as a logistically faster and more efficient way of alleviating immediate cash flow needs of the economy – but coming at the cost of banks’ profitability.

Experts feel that the coming few months are expected to be difficult to navigate as global trade has dwindled and all financial markets have witnessed a swift meltdown thereby opening up opportunities for long term investors to dip in.

“On a historical basis, we believe broader markets have coincided with long term averages currently, which does not surely indicate a bottom. However, at the same time it has started throwing up opportunities in the large-cap/midcap space,” ICICIdirect said in a report.

“In the current milieu, some of the large and best-managed companies are available at attractive valuations on a historical basis. Hence, in our view, one should venture out and accumulate companies, which have gone through such challenging cycles and have come out much stronger when such events subside,” the report added.

We spoke to various experts and collated a list of stocks that are likely to benefit the most from the stimulus package announced by the govt. & stocks which could offer stable returns:

Expert: Naveen Kulkarni, Chief Investment Officer, Axis Securities Limited

Bharti Airtel:

The need for telecommunication has increased significantly because of lockdowns. The revenues in the prepaid segment could be impacted as daily wage earners may not recharge their phone but data consumption will increase further.

Thus the overall revenue and earnings impact will be limited. Thus, a good time to accumulate telecom stocks.

TCS:

It is the largest IT company that has solid cash balance and developed countries are likely to come out of lockdowns ahead of India. While order flows will reduce but rupee depreciation could help.

RBI's significant rate cut means that rupee is more likely to depreciate further. Thus TCS is a good defensive bet in this market.

Expert: ICICIdirect

HDFC Bank:

HDFC Bank has efficiently focused on retail business and has garnered strong liability franchise to yield superior profitability over the years. Seasoned portfolio and management experience led to higher than industry advances growth at 24 percent CAGR in FY08-19.

Advances were at Rs 9.3 lakh crore as of December 2019, with major traction towards the retail book. Enriched customer experience, a strong network of 5345 branches and a focus on digitisation has enabled building a strong liability franchise with CASA comprising 40 percent of deposits.

Such high CASA limits the cost of funds and thereby enables to report of superior NIM above 4 percent consistently. Prudent asset quality has been core to the bank. The same has safeguarded the bank from NPA issues faced by the industry in recent fiscals.

Kotak Mahindra Bank:",https://www.moneycontrol.com/news/business/markets/hdfc-bank-itc-among-10-stocks-that-could-benefit-from-stimulus-package-5086581.html
7,"March 31, 2020 11:32 AM IST",1,Rakesh Patil,Reliance share price gains 4% even as Credit Suisse cuts target price,"Reliance Industries share price rose over 4 percent intraday on March 31 even as foreign research house Credit Suisse cuts the target price.
Credit Suisse has maintained neutral rating and cut target to Rs 1,150 from Rs 1,400 per share, reported CNBC-TV18.
At 10:52 hrs Reliance Industries was quoting at Rs 1,069.20, up Rs 36.85, or 3.57 percent on the BSE.
The share touched its 52-week high Rs 1,617.80 and 52-week low Rs 875.70 on 20 December, 2019 and 23 March, 2020, respectively.
Currently, it is trading 34.02 percent below its 52-week high and 21.9 percent above its 52-week low.","Research house do not expect a material recovery in refining margins, while it build in lower margin for the retail segment too.","Reliance Industries share price rose over 4 percent intraday on March 31 even as foreign research house Credit Suisse cuts the target price.

Credit Suisse has maintained neutral rating and cut target to Rs 1,150 from Rs 1,400 per share, reported CNBC-TV18.

It has also cut FY21/FY22 EPS by 11 percent/5 percent, while expecting the refining demand to be weak for the next two quarters.

Research house does not expect a material recovery in refining margins, while it build in lower margin for the retail segment too.

For Jio, the next round of price increase to be delayed to H2FY21, it added.

At 10:52 hrs Reliance Industries was quoting at Rs 1,069.20, up Rs 36.85, or 3.57 percent on the BSE.

The share touched its 52-week high Rs 1,617.80 and 52-week low Rs 875.70 on 20 December, 2019 and 23 March, 2020, respectively.

Currently, it is trading 34.02 percent below its 52-week high and 21.9 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/reliance-share-price-gains-4-even-as-credit-suisse-cuts-target-price-5090331.html
8,"April 01, 2020 07:02 AM IST",2,Nishant Kumar,"Hot Stocks | CESC, HUL, Nestle can give up to 16% return in short term","The Nifty reclaimed 8,575 this week after some lower-level buying was witnessed in heavyweights like Reliance Industries, HDFC twins and Infosys.
Traders can accumulate the stock in the Rs 400-410 range for the upside target of Rs 465 with a stop loss below Rs 365.
The V-shape recovery has been seen with marginally higher volumes, which suggests a further up move in the coming sessions as well.
Traders can accumulate the stock in the Rs 2,270-2,290 range for the upside target of Rs 2,670 with a stop loss below Rs 2,050.
Traders can accumulate the stock on dips in the range of Rs 15,850-15,700 for the upside target of Rs 18,370 with a stop loss below Rs 14,000.","The Nifty reclaimed 8,575 this week after some lower-level buying was witnessed in heavyweights like Reliance Industries, HDFC twins and Infosys.","Shitij Gandhi

After witnessing a steep cut in the previous session, the Indian market bounced back sharply on March 31, tracking firm global markets.

The Nifty reclaimed 8,575 this week after some lower-level buying was witnessed in heavyweights like Reliance Industries, HDFC twins and Infosys.

However, on the technical front, the Nifty and the Nifty Bank indices are still trading in a bearish channel and on the higher side, 8,800-9,000 zone for the Nifty while 19,500-20,000 zone for the Bank Nifty should act as a strong hurdle.

On the derivatives front, put writers were seen adding open interest at 8,400 and 8,500 strikes, which should provide some support to the market.

Till then, we can expect some stock-specific action along with some volatility in a broader range of 8,400-9,000 in the coming few sessions.

Here are three stock recommendations for the next 3-4 weeks:

CESC | Buy | LTP: Rs 407 | Target price: Rs 465 | Stop loss: Rs 365 | Upside: 14 percent

For the last two months, the stock has been beaten down as the prices have witnessed a sharp fall from Rs 700 towards Rs 370 levels.

On the technical front, however, the stock has tested its 200-day exponential moving average on monthly charts and bounced back sharply to reclaim above-Rs 400 level in a week’s time.

At the current juncture, some consolidation can be seen from the last four-five sessions and also the stock has formed a Doji star pattern on the daily charts.

The secondary oscillators are suggesting a bounce into the prices, as the stock has also given a breakout above the falling trendline of a sloping channel on a shorter timeframe.

Traders can accumulate the stock in the Rs 400-410 range for the upside target of Rs 465 with a stop loss below Rs 365.

Hindustan Unilever (HUL) | Buy | LTP: Rs 2,298.50 | Target price: Rs 2,670 | Stop loss: Rs 2,050 | Upside: 16 percent

After witnessing a steep fall from Rs 2,250 to Rs 1,800, the stock saw a V-shape recovery and made a new 52-week high on March 31.

The stock has once again surpassed its short and long-term moving averages on broader charts as well, with some long build-up into the prices.

The V-shape recovery has been seen with marginally higher volumes, which suggests a further up move in the coming sessions as well.

Traders can accumulate the stock in the Rs 2,270-2,290 range for the upside target of Rs 2,670 with a stop loss below Rs 2,050.

Nestle India | Buy | LTP: Rs 16,272.95 | Target price: Rs 18,370 | Stop loss: Rs 14,000 | Upside: 13 percent

In recent weeks, this stock has also given almost a V-shape recovery after testing 100-day exponential moving average on the weekly charts.

Despite the weak market sentiment, the stock has shown strength from the lower levels as recovery was seen with some heavy volumes, which suggests long build-up into the prices.

At the current juncture, however, the stock is facing immediate resistance at Rs 16,800 but positive divergences on secondary oscillators suggest that the stock can move beyond its 52-week high of Rs 16,835 in the coming sessions.

Traders can accumulate the stock on dips in the range of Rs 15,850-15,700 for the upside target of Rs 18,370 with a stop loss below Rs 14,000.

(The author is Senior Technical Analyst at SMC Global Securities)

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-cesc-hul-nestle-can-give-up-to-16-return-in-short-term-5092851.html
9,"March 31, 2020 01:54 PM IST",-2,Kshitij Anand,COVID-19 impact: Consumer durable sector face earnings downgrades,"After three good years of healthy double-digit growth, the past 2–3 quarters have been one of deceleration led by slowing infra and weakening disposable income profiles in the consumer durable sector.
For FY21, it expects lower growth across segment vis-à-vis their respective long-term growth rates).
Growth across players has come off over the past few quarters barring cooling products, reflecting the impact of weak infra, lower retail demand and deteriorating distribution channel health.
The recent stock correction to some extent factor near term earnings disruption from COVID-19 and valuation correction has been in line with broader indices.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.","Edelweiss slashed earnings by 9–18 percent for stocks in their coverage. It remains positive on Amber Enterprises which was recently added to the model portfolio along with KEI Industries, and Voltas.","After three good years of healthy double-digit growth, the past 2–3 quarters have been one of deceleration led by slowing infra and weakening disposable income profiles in the consumer durable sector.

The COVID-19-led disruption will add to sector woes since: i) channel appetite is already low; ii) infra spend outlook for FY21 remains subdued; and iii) weaker retail off-take implies consensus estimates are at risk, Edelweiss Securities said in a report.

The report also suggests that large players are trading at rich valuations. For FY21, it expects lower growth across segment vis-à-vis their respective long-term growth rates).

The brokerage firm slashed earnings by 9–18 percent for stocks in their coverage. It remains positive on Amber Enterprises which was recently added to the model portfolio along with KEI Industries, and Voltas.

Growth across players has come off over the past few quarters barring cooling products, reflecting the impact of weak infra, lower retail demand and deteriorating distribution channel health.

Top-line growth, particularly in electrical segments (excluding large appliances) has tapered to 6 percent (Q3FY20) which is lower than the five-year CAGR of 12 percent, said the report.

The recent stock correction to some extent factor near term earnings disruption from COVID-19 and valuation correction has been in line with broader indices.

But, the current scenario, in contrast, poses multiple challenges, implying a more enduring effect on demand potentially extending to medium term (12-18 months).

“It is possible that rich valuations do pose challenges as most stocks in the coverage are still trading at mid-cycle/lower end of the peak cycle. Only a few possess levers to outperform in a tough demand outlook,” said the report.

Out of the coverage universe, Edelweiss Securities reiterated their conviction for: a) Voltas - sustained leadership in RACs and potential to scale up the refrigerator business (JV), b) KEI - earnings growth resilience and balance sheet discipline.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-impact-consumer-durable-sector-face-earnings-downgrades-5086931.html
10,"April 01, 2020 10:49 AM IST",0,Rakesh Patil,"Maruti Suzuki March sales at 83,792 units","The four-wheelers manufacturer Maruti Suzuki India has sold 83,792 units in the month of March 2020.
Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.
The company ended FY 2019-20 with total sales of 15,63,297 units.
Maruti Suzuki remains committed to the safety and well-being of its employees, business partners and customers.
At 10:33 hrs, Maruti Suzuki India was quoting at Rs 4,349.30, up Rs 61.55, or 1.44 percent.","The company ended FY 2019-20 with total sales of 15,63,297 units.","The four-wheelers manufacturer Maruti Suzuki India has sold 83,792 units in the month of March 2020.

The company had sold 1,58,076 units in March 2019.

The sales during March 2020 are not comparable with sales in March 2019 due to the suspension of operations with effect from March 22nd 2020, in line with national policy, said the company in a release.

Total sales include 76,976 units in the domestic market, 2,104 units of domestic OEM sales and 4,712 units of exports.

The company ended FY 2019-20 with total sales of 15,63,297 units.

Maruti Suzuki remains committed to the safety and well-being of its employees, business partners and customers. The company will continue to support Government at the Centre and State levels and follow all advisories in combating COVID-19, it added.

At 10:33 hrs, Maruti Suzuki India was quoting at Rs 4,349.30, up Rs 61.55, or 1.44 percent.",https://www.moneycontrol.com/news/business/stocks/maruti-suzuki-march-sales-at-83792-units-5094561.html
11,"April 01, 2020 11:00 AM IST",-2,Kshitij Anand,Most Nifty companies hit 52-week low in March amid COVID-19 fall; should you buy?,"Nifty is down about 30 percent from its recent record high of 12,430 hit on January 20, and about 90 percent of the companies hit their 52-week low in March.
As many as 45 companies out of Nifty50 have hit their multi-year low amid the mayhem caused by the outbreak of COVID-19 virus across the globe.
Most of the companies which are part of the index are bluechip names and are leaders of their respective sectors.
With the recent fall seen in the markets, many of the blue-chip names are trading at multi-year lows.
Moneycontrol spoke to experts on this and they said, not all stocks which have hit their 52-week lows are long term buys, but only a select few.","Positions in quality stocks can be made in a staggered manner keeping in view the risk profile of investor(s) in order to avoid opportunity loss, suggest experts.","Nifty is down about 30 percent from its recent record high of 12,430 hit on January 20, and about 90 percent of the companies hit their 52-week low in March.

As many as 45 companies out of Nifty50 have hit their multi-year low amid the mayhem caused by the outbreak of COVID-19 virus across the globe. Foreign institutional investors (FIIs) have alone pulled out more than Rs 60,000 cr from the cash segment of the Indian equity market in March alone.

Stocks that have hit their fresh 52-week low in March include prominent names like Shree Cement, Eicher Motors, Bajaj Finserv, Maruti Suzuki, UltraTech Cements, Bajaj Finance, TCS, and Hero MotoCorp, according to data collated on March 27.

Most of the companies which are part of the index are bluechip names and are leaders of their respective sectors. With the recent fall seen in the markets, many of the blue-chip names are trading at multi-year lows.

The question now is – are these stocks good long-term buys? Moneycontrol spoke to experts on this and they said, not all stocks which have hit their 52-week lows are long term buys, but only a select few.

Some of the stocks which are going through a turmoil are due to structural or industry-specific issues, hence, it does make sense to avoid while some of them are under pressure due to institutional selling.

It makes a valid case for investors who are looking at an investment horizon of 2-3 years. Because the volatility is likely to continue amid the Coronavirus outbreak at least till the time a medically approved vaccine comes to light.

“Investor, looking to build long term portfolio, can start investing in blue chips companies such as Reliance Industries, HDFC twins, Bajaj finance, Asian paints, Colgate, Britannia, Dabur, L&T, Axis Bank, Titan, Cipla, Infosys and TCS which are available at a reasonable valuation,” Ajit Mishra, VP Research, Religare Broking told Moneycontrol.

“Though we do not rule out further downside in the stock price due to on-going virus concern and its impact on the economy, we would advise buying these fundamentally sound stocks in a phased manner for healthy returns over the next 2-3 years,” he said.

Experts do advise caution on the part of investors before making a buy or a sell decision. Positions in quality stocks can be made in a staggered manner keeping in view the risk profile of investor(s) in order to avoid opportunity loss, suggest experts.

“Markets are in grip of risk aversion due to the spread of coronavirus pandemic. Though the stocks have corrected significantly from their highs, the uncertainty involved in the markets has not abated given the escalation of new cases and causalities due to the virus esp. in the US and Europe,” Pankaj Bobade, Fundamental Research head, Axis Securities Limited told Moneycontrol.

“If one has more than 3 years of investment horizon, one can look at investing in the corrected blue chips in staggered manner thereby averaging the cost of acquisition,” he said.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/most-nifty-companies-hit-52-week-low-in-march-amid-covid-19-fall-should-you-buy-5090171.html
13,"March 31, 2020 11:43 AM IST",1,Sunil Matkar,L&T share price gains 3% after Credit Suisse upgrades stock to 'outperform',"The share price of Larsen & Toubro (L&T) gained 2.73 percent intraday on March 31 after Credit Suisse upgraded the stock to “outperform” from “neutral”, CNBC-TV18 reported.
The stock has fallen 42 percent in the last two months due to weak market conditions and spiralling coronavirus cases.
Credit Suisse, however, cut the price target on the stock to Rs 1,100 from Rs 1,325 per share as engineering, procurement and construction (EPC) and macro risks remained pertinent.
The stock trading below 10x on lower earnings can be the worst-case scenario, it feels.
The stock was trading at Rs 800.45, up Rs 1.80, or 0.23 percent, on the NSE at 1108 hours.",Credit Suisse revised its earnings estimates lower by (3.4)/(16.3)/(17.2) percent for FY20/21/22.,"The share price of Larsen & Toubro (L&T) gained 2.73 percent intraday on March 31 after Credit Suisse upgraded the stock to “outperform” from “neutral”, CNBC-TV18 reported.

""The risk-reward turned favourable with bottom valuations on stress case earnings,"" the brokerage said.

The stock has fallen 42 percent in the last two months due to weak market conditions and spiralling coronavirus cases.

Credit Suisse, however, cut the price target on the stock to Rs 1,100 from Rs 1,325 per share as engineering, procurement and construction (EPC) and macro risks remained pertinent.

It revised its earnings estimates lower by (3.4)/(16.3)/(17.2) percent for FY20/21/22. The stock trading below 10x on lower earnings can be the worst-case scenario, it feels.

The stock was trading at Rs 800.45, up Rs 1.80, or 0.23 percent, on the NSE at 1108 hours.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/lt-share-price-gains-3-after-credit-suisse-upgrades-stock-to-outperform-5090471.html
14,"March 31, 2020 11:09 AM IST",0,Sandip Das,"Oil & gas stocks rally after crude oil prices hit 18-year low; Morgan Stanley bullish on HPCL, BPCL","Sensex is up 740.96 points or 2.61 percent at 29,181.28, and the Nifty jumped 224.80 points or 2.71 percent at 8.505.90.
Global crude oil prices have plunged to their lowest level since 2002, an 18-year low on heightened fears that the global coronavirus shutdown could last months and demand for fuel could decline further.
The fall in oil prices has a positive impact on oil & gas stocks.
Nifty Energy jumped over 3 percent led by gains from Reliance Industries which jumped 4 percent followed by BPCL, GAIL India, HPCL, Indian Oil Corporation and ONGC which added 3-5 percent.
Morgan Stanley said both Hindustan Petroleum Corporation (HPCL) and Bharat Petroleum Corporation (BPCL) were its top picks.","Nifty Energy jumped over 3 percent led by gains from Reliance Industries which jumped 4 percent followed by BPCL, GAIL India, HPCL, Indian Oil Corporation and ONGC which added 3-5 percent.","Indian stock market is trading in the green tracking its Asian peers. Sensex is up 740.96 points or 2.61 percent at 29,181.28, and the Nifty jumped 224.80 points or 2.71 percent at 8.505.90.

Global crude oil prices have plunged to their lowest level since 2002, an 18-year low on heightened fears that the global coronavirus shutdown could last months and demand for fuel could decline further.

Data provider Genscape reported that US stockpiles at Cushing in Oklahoma rose more than 4 million barrels last week, which was the biggest one week increase in more than 10 years. With Saudi Arabia and Russia set to flood the market with oil next month, producers and shippers have been scrambling to lock oil up in storage as demand falls due to the coronavirus pandemic, a Reuters report said.

Brent futures fell USD 2.43, or 9.8 percent, to USD 22.50 a barrel by 10:40 a.m. EDT while US West Texas Intermediate (WTI) crude fell USD 1.22, or 5.7 percent, to USD 20.29.

The fall in oil prices has a positive impact on oil & gas stocks. Nifty Energy jumped over 3 percent led by gains from Reliance Industries which jumped 4 percent followed by BPCL, GAIL India, HPCL, Indian Oil Corporation and ONGC which added 3-5 percent.

Morgan Stanley said both Hindustan Petroleum Corporation (HPCL) and Bharat Petroleum Corporation (BPCL) were its top picks. ""We see significant tailwinds for refiners beyond the challenges of the shutdown. Hence we have overweight rating on IOC, BPCL and HPCL,"" said the global brokerage. However, the lockdown would result in a 6-9 percent impact to FY21 earnings, it added.

According to a report by ICICIdirect, lower demand of all kinds of fuels amid Coronavirus outbreak are expected to impact Q4FY20E, FY21E earnings of companies. A decline in stock prices presents investors with a buying opportunity. We prefer CGD companies and selective OMCs in our coverage. CGD companies are a structural play on increasing gas demand, favourable government policies and competitive price advantage against competing fuels.

The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/oil-morgan-stanley-bullish-on-hpcl-bpcl-5090191.html
15,"April 01, 2020 09:28 AM IST",-2,Kshitij Anand,Investors lose over Rs 30 lakh cr in March; 43 stocks in BSE 500 fall over 50%,"Relentless selling by foreign investors in March shaved off more than Rs 30 lakh crore of investor wealth in a single month.
The S&P BSE Sensex and the Nifty50 fell about 23 percent each to post their worst fall since October 2008.
Investors lost more than Rs 33 lakh crore in a single month as the average market capitalisation of BSE-listed companies fell from Rs 146.87 lakh cr on Feb 28 to Rs 113.48 recorded on March 31.
As many as 43 stocks in the BSE500 index fell over 50 percent in the month of March.
They have announced relief measures worth Rs 1.7 lakh crore targeted to the low-income segment,” Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC told Moneycontrol.",Stocks that shaved off more than half of their value include names like Dish Tv India and AU Small Finance Bank,"Indian market hit a wall in March as fears over rising cases of coronavirus threatened to push the global economy into a recessionary phase. Relentless selling by foreign investors in March shaved off more than Rs 30 lakh crore of investor wealth in a single month.

This is probably one month that investors would like to strike off from the calendar. Many mutual fund investors saw their portfolios lose value every single day.

The S&P BSE Sensex and the Nifty50 fell about 23 percent each to post their worst fall since October 2008. Investors lost more than Rs 33 lakh crore in a single month as the average market capitalisation of BSE-listed companies fell from Rs 146.87 lakh cr on Feb 28 to Rs 113.48 recorded on March 31.

The large part of the fall was led by consistent selling by foreign investors who have pulled out more than Rs 60,000 crore from Indian equity markets from the cash segment so far in March, provisional data showed.

With 21 days of lockdown in India and a complete halt of economic activity across the globe due to rising cases of COVID-19 has fueled fears of economic recession, one of its worst seen in the last 150 years.

In an exclusive interview with CNBC-Tv18, former IMF chief economist Kenneth Rogoff said that “We are going to have a giant recession this year. The depth of the recession will be lot large at the high end of the 100 worst recessions the whole world has experienced in the last 150 years,” he said.

In tandem with the global markets, D-Street witnessed one of its worst month in the last 12 years. More than 90 percent of the Nifty50 stocks hit a fresh 52-week low or multi-year lows in the same period.

However, the bigger carnage was seen in individual stocks. As many as 43 stocks in the BSE500 index fell over 50 percent in the month of March.

Stocks that shaved off more than half of their value include names like Dish Tv India, AU Small Finance Bank, KPIT Technologies, Repco Home, Ujjivan Financial, Welspun Corp, IndusInd Bank, and Future Retail.

As many as 28 out of 30 index components in the S&P BSE Sensex gave negative returns in March. Out of 28 stocks, 15 of them fell 24-70 percent underperforming the index that fell 23 percent in March.

Stocks that fell 24-70 percent include names like Tech Mahindra, HDFC Ltd, Titan Company, Bajaj Auto, SBI, Bajaj Finance, Axis Bank, and IndusInd Bank.

Sectoral Return (%):

Relief measures from Govt:

To battle the pandemic, the Indian government along with the Reserve Bank of India (RBI) have unleashed slew of measures to cushion the slowdown caused by the lockdown in the country for 21-Days, however, experts feel that more such measured could come in to support the economy.

“The Indian government is tackling the COVID-19 situation in a step-by-step manner. The government has already announced a 21-day lockdown in an attempt to stop the spread of the virus. They have announced relief measures worth Rs 1.7 lakh crore targeted to the low-income segment,” Mahesh Patil, CIO – Equity, Aditya Birla Sun Life AMC told Moneycontrol.

“Overall, these measures should give some confidence to investors that India should be able to contain the virus sooner rather than later. However, in comparison to other economies like US, Europe and China, where a very large stimulus of almost 8-10% of GDP has been announced, we need to do more,” he said.

The RBI also reduced rates by 75 bps, announced measures which will enhance liquidity in the system by 3.7 lakh crore, as well as a moratorium on loan and interest payments which should provide relief to a large swath of the population.

What should investors do?

Well, it looks like markets have factored in the worst, going by experts. But, if cases related to Coronavirus escalate the Nifty could retest the recent swing low of 7,511 recorded on March 24.

In case we breach 7511 in April the possibility of further decline towards 7300, and 7000 looks likely, but the current scenario is a good opportunity for long term investors to build a portfolio.

“The data suggests that we are in a recession for CY2020 and the stock prices has factored that. This stock market trend will continue to be challenging if the risk of recession is expanding even post lockdown,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol.

“If the lockdown of 21days in India becomes successful and the domestic market opens then the second part of April will be promising. At the same time recovery from global lockdown will be encouraging,” he said.

Sameer Paul, MD & CEO, Trustplutus suggests that investors should stick to large-cap stocks which are most liquid since there is a real risk that many mid and small-cap companies could become illiquid in the coming months. Liquidity at the bottom of the markets is always at a premium.

""Currently there is a bottom at a place at around 7,500 on the Nifty. At 7,500 selling abated and there was some buying witnessed across the board. However, markets have the tendency to retest the previous lows which investors should be careful about,"" he said.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/investors-lose-over-rs-30-lakh-cr-in-march-43-stocks-in-bse-500-fall-over-50-5093231.html
17,"March 31, 2020 01:16 PM IST",2,Sunil Matkar,"Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19","Cadila Healthcare and Ipca Labs are prominent manufacturers of HCQs and chloroquine in India.
""The US Food and Drug Administration has limited its authorisation to drugs supplied from strategic national stockpile,"" Morgan Stanley said, adding both drugs had shown activity in laboratory studies against coronavirus.
""Clinical trials are needed to provide evidence that these treatments are effective and Federal agencies are working together to plan clinical trials.""
Two US medical bodies -- the National Institutes of Health and the Biomedical Advanced Research and Development Authority -- are working to plan such trials.
Ipca Labs was trading at Rs 1,345, up Rs 46.95, or 3.62 percent, and Cadila Healthcare was up Rs 6.70, or 2.66 percent, at Rs 258.80 on the BSE at 1143 hours IST.",Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.,"The share price of Cadila Healthcare rallied 3.65 percent and that of Ipca Labs 8.8 percent intraday on March 31 after the US health regulator issued Emergency Use Authorisation (EUA) for hydroxychloroquine (HCQS) and chloroquine for COVID-19, CNBC-TV18 quoted Morgan Stanley as saying.

Cadila Healthcare and Ipca Labs are prominent manufacturers of HCQs and chloroquine in India. Both are antimalarial drugs.

""The US Food and Drug Administration has limited its authorisation to drugs supplied from strategic national stockpile,"" Morgan Stanley said, adding both drugs had shown activity in laboratory studies against coronavirus.

""Clinical trials are needed to provide evidence that these treatments are effective and Federal agencies are working together to plan clinical trials.""

In a statement published on March 29, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile, including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.

It said the FDA had allowed them ""to be distributed and prescribed by doctors to hospitalised teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.""

US Presient Donald Trump said last week that the two drugs could be a ""gift from God"", despite scientists warning against the dangers of overhyping unproven treatments.

Many researchers including Anthony Fauci, the United States' leading infectious disease expert, have urged the public to remain cautious until larger clinical trials validate smaller studies.

Two US medical bodies -- the National Institutes of Health and the Biomedical Advanced Research and Development Authority -- are working to plan such trials.

The US has more than 160, 700 cases, the highest in the world, and more than 3,000 people have died, according Johns Hopkins University. Global infections have crossed 786,000 and more than 37,000 people have died.

Ipca Labs was trading at Rs 1,345, up Rs 46.95, or 3.62 percent, and Cadila Healthcare was up Rs 6.70, or 2.66 percent, at Rs 258.80 on the BSE at 1143 hours IST.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

(With inputs from PTI)",https://www.moneycontrol.com/news/business/markets/cadila-ipca-gain-4-9-after-us-allows-emergency-use-of-antimalarial-drugs-for-covid-19-5090871.html
18,"April 01, 2020 10:06 AM IST",1,Kshitij Anand,"Gold price today: Yellow metal eases amid profit booking; sell for a target of 42,450","India Gold June Futures witnessed profit-taking at higher levels on April 1 extending the decline for the fourth consecutive session.
Experts feel that in the short term, traders could look at shorting the metal for a target of 42,450.
On the Multi Commodity Exchange (MCX), June gold contracts were trading lower by 222, or 0.52 percent, at Rs 42,734 per 10 gram at 09:30 hours.
“Moreover, any breakdown below 43000 can take prices to 42600-42200 levels where upside resistance is at 43100-42400 levels.
Intraday strategy: Gold June Sell in the range of 43000-43020 with 43200 as stop loss and target of 42450 levels,” she said.","Experts feel that in the short term traders could look at shorting the metal for a target of 42,450.","India Gold June Futures witnessed profit-taking at higher levels on April 1 extending the decline for the fourth consecutive session. Experts feel that in the short term, traders could look at shorting the metal for a target of 42,450.

On the Multi Commodity Exchange (MCX), June gold contracts were trading lower by 222, or 0.52 percent, at Rs 42,734 per 10 gram at 09:30 hours. Silver futures on MCX gained 0.5 percent to Rs 39,729 per kg.

International Gold has given a breakdown below $1600 level after a four day of consolidation which is a sign for some exhaustion & correction can be expected.

On a quarterly basis, Gold has risen by about 4 percent in March quarter, largely on account of economic concerns after the COVID-19 outbreak.

From a technical perspective, $1580-$1555 holds strong support where upside $1595-$1622 will act as resistance which suggests gold may trade in a range of $1560-$1598 levels in the coming session, suggest experts.

“On the domestic front, MCX Gold June, on the hourly chart is trading below 20 as well as 50 Hourly Moving Averages which suggest a negative trend for short momentum,” Neha Qureshi, Technical Analyst, Reliance Commodities told Moneycontrol.

“Moreover, any breakdown below 43000 can take prices to 42600-42200 levels where upside resistance is at 43100-42400 levels. Intraday strategy: Gold June Sell in the range of 43000-43020 with 43200 as stop loss and target of 42450 levels,” she said.

Track live gold price here

Expert: Jateen Trivedi, Senior Research Analyst (Commodity & Currency), LKP Securities

On the daily chart, Gold prices traded weak, but witnessed its sixth straight quarter of gains. Yet, the upward trajectory of gold remains in question as volatility caps daily moves at above $1,600 an ounce and Russia moves from big buyer to possible seller of bullion.

Major moving average 20, 50, 100-Days EMA are suggesting positive trades. Overall, the trend remains positive till the time 39500 holds on a closing basis but volatile sessions will be seen with some profit booking on rallies.

For the day 43000-43150 will act as resistance whereas 42750-42500 as supports

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/gold-price-today-yellow-metal-eases-amid-profit-booking-sell-for-a-target-of-42450-5094381.html
19,"March 31, 2020 03:53 PM IST",2,Sunil Matkar,Bharti Airtel share price up 4% as Motilal Oswal sees 44% upside on strong ARPU,"Bharti Airtel share price gained 4 percent intraday on March 31, as Motilal Oswal retained a 'buy' call on likely strong average revenue per user (ARPU) which has not been captured in the stock price yet.
With physical recharges being unavailable, there has been a shift to digital recharges (from 15 percent in the last 1-2 years to 35-40 percent currently),"" said Motilal Oswal.
Against this, increased data consumption should see upgrades in recharge values, thus, mitigating the impact,"" said Motilal Oswal, which estimated 13/19 percent revenue growth in Q4FY20/Q1FY21, on QoQ basis.
According to Motilal Oswal, the sharp reduction in crude prices could result in revenue softness in the short term, particularly in Nigeria, Congo and Chad.
However, Motilal Oswal expects the potential restoration of the past era (2G) when telcos had the opportunity to monetize investments for a prolonged period.","Motilal Oswal sees limited impact of COVID-19, currency and crude price swings on the Bharti stock and believes that it is the best hedged to face regulatory woes.","Bharti Airtel share price gained 4 percent intraday on March 31, as Motilal Oswal retained a 'buy' call on likely strong average revenue per user (ARPU) which has not been captured in the stock price yet.

The stock has fallen around 20 percent from its peak following the coronavirus outbreak and the 21-day lockdown in India to check the spread of virus.

But, the impact of the outbreak and the currency and crude price swing would be limited, as the company was best hedged to face regulatory woes, it said.

""Given the complete lockdown in India due to COVID-19, net subscriber adds (average 2-3 months) have stalled thus impacted by 1-2 percent. With physical recharges being unavailable, there has been a shift to digital recharges (from 15 percent in the last 1-2 years to 35-40 percent currently),"" said Motilal Oswal.

""In the current environment, more tech-savvy data subscribers with higher ARPUs and longer-term recharges of 90 days may see lower impact. However, the rest of feature phone subscribers doing monthly recharges (one-third the ARPU of data subscribers) could see some marginal impact.""

To protect the low-income subscribers (80 million), Bharti had extended free incoming calls to April 17, with an additional Rs 10 talk time.

""This could impact Q1FY21 revenue/EBITDA by Rs 220/180 crore ie equivalent to meager 1-2 percent. Against this, increased data consumption should see upgrades in recharge values, thus, mitigating the impact,"" said Motilal Oswal, which estimated 13/19 percent revenue growth in Q4FY20/Q1FY21, on QoQ basis.

The brokerage said the sharp depreciation in the rupee against the dollar should increase Bharti's USD capex/debt and put some of its African business under stress. But it does not expect a meaningful impact.

The dollar denominated India capex by Bharti is around 30 percent. Thus, 10 percent rupee depreciation could have around 3 percent increase, the research firm said.

Similarly, around 28 percent of its debt is dollar denominated, while India debt is 15 percent.

According to Motilal Oswal, the sharp reduction in crude prices could result in revenue softness in the short term, particularly in Nigeria, Congo and Chad. However, Bharti's free cash flow (FCF) positive position and lower leverage should have limited impact, said the brokerage.

Bharti remained in a win-win situation, irrespective of the Supreme Court's outcome on Vodafone Idea's fortunes, it said.

The government has been pitching for a healthy telecom market (3 private and 1 PSU player), which accentuates the need for Vodafone to stay afloat.

However, Vodafone Idea's survival would require a sharp ARPU increase (potentially over 30 percent) along with a moratorium on payments to service its

regulatory and debt obligations, which could also benefit Bharti, Motilal Oswal said.

Even in the worst-case scenario of no government support on AGR dues, the brokerage, said Bharti's financial position was strong enough to withstand the storm, and in fact, could lead to significant market share gain at the cost of Vodafone Idea.

In either case, Bharti could deliver a marked rise in earnings, it said. ""We see potential increase of around 39 percent in FY22 EBITDA estimate to Rs 62,100 crore.""

Over the last decade, Bharti has been saddled with high capex, spectrum acquisition cost and depressed EBITDA, which suppressed its FCF.

However, Motilal Oswal expects the potential restoration of the past era (2G) when telcos had the opportunity to monetize investments for a prolonged period.

""With a large part of the heavy lifting toward 4G network in place, incremental capex should be in check, while EBITDA should see a marked improvement. This should provide an opportunity to deleverage the balance sheet. Subsequently, we expect FCF (post interest) to increase to over Rs 30,000 crore in FY22 (if EBITDA grows to Rs 62,100 crore) from Rs 2,500 crore in FY20 and negative in FY19,"" it said.

The stock ended the day at Rs 440.6, up Rs 11.35, or 2.64 percent, on the BSE.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/bharti-airtel-share-price-up-4-as-motilal-oswal-sees-44-upside-on-strong-arpu-5091841.html
20,"March 31, 2020 02:36 PM IST",2,Sandip Das,"D-Street Buzz: Metal stocks shine after rise in China factory activity; RIL, ITC, ONGC top gainers","The top gainers included Steel Authority of India which surged 14 percent hitting upper circuit of Rs 23.40 per share.
The other gainers included Tata Steel, Vedanta, Hindustan Copper, Hindalco Industries, Jindal Steel & Power, JSW Steel and NALCO.
On the other hand, 311 stocks hit lower circuit of BSE including Future Lifestyle Fashion, Future Retail and IIFL Holdings among others.
ONGC, ITC and Reliance Industries are the top gainers adding 6-7 percent each in the afternoon session while IndusInd Bank, Maruti Suzuki and Bajaj Finance are the top losers.
The most active shares included Bajaj Finance, Reliance Industries, HDFC, HDFC Bank and IndusInd Bank.",India VIX is down 9.88 and is trading at 64.79 level.,"Indian stock market continues trading in the green tracking its Asian peers. Sensex is up 1,137.71 points or 4.00% at 29578.03, and the Nifty up 342.50 points or 4.14% at 8623.60.

The Metal index jumped almost 6 percent after factory activity in China unexpectedly expanded in March after contracting sharply to a record low, official data showed.

China’s official manufacturing purchasing managers’ index (PMI) bounced to 52.0 in March, up from a record low of 35.7 in February.

The top gainers included Steel Authority of India which surged 14 percent hitting upper circuit of Rs 23.40 per share.

The other gainers included Tata Steel, Vedanta, Hindustan Copper, Hindalco Industries, Jindal Steel & Power, JSW Steel and NALCO.

292 stocks hit 52-week low on BSE including Future Lifestyle Fashion, Future Retail, Oberoi Realty, Bajaj Finance, Cummins India, M&M Financial Services, Apollo Hospitals, Havell India and City Union Bank among others.

On the other hand, 311 stocks hit lower circuit of BSE including Future Lifestyle Fashion, Future Retail and IIFL Holdings among others.

ONGC, ITC and Reliance Industries are the top gainers adding 6-7 percent each in the afternoon session while IndusInd Bank, Maruti Suzuki and Bajaj Finance are the top losers.

The most active shares included Bajaj Finance, Reliance Industries, HDFC, HDFC Bank and IndusInd Bank.

India VIX is down 9.88 and is trading at 64.79 level.

The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-metal-stocks-shine-after-rise-in-china-factory-activity-ril-itc-ongc-top-gainers-5091281.html
21,"March 31, 2020 08:16 AM IST",0,,COVID-19: How investors can put the market's deep correction and the occasional bear market rally to good use,"Investors should get out of weak positions taking advantage of a bear market rally and redeploy the cash in strong businesses that are likely to survive and grow once normalcy returns.
@moneycontrolcom Madhuchanda Dey",Investors should get out of weak positions taking advantage of a bear market rally and redeploy the cash in strong businesses that are likely to survive and grow once normalcy returns.,"Investors should get out of weak positions taking advantage of a bear market rally and redeploy the cash in strong businesses that are likely to survive and grow once normalcy returns.

@moneycontrolcom Madhuchanda Dey",https://www.moneycontrol.com/news/business/moneycontrol-research/covid-19-how-investors-can-put-to-good-use-the-markets-deep-correction-and-the-occasional-bear-market-rally-5089161.html
22,"March 31, 2020 11:02 AM IST",2,Sunil Matkar,Just Dial share price jumps 8% as Jefferies upgrades stock to 'buy',"The share price of Just Dial gained 8 percent intraday on March 31 after Jefferies upgraded the stock to ""buy"".
The company has Rs 235 per share of cash on balance sheet and clean history on the use of cash,"" said the global brokerage.
Just Dial has a reasonably robust business with 5.35 lakh paid campaigns, it added.
However, the brokerage cut the price target to Rs 430 from Rs 500 per share, as it cut EPS estimates over FY20-21.
The stock was trading at Rs 291.55, up Rs 11.35, or 4.05 percent, on the BSE at 1047 hours.","Just Dial has a reasonably robust business with 5.35 lakh paid campaigns, Jefferies has said.","The share price of Just Dial gained 8 percent intraday on March 31 after Jefferies upgraded the stock to ""buy"".

""We upgraded on the back of compelling valuation and favourable risk-reward. The company has Rs 235 per share of cash on balance sheet and clean history on the use of cash,"" said the global brokerage.

Just Dial has a reasonably robust business with 5.35 lakh paid campaigns, it added.

However, the brokerage cut the price target to Rs 430 from Rs 500 per share, as it cut EPS estimates over FY20-21.

The stock was trading at Rs 291.55, up Rs 11.35, or 4.05 percent, on the BSE at 1047 hours.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/just-dial-share-price-jumps-8-as-jefferies-upgrades-stock-to-buy-5090321.html
23,"March 31, 2020 09:55 AM IST",1,Rakesh Patil,Suzlon Energy share price locked at upper circuit after lenders approve resolution plan,"Suzlon Energy share price was locked at 5 percent upper circuit on March 31 after resolution plan was unanimously approved by the consortium of lenders.
State Bank of India, the lead bank of the consortium of lenders, conveyed that the resolution plan of the company and its certain identified subsidiaries was approved by it and subsequently circulated to the consortium of lenders, and which has been approved by 100% of lenders by value, and 100% of lenders by numbers, as per the release.
The company is working on finalising various definitive agreements with the lenders.
There were pending buy orders of 726,689 shares, with no sellers available.
At 09:19 hrs, Suzlon Energy was quoting at Rs 2.00, up Rs 0.09, or 4.71 percent.","There were pending buy orders of 726,689 shares, with no sellers available.","Suzlon Energy share price was locked at 5 percent upper circuit on March 31 after resolution plan was unanimously approved by the consortium of lenders.

State Bank of India, the lead bank of the consortium of lenders, conveyed that the resolution plan of the company and its certain identified subsidiaries was approved by it and subsequently circulated to the consortium of lenders, and which has been approved by 100% of lenders by value, and 100% of lenders by numbers, as per the release.

The company is working on finalising various definitive agreements with the lenders.

There were pending buy orders of 726,689 shares, with no sellers available.

At 09:19 hrs, Suzlon Energy was quoting at Rs 2.00, up Rs 0.09, or 4.71 percent.",https://www.moneycontrol.com/news/business/stocks/suzlon-energy-share-price-locked-at-upper-circuit-after-lenders-approve-resolution-plan-5089951.html
24,"April 01, 2020 09:50 AM IST",1,Rakesh Patil,Biocon share price rises nearly 5% on EIR for Malaysia facility,"Biocon share price rose nearly 5 percent intraday on April 1 after the company received an establishment inspection report (EIR) for its Malaysia facility.
The company's subsidiary Biocon Sdn Bhd has received the EIR from the US FDA for the pre-approval inspection (PAI) of its Insulins manufacturing facility in Malaysia, for Insulin Glargine, company said in a release.
""The closing of the USFDA inspection of Malaysia facility is an important milestone in our journey of developing Insulin Glargine for patients in the US.
Our Insulin Glargine (Semglee) application filed by our partner Mylan, with the USFDA under the 505(b)(2) NDA pathway, is currently under review,” said Company Spokesperson.
At 09:31 hrs, Biocon was quoting at Rs 283.45, up Rs 12.85, or 4.75 percent on the BSE.",Company's subsidiary Biocon Sdn Bhd has received the establishment inspection report (EIR) from the US FDA for the pre-approval inspection of the Malaysia facility.,"Biocon share price rose nearly 5 percent intraday on April 1 after the company received an establishment inspection report (EIR) for its Malaysia facility.

The company's subsidiary Biocon Sdn Bhd has received the EIR from the US FDA for the pre-approval inspection (PAI) of its Insulins manufacturing facility in Malaysia, for Insulin Glargine, company said in a release.

The inspection was conducted between February 10 and February 21, 2020.

The inspection has been closed with a VAI (Voluntary Action Indicated) classification in the EIR, for the three observations issued at the conclusion of the inspection in February 2020.

This is an endorsement of our commitment to global standards of quality and compliance, it added.

""The closing of the USFDA inspection of Malaysia facility is an important milestone in our journey of developing Insulin Glargine for patients in the US. Our Insulin Glargine (Semglee) application filed by our partner Mylan, with the USFDA under the 505(b)(2) NDA pathway, is currently under review,” said Company Spokesperson.

At 09:31 hrs, Biocon was quoting at Rs 283.45, up Rs 12.85, or 4.75 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/biocon-share-price-rises-nearly-5-on-eir-for-malaysia-facility-5094411.html
0,"March 30, 2020 09:57 AM IST",-1,Rakesh Patil,IDBI Bank share price falls 5% after it withdraws bond issue,"IDBI Bank share price fell nearly 5 percent after the company withdrew its bond issue worth Rs 1,000 crore.
The bank has withdrawn the issue of bonds due to sudden RBI Policy Rate cut, CRR cut, liquidity support and other measures announced causing significant fall in interest rates in the market, as per BSE release.
Earlier, the bank was decided to issue Basel III Compliant Tier 2 Bonds for an aggregate total issue size of Rs 1000 crore, with a base size of Rs SOO crore and a Green Shoe option to retain oversubscription up to Rs 500 crore.
At 09:28 hrs IDBI Bank was quoting at Rs 19.00, down Rs 0.70, or 3.55 percent on the BSE.
The share touched its 52-week high Rs 76.90 and 52-week low Rs 31.30 on April 2 and March 24, respectively.","The share touched its 52-week high Rs 76.90 and 52-week low Rs 31.30 on 02 April, 2019 and 24 March, 2020, respectively.","IDBI Bank share price fell nearly 5 percent after the company withdrew its bond issue worth Rs 1,000 crore.

The bank has withdrawn the issue of bonds due to sudden RBI Policy Rate cut, CRR cut, liquidity support and other measures announced causing significant fall in interest rates in the market, as per BSE release.

Earlier, the bank was decided to issue Basel III Compliant Tier 2 Bonds for an aggregate total issue size of Rs 1000 crore, with a base size of Rs SOO crore and a Green Shoe option to retain oversubscription up to Rs 500 crore.

At 09:28 hrs IDBI Bank was quoting at Rs 19.00, down Rs 0.70, or 3.55 percent on the BSE.

The share touched its 52-week high Rs 76.90 and 52-week low Rs 31.30 on April 2 and March 24, respectively.",https://www.moneycontrol.com/news/business/stocks/idbi-bank-share-price-falls-5-after-it-withdraws-bond-issue-5085781.html
1,"March 30, 2020 02:14 PM IST",-1,Rakesh Patil,"ABB India share price declines 3%; arm gets listed on BSE, NSE","ABB India share price declined over 3 percent intraday on March 30, the day its arm, ABB Power Products and Systems India Limited, listed on BSE and NSE.
The Indian arm of ABB’s power grids business announced its listing on the exchange as ABB Power Products and Systems India Limited, a press release said.
The company demerged from ABB India with effect from December 1, 2019.
ABB Power Products and Systems India Limited is the standalone legal entity of ABB’s Power Grids business in India.
""Our listing on the Indian stock exchanges is a sign of our commitment to continue delivering value for our customers and shareholders,"" said N Venu, Country Managing Director of ABB Power GridsAt 1355 hours, ABB India was quoting at Rs 838.00, down Rs 15.10, or 1.77 percent on the BSE.",ABB Power Products and Systems India Limited is the standalone legal entity of ABB’s Power Grids business in India.,"ABB India share price declined over 3 percent intraday on March 30, the day its arm, ABB Power Products and Systems India Limited, listed on BSE and NSE.

The Indian arm of ABB’s power grids business announced its listing on the exchange as ABB Power Products and Systems India Limited, a press release said.

The company demerged from ABB India with effect from December 1, 2019.

For the period of April to December 2019, the business had a revenue of Rs 3,231 crore, with a profit before exceptional items and tax of Rs 261 crore (PBT at Rs 221 crore).

ABB Power Products and Systems India Limited is the standalone legal entity of ABB’s Power Grids business in India.

""Our listing on the Indian stock exchanges is a sign of our commitment to continue delivering value for our customers and shareholders,"" said N Venu, Country Managing Director of ABB Power Grids

At 1355 hours, ABB India was quoting at Rs 838.00, down Rs 15.10, or 1.77 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/abb-india-share-price-declines-3-arm-gets-listed-on-bse-nse-5086911.html
2,"March 30, 2020 01:51 PM IST",1,Sunil Matkar,"BPCL, HPCL rally 3-4% as Morgan Stanley sees tailwinds for refiners","Hindustan Petroleum Corporation (HPCL) and Bharat Petroleum Corporation (BPCL) rallied 2.6 percent and 3.7 percent, respectively, intraday on March 30 after Morgan Stanley said both were its top picks.
Hence we have overweight rating on IOC, BPCL and HPCL,"" said the global brokerage.
Morgan Stanley though cut its price target on IOC to Rs 127 (from Rs 136 per share), BPCL to Rs 517 (from Rs 550) and HPCL to Rs 246 (from Rs 283).
The fall in oil prices was a major supportive factor for refiners as it is the raw material for them.
HPCL was trading 0.47 percent higher at Rs 170.60, BPCL up 1.56 percent at Rs 283.25 and IOC up 0.26 percent at Rs 77.15 on the BSE at 13.30 hours IST.",Overall oil prices corrected nearly 68 percent from its 2020 highs seen in early January.,"Hindustan Petroleum Corporation (HPCL) and Bharat Petroleum Corporation (BPCL) rallied 2.6 percent and 3.7 percent, respectively, intraday on March 30 after Morgan Stanley said both were its top picks. IOC also gained 1.75 percent.

""We see significant tailwinds for refiners beyond the challenges of the shutdown. Hence we have overweight rating on IOC, BPCL and HPCL,"" said the global brokerage.

However, the lockdown would result in a 6-9 percent impact to FY21 earnings, it added.

Morgan Stanley though cut its price target on IOC to Rs 127 (from Rs 136 per share), BPCL to Rs 517 (from Rs 550) and HPCL to Rs 246 (from Rs 283).

The fall in oil prices was a major supportive factor for refiners as it is the raw material for them. International benchmark Brent crude futures dropped 8.7 percent to $22.76 a barrel today, the lowest level since October 2002.

Oil prices have corrected nearly 68 percent from its 2020 highs seen in early January.

HPCL was trading 0.47 percent higher at Rs 170.60, BPCL up 1.56 percent at Rs 283.25 and IOC up 0.26 percent at Rs 77.15 on the BSE at 13.30 hours IST.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/bpcl-hpcl-rally-3-4-as-morgan-stanley-sees-tailwinds-for-refiners-5086821.html
3,"March 30, 2020 02:37 PM IST",1,Kshitij Anand,"Nifty target at 10,000 by March, FY21 earnings growth seen at 2%: UBS","“Our revised Nifty target is 10,000 for end-March 2021, with upside and downside scenarios of 11,500 and 6,000, respectively,” he said.
UBS’s global macro team forecasts global GDP growth to tumble to -0.5 percent on a YoY basis, and are looking for 20-25 percent QoQ annualised declines in Q2 for a large number of economies.
Our India economist expects India's GDP growth of 4 percent for FY21.
In terms of earnings, UBS is of the view that a broad-based earnings cycle recovery over the next one to three years is clearly pushed out, with a more material near-term downside.
Our new top-down earnings growth forecasts for the Nifty are 8% for FY20, 2% for FY21, and 21% for FY22,” said the report.","In terms of earnings, UBS is of the view that a broad-based earnings cycle recovery over the next one to three years is clearly pushed out, with a more material near-term downside.","Indian market has plunged below its crucial support levels in a matter of just 2 months amid COVID-19 outbreak hurting supply chain, earnings of companies, as well as economies across the globe.

The Nifty has already corrected 37 percent since 17 January, compared to 35 percent for Global Emerging Markets and 30 percent for Asia, but the risk-to-reward ratio has turned attractive now.

India’s COVID-19 response measures have arguably been proactive, even as the number of officially confirmed cases has remained low, UBS Securities India said in a report.

“The fall in the markets reflects concerns around India’s high population density and relatively weak health infrastructure. From a market perspective, risk-reward appears attractive for India, but only if we presume the negative impact of COVID-19 is short-lived and not crippling,” Gautam Chhaochharia, Analyst, UBS Securities India Pvt. Ltd said in a report.

“Our revised Nifty target is 10,000 for end-March 2021, with upside and downside scenarios of 11,500 and 6,000, respectively,” he said.

UBS’s global macro team forecasts global GDP growth to tumble to -0.5 percent on a YoY basis, and are looking for 20-25 percent QoQ annualised declines in Q2 for a large number of economies.

Our India economist expects India's GDP growth of 4 percent for FY21. In an intermediate pandemic scenario (disruptions last until June), GDP growth could be 2.5 percent, while in a more severe pandemic scenario it could be negative, at -0.2 percent on a YoY basis.

In terms of earnings, UBS is of the view that a broad-based earnings cycle recovery over the next one to three years is clearly pushed out, with a more material near-term downside.

“In our Four Keys framework, policy retains near-term upside potential, but there could be a sharper downtick in the credit cycle before an uptick. Our new top-down earnings growth forecasts for the Nifty are 8% for FY20, 2% for FY21, and 21% for FY22,” said the report.

Given stimulus measures taken by the governments’ globally, markets have been waiting for policy stimulus, in vain until now. During the global financial crisis (GFC), India’s fiscal deficit expanded by 4.4 percent of GDP and news flow suggests 0.7 percent of GDP may be likely in this crisis.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/nifty-target-at-10000-by-march-fy21-earnings-growth-seen-at-2-ubs-5085951.html
4,"March 30, 2020 11:32 AM IST",1,Rakesh Patil,Cadila Healthcare share price rises over 2% on USFDA approval to Zydus for Parkinson's drug,"Cadila Healthcare share price rose over 2 percent intraday on March 30 after Zydus Cadila received tentative USFDA approval to market Carbidopa and Levodopa Extended-Release Capsules used for the treatment of Parkinson’s disease.
Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, as per release.
The drug will be manufactured at the group’s manufacturing facility at SEZ, AhmedabadThis combination medication is indicated for use in the treatment of Parkinsons or Parkinson-like symptoms (such as shakiness, stiffness, and difficulty moving).
The group now has 282 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.
At 11:00 hrs Cadila Healthcare was quoting at Rs 254.00, up Rs 1.20, or 0.47 percent on the BSE.","The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.","Cadila Healthcare share price rose over 2 percent intraday on March 30 after Zydus Cadila received tentative USFDA approval to market Carbidopa and Levodopa Extended-Release Capsules used for the treatment of Parkinson’s disease.

Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, as per release.

The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad

This combination medication is indicated for use in the treatment of Parkinsons or Parkinson-like symptoms (such as shakiness, stiffness, and difficulty moving).

The group now has 282 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.

At 11:00 hrs Cadila Healthcare was quoting at Rs 254.00, up Rs 1.20, or 0.47 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/cadila-healthcare-share-price-rises-over-2-on-usfda-approval-for-parkinsons-drug-5086211.html
5,"March 30, 2020 08:19 AM IST",-2,,"A comparison of the 2000 tech bubble, the financial crisis of 2008 and the 2020 Coronavirus crash","Investors fear that the supply chain disruption will squeeze liquidity out of the system and pop the numerous bubbles - the global equity and debt market, tech start-ups, real estate and shale energy - that have developed in the last decade.
@moneycontrolcom Sachin Pal","Investors fear that the supply chain disruption will squeeze liquidity out of the system and pop the numerous bubbles - the global equity and debt market, tech start-ups, real estate and shale energy - that have developed in the last decade.","Investors fear that the supply chain disruption will squeeze liquidity out of the system and pop the numerous bubbles - the global equity and debt market, tech start-ups, real estate and shale energy - that have developed in the last decade.

@moneycontrolcom Sachin Pal",https://www.moneycontrol.com/news/business/moneycontrol-research/a-comparison-of-the-2000-tech-bubble-the-financial-crisis-of-2008-and-the-2020-coronavirus-crash-5085001.html
6,"March 30, 2020 03:09 PM IST",-1,Sandip Das,SpiceJet share falls 5% as services remain suspended; HDFC Trustee buys 3.4 crore shares,"Shares of SpiceJet were down 5 percent as domestic and international flights remain suspended amid COVID-19 outbreak.
HDFC Trustee Company has bought 3.4 crore shares of SpiceJet from the open market constituting 5.45 percent of the airline.
It has touched an intraday high of Rs 1,698.55 and an intraday low of Rs 1,549.
""One of our colleagues, a first officer with SpiceJet, has tested positive for COVID-19.
It has touched an intraday high of Rs 37.00 and an intraday low of Rs 35.15.","In such times, HDFC Trustee's investment in SpiceJet is seen as a boost of confidence for the airline's management and investors.","Shares of SpiceJet were down 5 percent as domestic and international flights remain suspended amid COVID-19 outbreak. The stock touched lower circuit of Rs 35.15 per share.

HDFC Trustee Company has bought 3.4 crore shares of SpiceJet from the open market constituting 5.45 percent of the airline. ""The country's biggest mutual fund buying a substantial stake shows that it has some confidence in the airline coming out of the present crisis that the aviation industry finds itself in,"" said an industry executive.

In such times, HDFC Trustee's investment in SpiceJet is seen as a boost of confidence for the airline's management and investors.

On the other hand, the share price of HDFC was down 11 percent and was quoting at Rs 1,559.35, down Rs 194.75, or 11.10 percent. It has touched an intraday high of Rs 1,698.55 and an intraday low of Rs 1,549.

Rating agency CRISIL has downgraded the rating for Spicejet short term loans from ""BB-"" to ""B"" on significant deterioration of business risk profile. It has also cut the outlook in rating from positive to negative.

Aviation Ministry has allowed the use of passenger aircraft for cargo movement. IndiGo and GoAir have expressed interest in cargo movement.

SpiceJet said on March 29 that one of its pilots who did not fly any international flight in March has tested positive for the coronavirus. ""One of our colleagues, a first officer with SpiceJet, has tested positive for COVID-19. The test report came on March 28. He did not operate any international flight in March 2020,"" a spokesperson of the airline told PTI.

SpiceJet was quoting at Rs 35.25, down Rs 1.75, or 4.73 percent. It has touched an intraday high of Rs 37.00 and an intraday low of Rs 35.15.

It was trading with volumes of 312,389 shares, compared to its five day average of 742,609 shares, a decrease of -57.93 percent.",https://www.moneycontrol.com/news/business/markets/spicejet-share-falls-3-as-services-remain-suspended-hdfc-trustee-buys-3-4-crore-shares-5086291.html
7,"March 30, 2020 10:47 AM IST",1,Kshitij Anand,High-dividend stocks seem safe bet in times of uncertainty; which one should you buy?,"Low-interest rate regime along with high volatility in the equity market make high dividend-yielding stocks a better bet, suggest experts.
Dividend stocks usually do not get into a free fall, and outperform most of the time.
Top high dividend-yielding stocks according to an HDFC Securities report are Vedanta, Oil India, Balmer Lawrie, REC, ONGC, DB Corp, HEG, SJVN, IOC, PTC India, and NLC India.
Dividend yield (%) is the dividend per share paid by a company (on annual basis) divided by the price of that particular company/stock.
Investment in high dividend yield stocks is often seen as a way of safeguarding your investments in case of low capital appreciation as it provides consistent income.",Most of these high dividend-paying companies have healthy cash reserves which could be utilized for paying dividends in difficult times as well when the core businesses get impacted.,"Low-interest rate regime along with high volatility in the equity market make high dividend-yielding stocks a better bet, suggest experts.

Dividend stocks usually do not get into a free fall, and outperform most of the time. Most of these stocks have now corrected in double digits and investors can look at select stocks for the long term, suggest experts.

Top high dividend-yielding stocks according to an HDFC Securities report are Vedanta, Oil India, Balmer Lawrie, REC, ONGC, DB Corp, HEG, SJVN, IOC, PTC India, and NLC India. These stocks have a dividend yield of more than 10 percent.

What is the dividend yield?

Dividend yield (%) is the dividend per share paid by a company (on annual basis) divided by the price of that particular company/stock.

“We believe investing some of the corpus in high dividend-yield paying companies with strong fundamentals can cushion investors’ portfolios in case of an event of a fall but only to an extent,” Ajit Mishra, VP Research, Religare Broking told Moneycontrol.

“Most of these high dividend-paying companies have healthy cash reserves which could be utilized for paying dividends in difficult times as well when the core businesses get impacted,” he said.

Mishra further added that many of these stocks like Oil India and REC have decent fundamentals and therefore can be considered for long-term, assuming that these companies will continue with the current dividend rate.

India market plunged by about 30 percent since January 30 when benchmark indices hit a fresh record high amid the outbreak of COVID-19. The volatility as measured by India VIX has surpassed levels seen during the 2008 global financial crisis.

As many as 24 constituent companies in the Nifty have announced interim dividends so far in the year, according to a media report, as compared to 15 in the year-ago period.

Markets are in grip of risk aversion due to the spread of coronavirus pandemic. Post the Rs 1.7 lakh cr stimulus unveiled by the finance minister, expectations ate running high from the Reserve Bank of India to slash interest rates by 25-50 bps.

“High dividend yield stocks are worth investing in wake of falling interest rate scenario, but it must be remembered that only those high dividend-yielding stocks which have given the capital appreciation in recent past should be looked into,” Pankaj Bobade, Fundamental Research head, Axis Securities Limited told Moneycontrol.

“There have been instances of loss of invested capital, hence the investor must ensure that he should not end up into value trap in pursuit of high dividend,” he said. Bobade further added that investors should check the source of cash used for a dividend to ensure that the business generates sufficient cash for dividend distribution.

What should investors do now?

Investment in high dividend yield stocks is often seen as a way of safeguarding your investments in case of low capital appreciation as it provides consistent income. However, in case of an economic downturn only select few are better bets.

“Investors should analyze the components of dividend yield relatively i.e. the movement in the yield is not caused due to change in one single component,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor told Moneycontrol.

“In normal circumstances, high dividend-yielding stocks are a great choice however during the price drop or economic recession companies may reduce the dividend or stop it altogether. Therefore it is quite unlikely that it will provide significant cushion to investor’s portfolio,” he said.

Mishra of Religare Broking said that in a volatile market scenario, where most of these stocks are trading at a 52-week low, the dividend yield of the stocks has increased and is currently higher than the prevailing interest rate.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/high-dividend-stocks-seem-safe-bet-in-times-of-uncertainty-which-one-should-you-buy-5077231.html
8,"March 30, 2020 12:08 PM IST",0,Kshitij Anand,Market sustainability will depend on the behaviour of the COVID-19 curve: Naveen Kulkarni,"Sustainability in the market will depend on the behaviour of the COVID-19 curve and the new cases in the coming week, Naveen Kulkarni, Chief Investment Officer, Axis Securities Limited, said in an interview with Moneycontrol’s Kshitij Anand.
With these announcements through the market, sustainability will depend on the behavior of the COVID-19 curve and the new cases.
A lot will depend on the lockdown period.
Also, if the lockdown period gets extended then it is very likely that the bottom of 7,511 would be breached.
At present, it seems difficult as COVID-19 cases have continued to rise.",Rebalancing in ETFs and pension fund buying support helped the markets rally. The RBI announced an out-of-turn rate cut and measures to improve liquidity in the system.,"Sustainability in the market will depend on the behaviour of the COVID-19 curve and the new cases in the coming week, Naveen Kulkarni, Chief Investment Officer, Axis Securities Limited, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

A) The market has bounced back from the lows of 7,511 as stimulus packages were announced in the US and other developed markets.

Also rebalancing in ETFs and pension fund buying support helped the markets rally. The RBI announced an out-of-turn rate cut and measures to improve liquidity in the system.

All these factors helped the market bounce back. With these announcements through the market, sustainability will depend on the behavior of the COVID-19 curve and the new cases.

If the new cases get contained and the curve flattens then the markets will sustain otherwise the markets will correct.

A) April will be a very tricky month. A lot will depend on the lockdown period. If the lockdown period gets over by mid-April then it is very likely the markets will close the April series in positive.

If the lockdown period gets extended to end April or beyond then the markets are very likely to correct. Also, if the lockdown period gets extended then it is very likely that the bottom of 7,511 would be breached.

Q) What are your thoughts on the package announced by the government and RBI? Do you think these are enough to cushion the economic impact of COVID-19 on investors and citizens?

A) The government package of Rs 1.7 lakh crores is not very significant for the markets as it is primarily intended for the needy. The RBI will help the markets as they were expected and announcements have come at the right time.

Bond markets were seeing significant volatility. This will reduce with the injunction of liquidity measures. Overall the measures will provide some cushion to the market and help people to conduct their routines.

A) It is quite tricky to judge whether Nifty will cross the 10,000 mark. At present, it seems difficult as COVID-19 cases have continued to rise.

The number of cases in India will cross 1,000 this week and the next week will be very crucial. The level of community transmission and mortality rate will be quite critical parameters.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/market-sustainability-will-depend-on-the-behaviour-of-the-covid-19-curve-naveen-kulkarni-5084151.html
9,"March 30, 2020 11:59 AM IST",1,Rakesh Patil,Lupin share price jumps 5% on EIR from USFDA,"Lupin share price jumped 5 percent intraday on March 30 after the pharma company received an establishment inspection report from the US drug regulator.
The company received the EIR for its Inhalation Research Center located at Coral Springs, Florida.
The facility was inspected by the Food and Drug Administration between February 19, 2020 and February 26, 2020 on behalf of the UK Medicines and Healthcare products Regulatory Agency for Lupin’s generic Fostair application to the UK regulator.
""The receipt of the EIR with satisfactory VAI status validates our commitment towards ensuring the highest levels of quality and CGMP compliance at all our sites,"" said Vinita Gupta, CEO of Lupin.
At 1147 hours, Lupin was quoting at Rs 560.65, up Rs 13.65, or 2.50 percent on the BSE.","The company received the establishment inspection report for its Inhalation Research Center located at Coral Springs, Florida.","Lupin share price jumped 5 percent intraday on March 30 after the pharma company received an establishment inspection report from the US drug regulator.

The company received the EIR for its Inhalation Research Center located at Coral Springs, Florida.

The facility was inspected by the Food and Drug Administration between February 19, 2020 and February 26, 2020 on behalf of the UK Medicines and Healthcare products Regulatory Agency for Lupin’s generic Fostair application to the UK regulator.

""The receipt of the EIR with satisfactory VAI status validates our commitment towards ensuring the highest levels of quality and CGMP compliance at all our sites,"" said Vinita Gupta, CEO of Lupin.

At 1147 hours, Lupin was quoting at Rs 560.65, up Rs 13.65, or 2.50 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/lupin-share-price-jumps-5-on-eir-from-usfda-5086421.html
10,"March 30, 2020 11:37 AM IST",-2,Sunil Matkar,"Sun Pharma share falls 7% on USFDA red flag, but pares all losses","Shares of Sun Pharmaceutical Industries fell 6.75 percent in early trade after the US health regulator raised red flat on company's Halol facility, but the stock gradually recouped those losses to trade volatile.
It was trading at Rs 339.30, up Rs 1.15 or 0.34 percent after hitting a day's high of Rs 341.90 and low of Rs 315.3.
However, its subsidiary Sun Pharma Advanced Research Company was down Rs 1.95 or 2.06 percent at Rs 92.50.
The pharma company in its BSE filing on March 29 said it had received a communication from the US Food and Drug Administration (USFDA) indicating that the Halol facility has been classified as 'Official Action Indicated' (OAI).
The USFDA had inspected Halol (Gujarat) facility during December 3-13 and issued Form 483 with eight observations.","CLSA reiterated buy rating on the stock, though it slashed price target Rs 520 (from Rs 540 per share) on expected lower earnings.","Shares of Sun Pharmaceutical Industries fell 6.75 percent in early trade after the US health regulator raised red flat on company's Halol facility, but the stock gradually recouped those losses to trade volatile.

It was trading at Rs 339.30, up Rs 1.15 or 0.34 percent after hitting a day's high of Rs 341.90 and low of Rs 315.3. However, its subsidiary Sun Pharma Advanced Research Company was down Rs 1.95 or 2.06 percent at Rs 92.50.

The pharma company in its BSE filing on March 29 said it had received a communication from the US Food and Drug Administration (USFDA) indicating that the Halol facility has been classified as 'Official Action Indicated' (OAI).

The OAI classification implies interalia that the USFDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved.

The company said it continued to manufacture and distribute existing products for the US market, thereby not likely to have any adverse impact on current business from the facility.

The USFDA had inspected Halol (Gujarat) facility during December 3-13 and issued Form 483 with eight observations.

""Sun Pharma continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the company’s remedial action,"" the company said.

Hence, the global brokerage house CLSA cut its FY21-22 EPS estimates by 4 percent. ""No approvals from Halol led us to cut our US sales estimate by 3 percent.""

Despite this, the research house found risk-reward attractive as valuations largely reflected higher security and growth visibility of India business.

Hence, CLSA reiterated buy rating on the stock, though it slashed price target Rs 520 (from Rs 540 per share) on expected lower earnings.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/sun-pharma-share-falls-7-on-usfda-red-flag-but-pares-all-losses-5086231.html
11,"March 30, 2020 09:38 AM IST",-1,Rakesh Patil,Tata Power commences hydro power project in Georgia; share price down 3%,"Tata Power's joint venture has commenced a hydropower project in Georgia.
Adjaristsqali Georgia LLC (AGL), a joint venture between Tata Power, Norway’s Clean Energy Invest (CEI) and International Finance Corporation (IFC) announced the start of commercial operation of the 178 MW Shuakhevi Hydro Power Project (Shuakhevi HPP) located in southwest Georgia, as per company release.
Tata Power holds 40 percent shares in the joint venture.
The successful completion and start of commercial operations are considered crucial for the integrity, security and energy independence of Georgia.
At 09:27 hrs, Tata Power Company was quoting at Rs 33.20, down Rs 0.75, or 2.21 percent on the BSE.",Tata Power holds 40 percent shares in the joint venture.,"Tata Power's joint venture has commenced a hydropower project in Georgia.

The scrip slipped 3 percent on March 30.

Adjaristsqali Georgia LLC (AGL), a joint venture between Tata Power, Norway’s Clean Energy Invest (CEI) and International Finance Corporation (IFC) announced the start of commercial operation of the 178 MW Shuakhevi Hydro Power Project (Shuakhevi HPP) located in southwest Georgia, as per company release.

Tata Power holds 40 percent shares in the joint venture.

The successful completion and start of commercial operations are considered crucial for the integrity, security and energy independence of Georgia.

The power generated by the project will be exclusively sold within Georgia throughout the winter which is a period of energy deficit in that country, it added.

At 09:27 hrs, Tata Power Company was quoting at Rs 33.20, down Rs 0.75, or 2.21 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/tata-power-commences-hydro-power-project-in-georgia-share-price-down-3-5085791.html
12,"March 30, 2020 08:47 AM IST",0,Sandip Das,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Bears maintained their stronghold on the markets for the sixth consecutive week that ended on March 27.
However, benchmark indices underperformed their global peers as investors remained cautious over growth after a 21-day nationwide lockdown was announced earlier in the week to stop the spread of COVID-19.
While the BSE Sensex was down 100.37 points at 29,815.59, the Nifty50 dropped 85.20 points to 8,660.25.
The carnage was much worse in the broader markets as the Nifty Midcap and Smallcap indices plunged 7-8 percent.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​","Sudarshan Sukhani of s2analytics.com recommends buying Bharti Airtel with a stop loss of Rs 440, target at Rs 465 and Cipla with a stop loss of Rs 400, target at Rs 415.","Bears maintained their stronghold on the markets for the sixth consecutive week that ended on March 27. It made some recovery after the Rs 1.7 lakh crore welfare package announced by the Finance Ministry and the Rs 3.7 lakh crore liquidity stimulus package from the Reserve Bank of India (RBI) soothed sentiment.

However, benchmark indices underperformed their global peers as investors remained cautious over growth after a 21-day nationwide lockdown was announced earlier in the week to stop the spread of COVID-19.

While the BSE Sensex was down 100.37 points at 29,815.59, the Nifty50 dropped 85.20 points to 8,660.25. The carnage was much worse in the broader markets as the Nifty Midcap and Smallcap indices plunged 7-8 percent.

In an interview to CNBC-TV18, top market experts recommend which stocks to bet on for good returns:

Ashwani Gujral of ashwanigujral.com

Sell Bajaj Finance with a stop loss of Rs 2,600, target of Rs 2,450

Sell Maruti Suzuki with a stop loss of Rs 4,700, target of Rs 4,550

Buy Aurobindo Pharma with a stop loss of Rs 385, target of Rs 405

Buy Cipla with a stop loss of Rs 400, target of Rs 425

Buy Jubilant FoodWorks with a stop loss of Rs 1,400, target of Rs 1,455

Sudarshan Sukhani of s2analytics.com

Buy Bharti Airtel with a stop loss of Rs 440, target at Rs 465

Buy Cipla with a stop loss of Rs 400, target at Rs 415

Sell Page Industries with a stop loss of Rs 17,800, target at Rs 16,800

Sell CESC with a stop loss of Rs 396, target at Rs 381

Mitessh Thakkar of mitesshthakkar.com

Sell GAIL with a stop loss of Rs 71, target at Rs 65

Buy Cipla with a stop loss of Rs 400, target at Rs 422

Sell Siemens with a stop loss of Rs 1,060, target at Rs 1,025

Sell Adani Enterprises with a stop loss of Rs 133.5, target at Rs 123

The views and investment tips expressed by investment experts are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/top-buy-and-sell-ideas-by-ashwani-gujral-sudarshan-sukhani-mitesh-thakkar-for-short-term-66-5085751.html
13,"March 30, 2020 12:50 PM IST",1,Kshitij Anand,"'Nifty might rally back to 9,700 if COVID-19 cases come under control globally'","It started to recover from its recent low.
Last week, the US approved$2 trillion stimulus package to respond to the COVID-19 pandemic which helped the market cut some losses.
In April, we can say that Nifty might rally if Corona cases (domestically as well as globally) are in control.
Indian indices were given choppy movement on Friday after RBI Governor announced a massive 75 basis points cut in repo rates and 90 basis points cut in reverse repo rate to respond to the COVID-19 pandemic.
The Nifty50 might rally back to 9,700 if corona cases are in control else then we could see the Nifty dragging back and possibly even break its recent low of 7511.","The Nifty50 might rally back to 9,700 if corona cases are in control else then we could see the Nifty dragging back and possibly even break its recent low of 7511.","The Nifty50 might rally back to 9,700 if corona cases are brought in control else we could see the Nifty dragging back and possibly even break its recent low of 7,511, Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt:

Q) Last week was very volatile for the markets, but we managed to bounce back from 7,511. What is your take on the market action?

A) Indian equity markets started the week on a negative note. It started to recover from its recent low. Last week, the US approved$2 trillion stimulus package to respond to the COVID-19 pandemic which helped the market cut some losses.

The Indian market also recovered from its 4-year low after the Indian government announced a $22.5 billion relief package coupled with the rate cut.

This is the wildest time for the market in all kinds of market categories. On 27th March 2020, indices ended almost flat, however banking stocks gained after RBI Governor announced a massive 75 basis points cut in repo rates and 90 basis points cut in reverse repo rate to increase liquidity in the system.

Currently, we are nowhere close to overcoming the COVID-19 crisis. If we see a peak in cases in India and globally for another two to three weeks, (as we saw on Thursday in India when the highest number of people died in a day) then we could see the Nifty dropping back and might possibly even break its recent low. Otherwise, it might rally back to 9,700.

A) The rally which started after 2008 crises to the peak point, the Nifty has retraced nearly 50 percent of the gains from the recent all-time high of 12,430 which was made in January 2020.

The index has declined as much as 32.95 percent in the month of March so far. In April, we can say that Nifty might rally if Corona cases (domestically as well as globally) are in control.

If not, then we could see the Nifty dragging back. Stocks that investors should watch out for are Kotak Mahindra Bank Limited and Reliance Industries Limited.

A) On the last trading session of the week, indices ended almost flat after the RBI Governor announced a 75 & 90 basis points cut in the repo and reverse repo rate respectively to increase liquidity in the system and central government announced a relief package of Rs 1.7 lakh crore to respond to the Corona pandemic.

About 80 crore people will get benefit from the relief package. So, steps taken by the RBI and Indian government are in the right direction.

Apart from this for the fiscal year 2020-21, the government will also increase its borrowing plan. The government is planning to increase gross borrowing to Rs. 7.8 trillion.

A) Recently, the volatility index which is a measure of the market’s expectation of volatility over the near term is at the highest level since 2008.

Indian indices were given choppy movement on Friday after RBI Governor announced a massive 75 basis points cut in repo rates and 90 basis points cut in reverse repo rate to respond to the COVID-19 pandemic.

The Nifty50 might rally back to 9,700 if corona cases are in control else then we could see the Nifty dragging back and possibly even break its recent low of 7511.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/nifty-might-rally-back-to-9700-if-covid-19-cases-come-under-control-globally-5084871.html
14,"March 30, 2020 10:14 AM IST",-2,Sandip Das,"Godfrey Phillips suspends operations, share price falls 3%","The share price of Godfrey Phillips India slipped over 3 percent in the morning trade on March 30 after the tobacco manufacturing company said it was suspending operations at all its units.
Terming the current situation as extraordinary, Godfrey Phillips India (GPI) CEO Bhisham Wadhera said the company was prepared to take a hit for four weeks on its business.
""As an organisation what is of utmost importance to us is our employees' health and safety.
The stock, which gained 16 percent in the last 5 days, was quoting at Rs 899, down Rs 23.15, or 2.51 percent.
It was trading with volumes of 1,041 shares, compared to its five-day average of 10,667 shares, a decrease of 90.24 percent.",Godfrey Phillips India CEO Bhisham Wadhera said the company was prepared to take a hit to its business to protect its employees.,"The share price of Godfrey Phillips India slipped over 3 percent in the morning trade on March 30 after the tobacco manufacturing company said it was suspending operations at all its units.

""We would like to inform that in the wake of the COVID-19 pandemic, the company is taking various measures to ensure the safety and well being of all employees and is ensuring compliance with the directives issued by the Central Government, State Governments and local administration in this regard… the company has suspended operations at all its factories and plant locations,” it said in a filing to the exchanges.

Terming the current situation as extraordinary, Godfrey Phillips India (GPI) CEO Bhisham Wadhera said the company was prepared to take a hit for four weeks on its business.

""As an organisation what is of utmost importance to us is our employees' health and safety. In fact about 10 days ago, we announced work from home just to ensure that nobody gets exposed, much before the lockdown,"" Wadhera told PTI.

The stock, which gained 16 percent in the last 5 days, was quoting at Rs 899, down Rs 23.15, or 2.51 percent. It was trading with volumes of 1,041 shares, compared to its five-day average of 10,667 shares, a decrease of 90.24 percent.",https://www.moneycontrol.com/news/business/markets/godfrey-phillips-suspends-operations-share-price-falls-3-5086041.html
15,"March 30, 2020 02:38 PM IST",-2,Rakesh Patil,BGR Energy share price slips over 6%; board approves subsidiary stake sale,"S&P BSE Utlities | 2019 return: -9.42 percent | Price as on 31 Dec 2018: Rs 1946.60 | Price as on 13 Dec 2019: Rs 1763.28BGR Energy Systems share price slipped 6.7 percent intraday on March 30, the day its board approved a proposal to sell the company's stake in its subsidiary Progen Systems and Technologies.
These shares are to be acquired by BGR Investment Holdings Company Limited, a related party.
BGR Investment Holdings Company Limited holds the remaining 30.33% of Progen.
The sale of investment is expected to get completed on or before March 31, 2020 on receipt of sale consideration of Rs 43.35 crore.
At 1412 hours, BGR Energy Systems was quoting at Rs 20.30, down Rs 1.15, or 5.36 percent on the BSE.","The sale comprises 42,50,000 equity shares constituting 69.67 percent of the subscribed and paid-up capital of Progen Systems and Technologies.","S&P BSE Utlities | 2019 return: -9.42 percent | Price as on 31 Dec 2018: Rs 1946.60 | Price as on 13 Dec 2019: Rs 1763.28

BGR Energy Systems share price slipped 6.7 percent intraday on March 30, the day its board approved a proposal to sell the company's stake in its subsidiary Progen Systems and Technologies.

The sale comprises 42,50,000 equity shares constituting 69.67 percent of the subscribed and paid-up capital of Progen.

These shares are to be acquired by BGR Investment Holdings Company Limited, a related party.

BGR Investment Holdings Company Limited holds the remaining 30.33% of Progen.

The proceeds of divestment will be utilised to augment long-term financial resources for the company and consequently, Progen Systems would cease to be a subsidiary of the company.

The sale of investment is expected to get completed on or before March 31, 2020 on receipt of sale consideration of Rs 43.35 crore.

At 1412 hours, BGR Energy Systems was quoting at Rs 20.30, down Rs 1.15, or 5.36 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/bgr-energy-share-price-slips-over-6-board-approves-subsidiary-stake-sale-5086921.html
16,"March 30, 2020 04:32 PM IST",-1,Sandip Das,"'Selloff in bank & financial stocks due to FII book re-balancing, time to build positions'","Among the sectors, the Bank Nifty tanked 6 percent dragged by HDFC Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank which shed 6-8 percent each followed by RBL Bank, State Bank of India, Federal Bank and YES Bank.
Retail and MSME growth, especially that of the private banks and NBFCs has most likely come to an abrupt halt.
""We are likely to see significant revisions to underwriting policies which would consequently have an impact on growth, NIM and profitability.
The Nifty Financial Services fell over 7 percent dragged by Bajaj Finance, HDFC, HDFC Life, M&M Financial Services and Shriram Transport Finance.
""We believe that HDFC Bank will withstand the economic reverberation in a better way than others,"" he added.","The selloff we are seeing in names like HDFC Bank and Bajaj Finance is due to the impact of lockdown, which will have a bearing on asset quality and growth projection, says Amit Khurana of Dolat Capital.","The Indian stock market traded in the red on March 30 following Asian peers, with the Sensex down 1,375.27 points, or 4.61 percent, at 28440.32, and the Nifty ended 379.15 points, or 4.38 lower, at 8281.10.

The IMF has said the global economy had entered into a recession, which could be worse than the one that followed the 2008-09 financial crisis.

“It is clear that we have entered a recession” that will be worse than the one witnessed in 2009 following the global financial crisis, IMF chief Kristalina Georgieva said in an online press briefing.

Among the sectors, the Bank Nifty tanked 6 percent dragged by HDFC Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank which shed 6-8 percent each followed by RBL Bank, State Bank of India, Federal Bank and YES Bank.

Retail and MSME growth, especially that of the private banks and NBFCs has most likely come to an abrupt halt. ""We are likely to see significant revisions to underwriting policies which would consequently have an impact on growth, NIM and profitability. We should ideally expect lenders to scale down growth expectations in the more profitable unsecured books and non-salaried segments,"" research firm Kotak Institutional Equities said.

The restructuring or moratorium window usually tends to be much longer as regulators address the near-term challenges. A prolonged moratorium or restructuring window tends to be negative for the sector as the ability to understand the true loan book status or profitability comes under discussion, it said.

""We expect a struggle to get the re-rating for lenders, especially those with the high risk product segments like unsecured loans, MSME as we see risk in growth, NIM, operating costs and provisions,"" it added.

The Nifty Financial Services fell over 7 percent dragged by Bajaj Finance, HDFC, HDFC Life, M&M Financial Services and Shriram Transport Finance.

""Part of the sell-off that we are seeing in the market is re-balancing in the FII books considering the selling pressure we have in some of the emerging market portfolio. The kind of selloff that we are seeing in names like HDFC Bank and Bajaj Finance is due to the impact of lockdown, which will have an impact on asset quality and the growth projection. The selloff is also driven technically. We would take this opportunity to build up positions. Market volatility is not going to go up anytime soon. We are recommending to start nibbling at specific levels, don't rush to allocate full amount,"" said Amit Khurana, Head of Equities & Research of Dolat Capital.

The index formed an Inverted Hammer or Shooting Star candle on the daily chart, which indicates a pause in bounce back if follow-up supply happens in the next trading sessions. However, it still requires confirmation.

""8,000 would be seen as a key support. Traders are advised not to take aggressive / leveraged bets and should ideally keep booking profits on a regular basis. For a time being, the strategy would be to take one step at a time and keep focusing on quality names,"" Sameet Chavan, Chief Analyst-Technical and Derivatives at Angel Broking told Moneycontrol.

""We believe that HDFC Bank will withstand the economic reverberation in a better way than others,"" he added.",https://www.moneycontrol.com/news/business/markets/selloff-in-bank-financial-stocks-is-due-to-fii-book-re-balancing-time-to-build-positions-5087241.html
17,"March 30, 2020 10:00 AM IST",-2,Sandip Das,"Auto stocks tumble amid shutdown; Eicher Motors, M&M, Bajaj Auto top losers","Nifty Auto shed 4 percent in the morning session as the spread of COVID-19 has forced automakers to shut manufacturing operations.
Eicher Motors shed 6 percent, Bajaj Auto, Tata Motors and TVS Motor Company were down 4-5 percent each.
Moody's Investors Service has placed the ratings on Tata Motors on review for a possible downgrade.
However, Motilal Oswal has a buy rating on Tata Motors with target at Rs 178 signalling an upside of 102 percent.
MSIL would work with AgVa Healthcare to scale up the production of ventilators to reach a volume of 10,000 units per month.",Nifty Auto shed 4 percent in the morning session as spread of COVID-19 has forced auto makers to shut manufacturing operations.,"The Indian stock market had a gap down opening on March 30 following weak Asian cues as coronavirus pandemic continues to create havoc across the globe.

At 09:27 hrs, the Sensex was down 816.80 points or 2.74 percent at 28998.79, and the Nifty down 237.65 points or 2.74 percent at 8422.60.

Among the sectors, banks along with the auto index dragged the most, down almost 4 percent each.

Nifty Auto shed 4 percent in the morning session as the spread of COVID-19 has forced automakers to shut manufacturing operations. Share price of Mahindra & Mahindra was down over 7 percent after the company on March 22, 2020, announced suspension of the manufacturing operations at Nagpur Plant with immediate effect and Chakan (Pune) and Kandivali (Mumbai) from March 23, 2020, onwards.

Eicher Motors shed 6 percent, Bajaj Auto, Tata Motors and TVS Motor Company were down 4-5 percent each.

Moody's Investors Service has placed the ratings on Tata Motors on review for a possible downgrade. The review, which will be completed over the next 90 days, is on the Ba3 corporate family rating and Ba3 senior unsecured debt rating, Moody's said in a statement.

However, Motilal Oswal has a buy rating on Tata Motors with target at Rs 178 signalling an upside of 102 percent. It is of the view that the reduction in China sales resulting from the coronavirus impact is estimated to reduce JLR's full-year EBIT margin by about 1 percent, however, free cash flow in 4QFY20 is still expected to be modestly positive.

Showrooms across major cities and towns have downed shutters choking sales of Bharat Stage IV (BS4) vehicles, auto factories are under lockdown hampering supplies of BS6 upgrades and market sentiments are at its worst with the stock market going back to the levels of early 2017.

As per data shared by the SIAM, passenger vehicle sales in the domestic sector during April-February declined by 15 percent to 2.63 million units while commercial vehicle segment reported a fall of 22 percent compared to the same period last year.

Share price of auto ancillary stocks including Apollo Tyres, Motherson Sumi Systems, Bharat Forge and MRF were down 2-3 percent each as the coronavirus pandemic continues to bite.

""The industry was already under pressure due to plummeting sales and there was also uncertainty from BS4 to BS6 [shift]. Everything has come to a standstill. We do not know how long it will last. There is a production loss of Rs 1,200 crore a day for the component industry,"" said Vinnie Mehta, director-general, Automotive Component Manufacturers Association.

“At the request of the Government of India, Maruti Suzuki examined its ability to assist in the production of ventilators, masks and other protective equipment”, the company said in a statement.

MSIL entered into an arrangement with AgVa Healthcare, an existing approved manufacturer of ventilators. MSIL would work with AgVa Healthcare to scale up the production of ventilators to reach a volume of 10,000 units per month.

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/auto-stocks-tumble-amid-shutdown-eicher-motors-mm-bajaj-auto-top-losers-5085971.html
18,"March 30, 2020 04:56 PM IST",-2,Rakesh Patil,"Taking Stock: Bears back in control, Sensex sheds over 1,300 points, Nifty's 4-day winning spree ends","Let’s look at the final tally on D-Street: the S&P BSE Sensex fell 1,375 points to close at 28,440 while the Nifty50 closed 379 points lower at 8,281.
The average market capitalisaion of BSE-listed companies fell from Rs 112.49 lakh crore on March 27 to Rs 109.74 lakh crore on March 30.
The broader market outperformed as the S&P BSE Midcap index fell 2.1 percent while the S&P BSE Smallcap index was down just 1.75 percent.
Stocks & sectorsSectorally, the action was seen in the healthcare index that was up 1.07 percent, and the S&P BSE FMCG index was up 0.67 percent.
Selling pressure was visible in the S&P BSE Realty index that fell 7 percent, followed by the S&P BSE Finance index which was down 6.9 percent, and the Bankex fell 5.8 percent.",The broader market outperformed as the S&P BSE Midcap index fell 2.1 percent while the S&P BSE Smallcap index was down just 1.75 percent.,"Weak global cues, rise in coronavirus cases across the world, stress on banking stocks and fears of a global recession weighed heavy on markets on March 30.

Let’s look at the final tally on D-Street: the S&P BSE Sensex fell 1,375 points to close at 28,440 while the Nifty50 closed 379 points lower at 8,281. The Nifty is back below 8,300 after two sessions, which suggests that bears have regained their foothold.

Investors’ lost nearly Rs 3 lakh crore in a single trading session. The average market capitalisaion of BSE-listed companies fell from Rs 112.49 lakh crore on March 27 to Rs 109.74 lakh crore on March 30.

It looks like the market is factoring the worst. The fears of an economic recession is leading to a sharp selloff by institutional investors across the globe. FIIs have, so far, pulled out near Rs 60,000 crore from the cash segment of the Indian equity market in March.

“As expected, the markets have set aside the stimulus measures announced by the RBI and the government, and focused on the rising virus infections and its impact on the Indian economy,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol.

“With a global recession already declared by the IMF, the recessionary forces and the general uncertainty are forcing investors, especially the FIIs, to redeem their investments. CPI for Industrial workers is due tomorrow, although it is unlikely to have an effect in the current market scenario,” he said.

Sectorally, the action was seen in healthcare and FMCG stocks, while selling pressure was visible in realty, finance, Bankex, auto, and telecom stocks.

The broader market outperformed as the S&P BSE Midcap index fell 2.1 percent while the S&P BSE Smallcap index was down just 1.75 percent.

Top Nifty gainers include Dr Reddy’s Laboratories, Nestle India, Tech Mahindra, and Cipla.

Top Nifty losers include HDFC, and Bajaj Finance that fell more than 10 percent each.

Stocks & sectors

Sectorally, the action was seen in the healthcare index that was up 1.07 percent, and the S&P BSE FMCG index was up 0.67 percent.

Selling pressure was visible in the S&P BSE Realty index that fell 7 percent, followed by the S&P BSE Finance index which was down 6.9 percent, and the Bankex fell 5.8 percent.

Volume spike was seen in stocks like Godrej Properties, Dr Reddy’s Laboratories, Torrent Pharma, TCS, and Jubilant FoodWorks.

Long buildup was seen in stocks like Axis Bank, Jubilant FoodWorks, and Lupin.

Short buildup was seen in stocks like Godrej Properties, Biocon, Cummins India, and Voltas.

More than 400 stocks on the BSE hit a fresh 52-week low. These include Eicher Motors, Teamlease Services, Lakshmi Mills, Shriram City Union and Havells India.

Banking stocks witnessed massive selloff led by ICICI Bank & HDFC Bank, which contributed 75% to the Nifty Bank’s fall. Brokerages say that the disruption of the domestic and global economies due to coronavirus will have a meaningful impact on banks’ loan-book growth.

Stocks in news

Shares of SpiceJet were down 5 percent as domestic and international flights remain suspended. The stock touched the lower circuit of Rs 35.15 per share.

Lupin share price jumped 2 percent after the pharma company received an establishment inspection report from the US drug regulator.

The share price of motorcycle and scooter manufacturing company Hero MotoCorp fell 6 percent after the company decided to halt operations till March 31, at all its plants globally in face of the coronavirus outbreak.

Technical outlook

The Nifty formed a bearish candle on the daily charts.

For the time, it will be safe to presume that the index is retracing the last leg of the rally from the lows of 7,511–9,038.

In case 7,800 is breached on a closing basis, then one should be prepared for breach of the recent bottom of 7,511.

As long as the Nifty sustains above 7,800 one can remain hopeful of buying to emerge at lower levels, which should eventually resume the pullback on the upside.

A close above 8,660 shall be considered as an initial sign of strength and on such a close upswing shall again resume, say experts.

Traders are advised to wait for further clues to emerge over the next two- three trading sessions before initiating trading bets in any of the directions, they say.",https://www.moneycontrol.com/news/business/markets/taking-stock-bears-back-in-control-sensex-sheds-over-1300-points-niftys-4-day-winning-spree-ends-5087611.html
19,"March 30, 2020 11:39 AM IST",-2,Nishant Kumar,"Banks' earnings could fall up to 35%: Kotak Mahindra, HDFC Bank may see the least impact","India's banking sector is staring at a bumpy road ahead as COVID-19 will have a serious impact on banks' loan growth, asset quality and earnings, said brokerages and experts.
""We believe the impact on asset quality would be the least for HDFC Bank, Kotak Mahindra Bank, and DCB Bank, but it would be relatively high for IndusInd Bank,"" Phillip Capital said.
They have also witnessed a decline in credit card spends, which will certainly impact retail loan growth.""
JP Morgan believes HDFC Bank, Kotak Mahindra Bank and ICICI Bank offer safety with a strong funding base and minimal asset quality risk.
The brokerage has maintained buy recommendations on HDFC Bank and ICICI Bank with revised target prices of Rs 1,110 (Rs 1,420 earlier) and Rs 450 (Rs 660 earlier), respectively.",Experts and brokerages are of the view that the banking sector should be in the focus of policymakers as the sector is suffering the most and will have a contagion effect on all sectors of the economy.,"India's banking sector is staring at a bumpy road ahead as COVID-19 will have a serious impact on banks' loan growth, asset quality and earnings, said brokerages and experts.

Experts and brokerages are of the view that the banking sector should be in the focus of policymakers as the sector is suffering the most and will have a contagion effect on all sectors of the economy.

The government and the RBI understand this and have made a slew of announcements to mitigate the pain of this sector.

The RBI governor on March 27 said the central bank was closely monitoring the situation and will step in whenever required.

“Let me assure you that the RBI is at work in mission mode. We have been monitoring the evolving financial market and the macroeconomic conditions and calibrating its operations to meet any need for additional liquidity support as well as to take other measures if warranted,” said the RBI governor.

The impact

Brokerages highlight that the lockdown of the domestic and global economies due to the COVID-19 threat will have a meaningful impact on banks’ loan-book growth.

""We have factored a lockdown of 30-45 days in our revised estimates and cut individual banks’ loan growth in FY21 by 3-5 percent and taken deterioration in asset quality. Our earnings revisions are down between 10 percent and 35 percent,"" said brokerage firm Phillip Capital.

The uncertain outlook and the country-wide lockdown has made banks vulnerable to a new leg of asset-quality crisis, with the most uncertain part being the lockdown period and the time that the economy would take to return to normalcy.

""We believe the impact on asset quality would be the least for HDFC Bank, Kotak Mahindra Bank, and DCB Bank, but it would be relatively high for IndusInd Bank,"" Phillip Capital said.

Domestic brokerage ICICI Securities, too, believes that the loan-book growth will take a hit.

""With the lack of any major private sector capex in the current fiscal, system credit growth was largely driven by the retail segment, which contributed nearly 91 percent of incremental credit during the year up to January 2020. We believe COVID-19 may further delay private capex revival and also decelerate the retail loan growth trajectory,"" said ICICI Securities.

""A few banks have already signalled tightening of their retail credit norms. They have also witnessed a decline in credit card spends, which will certainly impact retail loan growth.""

Not only the loan-growth, but the current lockdown will also affect cash flows of borrowers, both individual and corporate which may lead to an increase in corporate as well as retail NPAs.

A decline in loan growth and a rise in credit cost will hit the earnings of the banks.

As per the analysis of ICICI Securities, 5 percent decline in loan growth and 50 bps increase in credit cost may adversely impact banks’ earnings by an average of about 22 percent, while 5 percent decline in loan growth and 25 bps increase in credit cost may hit their earnings by an average of 13 percent.

Stocks to watch out for

Banks with stronger business models have a higher ability to sail through this rough tide.

JP Morgan believes HDFC Bank, Kotak Mahindra Bank and ICICI Bank offer safety with a strong funding base and minimal asset quality risk.

""While forward earnings at this time have low visibility, one can only go by a track record of companies over past down cycles and those that have managed such headwinds (2008 global financial crisis, 2013 taper tantrum, 2016 demonetization and 2018 liquidity problems) should stand out relatively better,"" JP Morgan said.

Phillip Capital has made an assessment of their relative business strength and to gauge which business model has the ability to bounce back faster.

Phillip Capital has upgraded Kotak Mahindra Bank and DCB Bank to a 'buy' with a target price of Rs 1,500 and Rs 107, respectively.

The brokerage has maintained buy recommendations on HDFC Bank and ICICI Bank with revised target prices of Rs 1,110 (Rs 1,420 earlier) and Rs 450 (Rs 660 earlier), respectively.

ICICI Securities prefers HDFC Bank and Kotak Mahindra Bank, who have a proven history to contain NPAs through credit cycles with high-quality underwriting.

""We like HDFC Bank as nearly 80 percent of wholesale lending is to AA and above, nearly 75 percent of SME portfolio is secured and about 75-80 percent of unsecured loans are to salaried customers,"" ICICI Securities said.

""We will closely monitor BBB portfolio of Axis Bank (13 percent of corporate loans) and corporate & vehicle portfolio of IndusInd Bank from where incremental stress could emerge,"" it added.

Follow our full coverage here

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/banks-earnings-could-fall-up-to-35-kotak-mahindra-hdfc-bank-may-see-least-impact-5082261.html
20,"March 30, 2020 07:34 AM IST",0,Nishant Kumar,"Nifty may attempt to confirm reversal; DLF, Coal India, M&M top short-term bets","At the same time, Nifty confirmed short term reversal by closing above crucial resistance of 8,600 levels too.
Recommendations for the next 3-4 weeks:DLF | Buy | LTP: Rs 139 | Buy above: Rs 135 | Target: Rs 160 | Stop loss: Rs 117 | Upside: 15%After hitting a peak of Rs 265, the stock fell sharply towards Rs 115-120.
Coal India | Buy | LTP: Rs 131.15 | Buy around: Rs 130 | Target: Rs 148 | Stop loss: Rs 119 | Upside 13%Bargain hunting is seen at lower levels in the scrip from where it formed a strong base.
Traders can take an entry from the level of Rs 130 for the target of Rs 148 while keeping a stop loss at Rs 119.
Furthermore, the declining histogram in MACD adds the conviction of buying the scrip around Rs 290 for the target of Rs 315 with a stop loss at Rs 273.","Formation of positive divergence in RSI on a daily time frame supported reversing of prices, as index managed to take support from the strong demand zone standing around 7,500-7,300 levels on the higher time frame.","Shabbir Kayyumi

After falling 10 percent on Monday, bulls defended crucial levels of 7,500 which is 50 percent retracement mark from low of 2008 (2,252) and high of 2020 (12,430), giving relief to a sharp fall of almost 3,800 points in March.

Formation of positive divergence in RSI on a daily time frame supported reversing of prices, as index managed to take support from the strong demand zone standing around 7,500-7,300 levels on the higher time frame.

At the same time, Nifty confirmed short term reversal by closing above crucial resistance of 8,600 levels too.

But we need one higher closing on the weekly timeframe as a confirmation before declaring reversal and can start preparing for a push towards 20-DMA placed around 9,600.

On the flip side, a decisive close below strong psychological levels of 8,000 can push index towards the line of parity on a monthly time frame standing around 7,300 marks.

Banking Index has managed to close around crucial psychological levels of 20,000 and 5 day’s highest high is suggesting a reversal of short term trend and relief rally towards 25,000 levels cannot be ruled out; conversely, any decisive trading below 18,500 will be a sign of active bears.

Recommendations for the next 3-4 weeks:

DLF | Buy | LTP: Rs 139 | Buy above: Rs 135 | Target: Rs 160 | Stop loss: Rs 117 | Upside: 15%

After hitting a peak of Rs 265, the stock fell sharply towards Rs 115-120. From here, a chance of developing demand is higher.

As of now, the appearance of morning star on the daily chart is giving cues to accumulate this stock at lower levels.

The momentum oscillator RSI which is currently overbought zone took a turn on the north side.

As long as it sustains above the mentioned zone, the possibility of moving on the upside is higher and it can hit our target with ease.

Coal India | Buy | LTP: Rs 131.15 | Buy around: Rs 130 | Target: Rs 148 | Stop loss: Rs 119 | Upside 13%

Bargain hunting is seen at lower levels in the scrip from where it formed a strong base.

Currently, it formed a double bottom on the hourly chart along with the positive divergence in RSI which suggests a reversal is round the corner.

Indicators and oscillators also lending support to the price action. Traders can take an entry from the level of Rs 130 for the target of Rs 148 while keeping a stop loss at Rs 119.

Mahindra & Mahindra (M&M) | Buy | LTP: Rs 295 | Buy around: Rs 290 | Target: Rs 315 | Stop loss: Rs 273 | Upside 7%

The stock bottomed out near the levels of Rs 245-250 and has been consolidating for the last few days on the daily chart.

The emergence of Dragonfly Doji near the support line on the weekly chart indicates upside movement in the coming sessions.

Daily momentum indicator RSI seems to be taking support from its falling line while being trading in an oversold region on the daily chart also creating positive rhythm in the scrip.

Furthermore, the declining histogram in MACD adds the conviction of buying the scrip around Rs 290 for the target of Rs 315 with a stop loss at Rs 273.

(The author is Head of Technical Research, Narnolia Financial Advisors)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/nifty-may-attempt-to-confirm-reversal-dlf-coal-india-mm-top-short-term-bets-5084851.html
21,"March 30, 2020 02:47 PM IST",-2,Sandip Das,"D-Street Buzz: Over 350 stocks hit 52-week low on BSE; HDFC Bank, ICICI Bank down 6%","Among the sectors, Bank Nifty was down over 4 percent dragged by HDFC Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank which shed over 6 percent each followed by Federal Bank, Bank of Baroda, RBL Bank and YES Bank.
The Reserve Bank of India on March 28, 2020 said it has approved the amalgamation of Oriental Bank of Commerce and United Bank of India into Punjab National Bank, Syndicate Bank into Canara Bank, Andhra Bank and Corporation Bank into Union Bank of India and Allahabad Bank into Indian Bank.
The scheme will come into force with effect from April 1, 2020 and all the branches of Oriental Bank of Commerce and United Bank of India will function as branches of PNB branches; Syndicate Bank branches into Canara Bank branches; Andhra Bank and Corporation Bank branches into Union Bank of India branches and Allahabad Bank branches into Indian Bank branches.
Nifty Auto was down over 5 percent dragged by Eicher Motors, Mahindra & Mahindra, Maruti Suzuki, Hero MotoCorp, MRF, Tata Motors, TVS Motor Company and Bajaj Auto.
355 stocks hit 52-week low on BSE including JSPL, Eicher Motors, Sun TV, Cummins India, Future Retail, TVS Motor, Vedanta and Indian Oil Corporation among others.","About 799 shares have advanced, 1284 shares declined, and 148 shares are unchanged.","The Indian stock market continues trading in the red following Asian peers with Sensex is down 1,120.84 points or 3.76% at 28694.75, and the Nifty down 301.30 points or 3.48% at 8358.95.

IMF chief announced that the globe has entered into recession which would be worse than financial crisis seen in 2008-2009.

“It is clear that we have entered a recession” that will be worse than the one witnessed in 2009 following the global financial crisis, Kristalina Georgieva, IMF chief said in an online press briefing.

Among the sectors, Bank Nifty was down over 4 percent dragged by HDFC Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank which shed over 6 percent each followed by Federal Bank, Bank of Baroda, RBL Bank and YES Bank.

The Reserve Bank of India on March 28, 2020 said it has approved the amalgamation of Oriental Bank of Commerce and United Bank of India into Punjab National Bank, Syndicate Bank into Canara Bank, Andhra Bank and Corporation Bank into Union Bank of India and Allahabad Bank into Indian Bank. The scheme will come into force with effect from April 1, 2020 and all the branches of Oriental Bank of Commerce and United Bank of India will function as branches of PNB branches; Syndicate Bank branches into Canara Bank branches; Andhra Bank and Corporation Bank branches into Union Bank of India branches and Allahabad Bank branches into Indian Bank branches. Following the consolidation, there will be seven large public sector banks and five smaller ones. There were as many as 27 PSBs in 2017, according to a report by CNBC-TV18.

RBI's statement comes after Finance Minister Nirmala Sitharaman's clarification on March 26 that the mega bank consolidation plan was very much on track and would take effect from April 1.

Nifty has been seeing erratic swings in a broader range and we do not see this changing any time soon. The range for the next week could be 7,600-9,500 levels. While mostly sectoral indices are trading in line with the benchmark index, defensive viz. FMCG, pharma and IT are looking comparatively stronger. Considering the scenario, traders should limit their positions and prefer only hedged trades, said Ajit Mishra, VP - Research at Religare Broking.

Nifty Auto was down over 5 percent dragged by Eicher Motors, Mahindra & Mahindra, Maruti Suzuki, Hero MotoCorp, MRF, Tata Motors, TVS Motor Company and Bajaj Auto.

Moody's Investors Service has placed the ratings on Tata Motors on review for a possible downgrade. The review, which will be completed over the next 90 days, is on the Ba3 corporate family rating and Ba3 senior unsecured debt rating, Moody's said in a statement.

As per data shared by the SIAM, passenger vehicle sales in the domestic sector during April-February declined by 15 percent to 2.63 million units while commercial vehicle segment reported a fall of 22 percent compared to the same period last year.

Traders are advised not to take aggressive / leveraged bets and should ideally keep booking profits on a regular basis. For a time being, the strategy would be to take one step at a time and keep focusing on quality names,” Sameet Chavan, Chief Analyst-Technical and Derivatives at Angel Broking

India VIX is up 3.20 percent at 72.64 level.

355 stocks hit 52-week low on BSE including JSPL, Eicher Motors, Sun TV, Cummins India, Future Retail, TVS Motor, Vedanta and Indian Oil Corporation among others.

373 stocks hit lower circuit including Future Retail, Indiabulls Ventures, IDFC and AU Small Finance Bank among others.

About 799 shares have advanced, 1284 shares declined, and 148 shares are unchanged.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-over-350-stocks-it-52-week-low-on-bse-hdfc-bank-icici-bank-down-6-5087031.html
22,"March 30, 2020 11:16 AM IST",-2,Sandip Das,Hero Moto share price falls 6% on report of suppliers' payment suspension,"Amid the coronavirus lockdown, Hero MotoCorp has suspended full payments to suppliers since sales have paused and there is “no visibility of receivables,” according to a report by The Economic Times.
Also read: Hero MotoCorp suspends full payments to suppliers: ReportThe two-wheeler manufacturer's dealerships will be closed till April 14 due to a 21-day nationwide lockdown to contain the spread of COVID-19.
Hero MotoCorp told suppliers that several BS-IV AND BS-VI vehicles were unsold at the dealerships, the report said.
Hero MotoCorp has the highest share of the total 700,000 unsold BS-IV scooters and motorcycles in India, the report said.
In a report on March 16, Kota Institutional Equities upgraded Hero MotoCorp to “add” from a “sell”.","Hero MotoCorp has suspended full payments to suppliers since sales have paused and there is “no visibility of receivables,” according to a report.","The share price of motorcycle and scooter manufacturing company Hero MotoCorp fell 6 percent intraday on March 30 after the company decided to halt operations till March 31, 2020, at all its manufacturing plants globally to maintain the health and well‐being of employees, due to escalating COVID‐19 situation.

Amid the coronavirus lockdown, Hero MotoCorp has suspended full payments to suppliers since sales have paused and there is “no visibility of receivables,” according to a report by The Economic Times.

Moneycontrol could not independently verify the story.

Also read: Hero MotoCorp suspends full payments to suppliers: Report

The two-wheeler manufacturer's dealerships will be closed till April 14 due to a 21-day nationwide lockdown to contain the spread of COVID-19. Hero MotoCorp told suppliers that several BS-IV AND BS-VI vehicles were unsold at the dealerships, the report said.

Hero MotoCorp has the highest share of the total 700,000 unsold BS-IV scooters and motorcycles in India, the report said.

“Despite the challenging circumstances... we are prioritizing payments process to make full and on-time payments to a large number of MSMEs and small vendors,” the company said in an email to The Economic Times.

In a report on March 16, Kota Institutional Equities upgraded Hero MotoCorp to “add” from a “sell”. The brokerage firm has fixed the fair value of the stock at Rs 2,150, a 20 percent upside from the current market price.

""We upgrade the stock to 'add' from 'sell' on attractive valuations (11 times FY22E core EPS). While the catalysts for near- term growth are absent due to impact on consumption because of Covid-19 and shift to BS-VI norms from April 2020, we believe growth will resume for the company from the second half of FY21 led by a revival in rural demand,"" Kotak said.

The share price shed over 43 percent in the last 6 months and was quoting at Rs 1,550.00, down Rs 110.15, or 6.63 percent. It has touched an intraday high of Rs 1,655.00 and an intraday low of Rs 1,550.

It was trading with volumes of 31,277 shares, compared to its five day average of 41,402 shares, a decrease of -24.45 percent.

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hero-moto-share-price-falls-3-on-report-of-suppliers-payment-suspension-5086181.html
23,"March 30, 2020 12:08 PM IST",-2,Sandip Das,D-Street Buzz: Banks under pressure after RBI nod for PSU bank merger; Tata Steel tanks 6%,"Among the sectors, Bank Nifty was down over 2 percent dragged by RBL Bank and YES Bank which shed over 4 percent each followed by HDFC Bank, Federal Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank.
The Reserve Bank of India on March 28, 2020 said it has approved the amalgamation of Oriental Bank of Commerce and United Bank of India into Punjab National Bank, Syndicate Bank into Canara Bank, Andhra Bank and Corporation Bank into Union Bank of India and Allahabad Bank into Indian Bank.
The scheme will come into force with effect from April 1, 2020 and all the branches of Oriental Bank of Commerce and United Bank of India will function as branches of PNB branches; Syndicate Bank branches into Canara Bank branches; Andhra Bank and Corporation Bank branches into Union Bank of India branches and Allahabad Bank branches into Indian Bank branches.
Indian Bank, Bank of Baroda, J&K Bank shed over 3 percent each while Central Bank of India, State Bank of India, Union Bank of India and Punjab National Bank were the other losers.
Metal stocks are also under pressure with the index down over 2 percent dragged by Tata Steel, JSW Steel and Jindal Steel & Power which fell 4-6 percent followed by Ratnamani Metal, Vedanta and Hindalco Industries.","Indian Bank, Bank of Baroda, J&K Bank shed over 3 percent each while Central Bank of India, State Bank of India, Union Bank of India and Punjab National Bank were the other losers.","The Indian stock market continues trading in the red following Asian peers but is off the day's low. Sensex is down 588.01 points or 1.97 percent at 29227.58, and the Nifty shed 160.30 points or 1.85 percent at 8499.95.

Among the sectors, Bank Nifty was down over 2 percent dragged by RBL Bank and YES Bank which shed over 4 percent each followed by HDFC Bank, Federal Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank.

The Reserve Bank of India on March 28, 2020 said it has approved the amalgamation of Oriental Bank of Commerce and United Bank of India into Punjab National Bank, Syndicate Bank into Canara Bank, Andhra Bank and Corporation Bank into Union Bank of India and Allahabad Bank into Indian Bank. The scheme will come into force with effect from April 1, 2020 and all the branches of Oriental Bank of Commerce and United Bank of India will function as branches of PNB branches; Syndicate Bank branches into Canara Bank branches; Andhra Bank and Corporation Bank branches into Union Bank of India branches and Allahabad Bank branches into Indian Bank branches. Following the consolidation, there will be seven large public sector banks and five smaller ones. There were as many as 27 PSBs in 2017, according to a report by CNBC-TV18.

RBI's statement comes after Finance Minister Nirmala Sitharaman's clarification on March 26 that the mega bank consolidation plan was very much on track and would take effect from April 1.

Indian Bank, Bank of Baroda, J&K Bank shed over 3 percent each while Central Bank of India, State Bank of India, Union Bank of India and Punjab National Bank were the other losers.

Nifty has been seeing erratic swings in a broader range and we do not see this changing any time soon. The range for the next week could be 7,600-9,500 levels. While mostly sectoral indices are trading in line with the benchmark index, defensive viz. FMCG, pharma and IT are looking comparatively stronger. Considering the scenario, traders should limit their positions and prefer only hedged trades, said Ajit Mishra, VP - Research at Religare Broking.

Metal stocks are also under pressure with the index down over 2 percent dragged by Tata Steel, JSW Steel and Jindal Steel & Power which fell 4-6 percent followed by Ratnamani Metal, Vedanta and Hindalco Industries.

India VIX is up 2.97 percent at 72.48 level.

The top gainers are Tech Mahindra, Axis Bank, GAIL India, Cipla and BPCL while the top losers included Bajaj Finance, Eicher Motors, HDFC, JSW Steel and Tata Steel.

About 769 shares have advanced, 1087 shares declined, and 110 shares are unchanged.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-banks-under-pressure-after-rbi-nod-for-psu-bank-merger-tata-steel-tanks-6-5086351.html
24,"March 31, 2020 07:03 AM IST",1,Nishant Kumar,Hot Stocks | Here are 3 short-term buys that can give up to 10% return,"The positional trend of Nifty is still bearish as 50-days exponential moving average has been sustaining below 200-days exponential moving average.
The gap between 50-days exponential moving average and 200-days exponential moving average is substantial this time, which indicates the weakness in the overall trend.
Stocks below 200-days moving average has reached 89 percent, which was at 98 percent and 94 percent in 2008 and 2001, respectively.
Torrent Pharmaceuticals | Buy | LTP: Rs 1,948.05 | Target: Rs 2,150 | Stop loss: Rs 1,812 | Upside: 10%Torrent Pharma is one of the few stocks which are trading above its 200-day moving average.
Currently, a very low number of stocks from the NSE500 segment is trading above its 20-day moving average and this stock falls under that category.","As far as support is concerned, the level of 8,095 on Nifty would play a key role","Vinay Rajani

Last week, we saw Nifty rising more than 20 percent from the bottom of 7,511 towards 9,038. However, in the last two trading sessions, Nifty retraced more than 50 percent of that entire up move.

The positional trend of Nifty is still bearish as 50-days exponential moving average has been sustaining below 200-days exponential moving average.

In the past, we saw the development of death cross on Nifty charts in September 2019, November 2018 and December 2016 but the gap between these two averages did not enlarge to the extent which we are observing in the current scenario.

The gap between 50-days exponential moving average and 200-days exponential moving average is substantial this time, which indicates the weakness in the overall trend.

Short-term swings have widened in Nifty and 500 points move in a session has become normal nowadays.

On March 23, Nifty completed a fall of 40 percent in the span of 46 sessions, which is the second-fastest 40 percent fall after the bearish markets of the year 1992.

Stocks below 200-days moving average has reached 89 percent, which was at 98 percent and 94 percent in 2008 and 2001, respectively.

As far as support is concerned, the level of 8,095 would play a key role. The level of 8,095 happens to be the 61.8 percent retracement of the entire 20 percent pullback that Nifty registered from 7,511 to 9,038.

Retracement of more than 61.8 percent usually negates the chances of a resumption of the trend. So, any close below 8,095 would be considered bearish and Nifty could resume its primary downtrend.

If Nifty manages to hold above 8,095 then there would be two positive technical developments on the charts.

The first would be the higher bottom and the second would be the formation of inverse head and shoulder on daily line charts.

However, bullish confirmation would only come if Nifty closes above 8,660. Any close above 8,660 without violating 8,095 support could push Nifty towards 9,970, which would be derived from inverse head and shoulder pattern.

Here are three stock recommendations for the next 3-4 weeks:

Nippon India ETF Gold Bees | Buy | LTP: Rs 40 | Target: Rs 44 | Stop loss: Rs 38 | Upside: 10%

Year to date, Nifty has fallen by about 32 percent, while Gold Bees ETF has risen 16 percent.

Gold as an asset class has come out as a real outperformer in the turbulent times of global financial markets.

Gold as a commodity has resumed its uptrend after witnessing a correction. Depreciating rupee against the dollar has also been helping the Indian gold prices to outperform international gold.

Gold bees ETF has formed nice rounding bottom on the daily charts and closed at an all-time high level.

We believe that portfolios should have a higher allocation in gold at least for the next 3-6 months.

Torrent Pharmaceuticals | Buy | LTP: Rs 1,948.05 | Target: Rs 2,150 | Stop loss: Rs 1,812 | Upside: 10%

Torrent Pharma is one of the few stocks which are trading above its 200-day moving average.

Pharma as a sector is expected to outperform in the current scenario. Depreciating rupee against the dollar could also help this sector to remain strong in the coming weeks.

The stock is maintaining higher tops and higher bottoms on the monthly charts and the recent correction from the all-time high level seems to be the opportunity to create fresh long positions in the counter.

The stock tested its 200-day moving average and bounced recently. RSI has exited the oversold zone on the daily charts.

Colgate Palmolive (India) | Buy | LTP: Rs 1,220 | Target: Rs 1,345 | Stop loss: Rs 1,140 | Upside: 10%

The stock price has closed above its 5, 10 and 20-day moving average. Indicators and oscillators have turned bullish on the short-term charts.

FMCG sector is likely to do well in the current scenario. Consumer staple stocks can continue to do well in the next 1-2 months.

Currently, a very low number of stocks from the NSE500 segment is trading above its 20-day moving average and this stock falls under that category.

(The author is Technical Research Analyst at HDFC Securities)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-here-are-3-short-term-buys-that-can-give-up-to-10-return-5088131.html
1,"March 27, 2020 09:49 AM IST",1,,Tactical pick: Britannia,"We don’t see a strong pick-up in volume growth in the near term, but Britannia is expected to do better than some of its FMCG peers@moneycontrolcom Moneycontrol Research","We don’t see a strong pick-up in volume growth in the near term, but Britannia is expected to do better than some of its FMCG peers","We don’t see a strong pick-up in volume growth in the near term, but Britannia is expected to do better than some of its FMCG peers

@moneycontrolcom Moneycontrol Research",https://www.moneycontrol.com/news/business/moneycontrol-research/tactical-pick-britannia-5077981.html
2,"March 28, 2020 02:38 PM IST",1,Kshitij Anand,'Retail investors in 'buy mode' even as institutional entities search safer havens during sell-off',"This does seem well justified given the large-scale damage the Coronavirus is causing to people’s health as well as in markets.
Fear of the global impact of the coronavirus has sent markets on a downward spiral over the past few weeks.
Given the unpredictability of the economic impact of the coronavirus on companies, institutional investors are looking to move away from equities into safer assets such as US treasuries.
Retail investors in buy mode:However, an interesting trend that has emerged during this downturn is that while institutional investors have been rushing towards safer havens, retail investors have actually been calmly buying stocks during this sell-off.
Even more, interestingly, Indian retail investors have also been increasing their exposure to the US markets over the last few weeks.","Based on data from Fidelity and Vested, it seems like investors have been lapping up popular brands such as Apple, Amazon, Tesla, and Microsoft as these mega-caps have tumbled off of record highs.","Viram Shah

It is being said that during this 21-Day lockdown in India, there are two key topics of discussion among people: a) the COVID-19 and the other is, b) markets.

This does seem well justified given the large-scale damage the Coronavirus is causing to people’s health as well as in markets.

Fear of the global impact of the coronavirus has sent markets on a downward spiral over the past few weeks. Though the government stimulus announcements helped stage a mini-recovery over the last few days, the Sensex is still down 27.2 percent over the last three months while the S&P 500 is down 18.8 percent.

The S&P 500 hit the lower circuit breaker for the first time since 1997 on March 9th and since then it hit the circuit breaker 2 more times in six trading days.

Given the unpredictability of the economic impact of the coronavirus on companies, institutional investors are looking to move away from equities into safer assets such as US treasuries.

This can be seen in the short-term treasury yields as they turned negative for the first time in more than four years on March 25th.

Given that US government bonds or Treasury bills are the safest assets in the world, they are in high demand during times of volatility.

Retail investors in buy mode:

However, an interesting trend that has emerged during this downturn is that while institutional investors have been rushing towards safer havens, retail investors have actually been calmly buying stocks during this sell-off.

According to data from Fidelity and Vanguard, two of the biggest brokers in the US, their individual clients have shown no signs of panic.

For example, approximately 1 percent of the US Vanguard households traded each day over the last two weeks versus 0.4 percent trading on each typical day.

On March 9th, Fidelity saw a buy-to-sell ratio of 2.11 to 1 even though the market dropped by 7 percent. Even more, interestingly, Indian retail investors have also been increasing their exposure to the US markets over the last few weeks.

For example, at Vested we have seen a 4x increase in funds deposited on our platform during this quarter compared to the last quarter. In the last week alone, we saw a 65 percent increase in weekly accounts opened.

While this increase could be related to investors looking to invest abroad before their annual LRS limit expires on March 31st, a large portion of investors mentioned that their reason to start now is that the crash gave them a good opportunity to start investing in the US market.

What are these investors buying?

Based on data from Fidelity and Vested, it seems like investors have been lapping up popular brands such as Apple, Amazon, Tesla, and Microsoft as these mega-caps have tumbled off of record highs.

Along with these stocks, the index ETFs such as Invesco’s Nasdaq 100 ETF QQQ or iShares’ S&P 500 ETF IVV has also seen strong interest.

While it is indeed encouraging to see increased retail investor participation during such times, a word of caution – timing the market and hoping to get it right is next to impossible.

It would be prudent to create a well-diversified portfolio and continue to hold it for a long period of time to be able to grow one’s wealth over the long-term.

(The author is Co-Founder & CEO, Vested Finance)

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/retail-investors-in-buy-mode-even-as-institutional-entities-search-safer-havens-during-sell-off-5082651.html
3,"March 27, 2020 12:04 PM IST",-2,Sandip Das,"D-Street Buzz: Nifty Auto underperforms dragged by Maruti; IRCTC, Avenue Supermarts hit upper circuit","MPC voted for a sizable reduction in Repo Rate and maintaining Accommodative Stance.
Bank continue to lead the way with Axis Bank jumping 12 percent followed by State Bank of India, IndusInd Bank and ICICI Bank.
The most active stocks included ICICI Bank, HDFC Bank, State Bank of India, Axis Bank and Reliance Industries.
220 stocks hit 52-week low on BSE including Future Lifestyle, Future Retail and Kalpataru Power among others.
184 stocks hit upper circuit on BSE including IRCTC, Edelweiss Financial, Avenue Supermarts, DCB Bank and Bajaj Holdings.","220 stocks hit 52-week low on BSE including Future Lifestyle, Future Retaila and Kalpataru Power among others.","The Reserve Bank of India reduced repo rate by 75 basis points to 4.4 percent. MPC voted for a sizable reduction in Repo Rate and maintaining Accommodative Stance. There were some differences in quantum of reduction and MPC voted by 4:2 majority to reduce policy repo rate by 75 bps to 4.4 percent, the RBI Governor said in the press meet.

The Indian stock market seems not happy with the measures taken by RBI as Sensex is down 206.29 points or 0.69 percent at 29740.48, and the Nifty gained 9.80 points or 0.11 percent at 8651.25.

Although, the banking index is outperforming all other sectors, Nifty Auto is dragging the market lower. The index is down 1.5 percent, the top losers being Maruti Suzuki which fell over 4 percent as the auto factories remains under lockdown amid spread of coronavirus. The other losers included Hero MotoCorp, Bharat Forge, Eicher Motors, TVS Motor Company and Apollo Tyres.

Nifty Infra also shed over a percent dragged by Bharti Airtel which tanked over 6 percent and is the top index loser. Apollo Hospitals, Ramco Cements, Shree Cements and Tata Power are the other losers.

Among the oil & gas names, HPCL and GAIL India shed over 4 percent each followed by Indian Oil Corporation and Reliance Industries.

Bank continue to lead the way with Axis Bank jumping 12 percent followed by State Bank of India, IndusInd Bank and ICICI Bank. The most active stocks included ICICI Bank, HDFC Bank, State Bank of India, Axis Bank and Reliance Industries.

India VIX is down 0.49 and is trading at 71.18 level.

The market has been patiently waiting for our Central Bank's action in light of what all global Central Banks have done till now post the COVID-19 scare. The MPC has come with really big measures including rate cuts, CRR cut, floating rate long-term repos for investment grade corporate bonds and CPs, forbearance on loans in terms of moratoriums and deferral of interest payments, capital conservation buffer deferment by six months and offshore NDF market relaxations. This seems to be a comprehensive package and very necessary at this stage when growth will be under pressure, said Sudhakar Shanbhag, Chief Investment Officer, Kotak Mahindra Life Insurance.

220 stocks hit 52-week low on BSE including Future Lifestyle, Future Retail and Kalpataru Power among others.

184 stocks hit upper circuit on BSE including IRCTC, Edelweiss Financial, Avenue Supermarts, DCB Bank and Bajaj Holdings. On the other hand, 228 stocks hit lower circuit including Alok Industries, Future Consumer, Future Retail, Unitech, JMT Auto and Supreme Infra among others.

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/d-street-buzz-nifty-auto-underperforms-dragged-by-maruti-irctc-avenue-supermarts-hit-upper-circuit-5079181.html
4,"March 27, 2020 11:07 AM IST",-2,Kshitij Anand,The untold story! 2020's Nifty crash comparable to 1987 not 2008,"Close When we pointed out - get ready for 2008 crash not many paid heed and now it looks to be bigger than that and actually comparable to 1987!
Next low on Bank Nifty might be coming in first week of FebruaryIs Nifty showing signs of topping out?
The first chart is of Dow Jones Industrial Average (DJIA) from the year 1987 crash and the second chart is of Nifty Index year 2020 so far, Astonished Yet!
This clearly shows that the pattern and the intensity of fall seen on Nifty is nothing but a repetition of 1987.
The stock market acts as a barometer of social mood and the depressed stock market represents a negative social mood.",India is supposed to have entered the most delicate phase with respect to Corona Virus and Nifty has already rallied by 1100 points from the lows! Astonished Yet!,"Ashish Kyal, CMT We have been bold and strong over many weeks that major top is formed in Indian indices and it is comparable to the 2008 collapse. But, it seems we were conservative and the fall is actually comparable to 1987. Close When we pointed out - get ready for 2008 crash not many paid heed and now it looks to be bigger than that and actually comparable to 1987! Ashish Kyal Founder|Waves Strategy Advisors - wavesstrategy.com Coronavirus hits Indian market! Nifty bounces back but so did China: what is the way ahead?

Heads up! Next low on Bank Nifty might be coming in first week of February

Is Nifty showing signs of topping out? KST indicator has a story to tell Only a few who acted on the advice have been cashing the crash and the rest are occupied identifying the news or events resulting in the drastic downfall. We are facing unprecedented challenges to humanity and existence the way we know it. Given the current pandemic of coronavirus, human survival instincts are challenged. We have been able to flourish on this planet only because of the strong zeal to grow amidst the situations. Case in point is we do acknowledge the gravity of the situation but these are not the times to blame nature or anything else for the financial meltdown but to see what best can be made out of it. We have a history that shows that the best of the ideas and financial institutions came up during the Great depression of 1929! So, during these periods we need to take charge of our trading or investment decisions and see what is working in the current bear market. Now look at the below charts, Do you see any similarity in the fall? Weekly chart:

Let me reveal the secret! The first chart is of Dow Jones Industrial Average (DJIA) from the year 1987 crash and the second chart is of Nifty Index year 2020 so far, Astonished Yet!

This is the power of looking at patterns across the market and time frames. This clearly shows that the pattern and the intensity of fall seen on Nifty is nothing but a repetition of 1987.

Also, it shows that it is Greed, Fear and Hope that results in movement of the stock market and the events only result in short-term volatility or acts as a trigger.

Coronavirus is widely referred to as the only reason for the financial and economic collapse. But, the markets were already exhibiting series of negative divergences and loss of momentum.

The major global epidemic outbreak has been during the extended period of a bear market as pointed out by Robert Prechter, Executive Director, Socionomic Institute.

The stock market acts as a barometer of social mood and the depressed stock market represents a negative social mood. It is during this period that the society is more susceptible to the epidemic outbreaks.

India has just started to catch the Corona fever and the markets have topped out much earlier in January 2020. In fact, the day honorable Prime Minister – Modi announced the 21-day lockdown on 24th March evening, the very next day on 25th March Nifty closed up 497 points – 6.37 percent higher locked biggest gain in 11 years!

Followed by another 4.10 percent gain on 26th March 2020. This has resulted in an up move of more than 1100 points on the index from the lows of 7511 made on 24 March 2020 starting the day complete India lockdown was announced.

The above indicates that freely traded markets move ahead of events or news and any trading decision based on news outflow is like driving a car looking at the rearview mirror.

Events can result in a short-term random movement which can last for a few minutes or hours or days but the original trend eventually resumes!",https://www.moneycontrol.com/news/business/markets/the-untold-story-2020s-nifty-crash-comparable-to-1987-not-2008-5078541.html
5,"March 27, 2020 09:57 AM IST",1,Sandip Das,"Banking stocks gain after RBI cuts interest rates by 75 bps, CRR to 3%; IndusInd Bank, Axis Bank, SBI top gainers","Reserve Bank of India reduced repo rate by 75 basis points to 4.4 percent.
Among the sectors, the Bank Nifty outperformed all other indices, gaining over 6 percent.
The top gainers included Axis Bank and IndusInd Bank being the top gainers, jumping 9-11 percent each.
They were followed by IDFC First Bank, RBL Bank, YES Bank, Kotak Mahindra Bank and HDFC Bank.
Among the PSU banking names, State Bank of India jumped 6 percent followed by Union Bank of India, Indian Bank, Bank of India, Punjab National Bank and Canara Bank.",The Bank Nifty along with the Nifty PSU Bank index jumped 7-8 percent in the morning trade.,"Indian shares opened higher on March 27, with the Nifty opening above the psychologically important 9,000-mark. But the market is trading at day's low with Sensex up 518.45 points or 1.73 percent at 30465.22, and the Nifty gained 215.65 points or 2.5 percent at 8857.10 at 10:15 hrs IST.

Reserve Bank of India reduced repo rate by 75 basis points to 4.4 percent. MPC voted for a sizable reduction in Repo Rate and maintaining Accommodative Stance. There were some differences in quantum of reduction and MPC voted by 4:2 majority to reduce policy repo rate by 75 bps to 4.4 percent, the RBI Governor said in the press meet.

Among the sectors, the Bank Nifty outperformed all other indices, gaining over 6 percent.

The RBI's press conference comes a day after Finance Minister Nirmala Sitharaman announced a Rs 1.07 lakh crore relief package for the poor.

The economy has been battered by COVID-19 and governments across the globe have taken measure to combat the impact. While the finance minister's announcements were a mix of measures, including direct cash transfers and distribution of free food grains for three months to help the economically weaker sections, the RBI governor is expected provide some relief to corporate India as well.

The top gainers included Axis Bank and IndusInd Bank being the top gainers, jumping 9-11 percent each. They were followed by IDFC First Bank, RBL Bank, YES Bank, Kotak Mahindra Bank and HDFC Bank.

Among the PSU banking names, State Bank of India jumped 6 percent followed by Union Bank of India, Indian Bank, Bank of India, Punjab National Bank and Canara Bank.

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/banking-stocks-rally-ahead-of-rbi-press-meet-indusind-bank-axis-bank-zoom-14-15-5078661.html
6,"March 27, 2020 09:53 PM IST",1,,Watch: Ideas For Profit | Decoding the impact of COVID-19 on HDFC Bank's performance,"HDFC Bank, the largest and most profitable private sector bank, has been seen the most consistent performer on the bourses for many years.
It has delivered manifold returns since its listing in 1995.
It has generated compounded annual returns of around 19 percent in the past 20 years, significantly outperforming Nifty.
However, the bank's stock has corrected almost 30 percent from its 52-week high (all-time high) following the coronavirus outbreak.
In this edition of Ideas for Profit, Moneycontrol's Sakshi Batra will be discussing if the Covid-19 scare and subsequent containment measure of locking down the country mark an end to the stock's more than 25- year old bull run?",HDFC Bank has delivered manifold returns since it made its debut at the exchanges in 1995.,"HDFC Bank, the largest and most profitable private sector bank, has been seen the most consistent performer on the bourses for many years. It has delivered manifold returns since its listing in 1995.

It has generated compounded annual returns of around 19 percent in the past 20 years, significantly outperforming Nifty.

However, the bank's stock has corrected almost 30 percent from its 52-week high (all-time high) following the coronavirus outbreak.

In this edition of Ideas for Profit, Moneycontrol's Sakshi Batra will be discussing if the Covid-19 scare and subsequent containment measure of locking down the country mark an end to the stock's more than 25- year old bull run?",https://www.moneycontrol.com/news/business/earnings/watch-ideas-for-profit-decoding-the-impact-of-covid-19-on-hdfc-banks-performance-5080821.html
7,"March 28, 2020 09:42 AM IST",-2,Kshitij Anand,Carnage in broader markets; over 200 stocks in the small-cap space down 10-40%,"The S&P BSE Sensex fell 0.3 percent while the Nifty50 was down by 0.97 percent for the week ended March 27, but the big carnage was seen in the broader market space where the S&P BSE Small-cap index was down 6.09 percent, and the S&P BSE Mid-cap index plunged 5.4 percent in the same period.
As many as 230 stocks in the S&P BSE Small-cap index gave negative returns in the range of 10-40 percent.
Note: Here are the top 60 names out of 230 stocks in the Small-cap index that fell 10-40 percent for the week ended March 27.
It was an eventful week for Indian markets with a flurry of stimulus packages from central bankers across the world.
The broader markets relatively underperformed as the Nifty mid-cap and small-cap lost 7 percent and 8 percent, respectively.",In the coming truncated week we expect the index to consolidate in the broad range of 9000-7800 amid stock-specific action with elevated global volatility,"What a week for Indian markets! Bulls tried to make comeback but failed. And although they helped pare some losses towards the closing of the week in the benchmark indices, we cannot say the same for the broader markets.

The S&P BSE Sensex fell 0.3 percent while the Nifty50 was down by 0.97 percent for the week ended March 27, but the big carnage was seen in the broader market space where the S&P BSE Small-cap index was down 6.09 percent, and the S&P BSE Mid-cap index plunged 5.4 percent in the same period.

As many as 230 stocks in the S&P BSE Small-cap index gave negative returns in the range of 10-40 percent. These include names such as Indiabulls Ventures, Jindal Saw, Alok Industries, Simplex Infrastructure, Future Consumer, PNC Infra, Pennar Industries and Steel Strips among others.

Note: Here are the top 60 names out of 230 stocks in the Small-cap index that fell 10-40 percent for the week ended March 27.

More than 160 stocks in the S&P BSE 500 index fell 10-30 percent, including names such as Future Consumer, Lemon Tree, Credit Access, KRBL, Future Retail, Welspun India, Bajaj Finserv, and NCC among others.

It was an eventful week for Indian markets with a flurry of stimulus packages from central bankers across the world. The United States government also gave a nod to the $2 trillion packages which was signed by the US President Donald Trump on March 27 and back home, a flurry of stimulus measure were announced by Finance Minister Nirmala Sitharaman and the Reserve Bank of India (RBI) Governor Shaktikanta Das.

The government is trying to address the problem of slowdown which looks imminent. The commentary from the RBI was positive as it assured investors that the central bank is ready to take any measures whenever the situation arises.

The bounce back is encouraging but experts advise not to mistake it with a ‘reversal’. As long as the Nifty50 holds 7,511 which was the swing low March 24, things are likely to stay on the upside, however, a breach of the same could lead to further profit-taking.

""After the US’ $2 trillion stimulus, a whopping 9.5 percent of its GDP, Germany granted 21.1 percent of its GDP as a stimulus, and China granted 2.8 percent, India’s stimulus quantum looks small, but nonetheless is arriving in piecemeal packets regularly,” Jimeet Modi, Founder & CEO, SAMCO Securities & StockNote said in a note.

""While these are temporary steroids for the economy, nobody can estimate the intensity of the pain that this pandemic and lockdown is going to befall upon our economy and businesses,"" he said.

Modi further added that earnings contraction in the next two quarters is certainly a given with tourism, airlines, hotels, metals, retail outlets not under essential goods getting impacted the most, and investors must not mistake this bounce as a sharp rally, but a normal correction which will face selling pressure at higher levels.

Technical Outlook:

Equity benchmarks continue to trade with high volatility as Nifty during the previous week oscillated in a 1,500 points range and closed marginally lower by 1 percent at 8,660 to extend the decline for a six consecutive week.

The broader markets relatively underperformed as the Nifty mid-cap and small-cap lost 7 percent and 8 percent, respectively. The weekly candle suggests that the selling pressure might just be abating, and the index could consolidate in the coming week.

""The weekly price action resembles thrusting line bull candle indicating abating downward momentum, as Nifty posed a strong pullback after holding 7,500 mark twice during the week, as prices approached deep oversold trajectory after 40 percent decline from all-time high (12,430),"" Dharmesh Shah, Head – Technical, ICICI direct told Moneycontrol.

""Going ahead in the coming truncated week we expect the index to consolidate in the broad range of 9,000-7,800 amid stock-specific action with elevated global volatility aiding the index to bring some stability in the market,"" he said.

Shah further added that a retracement towards 8,000-7,800 (80 percent retracement of last week’s gain) should be utilised as an incremental buying opportunity.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/carnage-in-broader-markets-over-200-stocks-in-the-small-cap-space-down-10-40-5082271.html
8,"March 29, 2020 02:10 PM IST",1,Sunil Matkar,Time to become greedy? Motilal Oswal suggests 10 stocks available at attractive valuations,"With the first ever two consecutive quarters of GDP decline, the Indian economy could see its first technical recession since 1990s,"" Motilal Oswal said in a strategy note.
Long term investors with good quality stocks should hold on to their portfolios and see through the current storm.
As the volatility is the friend of long term investors by making good stocks cheaper and attractive, the best strategy for retail investors would be to accumulate good fundamental and quality stocks gradually over the next few weeks and months, the brokerage suggests.
""While it is very difficult to predict the bottom of the market, it always rewards investors in the long term who take the benefit of such sharp fall,"" Motilal Oswal said.
As most of index heavyweights and quality stocks turned attractive in valuations, Motilal Oswal picks top 10 ideas which are Reliance Industries, HDFC Bank, Hindustan Unilever, HDFC, Infosys, Bharti Airtel, ICICI Bank, UltraTech Cement, Alkem Labs and Tata Consumer.","Motilal Oswal feels markets may continue to fall in near term, and that's the time to start becoming greedy. Hence the brokerage suggests accumulating on a gradual basis.","The rising fatalities and infected cases worldwide due to COVID-19 has dented market sentiment for nearly one-and-half-month now.

The benchmark indices have crashed more than 38 percent (from their record high seen in January) till March 23, but there was some short-covering and value buying in last four trading sessions due to government measures for poor and daily wage earners, and liquidity stimulus by RBI.

Now the market loss stands at over 30 percent from record highs. Globally, markets fell in the range of 20-30 percent as several industries shut their offices and plants.

With the number of cases surpassing 6.5 lakh and death toll crossing 30,000 mark worldwide, almost all the countries have announced lockdown to control the pandemic. Global activity has come to a halt, disrupting the economy and earnings in a major way.

For the time being, with the 875 active cases and 25 deaths, India's situation is relatively better than others as the government quickly implemented 21-day lockdown (except essential services) effective from March 25. It will definitely have major adverse effects on earnings and economy, but the government along with regulators have been trying hard to minimise the impact.

""A sensitivity analysis of the adverse impact of lockdown on economic activity suggests that real GDP could decline around 3 percent YoY in Q4FY20 while it could decline 12.2 percent YoY in Q1FY21, assuming that things normalise from mid-May 2020. With the first ever two consecutive quarters of GDP decline, the Indian economy could see its first technical recession since 1990s,"" Motilal Oswal said in a strategy note.

The brokerage feels if the economy, however, remains affected for a longer period, the 'self-employed' people (around 52 percent of all employment), and the 'regular wage/salaried workers' (around 23 percent) would also be seriously affected.

Complete lockdown in an already sluggish economic growth environment of India is leading to extremely volatile market conditions, Motilal Oswal said, adding if not contained well, the spread of the virus can have a significant impact on the domestic consumption-driven economy.

According to the brokerage, what makes this slowdown unique is that the policymakers' intervention – monetary or fiscally – will be broadly ineffective in addressing the economic effects unless the COVID-19 subside.

The volatility also increased sharply in last couple of weeks, as VIX hit 86 levels before falling to 70 last Friday. In such conditions, all experts advised traders to be calm and not to panic as high volatility is likely to bring more pressure on bulls, but for long term investors, it is right time to invest in quality stocks.

""Once the virus is contained, markets would stabilise. Long term investors with good quality stocks should hold on to their portfolios and see through the current storm. Traders should refrain taking long positions as all the global markets are in strong bear grip and all the small bounces have been used as selling opportunity,"" Motilal Oswal said.

As the volatility is the friend of long term investors by making good stocks cheaper and attractive, the best strategy for retail investors would be to accumulate good fundamental and quality stocks gradually over the next few weeks and months, the brokerage suggests.

Ace investors always say when the market is falling, it is difficult to predict the bottom, whereas when the market is rising and rising, the top would be difficult to predict. They further say when the market falls sharply, better be greedy and accumulate quality stocks, but when the market starts rising fast with a risk-on rally, the one should be fearful of the rally and better be out of market.

""While it is very difficult to predict the bottom of the market, it always rewards investors in the long term who take the benefit of such sharp fall,"" Motilal Oswal said.

He feels markets may continue to fall in the near term, and that's the time to start becoming greedy. Hence the brokerage suggests accumulating on a gradual basis.

As most of index heavyweights and quality stocks turned attractive in valuations, Motilal Oswal picks top 10 ideas which are Reliance Industries, HDFC Bank, Hindustan Unilever, HDFC, Infosys, Bharti Airtel, ICICI Bank, UltraTech Cement, Alkem Labs and Tata Consumer.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/time-to-become-greedy-motilal-oswal-suggests-10-stocks-available-at-attractive-valuations-5084271.html
9,"March 27, 2020 07:22 PM IST",1,Kshitij Anand,"The Market Podcast | Dalal Street will bounce back, right time to accumulate jewels of India'","Most of the money which was flowing out was the ETF selling and India has a 10 percent weightage in the emerging market basket.
With the introduction of the stimulus package from the US Fed, where they said they would buy corporate bond ETF, the move is likely to calm nerves of global investors, Kumar said.
He added that the fall is good for long-term investors because India should be able to get back on its feet in a quick time, and the time is right to accumulate jewels of India.
But, the long-term story remains intact and this is the time to buy the jewels of India,” Kumar added.
Investors should look at buying the companies where there is a strong business model, and management credibility is very strong.","Investors should look at buying the companies where there is a strong business model, says Shailendra Kumar.","The Indian market might have given a mixed response to the measures introduced by the Reserve Bank of India (RBI) on Friday, but these are strong measures and will help India back on its feet much quicker than other global counterparts, Shailendra Kumar, CIO, Narnolia Financial Advisors, said in the ‘Market podcast’ with Moneycontrol.

The bottoming out process for Indian markets has already begun. “We turned positive on Indian markets on Tuesday and the primary reason is that FPI selling is likely to reduce now, which was the primary reason for the fall in the first place,” he said.

Most of the money which was flowing out was the ETF selling and India has a 10 percent weightage in the emerging market basket. With the introduction of the stimulus package from the US Fed, where they said they would buy corporate bond ETF, the move is likely to calm nerves of global investors, Kumar said.

Indian equities, having 10 percent weight in emerging market ETFs, suffered the collateral damage. This high selloff in such a short time span cannot get matching domestic buyers.

This sharp fall in all the liquid investment asset classes happened as most of the corporations and investors moved towards cash (‘move to cash’ trades) to tide over the near term pain of a standstill economy.

He added that the fall is good for long-term investors because India should be able to get back on its feet in a quick time, and the time is right to accumulate jewels of India.

“History suggests that humanity has always won, and this too shall pass. No doubt the economy is in a difficult zone and we might be staring at a negative GDP growth in the next quarter. But, the long-term story remains intact and this is the time to buy the jewels of India,” Kumar added.

Investors should look at buying the companies where there is a strong business model, and management credibility is very strong.

COVID-19 is a threat to humanity and damage to the underlying economy is significant. Being the barometer, the equity market has fallen in tandem with this Black Swan event.

But the valuation compression is significant and the market has extrapolated current economic pains even for long-term earning potentials of the companies.

On a simplified basis, any price below the Nifty levels of 9,500 is an undervaluation level, though when the market is not in a normal rational state, it can show us any price but those surely would not be a long term reality.

(Tune in to the podcast for more)

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/podcast/market-podcast-market-will-bounce-back-right-time-to-accumulate-jewels-of-india-5080901.html
11,"March 30, 2020 06:55 AM IST",0,Nishant Kumar,Hot Stocks | Here's why TCS and Coal India are short-term buys,"As long as the index holds above 8,000, we can expect the positive momentum to continue towards 9,350 than 9,500.
We have already seen a strong pullback from lower levels, so risk and reward are not in favour of the longs.
The immediate support is now placed at 8,300 and below that, the index may again slip towards 8,000 levels.
Now, it seems like the stock may attempt to fill the gap which is placed at Rs 1,900 levels in the short-term.
The momentum indicator RSI has also reversed from the oversold territory which indicates positive momentum in the stock.",The volatility index India VIX fell for the third consecutive session and it ended near 71 levels; now it has to fall below 50 levels to give comfort to the bulls.,"Nilesh Ramesh Jain

After logging gains for three consecutive sessions, the Indian market witnessed profit-booking on March 27 and Nifty gave away all the gains after facing stiff resistance at 9,000-mark.

Nifty is making higher top higher bottom on intraday charts. As long as the index holds above 8,000, we can expect the positive momentum to continue towards 9,350 than 9,500.

However, the broader structure still looks weak and one should refrain from creating any aggressive long positions.

We have already seen a strong pullback from lower levels, so risk and reward are not in favour of the longs. Although, we are expecting pullback which is unlikely to sustain at higher levels and we may see another leg on the downside once this pullback gets over.

The immediate support is now placed at 8,300 and below that, the index may again slip towards 8,000 levels.

The volatility index India VIX fell for the third consecutive session and it ended near 71 levels; now it has to fall below 50 levels to give comfort to the bulls.

Bank Nifty underperformed Nifty in the previous week and remained under pressure. The immediate resistance is placed at 22,500 levels. Immediate support is pegged at 18,600 and below that, it may drift to 17,500 levels.

Here are three stock recommendations for the next 3-4 weeks:

Tata Consultancy Services (TCS) | Buy | LTP: 1,850 | Target price: Rs 1,900-1,950 | Stop loss: Rs 1,770 | Upside: 5%

The stock has provided a breakout from its symmetrical triangle pattern on the intraday chart.

The MACD has also provided fresh buy crossover on the daily chart. Now, it seems like the stock may attempt to fill the gap which is placed at Rs 1,900 levels in the short-term.

Coal India | Buy | LTP: 131.15 | Target price: Rs 139 | Stop loss: Rs 125 | Upside: 6%

The stock seems to be forming a base and is on the verge of a breakout from its rectangle pattern on the intraday chart which is placed at Rs 134 levels.

Above that, a sharp move could be seen towards Rs 144 levels.

The momentum indicator RSI has also reversed from the oversold territory which indicates positive momentum in the stock.

TVS Motor Company | Sell | LTP: Rs 304 | Target price: Rs 285 | Stop loss: Rs 316 | Downside: 6%

The stock has provided breakdown from a rounding top pattern and also making lower high and lower low formation on the weekly scale.

The momentum oscillator MACD is very well in sell mode on the weekly chart.​

(The author is derivative analyst- Equity Research, Anand Rathi Share and Stock Brokers)

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-heres-why-tcs-and-coal-india-are-short-term-buys-5082411.html
13,"March 27, 2020 10:17 AM IST",2,Sandip Das,Aurobindo Pharma share price jumps 11% after US FDA nod for muscle relaxant,"The share price of Aurobindo Pharma spiked over 11 percent in the morning trade on March 27 after the company received the US drug regulator’s nod for its muscle relaxant Tizanidine Hydrochloride.
The stock hit upper circuit of Rs 397.50 per share.
It was quoting at Rs 399, up Rs 37.60, or 10.40 percent.
Its API manufacturing facility at Gaddapotharam, Hyderabad, had received the establishment inspection report (EIR) with voluntary action initiated status from US Food and Drug Administration, the company told the exchanges the previous day.
On November 6 2019, the company, in a regulatory filing, said the FDA had inspected its Unit VIII at Gaddapotharam and was issued a 'Form 483' with 4 observations for the facility.","The stock hit upper circuit of Rs 397.50 per share. It was quoting at Rs 399.00, up Rs 37.60, or 10.40 percent.","The share price of Aurobindo Pharma spiked over 11 percent in the morning trade on March 27 after the company received the US drug regulator’s nod for its muscle relaxant Tizanidine Hydrochloride.

The stock hit upper circuit of Rs 397.50 per share. It was quoting at Rs 399, up Rs 37.60, or 10.40 percent.

Its API manufacturing facility at Gaddapotharam, Hyderabad, had received the establishment inspection report (EIR) with voluntary action initiated status from US Food and Drug Administration, the company told the exchanges the previous day.

On November 6 2019, the company, in a regulatory filing, said the FDA had inspected its Unit VIII at Gaddapotharam and was issued a 'Form 483' with 4 observations for the facility.

The stock, which has gained over 21 percent in the last three days, was trading with volumes of 61,891 shares, compared with its five-day average of 167,349, a decrease of 63.02 percent.",https://www.moneycontrol.com/news/business/markets/aurobindo-pharma-share-price-jumps-11-after-us-fda-nod-for-muscle-relaxant-5078801.html
14,"March 29, 2020 04:15 PM IST",-1,Kshitij Anand,"For the time being, 7,511 can be taken as a bottom in the intermediate-term: Umesh Mehta","It can close in positive since the markets are deep in the oversold zone, but for the time being, 7,511 can be taken as a bottom in the intermediate-term, Umesh Mehta, Head of Research, Samco Securities, said in an interview with Moneycontrol’s Kshitij Anand.
A) In October 2008 when the US Fed had announced a stimulus package, markets rebounded for some time, but thereafter the slide continued.
Q) After registering a series on series fall of more than 25 percent in March, what is the sense you are getting for the April series.
A) April series will be positive given that markets will try and bounce back from oversold levels.
It can close in positive since the markets are deep in the oversold zone, but for the time being, 7,511 can be taken as a bottom in the intermediate-term.","April may turn out to be a sucker rally where the fence-sitters will be pulled in. We will see some amount of price stabilizing but a major rally to go past 10,000 on the Nifty is less likely.","April will most likely be a ""wait and watch"" period. It can close in positive since the markets are deep in the oversold zone, but for the time being, 7,511 can be taken as a bottom in the intermediate-term, Umesh Mehta, Head of Research, Samco Securities, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Q) It was a volatile week for Indian markets, but the good part is we managed to bounce back from 7,511 thanks to the various fiscal measures taken by the government and authorities around the world. What is your take on the market action?

A) In October 2008 when the US Fed had announced a stimulus package, markets rebounded for some time, but thereafter the slide continued. Price destruction was lesser post the stimulus package.

Time-wise it took another 5 months for the market to really begin the bull run. The current actions across the world including lockdowns, stimulus packages, fiscal & monetary incentives will help markets stabilise, but it will take time for markets to enter a new bull orbit. Substantial price correction may not happen, but time correction may happen.

Q) After registering a series on series fall of more than 25 percent in March, what is the sense you are getting for the April series. Do you think we could hopefully close in the positive – what does the data suggest and any stocks which investors should watch/avoid? Have we made a bottom around 7511?

A) April series will be positive given that markets will try and bounce back from oversold levels. As such the lockdown effect will be felt in months to come.

April will most likely be a ""wait and watch"" period. It can close in positive since the markets are deep in the oversold zone, but for the time being, 7,511 can be taken as a bottom in the intermediate-term.

A) The package announced by the government addressed the bottom of the pyramid i.e. 20 percent economic interest; however, 80 percent of the economic interest has not been touched upon.

It is here where the slowdown will have an impact, least to say RBI has only allowed postponement of interest/ loan repayment by 3 months, nonetheless, they will have to be paid.

Therefore, as such government in the name of welfare policies has helped the weaker economic population, but MSMEs, entrepreneurs, businessmen - large & small, organized workforce are left on their own.

A) April may turn out to be a sucker’s rally where the fence-sitters will be pulled in. We will see some amount of price stabilizing but a major rally to go past 10,000 on the Nifty is less likely.

A) As such announcements will not have a direct impact on companies, but the Financials sector will get respite.

The RBI has in a way relaxed conditions for NPAs, therefore financials space will stabilize going forward. We would wait for some more time to assess the actual impact of Coronavirus on businesses before suggesting particular stocks for long term investment.

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/for-the-time-being-7511-can-be-taken-as-a-bottom-in-the-intermediate-term-umesh-mehta-5084291.html
15,"March 27, 2020 03:51 PM IST",1,Kshitij Anand,Experts feel the next round of package could be for the industry,"The relief package is just one of the measures which the government has deployed to cushion the economic impact, but it may not be enough, fear experts.
This is a package for lockdown impacted segments,” Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services told Moneycontrol.
Experts feel that the next round of packages could be for the industry and especially for the sectors such as banks, consumption, hospitality, auto, durables, agriculture, and healthcare.
We spoke to various experts on expectations of the package which could be announced for the industry.
License renewal expansion could also be the kind of Stimulus package.","Experts feel that the next round of packages could be for the industry and especially for the sectors such as banks, consumption, hospitality, auto, durables, agriculture, and healthcare.","Just 36 hours after the 21-Day lockdown was announced, the government unveiled a slew of measures to support the underprivileged section of the society to the tune of Rs 1.7 lakh cr, but experts feel that the second round of package for the industry could be in the offing.

COVID-19 outbreak across the world has disrupted economic activity across the world. The relief package is just one of the measures which the government has deployed to cushion the economic impact, but it may not be enough, fear experts.

Apart from the package which was announced on Thursday, there is a desperate need to support industries like manufacturing, tourism, aviation as well as automobiles. The total cost of the stimulus, including the one which was announced on Thursday, could well be in the range of 1-2 percent of GDP, suggest experts.

The Rs 1.7 lakh cr relief package announced under the ‘Gareeb Kalyan Scheme’ is targeted at the most vulnerable sections of the society to support them with food as well as direct cash transfers as the economy takes a halt in the 21-Days lockdown for a period of 3-months.

Also read: Food for poor, cash for needy: 10 key announcements by FM Nirmala Sitharaman

“Comprehensive package for the poor and vulnerable. The focus is ""nobody should go hungry.” No announcements for stimulating the economy. Perhaps later. This is a package for lockdown impacted segments,” Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services told Moneycontrol.

“Regarding relief to MSMEs etc the FM said ""we will look into it. "" So industry-specific measures likely to be announced in the next package. The govt is prioritising. This can go a long way in implementing the lockdown,” he said.

Experts feel that the next round of packages could be for the industry and especially for the sectors such as banks, consumption, hospitality, auto, durables, agriculture, and healthcare.

“A package from the government has to address three broad areas (1) protecting livelihoods, (2) protecting businesses, and (3) strengthening the healthcare infrastructure for COVID-19. To this end, the government needs to provide for viability of businesses and employees which will be at the highest risk from social distancing and lockdown such as hotel, restaurants, transport, entertainment, etc.,” Suvodeep Rakshit, Vice President & Sr. Economist, Kotak Institutional Equities told Moneycontrol.

“The support to these segments could be in the form of cheap credit lines, regulatory/financial forbearance, tax benefits, direct cash transfers, and income supports,” he said.

Rakshit further added that while the cost will depend on the extent and depth of the program as well as the expected time period of a hard lockdown, we pencil in around 2.0-2.5% of GDP as the probable stimulus size that the government may have to look at.

We spoke to various experts on expectations of the package which could be announced for the industry. Here’s what they have to say:

Expert: Vinod Nair, Head of Research at Geojit Financial Services

The package should have direct cash transfer to daily workers, unorganized and farm sectors. The idea should be to restrict job losses in the country, and provide relief to the highly hit sectors and encourage the health segment to handle the COVID-19 issue.

Ease measures is also expected for Banks to manage the risk of an increase in NPA. The size of the package could be about 1% of India’s GDP which could be about $30bn, Rs2trn in INR.

Expert: Asutosh Mishra, Head of Research - Institutional Equity, Ashika Stock Broking

We expect stimulus package to primarily address income loss of urban workforce by giving direct cash transfer, free gas cylinders, interest subvention on selected personal loans and higher spending on the healthcare and pharma sector.

Apart from that, we expect a comprehensive package for airlines, hospitality, tourism sectors and export segments, which are worst impacted by the COVID-19 outbreak. Given the level of disruption, we expect a package to be approx 1-1.5% of the nominal GDP.

Expert: Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

We need to spend money on medical supplies, ventilators, masks and getting protective equipment for medical workers quickly. People are going to lose jobs not only in rural areas but in urban areas also.

In terms of sectors, the government should provide stimulus package for the most impacted ones like Hotels & Hospitality, Tourism, Aviation, Automobile, as these are major employment contributing sectors for the Indian economy and these are some of the worst-affected sectors due to travel bans, social distancing, and suspension of business activities.

As these sectors are having huge debts as well so a loan restructuring scheme could be announced. Apart from this government may allow them for delayed bills payments. License renewal expansion could also be the kind of Stimulus package.

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/experts-feel-the-next-round-of-package-could-be-for-the-industry-5075181.html
16,"March 28, 2020 08:34 AM IST",2,Kshitij Anand,"'Bulls could return on D-Street if Nifty crosses above 10,000 in April series'","But if the situation further deteriorates from here then the market will again adjust itself in the downside.
We can say that the April series is going to be very choppy with moves on both sides, unlike March series where the market has fallen vertically.
Some public sector utility (PSU) stocks are also looking very attractive as their current dividend yield is much higher than the risk-free rate of return.
If Nifty manages to cross 10,000 levels then we can say that the bear market has been over and it is the start of a fresh bull market.
Hindustan Unilever, ITC, Dabur, Colgate Palmolive, and Nestle are some stocks that could do well if the market sees any kind of strength.","If Nifty can come above 10,000 levels if the situations in front of COVID-19 improves from here because valuations are very attractive at current levels.","Q. A volatile week for Indian markets! But, the good part is that we bounced back from the swing low of 7,511 – thanks to measures taken by the US Fed as well as our own government to help the economy and citizens in these tough times. What is your take on the market action?

A. A roller coaster ride from the last weekend ended almost on a flat note where the week begins with a black Monday but then the market formed a near term bottom at 7,511 levels for a very strong pullback rally which paused after the exact move of 20 percent.

The major problem of the coronavirus (COVID-19) is still persisting where the current bear market rally was on the back of major stimulus announced in the United States and India, therefore, a real test of this rally will be in the next week.

The real test of the low will happen in the coming week as major announcements have already happened, and now the trend in new cases of COVID-19 will dictate the next trend of the market from here.

A. It is very tough to make a call for April series after a brutal fall in March series because there are still lots of uncertainty about COVID-19 where the market has discounted almost worst-case scenario including a lockdown of 21-days. But if the situation further deteriorates from here then the market will again adjust itself in the downside.

We can say that the April series is going to be very choppy with moves on both sides, unlike March series where the market has fallen vertically.

If we see some improvement in the curve of new cases of COVID-19 especially in the US and India then we can say that 7,511 is a bottom for the market otherwise one more move on the downside cannot be ruled out.

In terms of stocks -- healthcare and pharma stocks are looking very lucrative because they will have face any major impact of the lockdown while governments around the world will come with a higher budget for the healthcare sector in the future.

Some public sector utility (PSU) stocks are also looking very attractive as their current dividend yield is much higher than the risk-free rate of return.

A. The government came out with a relief package for the poor while it may come out with a stimulus package for the economy in the future.

If we talk about RBI’s measures then we can say that these measures will definitely help in the stability of the financial system and it will also help the financial sector to deal with any liquidity problem.

All measures will be helpful for the economy but the situation of COVID-19 should not deteriorate from here otherwise things will become tough for the overall economy.

A. As I said it is tough to make a call about April month but Nifty definitely can come above 10,000 levels if the situations in front of COVID-19 improves from here because valuations are very attractive at current levels.

If Nifty manages to cross 10,000 levels then we can say that the bear market has been over and it is the start of a fresh bull market.

A. If we talk about recent announcements then it is clear that government is caring about the poor. Hand-outs to the lowest sections of society may result in higher off-take of consumer staples, therefore, FMCG is the sector which may outperform the market as it is also comparatively less impacted by lockdown in the country.

Hindustan Unilever, ITC, Dabur, Colgate Palmolive, and Nestle are some stocks that could do well if the market sees any kind of strength.

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/bulls-could-return-on-d-street-if-nifty-crosses-above-10000-in-april-series-5081261.html
17,"March 28, 2020 04:37 PM IST",-1,Jocelyn Fernandes,Coronavirus pandemic | I became a disciplined investor over 40 years; the virus broke me in 40 days,"That Friday, March 13, stock markets staged a late-afternoon rally as Trump promised new measures to contain the virus and shore up the economy.
The most recent bear market, which started in 2007, lasted 17 months.
I take heart from this: During that previous bear market, the S&P was never down more than 50% from its 2007 peak.
Even in the Great Depression, the worst bear market ever, the S&P dropped 86%.
Some of the biggest rallies have come in the middle of the worst bear markets.","I've owned stocks for nearly 40 years. I've lived through, survived and even prospered through four crashes. So I should be prepared. Yet, looking back at the last few weeks, I recognize that I've violated most of my time-tested rules","James B. Stewart

It’s Thursday morning, March 19 — four weeks into the coronavirus crash of 2020. The Dow Jones industrial average has opened down another 700 points, after plunging below 20,000 a day before. It’s down 30% in a month, the steepest drop ever, even worse than during the Great Depression.

The fall has been nauseating. Yet I know this is a time to be buying stocks based on rules I’ve developed over decades of investing. But in order to do that, I have to log on to my brokerage account. When I do, the first number I’ll see is the current market value of my portfolio.

Isolated at a farmhouse in rural New York, surrounded by wilderness, I haven’t looked in days. I don’t want to look now.

I decide I’d better check the weather forecast instead. And then there’s email to catch up on. An hour later, I’ve done nothing.

I’m paralyzed.

I’ve owned stocks for nearly 40 years. I’ve lived through, survived and even prospered through four crashes.

So I should be prepared. Yet, looking back at the last few weeks, I recognize that I’ve violated most of my time-tested rules. Whipsawed between optimism and despair as the bad news mounted and my daily life was upended, I’ve let emotions influence my decisions. I’m doing it again this morning.

An Unfathomable Fall

I first bought a stock mutual fund during the summer of 1982, as soon as I’d saved enough money to invest. My father, a Cadillac-driving sales manager for NBC’s local TV and radio affiliates, had been an avid believer in the stock market, and he’d drummed his faith into me.

It turned out that 1982 was a great year to buy, not that I realized it at the time. For years, I enjoyed the positive reinforcement of a steadily rising market. I loved looking up my mutual fund in the newspaper stock tables. Over the next five years the market tripled.

On Oct. 19, 1987, I was visiting my brother, who was spending a semester in France. When I left my hotel in Strasbourg early the next morning, I noticed the front pages on newsstands carried banner headlines reporting the Dow had dropped “23.” I wondered why the U.S. market was front-page news in France. I looked more closely and saw the 23 preceded a percentage symbol. The Dow had dropped an unfathomable 508 points in one day. On a percentage basis, it was the stock market’s worst day ever.

I felt a powerful urge to salvage what was left of my modest savings by selling. But I was far away and had no choice but to hold.

Once I was back in the United States, the market seemed to stabilize. But volatility soon returned. In one of those downdrafts, I panicked and sold my entire fund.

By September 1989, the market had recovered all its losses. I watched from the sidelines, waiting in vain for a good time to get back in.

I vowed to never again trade in a panic. I made a rule — never sell on a down day — and a corollary: Never buy on an up day.

That served me well over the next decade’s record bull market, fueled by the tech boom. Times were even headier than during the 1980s. I often overheard personal trainers at the gym boasting about their favorite tech stocks.

The notion of diversification was largely unknown to me. In early 2000, when the tech bubble burst and the next crash came, I was fully invested and stayed that way. I watched as the value of my investments shriveled. I stopped looking at stock tables, which at least provided some psychological comfort. I dropped my monthly paper statements into the trash unopened.

But at least I adhered to my 1987 principle: I did not sell.

In the wake of the two-year bear market, I refined my strategy. I figured that if I bought every time the market average declined by 10% from its previous high — the standard definition of a correction — and then bought some more after each subsequent decline of 10%, then I’d never be buying at the top of the cycle.

I didn’t think of this as market timing since I made no prediction where the market was headed. My strategy was a variation of the now widespread practice of portfolio rebalancing — selling some asset classes and buying others to maintain a steady allocation.

I put this system into practice during the 2008 financial crisis. I recall shocked reactions that October when — with the market plunging and others boasting that they’d had the foresight to get out — I said I was buying.

What’s Another Virus Scare?

There have been only five 10% corrections since then, and each was a buying opportunity for me. None was followed by a second 10% decline. The last of these corrections came at the end of 2018. As cash built up in my account, I wondered when, if ever, I’d get another such opportunity. I grew impatient. On Feb. 19, the S&P 500 closed at a record high. No one seemed to see a bear market or recession on the horizon, even as stock multiples teetered at record highs and a strange virus began to spread.

Until a week later.

Stocks fell, slowly at first, then gaining steam. By Feb. 25 the S&P 500 had dropped 7.6% from its peak.

So I bought stock (a broad-based index fund) on Feb. 25, jumping the gun on my own 10% buying target. My pent-up eagerness and optimism overwhelmed my disciplined strategy. I didn’t make a conscious decision to violate it. I didn’t even think about it in my haste to take advantage of what I assumed would be a fleeting opportunity.

Stocks dropped a little more the next day. Then, on Feb. 27, the S&P plunged nearly 5%. Now the market was officially in a correction, its fastest ever, down 12% from the peak the prior week. The coronavirus had spread globally, including to the United States.

I realized I should have waited. I felt foolish and guilty for violating my rules. I vowed not to do it again.

The Biggest Drop Since Black Monday

But how smart I felt the next Monday. The S&P soared nearly 5%, amid rumors the Federal Reserve was about to cut interest rates.

The high was short-lived. By the end of the week, the S&P had erased Monday’s gains. By now I was worried, too, but I’m not an infectious disease expert. I figured stocks had priced in the risks. What I did know was that they were now deep into a correction, and so I bought more.

My buying may have been premature the first time, but now I was back on track, sticking to my playbook. At a time of soaring uncertainty on so many fronts, I felt like I was taking charge of my destiny.

That was the last time that buying stocks felt good, like I was pouncing on a fleeting opportunity. It soon became a source of profound anxiety.

Over the first weekend in March, headlines were all about the explosive spread of the virus in Italy. Photos of deserted piazzas drove home the gravity of the situation. What had seemed a distant threat now seemed close to home.

If that weren’t bad enough, Russia and Saudi Arabia decided to launch an oil price war just as demand was collapsing. Oil prices plummeted, dragging down the entire energy sector.

I expected it would be a bad Monday in the markets, but it was even worse. Circuit breakers kicked in to halt chaotic trading. The S&P closed down that day by 7%, the biggest drop since Black Monday in 1987.

I summoned the nerve to look at my brokerage account. I was shocked: The stock portion was down far more than the broad U.S. market averages. My international stock index fund was down 20% from its February peak, and the emerging markets fund had lost one-quarter of its value.

On Thursday, March 12, after President Donald Trump banned most air travel between the United States and continental Europe and after economies around the world started shutting down, the carnage in the stock market was even worse than Monday. The S&P dropped 10%, leaving it 27% below its peak a few weeks earlier.

According to my own rules, it was time to buy.

I hardly noticed. I was busy canceling a planned vacation the next week to the Virgin Islands. I began pondering the prospect of my own isolation, something that even a few days earlier had seemed unthinkable.

Worse, a friend in Spain, a healthy 40-year-old I had just visited in November, had fallen seriously ill with the virus. He was in a coma in a Madrid hospital.

Still, during the following days, when I pondered the rush of events during some long walks along a country road, I recognized I was running out of excuses for inaction. I knew I should be buying again, with the S&P remaining well below my 20% target. But trading was more volatile than anything I’d ever witnessed. The S&P logged a record seven straight days of swings of 4% or more.

That Friday, March 13, stock markets staged a late-afternoon rally as Trump promised new measures to contain the virus and shore up the economy. The S&P 500 closed almost exactly 20% below its peak. Still I did nothing.

It was just as well. On Monday, the market collapsed, erasing all of Friday’s gains. The Dow fell below the 20,000 milestone for the first time in three years. Markets were now down 30%. It was time for me to buy.

Having skipped the 20% buying “opportunity,” I knew it was time to step up. But I wasn’t going to do it on a day the markets had been in free fall. And in any event, I was back to avoiding my brokerage’s website.

The next day the stock market jumped higher. I felt a strong temptation to buy, gripped by the notion that the worst might be over. I worried I was missing the bottom by again failing to act on my strategy. But the 30% window had closed, and I reminded myself that my rule is never to buy on an up day.

The next day brought what seemed like good news: New infections in China had dropped to zero. Even so, that morning markets sank, again triggering my 30% buying target. This time I was determined to act.

And yet I dawdled. I checked the news, the weather, my emails. I told myself this was absurd. Whether I looked or not, my portfolio value was what it was.

So I looked. It was bad but not nearly the shock of the last time (perhaps because percentage declines now translated to lower dollar amounts). I still had ample cash on hand as interest and dividends had accumulated over recent years.

So I stepped in and bought.

I won’t say I felt euphoric, but I felt better than I had in weeks, at least about my personal finances. I’d mustered the courage to face the truth, however grim. I’d acted according to a plan. I had more cash if needed for the next 10% decline.

My renewed confidence survived the next downdraft, which came the very next day.

The Market Soared. I Felt No Elation.

Nothing I experienced in the past prepared me for the speed of this market crash. The decline after stocks peaked in March 2000 lasted until October 2002 — 2 1/2 years. The most recent bear market, which started in 2007, lasted 17 months. Nobody knows how long this bear market will last.

I take heart from this: During that previous bear market, the S&P was never down more than 50% from its 2007 peak. Even in the Great Depression, the worst bear market ever, the S&P dropped 86%. Small comfort, perhaps, but it never went to zero. And after those steep drops, the market not only recovered but eventually went on to record highs.

This week brought some good news. My friend in Spain emerged from his coma. Doctors say his recovery will be slow, but they’re optimistic.

On Tuesday the market soared, followed by two more days of gains. This time I felt no elation. Some of the biggest rallies have come in the middle of the worst bear markets.

My next target is when the S&P falls 40% from its peak. I may be buying again soon.

c.2020 The New York Times Company",https://www.moneycontrol.com/news/business/markets/coronavirus-pandemic-i-became-a-disciplined-investor-over-40-years-the-virus-broke-me-in-40-days-5083151.html
18,"March 27, 2020 10:55 AM IST",2,Sunil Matkar,"Finolex, V-Guard among 4 midcap bets by Jefferies","Global brokerage house Jefferies has upgraded Finolex Cables to buy on favourable valuation and strong balance sheet, but cut price target to Rs 500 from Rs 765 per share.
Its other top midcap picks are Supreme Industries, V-Guard Industries, and Kajaria Ceramics.
It has a buy call on all these stocks but slashed targets to Rs 1,260 (from Rs 1,530), Rs 240 (from Rs 290) and Rs 530 (from Rs 775), respectively.
The reason behind the cut in price target is that earnings are expected to take a hit by lockdown due to novel coronavirus.
""We see a tepid first half of FY21 with maximum impact in Q1 due to lockdown,"" said Jefferies which cut FY21/22 EPS estimates by 12-20 percent.",The reason behind cut in price target is that earnings are expected to get impacted by lockdown due to novel coronavirus.,"Global brokerage house Jefferies has upgraded Finolex Cables to buy on favourable valuation and strong balance sheet, but cut price target to Rs 500 from Rs 765 per share.

Its other top midcap picks are Supreme Industries, V-Guard Industries, and Kajaria Ceramics. It has a buy call on all these stocks but slashed targets to Rs 1,260 (from Rs 1,530), Rs 240 (from Rs 290) and Rs 530 (from Rs 775), respectively.

The reason behind the cut in price target is that earnings are expected to take a hit by lockdown due to novel coronavirus.

""We see a tepid first half of FY21 with maximum impact in Q1 due to lockdown,"" said Jefferies which cut FY21/22 EPS estimates by 12-20 percent.

The Nifty Midcap index and benchmark Nifty50 corrected more than 35 percent from highs seen in 2020 due to rising concerns with respect to COVID-19.

Coronavirus already infected more than 700 people in India with 13 deaths so far, while the worldwide infected cases jumped over 5 lakh mark with 24,000 deaths, reports CNBC.

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/finolex-v-guard-among-4-midcap-bets-by-jefferies-5078911.html
19,"March 28, 2020 07:59 AM IST",-2,Kshitij Anand,Can't handle volatility? You might regret your decision of panic exit in medium term,"The Volatility Index or India VIX (a widely followed fear gauge) exceeded the level last reached at the peak of the Global Financial Crisis in November 2008.
So the panic in the markets has reached a peak.
A problem with assessing damage from the current crisis is that it is not an event but a fast-evolving condition.
An exit in a panic now will likely lead to regret from a medium-term perspective.
The most prudent and rational course of action is to use the current prices to start investing (given a good risk-reward available) but to do so gradually over a period of time.","While negative emotions are running high, we believe this is perhaps the worst time to exit/redeem equities. An exit in a panic now will likely lead to regret from a medium-term perspective.","Harshad Patwardhan

The past month was brutal for the Indian equity markets. The Nifty50 collapsed over 30 percent, making it one of the worst monthly performances ever.

The markets appear to be gripped by extreme panic. The Volatility Index or India VIX (a widely followed fear gauge) exceeded the level last reached at the peak of the Global Financial Crisis in November 2008.

So the panic in the markets has reached a peak. But, is the situation today as bad as what was experienced in 2008?

A problem with assessing damage from the current crisis is that it is not an event but a fast-evolving condition. It will impact both demand as well as supply and it is hard to fathom its extent and duration- leading to fear of the unknown.

Often, when we are in the middle of a crisis; it is easy to overlook the effect of countervailing forces that are unleashed by the policymakers.

We are beginning to see a coordinated monetary and fiscal action by the central bank and the governments. While the Indian markets seem to have shrugged off these measures so far, we believe policymakers are in the mood to do whatever it takes to stabilise the situation.

With so much of negativity, it is also easy to overlook the two positives that have emerged. Firstly, oil prices have collapsed. This is a huge positive for India. It is good for the current account, fiscal balance, inflation and interest rates.

Most importantly, it gives the government much-needed headroom to do targeted spending to tide over the current situation.

Secondly, with a sharp downturn in stock prices, valuations are getting attractive, even compelling in some cases.

Overall, the Nifty for a long time was trading at a premium to long-term trading averages, and is now available at a discount, even after accounting for a potential cut in an earnings forecast.

So, what should investors do? Here is what we think:

While negative emotions are running high, we believe this is perhaps the worst time to exit/redeem equities. An exit in a panic now will likely lead to regret from a medium-term perspective.

While prices have fallen off the cliff, we would caution that it is also risky to invest all your investible surplus at one go. The crisis is far from over and we do not know where the bottom is.

The most prudent and rational course of action is to use the current prices to start investing (given a good risk-reward available) but to do so gradually over a period of time.

The author is CIO, Equities, Edelweiss AMC

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/cant-handle-volatility-you-might-regret-your-decision-of-panic-exit-in-medium-term-5081131.html
20,"March 27, 2020 08:47 AM IST",0,Sandip Das,"Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term","Sensex closed the day 1,411 points, or 4.94 percent, at 29,946.77, while Nifty ended 324 points, or 3.89 percent, up at 8,641.45.
According to the pivot charts, the key support level is placed at 8,381.22, followed by 8,120.98.
If the index continues moving upward, key resistance levels to watch out for are 8,825.37 and 9,009.28.
The important pivot level, which will act as crucial support for the index, is placed at 18,515.84, followed by 17,417.77.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​","Mitesh Thakkar of miteshthakkar.com recommends buying Ashok Leyland with a stop loss of Rs 41.5, target at Rs 45 and Bharat Forge with a stop loss of Rs 279, target at Rs 294.","The Finance Minister announced an economic package worth Rs 1.7 lakh crore under the 'Prime Minister Gareeb Kalyan Scheme' with an aim to protect the poor from the economic fallout of the lockdown.

Sensex closed the day 1,411 points, or 4.94 percent, at 29,946.77, while Nifty ended 324 points, or 3.89 percent, up at 8,641.45.

According to the pivot charts, the key support level is placed at 8,381.22, followed by 8,120.98. If the index continues moving upward, key resistance levels to watch out for are 8,825.37 and 9,009.28.

The Nifty Bank index closed at 19,613.90, up 6.13 percent. The important pivot level, which will act as crucial support for the index, is placed at 18,515.84, followed by 17,417.77. On the upside, key resistance levels are placed at 20,560.64 and 21,507.37.

In an interview to CNBC-TV18, top market experts recommend which stocks to bet on for good returns:

Ashwani Gujral of ashwanigujral.com

Buy Bajaj Auto with a stop loss of Rs 2,075, target at Rs 2,200

Buy L&T with a stop loss of Rs 830, target at Rs 855

Buy ICICI Bank with a stop loss of Rs 320, target at Rs 345

Buy HDFC Bank with a stop loss of Rs 875, target at Rs 950

Buy Ashok Leyland with a stop loss of Rs 38, target at Rs 50

Mitesh Thakkar of miteshthakkar.com

Buy Ashok Leyland with a stop loss of Rs 41.5, target at Rs 45

Buy Bharat Forge with a stop loss of Rs 279, target at Rs 294

Buy ITC with a stop loss of Rs 153, target at Rs 165

Buy ONGC with a stop loss of Rs 63.4, target at Rs 68

Prakash Gaba of prakashgaba.com

Buy Ashok Leyland with a stop loss of Rs 40, target of Rs 55

Buy Dabur with a stop loss of Rs 420, target of Rs 460

Sell Divi's Labs with a stop loss of Rs 1,920, target of Rs 1,800

Sell HPCL with a stop loss of Rs 182, target of Rs 165

The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/top-buy-and-sell-ideas-by-ashwani-gujral-mitesh-thakkar-prakash-gaba-for-short-term-19-5077831.html
22,"March 28, 2020 07:44 AM IST",2,Nishant Kumar,Kotak advises accumulating these 10 large-cap stocks amid virus-led uncertainty,"Take a look:ICICI Bank | BuyAs per Kotak, the company has seen no major signs of stress in any other retail segment.
Kotak has retained its fair value of Rs 10,200 for Bajaj Finserv.
Bajaj Finance, valued at its RGM-based fair value, adds 74 percent to the SoTP.
We remain buyers; fair Value revised to Rs 300 per share,"" Kotak said.
""These two changes, plus rollover, drive an increase in fair value estimate to Rs 1,475,"" said Kotak.","The gains of the last two consecutive sessions have given bulls some support. However, experts say the market will see a sustained rise only if the cases of coronavirus show a continuous decline going forward.","COVID-19 has shaken the market worldwide. Investor sentiment is unusually low as experts fear the economic impact of the lockdown and widespread coronavirus.

Global brokerage JP Morgan expects about 60 percent of the GDP to be significantly hit by the lockdown.

Deutsche Bank thinks India's GDP growth will collapse in April-June and maybe a negative print of 5 percent year-on-year (YoY) or even more. It said there is a possibility that the July-September real GDP will also be negative.

The gains of the last two consecutive sessions have given bulls some support. However, experts say the market will see a sustained rise only if the cases of coronavirus show a continuous decline going forward.

""The rally was driven by expectations of stimulus measures to support the respective economies and not because of any change in ground realities. A much more stable rally can happen only after any news regarding the virus containment comes in,"" said Vinod Nair, Head of Research at Geojit Financial Services.

During times of uncertainty, have a prudent approach in stock picking. A well-calculated move will maximise the chances of gains and minimise the risk if one has a long-term approach, say experts.

Brokerage firm Kotak Securities suggests following 10 large-cap stocks for accumulation. Take a look:

ICICI Bank | Buy

As per Kotak, the company has seen no major signs of stress in any other retail segment. Corporate slippages of Rs 2,470 crore (nearly 4.2 percent of corporate loans) were mainly from outside the ‘BB and below’ book (nearly 70 percent of corporate slippages) and were largely driven by stockbroking account (fully provided during the quarter) and a South India-based industrial account.

The estimates of Kotak shows ICICI Bank's net NPL may reduce to about 1 percent by FY22E with slippages of nearly 1.7 percent in FY21-22E. Loan growth may improve to nearly 17 percent by FY21-22E while it expects CASA CAGR of nearly 13 percent over FY19-22E and stable CASA ratio of nearly 46 percent. Calculated NIM may stand at nearly 3.6 percent over FY20-22E.

Kotak believes ICICI bank's RoE is well-positioned for nearly 15 percent or even more in medium term. They have a positive value and value the bank at Rs 615 implying 2.4 times book and 15 times December FY21 EPS.

Bajaj Finserv | Add

With increasing share of protection business (6 percent of APE in FY2019) and non-par savings (18 percent of individual APE in Q3FY20, up from 4 percent in Q2FY19), VNB margins will likely expand, said Kotak.

Kotak has retained its fair value of Rs 10,200 for Bajaj Finserv. Bajaj Finance, valued at its RGM-based fair value, adds 74 percent to the SoTP. It values the general insurance business at 4.5 times book, similar to the valuation multiple assigned to ICICI Lombard. It values Bajaj Life at 1.5 times EV, significantly lower than its peers, as it expects its operating RoEV to remain at 11-12 times.

HDFC | Buy

Kotak believes HDFC's gross stage-3 loans will remain stable around about 1.5 percent over FY21-22E (up from 1.4 percent in FY19) with 49 percent coverage, 17 percent CAGR in AUM over FY21-22E, core NIM to increase to 2.6 percent in FY22E from about 2.4 percent in FY20E.

Moreover, Kotak expects HDFC to deliver 17 percent core earnings CAGR in FY20-22E on the back of 11 percent YoY growth in FY20E. At its fair value of Rs 2,680, HDFC will trade at 2.6 times core book December 2021E (juxtaposed to medium-term RoE of 19-20 percent even as near-term RoE may be lower).

HDFC Life Insurance Company | Add

In Q3FY20, HDFC Life reported a 25 percent growth in VNB on the back of 19 percent APE growth and moderate VNB expansion to 24.7 percent from 23.4 percent in Q3FY19.

HDFC Life remains a highly profitable life insurance company with about 20-21 percent operating RoEV and 20 percent EVOP CAGR during FY2019-22E; this is supported by VNB margins of nearly 26 percent.

Colgate Palmolive (India) | Add

Kotak highlighted that selective price hikes and favorable RM environment cushioned the impact of continued aggression on promotions.

""It is encouraging to note that Colgate has continued its brand investment in Q3FY120 where several of its peers pulled back sharply. Ad spend effectiveness remains low, however,"" Kotak said.

Lower revenue growth, as well as margin assumptions, drive a 6-7 percent cut in our FY20-22E EPS forecasts. ""We keep the faith and retain 'add' even as the street may now prefer waiting for evidence,"" said Kotak.

ITC | Buy

National Calamity Contingent Duty (NCCD) hikes in the Budget, different for different stick lengths implies a portfolio level weighted-average tax/stick increase of around 10 percent, Kotak said.

""Weak 9-months FY20 numbers, NCCD hikes and ability to protect volumes in a poor macro backdrop prompt us to lower our volume assumptions and now bake in a 5 percent EBIT growth for the cigarette business in FY21E versus 9.7 percent earlier,"" said Kotak.

""Valuations are cheap, especially on a relative basis, but unlikely to act as a trigger. We remain buyers; fair Value revised to Rs 300 per share,"" Kotak said.

Titan Company | Add

Even assuming Titan’s addressable market is around 50-60 percent of the total jewellery market in India, Titan’s share of the addressable market is in the 10-12 percent range, Kotak said.

After Q3FY20 results the company had maintained its guidance of 11-13 percent revenue growth for Q4FY20.

Kotak has now lowered the cost of equity assumption in its DCF by 50 bps to 10.75 percent and also taken up terminal growth rate assumption by 50 bps to 5.75 percent. ""These two changes, plus rollover, drive an increase in fair value estimate to Rs 1,475,"" said Kotak.

Cipla | Buy

Kotak highlighted that Cipla’s Goa facility had received a warning letter but its earnings impact is limited given limited new product dependence on Goa.

The impact of the warning letter is not material to FY21 earnings, considering that single source products from the facility account for less than 10 percent of US revenues (nearly 20 percent of US in total) and limited (single digit) approvals linked to the facility over the next 12-18 months.

Cipla management has been highlighting its renewed commitment to the domestic business, which accounts for more than 50 percent of EBITDA. Kotak believes the domestic business should grow in line or slightly higher than the market over the next few years.

Moreover, Kotak sees a strong US generics build-out over FY21-23, given Q4CY20 launch for ProVentil and Q4CY20 partner launch for CiproDex.

Kotak expects the momentum to continue in FY22/23 with potential launches of generic Advair (March 2019 filing) and Abraxane.

Reliance Industries (RIL) | Buy

RIL turned FCF positive for the first time since Q3FY13, with capex declining by 27 percent QoQ to Rs 14.020 crore.

Kotak reiterates a 'buy' notwithstanding a bleak downstream outlook, as the company may benefit meaningfully from plausible consolidation in telecom, the culmination of key transactions, rising FCF trajectory and sustained growth in the retail segment.

Kotak believes higher crude discounts, weaker rupee and potential hike in ARPUs may mitigate lower downstream margins.

Bharti Airtel | Buy

""Bharti is extremely well positioned to benefit from whatever direction industry dynamics take from hereon, in our view. From an execution standpoint, there is ample evidence to suggest that the company is now operating in top gear,"" said Kotak.

""Sharp run up in the past year or so notwithstanding, Bharti remains a solid multi-year compounding play as long as the company and R-Jio resist the alpha-male tendencies in the forthcoming spectrum auctions,"" Kotak added.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/kotak-advises-accumulating-these-10-large-cap-stocks-amid-virus-led-uncertainty-5073851.html
24,"March 29, 2020 03:11 PM IST",1,Sunil Matkar,Story in a charts: Cup & Handle pattern suggests buying opportunity in India Cements,"Shabbir KayyumiThe Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community.
In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal.
A Cup & Handle reversal pattern forms after a downtrend, and its completion marks a trend reversal to uptrend.
In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle.
Cup & Handle pattern and Buy signal on INDIACEM1.",Entire bullish view negates on breaching of Handle on closing basis and one should exit from long position.,"Shabbir Kayyumi

The Cup & Handle pattern is believed to be one of the most reliable and popular patterns among traders community.

In technical analysis, a Cup & Handle pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal. A Cup & Handle reversal pattern forms after a downtrend, and its completion marks a trend reversal to uptrend.

In the standard Cup & Handle pattern, we connect the high after Cup with the high created after the handle. A trend line is drawn by connecting these highest points of the two peaks, which is called as 'Neckline'. This trend line is the most important component of C & H pattern.

Why Buy India Cements?

C & H pattern is an integral part of technical analysis, but successful traders combine these techniques with technical indicators and other forms of technical analysis to maximise their odds of success.

India Cements has a strong resistance line standing around Rs 102 levels indicating strong bullish breakout only above these levels. The recent formation of Cup and Handle pattern will give a breakout on a close above Rs 102 mark which suggests buying in the stock for higher targets of Rs 122. Volume can also add further insight while trading these patterns. Decent volume participation while giving breakout is also giving support to C & H pattern.

Figure.1. Cup & Handle pattern and Buy signal on INDIACEM

1. A close above neckline (Rs 102) of Cup & Handle pattern is indicating a trend reversal.2. Short- term moving average 20 DMA (Rs 99.50), which defines short-term trend, is providing support to buyers as prices are sustained and trading above it.3. Mid- term moving average 50 DMA (Rs 96.15), which defines mid-term trend, augurs well with the bulls as prices are sustained and trading above it.

4. Decent volume participation while pattern breakout will also give additional confirmation.

Profit Booking

Target as per Cup & Handle pattern is calculated by adding the height of Cup to the neckline which comes to Rs 122, however one can book profits near previous swing high which is around Rs 120.

Stop Loss

Entire bullish view negates on breaching of Handle on a closing basis and one should exit from a long position. In the case of India Cements, it is placed around Rs 89 levels.

Conclusion

We recommend buying The India Cements above Rs 102 with a stop loss of Rs 89 for higher targets of Rs 122 as indicated in the above chart.

(The author is Head - Technical Research at Narnolia Financial Advisors.)

Disclosure: Narnolia Financial Advisors/Analyst (s) does/do not have any holding in the stocks discussed but these stocks may have been recommended to clients in the past. Clients of Narnolia Financial Advisors Ltd. may be holding aforesaid stocks. The stocks recommended are based on our analysis which is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/story-in-a-charts-cup-handle-pattern-suggests-buying-opportunity-in-india-cements-5084391.html